Publikationen/Publications (Journals/Book-Chapters/Books)

  • see NCBI (PubMed): https://www.ncbi.nlm.nih.gov/pubmed/?term=Burg+g
  • 456  Original Papers
  • 146 Review-Papers
  • 139 Book-Chapters
  • >30 Books (Author and/or Editor)

Original-Publications (Selection; complete chronologic list: see below)

 

·   

BURG G, BRAUN-FALCO O (1974):Qualitative und quantitative Aspekte der cellulären Reaktion in Haut und Blut bei Mycosis fungoides. Hautarzt 25: 178-187

BURG G, BRAUN-FALCO O (1975): Classification and Differentiation of Cutaneous Lymphomas. Enzyme-cytochemical and immunocytological studies. Br J Dermatol 93: 597-599

 

·      BURG G, ROBINS P (1972). Chemochirurgie. Chirurgische Entfernung chemisch fixierten Tumorgewebes mit mikroskopi­scher Kontrolle. Hautarzt 23: 16-20

 

·      BURG G, BRAUN-FALCO O (1977). 1-Chlor-2,4-dinitrobenzol (DNCB)-Salbe zur Sensibilisierung, Testung und Behandlung von Patienten mit malignem Melanom. Dtsch med Wschr 102: 210-211

 

·      BURG G, BRAUN-FALCO O, HOFFMANN-FEZER G, RODT H, SCHMOECKEL C (1978): Patterns of cutaneous lymphomas. Histological, Enzyme Cytochemical, and Immunological Typing of Lymphorecticular Proliferations in the Skin. Dermatologica 157: 282-291

 

·      BURG G, RODT H, GROSSE-WILDE H, BRAUN-FALCO O (1978): Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary's syndrome. J Invest Derm 70: 257-259

 

·      BURG G, HOFFMANN-FEZER G, NIKOLOWSKI J, SCHMOECKEL C, BRAUN-FALCO O, STÜNKEL L (1981): Lymphomatoid papulosis: A cutaneous T-cell pseudolymphoma. Acta Dermatovener (Stockholm) 61: 491-496

 

·      PRZYBILLA B, BURG G, THIEME CH (1983): Evaluation of the immune status in vivo by the 2,4-dinitro-1-chlorobenzene contact allergy time (DNCB-CAT). Dermatologica 167:1-5

 

·      KAUDEWITZ P, STEIN H, BURG G, MASON DY, BRAUN-FALCO O (1986): Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1. J Invest Dermatol 86:350-354

 

·      BURG G, ZOLLER W, STRASSNER C, DOSS M (1988): Erythrozytopherese zur Behandlung der Porphyria cutanea tarda. Hautarzt 39, S VIII: 300-302

 

·      BURG G, BURG D (1990): Das Bureau-Barrière-Syndrom. Phlebol Proktol 19:147-152

 

·      DUMMER R, SCHÄFER E, EILLES C, BÖRNER W, BURG G (1991): Lymphokine-activated killer-cell traffic in metastatic melanoma. Lancet 338:456-457

 

·      BURG G, DUMMER R, WILHELM M, NESTLE F, OTT MM, FELLER A, HEFNER H, LANZ U, SCHWINN A, WIEDE J (1991): A Subcutaneous Delta-Positive T-Cell Lymphoma That Produces Interferon Gamma, New Engl J Med 325:1078-1081

 

·      BURG G, DUMMER R, NESTLE FO, DOEBBELING U, HÄFFNER A (1996): Cutaneous Lymphomas Consist of a Spectrum of Nosologically Different Entities Including Mycosis Fungoides and Small Plaque Parapsoriasis. Arch Dermatol 132: 567 – 572

 

·      WOOD GS, HARDMAN DL, BÖNI R, DUMMER R, KIM Y-H, SMOLLER BR, TAKESHI­TA M, KIKUCHI M, BURG G (1996): Lack of the t (2;5) or Other Mutations Resulting in Expression of Anaplastic Lymphoma Kinase Catalytic Domain in CD30+ Primary Cutaneous Lymphoproliferative Disorders and Hodgkin’s Disease Blood (88) 5; 1765 – 1770

 

·      VILLENEUVE P, HAFNER J, PRENOSIL JE, ELSNER P, BURG G (1998): A novel culturing and grafting system for the treatment of leg ulcers. Br J Dermatol 138: 849 – 851

 

·      BURG G, KEMPF W, HÖCHLI M, HUWYLER T, PANIZZON RG (1998): "Tubular" epitheliod cell nevus: a new variant of Spitz's nevus. J Cutan Pathol 25: 475-478

 

·      BRÄUNINGER A, HANSMANN M-L, STRICKLER JG, DUMMER R, BURG G, RAJEWS­KY K, KÜPPERS R (1999): Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma. New England Journal of Medicine 340: 1239 – 1247

 

·      HESS SCHMID M, BIRD P, DUMMER R, KEMPF W, BURG G (1999): Tumor Burden Index as a Prognostic Tool for Cutaneous T-Cell Lymphoma. Arch Dermatol 135: 1204 – 1208

 

·      SCHMID-GRENDELMEIER P, MASENGA EJ, HAEFFNER A, BURG G (2000): Teledermatology as a new tool in sub-Saharan Africa: An experience from Tanzania. J Am Acad Dermatol 42: 833 – 835

 

·      BURG G, DUMMER R, HÄFFNER A, KEMPF W, KADIN M (2001): From Inflammation to Neoplasia. Mycosis fngoides evolves from reactive onflammatroy conditions (Lymphoid Infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol 137: 949 – 952

 

·      HEINZERLING L, DUMMER R, PAVLOVIC J, SCHULTZ J, BURG G, MOELLING K (2002): Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice. Experimental Dermatology 2002: 11: 232-240

 

·      BURG G, KEMPF W, KAZAKOV DV, DUMMER R, FROSCH PJ, LANGE-IONESCU S, NISHIKAWA T, KADIN ME (2003): Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature.British Journal of Dermatology 2003; 148: 580-586

 

LIU JY, HAFNER J, DRAGIEVA G, SEIFERT B, BURG G (2004): Autologous cultured keratinocytes on porcine gelatin microbeads effectively heal chronic leg ulcers. Wound Repair and Regeneration 2004; 12: 148-156
 
FEIT J., KEMPF W., JEDLICKOVA H., BURG G. (2005): Hypertext atlas of dermatopathology with expert system for epithelial tumors of the skin. Journal of Cutaneous Pathology 2005:32:433-437
 
BURG G, KEMPF W, COZZIO A, et al. (2005)
 
WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. Journal of Cutaneous Pathology 2005;32:647-674

 

·      WILLEMZE R, JAFFE E. S, BURG G, et al.  (2005).: WHO-EORTC classification for cutaneous lymphomas. Blood 105(10): 3768-85

Books (Author or Editor)

·      250 Fragen aus der Dermatologie : Mit Antworten u. Literaturhinw. Examina medica. Burg, Günter, Gerd Geißl und Günter Geißl Gerd Burg. München : J. F. Lehmann 1970.

·      Dermatochirurgie in Klinik und Praxis (Eds.: B. Konz und G. Burg) Springer 1977

·      Examens-Fragen Dermatologie : zum Gegenstandskatalog. G. Burg ; R. Kolz ; G. Lonsdorf. Springer, 1978

·      New Trends in Allergy. (Eds.: J. Ring and G. Burg). Springer 1981

·      Cutaneous Lymphomas, Pseudolymphomas and Related Disorders. G. Burg and O. Braun-Falco. Springer 1983

·      Fortschritte der praktischen Dermatologie und Venerologie: Vorträge der X. Fortbildungswoche der Dermatologischen Klinik und Poliklinik der ... Dermatologen e.V. vom 25.–29. Juli 1983, (Eds.: O. Braun-Falco and G. Burg)Springer1984 New Trends in Allergy II. (Eds.: J. Ring and G. Burg). Springer 1986

·      Dermatologie. Entwicklungen und Beziehungen zu anderen Fachgebieten. (Herrn Prof. Dr. med. Dr. h.c. mult. Otto Braun-Falco zum 65. Geburtstag gewidmet). Burg, Günter (Hrsg.). München./ Baltimore / Wien. Urban & Schwarzenberg,1988

  • ·      Leiber: Die klinischen Syndrome.Syndrome, Sequenzen und Symptomenkomplexe. - Hrsg. 7. Aufl: BURG G, KUNZE J, PONGRATZ D, SCHEURLEN PG, SCHINZEL A, SPRANGER J.; Urban & Schwarzenberg, München, Wien, Baltimore 1990

·      Der Ekzempatient in der Praxis. G. Burg, P. Elsner, A.A.Hartmann. de Gruyter 1990

·      Onkologische Dermatologie: Neue Aspekte Altersbedingte Besonderheiten (Fortschritte der operativen und onkologischen Dermatologie) (German Edition) (Eds.: G.Burg, A.A. Hartmann, B. Konz)– Springer, 1992

·      Das Melanom : Wissenswertes über Muttermal, Sonne und andere Risikofaktoren; Informationen und Ratschläge ; mit 6 Tabellen. G. Burg. VCH-Verlag 1993

·      Cutaneous Lymphomas. Dermatologic Clinics (Eds.: G. Burg, H. Kerl, B. Thiers). Saunders 1994

·      Operative und konservative Dermatoonkologie im interdisziplinären Grenzbereich (Eds.: Dummer, Reinhard, Renato Panizzon und Günter Burg. Springer 1996

·      Strategies for Immunointerventions in Dermatology. (Eds.: G. Burg and R. Dummer). Springer 1997

·      Physikalische Therapie in der Dermatologie. (EDS.: Reinhard Dummer, Renato G. Panizzon, Günter Burg). Springer 1998

·      Atlas of Cancer of the Skin (Ed.: G Burg). Churchill Livingston 2000

·      85 Jahre Universitätsklinik für Dermatologie und Venerologie Zürich (1916-2001): Eine Bilanz der letzten 10 Jahre anlässlich des 60. Geburtstages von Herrn Professor Dr. G. Burg. Steinkopf/Springer 2001 (Eds.: F. Nestle, R. Dummer)

·      Cutaneous Lymphomas: Unusual Cases. (Eds.: G. Burg, P. LeBoit, W. Kempf, B. Müller). Steinkopff 2001

·      Hyperhidrosis and Botulinum Toxin in Dermatology (Current Problems in Dermatology, Vol. 30) (Eds.: O.P. Kreyden, R. Böni, G. Burg). Karger 200

  • ·      Geschichte der Deutschsprachigen Dermatologie/History of German Dermatology (A. Scholz, K. Holubar, G.Burg, Eds.; Wiley, London 2009)
  • ·       Die Haut, in der wir Leben, Eds.: G. Burg, M. Geiges. Rüffer&RubSachbuchverlag 2001

·       Cancers oft he Skin. Proceedings of the 8th World Congress (Eds._: R. Dummer, F.O. Nestle, G. Burg) Springer 2002

 

·      In primo loco. Chronik der Medizinischen Fakultät Zürich 1833-2003. Michele Jäggi und Günter Burg. Verlag Rüffer&Rubb 2004

 

·      Cutaneous Lymphomas. Unusual Cases 2. (Eds.: G. Burg, W. Kempf, S. Michaeli, J. Feit). Steinkopff 2006

  • ·      Rundum Haut. Eds.: G. Burg, M. Geiges. Rüffer&RubSachbuchverlag 2006
  • ·      WebBook Dermatologie (deutsch) 2012
  • ·      WebBook Dermatology (englisch) 2017
  • ·      Atlas of Dermatopathology, Vol. I: Practical Differentialdiagnosis by Clinicopathologic Pattern. Vol.I. Eds.: G. Burg, W.Kempf, H.Kutzner, J Feit, L. Karai. Wiley Publisher, Oxford 2015, https://www.wiley.com/en-us/Atlas+of+Dermatopathology%3A+Practical+Differential+Diagnosis+by+Clinicopathologic+Pattern-p-9781118658314
  • ·      Atlas of Dermatopathology, Vol. II: Tumors, Nevi, and Cysts. Vol.II. Eds.: G. Burg, H.Kutzner, W.Kempf, J Feit, B. Smoller. Wiley Publisher, Oxford 2019, https://www.wiley.com/en-ag/Atlas+of+Dermatopathology%3A+Tumors%2C+Nevi%2C+and+Cysts-p-9781119371564
  •       Telemedicine and Teledermatology, (Ed.: G. Burg) Karger 2003

    ·      Cutaneous Lymphomas (Eds.: Burg, G. and Kempf W) Marcel Dekker, Francis&Taylor, 2005.

  • ·      WHO Books: Tumors of the Skin. (Eds.: LeBoit, Ph, Burg, G, Weedon, D, Sarasin, A.) 2006
   

Web-Based Media Contributions

Dermatology Online with Interactive Technology (DOIT, www.cyberderm.net), ein mehrsprachiges interaktives e-Learning-Programm für Studierende der Medizin (2002, 2004, 2008, 2012, 2016)

 

·      Dermokrates (www.dermokrates.com), eine interaktive Web-basierte Plattform für Weiter- und Fortbildung in der Dermatologie (2012-2017)

 

·      Hypertext atlas of dermatopathology (https://atlases.muni.cz) (Co-Editor)

Publikations, Chronological

Burg, G. (1969). [Protoporhyrinemic photodermatosis simulating hydroa aestivalia]. Dtsch Med Wochenschr, 94(25), 1314-1325.

Burg, G. (1969). [Protoporhyrinemic photodermatosis simulating hydroa aestivalia]. Dtsch Med Wochenschr, 94(25), 1314-1325.

Burg, G., Rassner, G., & Braun-Falco, O. (1969). [The effect of cyclophosphamide (Endoxan) on acute and chronic inflammation in the guinea pig]. Arch Klin Exp Dermatol, 236(1), 61-71.

Burg, G., Rassner, G., & Braun-Falco, O. (1969). [The effect of cyclophosphamide (Endoxan) on acute and chronic inflammation in the guinea pig]. Arch Klin Exp Dermatol, 236(1), 61-71.

Zaun, H., & Burg, G. (1969). [True twisted hair (Galewsky-Ronchese) with involvement of eyebrows and lanugo]. Asthet Med (Berl), 18(5), 95-100.

Zaun, H., & Burg, G. (1969). [True twisted hair (Galewsky-Ronchese) with involvement of eyebrows and lanugo]. Asthet Med (Berl), 18(5), 95-100.

Braun-Falco, O., & Burg, G. (1970). [Cytostatics and immunosuppressive agents in dermatology]. Hautarzt, 21(9), 391-397.

Braun-Falco, O., & Burg, G. (1970). [Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol, 236(3), 297-314.

Braun-Falco, O., & Burg, G. (1970). [Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. Arch Klin Exp Dermatol, 239(3), 307-322.

Braun-Falco, O., & Burg, G. (1970). [Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol, 236(2), 173-189.

Braun-Falco, O., & Burg, G. (1970). [Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol, 236(2), 173-189.

Braun-Falco, O., & Burg, G. (1970). [Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. Arch Klin Exp Dermatol, 239(3), 307-322.

Braun-Falco, O., & Burg, G. (1970). [Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol, 236(3), 297-314.

Braun-Falco, O., & Burg, G. (1970). [Cytostatics and immunosuppressive agents in dermatology]. Hautarzt, 21(9), 391-397.

Braun-Falco, O., Schmidt, D., & Burg, G. (1970). [Protoperphyrinaemic photodermatosis of the Quinckes's edema type]. Munch Med Wochenschr, 112(32), 1443-1447.

Braun-Falco, O., Schmidt, D., & Burg, G. (1970). [Protoperphyrinaemic photodermatosis of the Quinckes's edema type]. Munch Med Wochenschr, 112(32), 1443-1447.

Burg, G. (1970). [Erythropoietic protoporphyrinemic light dermatosis. Contribution to optical fluorescence demonstration, pathogenesis and therapy]. Dtsch Med Wochenschr, 95(20), 1120-1123. doi:10.1055/s-0028-1108598

Burg, G. (1970). [Erythropoietic protoporphyrinemic light dermatosis. Contribution to optical fluorescence demonstration, pathogenesis and therapy]. Dtsch Med Wochenschr, 95(20), 1120-1123. doi:10.1055/s-0028-1108598

Braun-Falco, O., & Burg, G. (1971). [Cytostatic and immunosuppressive treatment of dermatologic diseases]. Ther Ggw, 110(4), 488-500.

Braun-Falco, O., & Burg, G. (1971). [Dynamics of skin reaction following horn layer stripping. Histochemical and cytochemical studies on guinea pig ears]. Arch Dermatol Forsch, 241(1), 1-14.

Braun-Falco, O., & Burg, G. (1971). [Dynamics of skin reaction following horn layer stripping. Histochemical and cytochemical studies on guinea pig ears]. Arch Dermatol Forsch, 241(1), 1-14.

Braun-Falco, O., & Burg, G. (1971). [Cytostatic and immunosuppressive treatment of dermatologic diseases]. Ther Ggw, 110(4), 488-500.

Braun-Falco, O., Burg, G., & Schoefinius, H. H. (1971). [The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations]. Arch Dermatol Forsch, 241(3), 217-236.

Braun-Falco, O., Burg, G., & Schoefinius, H. H. (1971). [The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations]. Arch Dermatol Forsch, 241(3), 217-236.

Burg, G. (1971). [Therapy of porphyrias]. Dtsch Med Wochenschr, 96(21), 914-915. doi:10.1055/s-0028-1108358

Burg, G. (1971). [Therapy of porphyrias]. Dtsch Med Wochenschr, 96(21), 914-915. doi:10.1055/s-0028-1108358

Braun-Falco, O., Burg, G., & Farber, E. M. (1972). [Psoriasis. A questionnaire study of 536 patients]. Munch Med Wochenschr, 114(23), 1105-1110.

Braun-Falco, O., Burg, G., & Farber, E. M. (1972). [Psoriasis. A questionnaire study of 536 patients]. Munch Med Wochenschr, 114(23), 1105-1110.

Burg, G. (1972). [Therapy of porphyrias]. Minerva Med, 63(31), 1813-1815.

Burg, G. (1972). [Therapy of porphyrias]. Minerva Med, 63(31), 1813-1815.

Burg, G., & Braun-Falco, O. (1972). [Cytochemical studies on cellular stroma reaction in melanoma]. Arch Dermatol Forsch, 244, 261-264.

Burg, G., & Braun-Falco, O. (1972). The cellular stromal reaction in malignant melanoma. A cytochemical investigation. Arch Dermatol Forsch, 245(4), 318-333.

Burg, G., & Braun-Falco, O. (1972). The cellular stromal reaction in malignant melanoma. A cytochemical investigation. Arch Dermatol Forsch, 245(4), 318-333.

Burg, G., & Braun-Falco, O. (1972). [Cytochemical studies on cellular stroma reaction in melanoma]. Arch Dermatol Forsch, 244, 261-264.

Burg, G., & Plewig, G. (1972). [Seasonal pruritus as a symptom of erythropoietic protoporphyrinemic photodermatosis (EPL)]. Hautarzt, 23(12), 553-555.

Burg, G., & Plewig, G. (1972). [Seasonal pruritus as a symptom of erythropoietic protoporphyrinemic photodermatosis (EPL)]. Hautarzt, 23(12), 553-555.

Burg, G., & Robins, P. (1972). [Chemosurgery. Surgical removal of chemically fixed tumor tissue with microscopic control]. Hautarzt, 23(1), 16-20.

Burg, G., & Robins, P. (1972). [Chemosurgery. Surgical removal of chemically fixed tumor tissue with microscopic control]. Hautarzt, 23(1), 16-20.

Kolomiichenko, A. I., Kharshak, E. M., Lifanov, V. L., Burg, G. M., & Moroz, B. S. (1972). [Mobile audiometric laboratory]. Zh Ushn Nos Gorl Bolezn, 32(1), 103-104.

Kolomiichenko, A. I., Kharshak, E. M., Lifanov, V. L., Burg, G. M., & Moroz, B. S. (1972). [Mobile audiometric laboratory]. Zh Ushn Nos Gorl Bolezn, 32(1), 103-104.

Braun-Falco, O., & Burg, G. (1973). [Enzyme histochemistry of malignant melanoma. Investigations on primary tumors and metastases (author's transl)]. Arch Dermatol Forsch, 246(4), 303-316.

Braun-Falco, O., & Burg, G. (1973). [Enzyme histochemistry of malignant melanoma. Investigations on primary tumors and metastases (author's transl)]. Arch Dermatol Forsch, 246(4), 303-316.

Burg, G. (1973). [Erythropoetic, protoporphyrinemic light dermatosis with secondary cutaneous hyalinosis]. Hautarzt, 24(12), 564.

Burg, G. (1973). [Erythropoetic, protoporphyrinemic light dermatosis with secondary cutaneous hyalinosis]. Hautarzt, 24(12), 564.

Huhn, D., Burg, G., & Mempel, W. (1973). [Specific cutaneous changes in Hodgkin's disease (author's transl)]. Dtsch Med Wochenschr, 98(52), 2469-2472. doi:10.1055/s-0028-1107281

Huhn, D., Burg, G., & Mempel, W. (1973). [Specific cutaneous changes in Hodgkin's disease (author's transl)]. Dtsch Med Wochenschr, 98(52), 2469-2472. doi:10.1055/s-0028-1107281

Braun-Falco, O., & Burg, G. (1974). [Cellular infiltrate and capillaries in atopic dermatitis. Quantitative enzyme-cytochemical and histochemical investigations (author's transl)]. Arch Dermatol Forsch, 249(2), 113-124.

Braun-Falco, O., & Burg, G. (1974). [Cellular infiltrate and capillaries in atopic dermatitis. Quantitative enzyme-cytochemical and histochemical investigations (author's transl)]. Arch Dermatol Forsch, 249(2), 113-124.

Burg, G., & Braun-Falco, O. (1974). [Qualitative and quantitative aspects of the cellular reaction in the skin and blood in mycosis fungoides. A cytochemical study]. Hautarzt, 25(4), 178-187.

Burg, G., & Braun-Falco, O. (1974). [Advances in cytochemical differentiation of cellular infiltrates into the skin]. Hautarzt, 25(1), 1-8.

Burg, G., & Braun-Falco, O. (1974). [Advances in cytochemical differentiation of cellular infiltrates into the skin]. Hautarzt, 25(1), 1-8.

Burg, G., & Braun-Falco, O. (1974). [Qualitative and quantitative aspects of the cellular reaction in the skin and blood in mycosis fungoides. A cytochemical study]. Hautarzt, 25(4), 178-187.

Burg, G., & Dorn, M. (1974). [Chemosurgery of basaliomas]. Z Hautkr, 49(17), 713-714.

Burg, G., & Dorn, M. (1974). [Chemosurgery of basaliomas]. Z Hautkr, 49(17), 713-714.

Kerl, H., Burg, G., & Braun-Falco, O. (1974). Quantitative and qualitative dynamics of the epidermal and cellular inflammatory reaction in primary toxic and allergic dinitrochlorobenzene contact dermatitis in guinea pigs. Arch Dermatol Forsch, 249(3), 207-226.

Kerl, H., Burg, G., & Braun-Falco, O. (1974). Quantitative and qualitative dynamics of the epidermal and cellular inflammatory reaction in primary toxic and allergic dinitrochlorobenzene contact dermatitis in guinea pigs. Arch Dermatol Forsch, 249(3), 207-226.

Burg, G. (1975). [Procceedings: Hereditary onycholysis mit scleronychia]. Hautarzt, 26(7), 386.

Burg, G., & Braun-Falco, O. (1975). [T and B lymphocytes in skin changes of cutaneous lymphoma (author's transl)]. Dtsch Med Wochenschr, 100(50), 2562-2564. doi:10.1055/s-0028-1106585

Burg, G., & Braun-Falco, O. (1975). Classification and differentiation of cutaneous lymphomas. Enzyme-cytochemical and immunocytological studies. Br J Dermatol, 93(5), 597-599.

Burg, G., Hirsch, R. D., Konz, B., & Braun-Falco, O. (1975). Histographic surgery: accuracy of visual assessment of the margins of basal-cell epithelioma. J Dermatol Surg, 1(3), 21-24.

Falco, O. B., & Burg, G. (1975). [Lymphoreticular proliferations in the skin. Cytochemical and immunocytological studies in lymphadenosis benigna cutis]. Hautarzt, 26(3), 124-132.

Kerl, H., & Burg, G. (1975). [Acquired (postinflammatory) dermatchalasis, dermatitis herpetiformis Duhring, celiac syndrome, dermatochalasis]. Hautarzt, 26(4), 191-196.

Weber, K., Burg, G., Wolff, H. H., Braun-Falco, O., & Ehlers, G. (1975). [Sezary's syndrome. Case report]. Hautarzt, 26(5), 255-259.

Braun-Falco, O., & Burg, G. (1976). Proceedings: Enzyme cytochemical and immunocytological characterization of cutaneous lymphomas. Br J Dermatol, 95 Suppl 14, 9-10.

Braun-Falco, O., Burg, G., & Wolff, H. H. (1976). [Cutaneous lymphomas, and pseudolymphomas. Immunocytological, enzymocytochemical and electron microscopical studies (authors transl)]. Ther Umsch, 33(8), 543-550.

Burg, G. (1976). [Progress in the diagnosis of cutaneous lymphomas. Enzyme cytochemical and immunocytological studies]. Fortschr Med, 94(18), 1089-1098.

Burg, G., & Braun-Falco, O. (1977). [1-Chloro-2,4-dinitrobenzene ointment for sensitization, testing and therapy of malignant melanoma patients]. Dtsch Med Wochenschr, 102(6), 210-211.

Burg, G., & Braun-Falco, O. (1977). Morphological and functional differentiation and classification of cutaneous lymphomas. Bull Cancer, 64(2), 225-240.

Burg, G., & Braun-Falco, O. (1977). [Enzyme cytochemical and immunocytologic studies of mycosis fungoides]. Acta Histochem Suppl, Suppl 18, 209-214.

Burg, G., Rodt, H., Grosse-Wilde, H., Netzel, B., Fateh-Moghadam, A., & Braun-Falco, O. (1977). Enzymecytochemical and immunocytological studies as a basis for the revaluation of the histology of cutaneous B-cell and T-cell lymphomas. Haematol Blood Transfus, 20, 179-187.

Hofmann, C., Burg, G., Plewig, G., & Braun-Falco, O. (1977). [Photochemotherapy of cutaneous lymphoma: oral and local 8-MOP-UVA treatment (author's transl)]. Dtsch Med Wochenschr, 102(18), 675-679. doi:10.1055/s-0028-1104951

Schmoeckel, C., Burg, G., Wolf, H. H., & Braun-Falco, O. (1977). The ultrastructure of lymphadenosis benigna cutis (pseudolymphoma cutis). Arch Dermatol Res, 258(2), 161-167.

Bode, U., & Burg, G. (1978). [The acquired digital fibrokeratoma]. Hautarzt, 29(12), 659-660.

Braun-Falco, O., Guggenberger, K., Burg, G., & Fateh-Moghadam, A. (1978). [Immunocytoma simulating chronic acrodermatitis atrophicans]. Hautarzt, 29(12), 644-647.

Burg, G., & Braun-Falco, O. (1978). Cutaneous non-Hodgkin lymphoma: re-evaluation of histology using enzymecytochemical and immunologic studies. Int J Dermatol, 17(6), 496-505.

Burg, G., Braun-Falco, O., Hoffmann-Fezer, G., Rodt, H., & Schmoeckel, C. (1978). Patterns of cutaneous lymphomas. Histological, enzyme cytochemical, and immunological typing of lymphoreticular proliferations in the skin. Dermatologica, 157(5), 282-291.

Burg, G., Braun-Falco, O., & Schmoeckel, C. (1978). [Cutaneous T-cell lymphomas]. Fortschr Med, 96(5), 199-205.

Burg, G., Rodt, H., Grosse-Wilde, H., & Braun-Falco, O. (1978). Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sezary's syndrome. J Invest Dermatol, 70(5), 257-259.

Burg, G., Schmoeckel, C., Braun-Falco, O., & Wolff, H. H. (1978). Monocytic leukemia. Clinically appearing as 'malignant reticulosis of the skin'. Arch Dermatol, 114(3), 418-420.

Bonniger, F., & Burg, G. (1979). [Multiple keratoacanthomas]. Hautarzt, 30(2), 92-94.

Braun-Falco, O., Schmoeckel, C., Burg, G., & Ryckmanns, F. (1979). Pagetoid reticulosis. A further case report with a review of the literature. Acta Derm Venereol Suppl (Stockh), 59(85), 11-21.

Burg, G. (1979). [Reticuloses and lymphomas of the skin from the present viewpoint]. Hautarzt, 30(3), 167-168.

Butenschon, H., Burg, G., & Lentze, M. (1979). [LEOPARD syndrome]. Z Hautkr, 54(13), 613-618.

Kerl, H., & Burg, G. (1979). [Immunocytomas and immunoblastic lymphomas of the skin]. Hautarzt, 30(12), 666-672.

Kienitz, T., Burg, G., Schmoeckel, C., Weitz, H., & Braun-Falco, O. (1979). High-grade malignant lymphoma arising from Sezary's syndrome. A case report. Dermatologica, 158(2), 126-136.

Schmoeckel, C., Burg, G., & Braun-Falco, O. (1979). Quantitative analysis of lymphoid cells in cutaneous low-grade malignant B-cell lymphomas. Arch Dermatol Res, 266(3), 239-251.

Schmoeckel, C., Burg, G., & Braun-Falco, O. (1979). Quantitative analysis of lymphoid cells in myocosis fungoides, Sezary's syndrome and parapsoriasis en plaques. Arch Dermatol Res, 264(1), 17-28.

von Liebe, V., Karge, H. J., & Burg, G. (1979). [Contact urticaria]. Hautarzt, 30(10), 544-546.

Braun-Falco, O., Burg, G., Hoffmann-Fezer, G., Fateh-Moghadam, A., & Herterich, J. (1980). [Reticulosis of the skin - a heterogenic group of diseases]. Acta Histochem Suppl, 21, 57-69.

Braun-Falco, O., Burg, G., Selzle, D., & Schmoeckel, C. (1980). [Diffuse congenital melanosis]. Hautarzt, 31(6), 324-327.

Burg, G. (1980). [Enzyme cytochemical and immunological procedures for diagnosis of pseudolymphomas and skin lymphomas]. Z Hautkr, 55(20), 1351-1366.

Burg, G., Guggenberger, K., Schmoeckel, C., & Braun-Falco, O. (1980). [Therapy of mycosis fungoides]. Ther Ggw, 119(7), 773-790.

Kolz, R., Lonsdorf, G., & Burg, G. (1980). [Intolerance reactions following parenteral administration of vitamin B]. Hautarzt, 31(12), 657-659.

Schmoeckel, C., Braun-Falco, O., & Burg, G. (1980). [Atypical fibroxanthoma]. Hautarzt, 31(4), 213-215.

Braun-Falco, O., Burg, G., & Schmoeckel, C. (1981). Recent advances in the understanding of cutaneous lymphoma. Clin Exp Dermatol, 6(1), 89-109.

Burg, G. (1981). Malignant histiocytic disorders of the skin. Haematol Blood Transfus, 27, 221-224.

Burg, G., Hoffmann-Fezer, G., Nikolowski, J., Schmoeckel, C., Braun-Falco, O., & Stunkel, K. (1981). Lymphomatoid papulosis: a cutaneous T-cell pseudolymphoma. Acta Derm Venereol, 61(6), 491-496.

Landthaler, M., Burg, G., & Zirbs, S. (1981). [Dye and nickel allergy in the hairdressing salon]. Hautarzt, 32(6), 281-284.

Schmoeckel, C., Burg, G., Braun-Falco, O., & Klingmuller, G. (1981). [High-grade malignant mycosis fungoides with cytological transformation (author's transl)]. Ann Dermatol Venereol, 108(3), 231-236, 239-241.

Forg, T., Burg, G., & Zirbs, S. (1982). [Frequency of contact allergy in housewives (author's transl)]. Derm Beruf Umwelt, 30(2), 48-50.

Ring, J., Lonsdorf, G., Schury, W., & Burg, G. (1982). [Bee and wasp venom allergy. Clinical aspects, prevention and therapy]. MMW Munch Med Wochenschr, 124(24), 587-590.

Schmoeckel, C., Burg, G., Hoffmann-Fezer, G., Stolz, W., Weitz, H., Lohrs, U., & Braun-Falco, O. (1982). Cutaneous immunoblastic T-cell lymphoma. Arch Dermatol Res, 274(1-2), 141-154.

Braun-Falco, O., & Burg, G. (1983). [Malignant lymphomas of the skin]. Internist (Berl), 24(6), 306-320.

Braun-Falco, O., Nikolowski, J., Burg, G., & Schmoeckel, C. (1983). [Lymphomatoid papulosis. Review and personal observation of 4 patients]. Hautarzt, 34(2), 59-65.

Hoffmann, R., van de Graaff, S., & Burg, G. (1983). [Spread of tuberculosis in ornamental fishes]. Tierarztl Prax, 11(2), 261-267.

Kerl, H., Burg, G., & Hashimoto, K. (1983). Fatal, penicillin-induced, generalized, postinflammatory elastolysis (cutis laxa). Am J Dermatopathol, 5(3), 267-276.

Oehlschlaegel, G., Marquart, K. H., Steuer, G., & Burg, G. (1983). [Iatrogenic pseudotumor of the skin induced by polyvinyl pyrrolidone]. Hautarzt, 34(11), 555-560.

Przybilla, B., Burg, G., Schmoeckel, C., & Braun-Falco, O. (1983). Treatment of cutaneous T-cell lymphomas with TP-5. Evaluation of the clinical effect in 8 patients. Acta Derm Venereol, 63(6), 524-529.

Przybilla, B., Burg, G., & Thieme, C. (1983). Evaluation of the immune status in vivo by the 2,4-dinitro-1-chlorobenzene contact allergy time (DNCB-CAT). Dermatologica, 167(1), 1-5.

Przybilla, B., Ring, J., & Burg, G. (1983). [Anaphylaxis following ingestion of coffee, chronic urticaria and analgesics idiosyncrasy]. Hautarzt, 34(2), 73-76.

Ring, J., Bode, U., Kadach, U., Stix, E., & Burg, G. (1983). [Gammaglobulins and allergy. Clinical results of a controlled study with standard human IgG and placebo in pollinosis]. MMW Munch Med Wochenschr, 125(14), 289-292.

Stolz, W., Schmoeckel, C., Burg, G., & Braun-Falco, O. (1983). Circulating Sezary cells in the diagnosis of Sezary syndrome (quantitative and morphometric analyses). J Invest Dermatol, 81(4), 314-319.

Burg, G., Kerl, H., Kaudewitz, P., Braun-Falco, O., & Mason, D. Y. (1984). Immunoenzymatic typing of lymphoplasmacytoid skin infiltrates. J Dermatol Surg Oncol, 10(4), 284-290.

Burg, G., Kerl, H., Przybilla, B., & Braun-Falco, O. (1984). Some statistical data, diagnosis, and staging of cutaneous B-cell lymphomas. J Dermatol Surg Oncol, 10(4), 256-262.

Burg, G., Kerl, H., & Schmoeckel, C. (1984). Differentiation between malignant B-cell lymphomas and pseudolymphomas of the skin. J Dermatol Surg Oncol, 10(4), 271-275.

Eberth-Willershausen, W., Steger, O., Barran, W., Burg, G., Ryckmanns, F., & Kaudewitz, P. (1984). [Histiocytosis X. An oligosymptomatic form of Hand-Schuller-Christian disease with a new form and possibilities of diagnosis]. Hautarzt, 35(10), 539-542.

Geerts, M. L., Burg, G., Schmoeckel, C., & Braun-Falco, O. (1984). Alkaline phosphatase activity in non-Hodgkin's lymphomas and pseudolymphomas of the skin. J Dermatol Surg Oncol, 10(4), 306-312.

Geerts, M. L., Burg, G., Schmoeckel, C., & Braun-Falco, O. (1984). Alkaline phosphatase positive lymphoma. Dermatologica, 169(6), 342-347.

Kaudewitz, P., Burg, G., Klepzig, K., Munker, R., Rieber, P., & Braun-Falco, O. (1984). Cells reactive with anti-T-cell monoclonal antibodies in malignant cutaneous B-cell lymphomas and pseudolymphomas. J Dermatol Surg Oncol, 10(4), 313-314.

Kerl, H., & Burg, G. (1984). Histomorphology and cytomorphology of cutaneous B-cell lymphomas. J Dermatol Surg Oncol, 10(4), 266-270.

Burg, G., Kaudewitz, P., Klepzig, K., Przybilla, B., & Braun-Falco, O. (1985). Cutaneous B-cell lymphoma. Dermatol Clin, 3(4), 689-704.

Kaudewitz, P., Burg, G., Stein, H., Klepzig, K., Mason, D. Y., & Braun-Falco, O. (1985). Monoclonal antibody patterns in lymphomatoid papulosis. Dermatol Clin, 3(4), 749-757.

Maier, H., Schmoeckel, C., Burg, G., & Braun-Falco, O. (1985). Primary cutaneous atypical histiocytosis with possible dissemination. Am J Dermatopathol, 7(4), 373-382.

Schanne, R., Burg, G., & Braun-Falco, O. (1985). [Nosologic relation of dyskeratosis follicularis (Darier) and pemphigus benignus chronicus familiaris (Hailey-Hailey). Position based on a case report]. Hautarzt, 36(9), 504-508.

Smolle, J., Kaudewitz, P., Burg, G., Kresbach, H., & Kerl, H. (1985). Significance of non-lymphoid ('accessory') cells in malignant lymphomas and pseudolymphomas of the skin. Br J Dermatol, 113(6), 677-685.

Burg, G. (1986). [Pagetoid skin infiltrates]. Pathologe, 7(4), 199-206.

Burg, G., Klepzig, K., Kaudewitz, P., Wolf, H., & Braun-Falco, O. (1986). Acyclovir in lymphomatoid papulosis and mycosis fungoides. JAMA, 256(2), 214-215.

Burg, G., Klepzig, K., Kaudewitz, P., Wolff, H., & Braun-Falco, O. (1986). [Acyclovir in mycosis fungoides and lymphomatoid papulosis]. Hautarzt, 37(10), 533-536.

Hofmann, C., Burg, G., & Jung, C. (1986). [Cutaneous side effects of gold therapy. Clinical and histologic results]. Z Rheumatol, 45(3), 100-106.

Imai, S., Burg, G., & Braun-Falco, O. (1986). Mycosis fungoides and Sezary's syndrome show distinct histomorphological features. Dermatologica, 173(3), 131-135.

Kaudewitz, P., Burg, G., Smolle, J., & Braun-Falco, O. (1986). [Immunologic phenotyping of cutaneous lymphomas]. Hautarzt, 37(12), 647-655.

Kaudewitz, P., Soldner, R., Burg, G., Bieber, T., Berger, C., Edelson, R., . . . Braun-Falco, O. (1986). Reactivity of monoclonal antibody BE 2 in different stages of mycosis fungoides and in benign dermal infiltrates. Arch Dermatol Res, 279(2), 83-88.

Kaudewitz, P., Stein, H., Burg, G., Mason, D. Y., & Braun-Falco, O. (1986). Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1. J Invest Dermatol, 86(4), 350-354.

Bieber, T., Ruzicka, T., & Burg, G. (1987). [Erosive pustulous dermatitis of the scalp]. Hautarzt, 38(11), 687-689.

Burg, G., Stunkel, K. G., Bieber, T., Opitz, U., & Kaudewitz, P. (1987). Cutaneous infiltrates of histiocytosis X contain plasminogen activator-bearing epidermotropic dendritic cells different from Langerhans cells. Arch Dermatol Res, 279 Suppl, S88-91.

Hofmann, C., Richter, W., Hiller, C., & Burg, G. (1987). [Urticaria vasculitis]. Z Rheumatol, 46(5), 233-236.

Kaudewitz, P., Burg, G., Majiewski, G., Gerdes, J., Schwarting, R., & Braun-Falco, O. (1987). Cell populations in pagetoid reticulosis: an immunological study using cell activation associated monoclonal antibodies. Acta Derm Venereol, 67(1), 24-29.

Ruzicka, T., & Burg, G. (1987). Effects of chronic intracutaneous administration of arachidonic acid and its metabolites. Induction of leukocytoclastic vasculitis by leukotriene B4 and 12-hydroxyeicosatetraenoic acid and its prevention by prostaglandin E2. J Invest Dermatol, 88(2), 120-123.

Smolle, J., Kaudewitz, P., Aberer, E., Torne, R., Burg, G., & Kerl, H. (1987). [Immunohistochemical classification of cutaneous lymphomas and pseudolymphomas]. Hautarzt, 38(8), 461-466.

Burg, G., Bieber, T., & Langecker, P. (1988). [Localized neutrophilic eccrine hydradenitis in mitoxantrone therapy: a typical side-effect of cytostatic drugs]. Hautarzt, 39(4), 233-236.

Burg, G., & Landthaler, M. (1988). [Proliferating tricholemmal tumor]. Hautarzt, 39(2), 117-119.

Burg, G., von der Helm, D., Kaudewitz, P., Klepzig, K., & Braun-Falco, O. (1988). Antihuman T-cell leukemia/lymphoma virus antibodies in three patients with primary cutaneous B-cell lymphoma. J Dermatol Surg Oncol, 14(6), 653-656.

Eckert, F., Burg, G., Braun-Falco, O., Schmid, U., & Gloor, F. (1988). Immunostaining in atypical fibroxanthoma of the skin. Pathol Res Pract, 184(1), 27-34. doi:10.1016/S0344-0338(88)80187-0

Eckert, F., Hein, R., Krieg, T., & Burg, G. (1988). [Local recurrent centroblastic lymphoma of the skin]. Hautarzt, 39(12), 791-794.

Enders, F., Przybilla, B., Ring, J., Burg, G., & Braun-Falco, O. (1988). [Epicutaneous testing with a standard series. Results in 12,026 patients]. Hautarzt, 39(12), 779-786.

Gollhausen, R., Enders, F., Przybilla, B., Burg, G., & Ring, J. (1988). Trends in allergic contact sensitization. Contact Dermatitis, 18(3), 147-154.

Kampgen, E., Burg, G., & Wank, R. (1988). Association of herpes simplex virus-induced erythema multiforme with the human leukocyte antigen DQw3. Arch Dermatol, 124(9), 1372-1375.

Schmoeckel, C., & Burg, G. (1988). Congenital spiradenoma. Am J Dermatopathol, 10(6), 541-545.

Schrallhammer, K., Burg, G., Stolz, W., & Braun-Falco, O. (1988). [Congenital poikiloderma with verrucous hyperkeratosis. An unusual form of Thomson's syndrome?]. Hautarzt, 39(3), 143-148.

von der Helm, D., von der Helm, K., Burg, G., Braun-Falco, O., & Deinhardt, F. (1988). [Antibodies against HTLV I in T-lymphoproliferative diseases of the skin]. Hautarzt, 39(6), 348-350.

Burg, G., & Bergner, T. (1989). Pigmentary disorders associated with nutritional deficiency states. Clin Dermatol, 7(2), 36-43.

Burg, G., Vieluf, D., Stolz, W., Landthaler, M., & Braun-Falco, O. (1989). [Malignant atrophic papulosis (Kohlmeier-Degos disease)]. Hautarzt, 40(8), 480-485.

Eckert, F., Schmid, U., Kaudewitz, P., Burg, G., & Braun-Falco, O. (1989). Follicular lymphoid hyperplasia of the skin with high content of Ki-1 positive lymphocytes. Am J Dermatopathol, 11(4), 345-352.

Hackel, H., Burg, G., Lechner, W., Stolz, W., Ring, J., & Braun-Falco, O. (1989). [Keratoacanthoma centrifugum marginatum]. Hautarzt, 40(12), 763-766.

Hartmann, A. A., & Burg, G. (1989). [Fulminant acne in Klinefelter syndrome treated with testosterone. A side effect of anti-tallness therapy]. Monatsschr Kinderheilkd, 137(8), 466-467.

Kaudewitz, P., Stein, H., Dallenbach, F., Eckert, F., Bieber, K., Burg, G., & Braun-Falco, O. (1989). Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics. Am J Pathol, 135(2), 359-367.

Kleber, R., Landthaler, M., & Burg, G. (1989). [Post-zoster granuloma anulare]. Hautarzt, 40(2), 110-111.

Pierard-Franchimont, C., Burg, G., Grosshans, E., Kerl, H., & Pierard, G. E. (1989). [Prevalence of skin cancers in the Mosane region and in European countries of the same latitude]. Rev Med Liege, 44(18), 541-545.

Stolz, W., Graubner, U., Gerstmeier, J., Burg, G., & Belohradsky, B. H. (1989). Chediak-Higashi syndrome: approaches in diagnosis and treatment. Curr Probl Dermatol, 18, 93-100.

Braun-Falco, O., Burg, G., & Vieluf, D. (1990). [History of the Munich Dermatology Society]. Hautarzt, 41(5), 290-294.

Burg, G., & Kaudewitz, P. (1990). Where are we today in the diagnosis of cutaneous lymphoma? Curr Probl Dermatol, 19, 90-104.

Burg, G., & Sobetzko, R. (1990). [Florid oral papillomatosis: an indication for etretinate?]. Hautarzt, 41(6), 314-316.

Cavey, D., Bouclier, M., Burg, G., Delamadeleine, F., & Hensby, C. N. (1990). The pharmacological modulation of delayed type hypersensitivity (DTH) reactions to topical oxazolone in mouse skin. Agents Actions, 29(1-2), 65-67.

Dummer, R., Welters, H., Keilholz, U., Tilgen, W., & Burg, G. (1990). [Interleukin 2: immunologic background and clinical use in tumor therapy]. Hautarzt, 41(2), 53-55.

Elsner, P., Hartmann, A. A., & Burg, G. (1990). [Experiences with oxytetracycline treatment of non-gonorrhea urethritis caused by Ureaplasma urealyticum]. Hautarzt, 41(2), 94-97.

Encke, A., Hermanek, P., & Burg, G. (1990). [News on TNM consultation activity of the German Language Committee]. Leber Magen Darm, 20(1), 47.

Hackel, H., Hartmann, A. A., Elsner, P., & Burg, G. (1990). Prevalence of Ureaplasma urealyticum in the urethra of men without urethritis in relation to clinical diagnosis. Dermatologica, 180(2), 76-78.

Hackel, H., Zillikens, D., Lechner, W., & Burg, G. (1990). [Unusual manifestation of scleroderma of the trunk]. Hautarzt, 41(2), 91-93.

Kaudewitz, P., Burg, G., & Stein, H. (1990). Ki-1 (CD30) positive cutaneous anaplastic large cell lymphomas. Curr Probl Dermatol, 19, 150-156.

Kaudewitz, P., Stein, H., Plewig, G., Schwarting, R., Gerdes, J., Burg, G., . . . Braun-Falco, O. (1990). Hodgkin's disease followed by lymphomatoid papulosis. Immunophenotypic evidence for a close relationship between lymphomatoid papulosis and Hodgkin's disease. J Am Acad Dermatol, 22(6 Pt 1), 999-1006.

Sepp, N., Schuler, G., Romani, N., Geissler, D., Gattringer, C., Burg, G., . . . Fritsch, P. (1990). "Intravascular lymphomatosis" (angioendotheliomatosis): evidence for a T-cell origin in two cases. Hum Pathol, 21(10), 1051-1058.

Stolz, W., Vogt, T., Braun-Falco, O., Abmayr, W., Eckert, F., Kaudewitz, P., . . . Burg, G. (1990). Differentiation between lymphomas and pseudolymphomas of the skin by computerized DNA-image cytometry. J Invest Dermatol, 94(2), 254-260.

Weiss, J., Garbe, C., Bertz, J., Biltz, H., Burg, G., Hennes, B., . . . et al. (1990). [Risk factors for the development of malignant melanoma in West Germany. Results of a multicenter-case control study]. Hautarzt, 41(6), 309-313.

Zillikens, D., Miller, K., Hartmann, A. A., & Burg, G. (1990). IgA pemphigus foliaceus: a case report. Dermatologica, 181(4), 304-307.

Bastian, B. C., & Burg, G. (1991). [Computer networks in clinical practice--a histology data bank system]. Hautarzt, 42(6), 376-379.

Bastian, B. C., Romisch, J., Paques, E. P., & Burg, G. (1991). [Lipocortins and phospholipases: new aspects in the physiology of glucocorticosteroid effect]. Hautarzt, 42(7), 417-423.

Becker, J. C., Dummer, R., Hartmann, A. A., Burg, G., & Schmidt, R. E. (1991). Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol, 147(12), 4398-4401.

Burg, G., Dummer, R., Wilhelm, M., Nestle, F., Ott, M. M., Feller, A., . . . Wiede, J. (1991). A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med, 325(15), 1078-1081. doi:10.1056/NEJM199110103251506

Burg, G., & Kerl, H. (1991). Seminars in diagnostic pathology. Introduction. Semin Diagn Pathol, 8(2), 53-54.

Dummer, R., Muller, W., Nestle, F., Wiede, J., Dues, J., Lechner, W., . . . Burg, G. (1991). Formation of neutralizing antibodies against natural interferon-beta, but not against recombinant interferon-gamma during adjuvant therapy for high-risk malignant melanoma patients. Cancer, 67(9), 2300-2304.

Dummer, R., Schafer, E., Eilles, C., Borner, W., & Burg, G. (1991). Lymphokine-activated killer-cell traffic in metastatic melanoma. Lancet, 338(8764), 456-457.

Dunkel, F. G., Elsner, P., & Burg, G. (1991). Contact allergies to topical corticosteroids: 10 cases of contact dermatitis. Contact Dermatitis, 25(2), 97-103.

Goldstein, R. K., Bastian, B. C., Elsner, P., & Burg, G. (1991). Giant lichenification of the vulva with marked ulcerations. A case report. J Reprod Med, 36(4), 309-311.

Goldstein, R. K., Zillikens, D., Miller, K., Elsner, P., & Burg, G. (1991). [Local treatment of disseminated granuloma anulare with a vitamin E emulsion]. Hautarzt, 42(3), 176-178.

Hackel, H., Hartmann, A. A., & Burg, G. (1991). Vulvitis granulomatosa and anoperineitis granulomatosa. Dermatologica, 182(2), 128-131.

Hackel, H., Hartmann, A. A., Elsner, P., Martius, J., Engel, C., & Burg, G. (1991). [The value of Gardnerella-vaginalis-culture in bacterial-vaginitis- score-confirmed bacterial vaginosis]. Hautarzt, 42(3), 173-175.

Hackel, H., Miller, K., Elsner, P., & Burg, G. (1991). Unusual combined sensitization to palladium and other metals. Contact Dermatitis, 24(2), 131-132.

Kaudewitz, P., & Burg, G. (1991). Lymphomatoid papulosis and Ki-1 (CD30)-positive cutaneous large cell lymphomas. Semin Diagn Pathol, 8(2), 117-124.

Kerl, H., Cerroni, L., & Burg, G. (1991). The morphologic spectrum of T-cell lymphomas of the skin: a proposal for a new classification. Semin Diagn Pathol, 8(2), 55-61.

Ostmeier, H., Schumann, J., Otto, F., Krieg, V., Fuchs, B., Biess, B., . . . Suter, L. (1991). The relationship between characteristics of the tumor cells and sex of the patients in primary malignant melanomas. J Cancer Res Clin Oncol, 117(4), 364-366.

Schulz, A., Elsner, P., & Burg, G. (1991). Quantification of irritant contact dermatitis in vivo: comparison of the Dermatest system with the evaporimeter. Contact Dermatitis, 24(3), 235-237.

Vogt, T., Stolz, W., Braun-Falco, O., Kaudewitz, P., Eckert, F., Abmayr, W., . . . Burg, G. (1991). Prognostic significance of DNA cytometry in cutaneous malignant lymphomas. Cancer, 68(5), 1095-1100.

Zillikens, D., Bammel, A., Lurz, C., Elsner, P., & Burg, G. (1991). [Eosinophilia-myalgia syndrome after L-tryptophan intake]. Hautarzt, 42(3), 154-157.

Zillikens, D., Mehringer, A., Lechner, W., & Burg, G. (1991). Hypo- and hyperpigmented areas in incontinentia pigmenti. Light and electron microscopic studies. Am J Dermatopathol, 13(1), 57-62.

Ambach, A., Zillikens, D., Klingert, B., Hartmann, A. A., & Burg, G. (1992). [Immune phenotyping of mononuclear infiltrate in bullous pemphigoid]. Hautarzt, 43(2), 81-85.

Baumgartner, R., Trueb, R., Bruckner, L., Schmid, U., Speiser, P., & Burg, G. (1992). [Recurrent eyelid tumor in necrotizing panniculitis]. Klin Monbl Augenheilkd, 200(5), 529-531. doi:10.1055/s-2008-1045816

Becker, J. C., Dummer, R., Schmidt, R. E., Burg, G., & Hartmann, A. A. (1992). [Shedding of soluble intercellular adhesion molecule 1 (ICAM-1) from melanoma cells and the effect on cellular cytotoxicity]. Immun Infekt, 20(2), 62-63.

Becker, J. C., Dummer, R., Schwinn, A., Hartmann, A. A., & Burg, G. (1992). Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy. J Immunother (1991), 12(2), 147-150.

Becker, J. C., Dummer, R., Von Wussow, P., Burg, G., & Schmidt, R. E. (1992). Non-MHC-restricted T-cell interaction with B cells: role of the T-cell receptor. Scand J Immunol, 36(2), 177-181.

Boyera, N., Cavey, D., Bouclier, M., Burg, G., Rossio, P., & Hensby, C. (1992). Repeated application of dinitrochlorobenzene to the ears of sensitized guinea pigs: a preliminary characterization of a potential new animal model for contact eczema in humans. Skin Pharmacol, 5(3), 184-188.

Burg, G. (1992). [The First Bruno Bloch Memorial Lecture]. Hautarzt, 43(6), 390.

Burg, G. (1992). Disseminated granuloma anulare: therapy with vitamin E topically. Dermatology, 184(4), 308-309. doi:10.1159/000247580

Burg, G., & Dummer, R. (1992). [Current treatment methods in skin tumors]. Schweiz Rundsch Med Prax, 81(19), 610-614.

Burg, G., & Schmockel, C. (1992). Syringolymphoid hyperplasia with alopecia--a syringotropic cutaneous T-cell lymphoma? Dermatology, 184(4), 306-307. doi:10.1159/000247579

Cavegn, B., Puppin, D., Jr., & Burg, G. (1992). [Controversial aspects of stage I skin melanomas]. Schweiz Med Wochenschr, 122(49), 1883-1888.

Dummer, R., Becker, J. C., Boser, B., Hartmann, A. A., & Burg, G. (1992). Successful therapy of metastatic eccrine poroma using perilesional interferon alfa and interleukin 2. Arch Dermatol, 128(8), 1127-1128.

Dummer, R., Posseckert, G., Nestle, F., Witzgall, R., Burger, M., Becker, J. C., . . . Burg, G. (1992). Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo? J Invest Dermatol, 98(1), 50-54.

Dummer, R., Roger, J., Vogt, T., Becker, J., Hefner, H., Sindermann, H., & Burg, G. (1992). Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas. Prog Exp Tumor Res, 34, 160-169.

Dunkel, F. G., & Burg, G. (1992). [The pathogenesis of psoriasis--new results]. Fortschr Med, 110(25), 457-460.

Elder, D. E., Freeman, R. G., Bergfeld, W. F., Ackerman, A. B., Azar, H. A., Fechner, R. E., . . . et al. (1992). Do you use the term "dysplasia"? If so, what do you mean by it, and if not, why not? Am J Dermatopathol, 14(5), 462-486.

Goldstein, R. K., Augustin, A., Milz, J., Burg, G., & Lutz, J. (1992). Influence of free radical scavengers on myeloperoxidase activity and lipid peroxidation in acute skin grafts. Adv Exp Med Biol, 316, 253-258.

Haffner, A. C., Garbe, C., Burg, G., Buttner, P., Orfanos, C. E., & Rassner, G. (1992). The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients. Br J Cancer, 66(5), 856-861.

Hafner, J., Enderlin, A., Seger, R. A., Wuthrich, B., Bruckner-Tudermann, L., Panizzoni, P., & Burg, G. (1992). Discoid lupus erythematosus-like lesions in carriers of X-linked chronic granulomatous disease. Br J Dermatol, 127(4), 446-447.

Hermanek, P., Encke, A., & Burg, G. (1992). [Histologic study of lymph nodes in tumor resections--results of a survey of the German TNM Committee]. Chirurg, 63(6), Suppl 93-97.

Trueb, R., & Burg, G. (1992). [Drug reaction to amoxicillin simulating toxic pustular dermatosis]. Hautarzt, 43(9), 595-596.

Trueb, R. M., & Burg, G. (1992). [Loose anagen hair]. Hautarzt, 43(8), 505-508.

Wilhelm, M., Meyer, P., Batram, C., Tony, H. P., Dummer, R., Nestle, F., . . . Wilms, K. (1992). Gamma/delta receptor-expressing T-cell clones from a cutaneous T-cell lymphoma suppress hematopoiesis. Ann Hematol, 65(3), 111-115.

Zillikens, D., Ambach, A., Schuessler, M., Dummer, R., Hartmann, A. A., & Burg, G. (1992). The interleukin-2 receptor in lesions and serum of bullous pemphigoid. Arch Dermatol Res, 284(3), 141-145.

Zillikens, D., Blum, C., Dummer, R., Hartmann, A. A., & Burg, G. (1992). Serum levels of soluble interleukin-2 receptor in systemic and circumscribed scleroderma. Dermatology, 184(3), 233-234. doi:10.1159/000247555

Zillikens, D., Mehringer, A., Lechner, W., & Burg, G. (1992). Hypo- and hyperpigmented areas in incontinentia pigmenti. Reply by Zillikens et al. Am J Dermatopathol, 14(3), 288-289.

Ballmer-Weber, B. K., Widmer, M., & Burg, G. (1993). [Acetylsalicylic acid-induced generalized pustulosis]. Schweiz Med Wochenschr, 123(12), 542-546.

Becker, J. C., Schwinn, A., Dummer, R., Burg, G., & Brocker, E. B. (1993). Lesion-specific activation of cloned human tumor-infiltrating lymphocytes by autologous tumor cells: induction of proliferation and cytokine production. J Invest Dermatol, 101(1), 15-21.

Becker, J. C., Schwinn, A., Dummer, R., Burg, G., & Brocker, E. B. (1993). Tumour-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expression. Clin Exp Immunol, 91(1), 121-125.

Blum, C., Zillikens, D., Tony, H. P., Hartmann, A. A., & Burg, G. (1993). [Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus]. Hautarzt, 44(5), 290-295.

Burg, G. (1993). Collision dermatosis: angiolymphoid hyperplasia with eosinophilia developing within a congenital port wine nevus. Dermatology, 187(4), 293-295. doi:10.1159/000247272

Burg, G., Dommann, S., & Dummer, R. (1993). [Malignant lymphoma of the skin]. Ther Umsch, 50(12), 828-834.

Burg, G., Dummer, R., Cavegn, B., & Panizzon, R. (1993). [Malignant melanoma of the skin]. Ther Umsch, 50(12), 822-827.

Dummer, R., Becker, J. C., Eilles, C., Schafer, E., Borner, W., & Burg, G. (1993). T cells migrate to tumour sites after extracorporeal interleukin 2 stimulation and reinfusion in a patient with metastatic melanoma. Br J Dermatol, 128(4), 399-403.

Dummer, R., Burg, G., Nestle, F., & Kohl, O. (1993). Soluble interleukin-2 receptors and cutaneous T-cell lymphoma. Cancer, 71(11), 3793-3795.

Dummer, R., Kohl, O., Gillessen, J., Kagi, M., & Burg, G. (1993). Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation. Arch Dermatol, 129(4), 433-436.

Dummer, R., Krasovec, M., Roger, J., Sindermann, H., & Burg, G. (1993). Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study. J Am Acad Dermatol, 29(6), 963-970.

Dummer, R., Meyer, J. C., Ballmer-Weber, B. K., Muletta, S., Panizzon, R., & Burg, G. (1993). UVA suppresses shedding of ICAM-1 from interferon-gamma (IFN-gamma)-pretreated transformed keratinocytes. Arch Dermatol Res, 285(4), 230-232.

Elsner, P., & Burg, G. (1993). Irritant reactivity is a better risk marker for nickel sensitization than atopy. Acta Derm Venereol, 73(3), 214-216.

Encke, A., Hermanek, P., & Burg, G. (1993). [Report of the German-Speaking TNM Committee]. Zentralbl Chir, 118(5), 310.

Hafner, J., Panizzon, R., Bruckner-Tuderman, L., Wuthrich, B., Seger, R. A., & Burg, G. (1993). [Lupus erythematosus discoid-like dermatosis in a carrier of septic granulomatosis]. Hautarzt, 44(7), 452-456.

Krasovec, M., Elsner, P., & Burg, G. (1993). Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors. Dermatology, 186(4), 248-252. doi:10.1159/000247363

Krasovec, M., Widmer, M., Gilliet, F., & Burg, G. (1993). [A case from practice (275). Lupus vulgaris with scar-forming alopecia in florid pulmonary tuberculosis]. Schweiz Rundsch Med Prax, 82(33), 893-895.

Trueb, R. M., Bruckner-Tuderman, L., & Burg, G. (1993). Ectrodactyly-ectodermal dysplasia-clefting syndrome with scalp dermatitis. J Am Acad Dermatol, 29(3), 505-506.

Trueb, R. M., & Burg, G. (1993). [Unilateral "nevoid" spider nevi]. Vasa, 22(1), 82-85.

Trueb, R. M., & Burg, G. (1993). Acute generalized exanthematous pustulosis due to doxycycline. Dermatology, 186(1), 75-78. doi:10.1159/000247308

Trueb, R. M., & Burg, G. (1993). Idiopathic middermal elastolysis. Dermatology, 187(1), 62-66. doi:10.1159/000247201

Trueb, R. M., Elsner, P., & Burg, G. (1993). [Pseudomonas aeruginosa folliculitis after epilation]. Hautarzt, 44(2), 103-105.

Trueb, R. M., Panizzon, R. G., & Burg, G. (1993). Cutaneous ossification in Albright's hereditary osteodystrophy. Dermatology, 186(3), 205-209. doi:10.1159/000247347

Widmer, M., Reverdin, E., Kung, E., Vesti, B., Bollinger, A., Linke, R. P., & Burg, G. (1993). [Amyloidosis cutis nodularis atrophicans (Gottron)]. Hautarzt, 44(5), 319-323.

Wyss, M., Elsner, P., Wuthrich, B., & Burg, G. (1993). Allergic contact dermatitis from natural latex without contact urticaria. Contact Dermatitis, 28(3), 154-156.

Zillikens, D., Ambach, A., Zentner, A., Dummer, R., Schussler, M., Burg, G., & Brocker, E. B. (1993). Evidence for cell-mediated immune mechanisms in the pathology of pemphigus. Br J Dermatol, 128(6), 636-643.

Zillikens, D., Zentner, A., Burger, M., Hartmann, A. A., & Burg, G. (1993). [Pemphigus foliaceus caused by penicillamine]. Hautarzt, 44(3), 167-171.

Burg, G., Dummer, R., & Kerl, H. (1994). Classification of cutaneous lymphomas. Dermatol Clin, 12(2), 213-217.

Burg, G., Dummer, R., & Nestle, F. (1994). Distinct subtypes of subcutaneous T-cell lymphoma. Arch Dermatol, 130(8), 1073.

Burg, G., Schmid, M. H., Kung, E., Dommann, S., & Dummer, R. (1994). Semimalignant ("pseudolymphomatous") cutaneous B-cell lymphomas. Dermatol Clin, 12(2), 399-407.

Burg, G., Wursch, T., Fah, J., & Elsner, P. (1994). Eruptive hamartomatous clear-cell acanthomas. Dermatology, 189(4), 437-439. doi:10.1159/000246904

Burg, G., Zwingers, T., Staegemeir, E., & Santucci, M. (1994). Interrater and intrarater variabilities in the evaluation of cutaneous lymphoproliferative T-cell infiltrates. EORTC-Cutaneous Lymphoma Project Group. Dermatol Clin, 12(2), 311-314.

Dommann, S. N., Widmer, M., Dommann-Scherrer, C., Bernasconi, E., & Burg, G. (1994). [Actinobacillus actinomycetemcomitans isolated from a mycetoma (of the forearm)]. Hautarzt, 45(6), 402-405.

Dummer, R., Sigg-Zemann, S., Kalthof, K., Muletta, S., Meyer, J. C., & Burg, G. (1994). Various cytokines modulate ICAM-1 shedding on melanoma- and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sezary cell line by interferon-gamma. Dermatology, 189(2), 120-124. doi:10.1159/000246813

Jorg, B., Kerl, H., Thiers, B. H., Brocker, E. B., & Burg, G. (1994). Therapeutic approaches in cutaneous lymphoma. Dermatol Clin, 12(2), 433-441.

Lubbe, J., Kleihues, P., & Burg, G. (1994). [The tumor suppressor gene p53 and its significance for dermatology]. Hautarzt, 45(11), 741-745.

Lubbe, J., Reichel, M., Burg, G., & Kleihues, P. (1994). Absence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol, 102(5), 819-821.

Santucci, M., Burg, G., & Feller, A. C. (1994). Interrater and intrarater reliability of histologic criteria in early cutaneous T-cell lymphoma. An EORTC Cutaneous Lymphoma Project Group study. Dermatol Clin, 12(2), 323-327.

Schneider-Yin, X., Schafer, B. W., Mohr, P., Burg, G., & Minder, E. I. (1994). Molecular defects in erythropoietic protoporphyria with terminal liver failure. Hum Genet, 93(6), 711-713.

Schultz, E. S., Dummer, R., Becker, J. C., Zillikens, D., & Burg, G. (1994). Influence of various cytokines on the interleukin-2-dependent lysis of melanoma cells in vitro. Arch Dermatol Res, 286(2), 73-76.

Trueb, R., Burg, G., Bottani, A., & Schinzel, A. (1994). Ectodermal dysplasia with corkscrew hairs: observation of probable autosomal dominant tricho-odonto-onychodysplasia with syndactyly. J Am Acad Dermatol, 30(2 Pt 1), 289-290.

Trueb, R. M., Spycher, M. A., Schumacher, F., & Burg, G. (1994). [Pili torti et canaliculi in ectodermal dysplasia]. Hautarzt, 45(6), 372-377.

Widmer, J., Elsner, P., & Burg, G. (1994). Skin irritant reactivity following experimental cumulative irritant contact dermatitis. Contact Dermatitis, 30(1), 35-39.

Adams, V., Kempf, W., Schmid, M., Muller, B., Briner, J., & Burg, G. (1995). Absence of herpesvirus-like DNA sequences in skin cancers of non-immunosuppressed patients. Lancet, 346(8991-8992), 1715-1716.

Boni, R., Dummer, R., & Burg, G. (1995). [Are skin tumors on the increase?]. Schweiz Med Wochenschr, 125(35), 1619-1624.

Boni, R., Dummer, R., Dommann-Scherrer, C., Dommann, S., Zimmermann, D. R., Joller-Jemelka, H., & Burg, G. (1995). Necrotizing herpes zoster mimicking relapse of vasculitis in angioimmunoblastic lymphadenopathy with dysproteinaemia. Br J Dermatol, 133(6), 978-982.

Burg, G. (1995). Report from the president (V) 1992-1994. Am J Dermatopathol, 17(5), 534-537.

Burg, G., Dummer, R., Dommann, S., Nestle, F., & Nickoloff, B. (1995). Pathology of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am, 9(5), 961-995.

Buttner, P., Garbe, C., Bertz, J., Burg, G., d'Hoedt, B., Drepper, H., . . . et al. (1995). Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer, 75(10), 2499-2506.

Dommann, S. N., Dommann-Scherrer, C. C., Zimmerman, D., Dours-Zimmermann, M. T., Hassam, S., & Burg, G. (1995). Primary cutaneous T-cell-rich B-cell lymphoma. A case report with a 13-year follow-up. Am J Dermatopathol, 17(6), 618-624.

Dommann, S. N., Ziegler, T., Dommann-Schener, C. C., Meyer, J., Panizzon, R., & Burg, G. (1995). CD44v6 is a marker for systemic spread in cutaneous T-cell lymphomas. A comparative study between nodal and cutaneous lymphomas. J Cutan Pathol, 22(5), 407-412.

Dummer, R., Davis-Daneshfar, A., Dohring, C., Dobbeling, U., & Burg, G. (1995). [Strategies for gene therapy of melanoma]. Hautarzt, 46(5), 305-308.

Garbe, C., Buttner, P., Bertz, J., Burg, G., d'Hoedt, B., Drepper, H., . . . et al. (1995). Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer, 75(10), 2492-2498.

Garbe, C., Buttner, P., Bertz, J., Burg, G., d'Hoedt, B., Drepper, H., . . . et al. (1995). Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer, 75(10), 2484-2491.

Hafner, J., Haenseler, E., Ossent, P., Burg, G., & Panizzon, R. G. (1995). Benzidine stain for the histochemical detection of hemoglobin in splinter hemorrhage (subungual hematoma) and black heel. Am J Dermatopathol, 17(4), 362-367.

Hinnen, U., Elsner, P., & Burg, G. (1995). Assessment of skin irritancy by 2 short tests compared to acute irritation induced by sodium lauryl sulfate. Contact Dermatitis, 33(4), 236-239.

Krasovec, M., Elsner, P., & Burg, G. (1995). [Cowden's syndrome]. Hautarzt, 46(7), 472-476.

Lubbe, J., Schlupen, E. M., Fierz, W., Panizzon, R. G., & Burg, G. (1995). Identification of Borrelia afzelii in a juxta-articular fibroid nodule from a human immunodeficiency virus-positive patient with acrodermatitis chronica atrophicans. Arch Dermatol, 131(11), 1341-1342.

Steinert, H. C., Huch Boni, R. A., Buck, A., Boni, R., Berthold, T., Marincek, B., . . . von Schulthess, G. K. (1995). Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology, 195(3), 705-709. doi:10.1148/radiology.195.3.7753998

Trueb, R. M., Becker-Wegerich, P., Hafner, J., Wuthrich, B., & Burg, G. (1995). Relapsing eosinophilic perimyositis. Br J Dermatol, 133(1), 109-114.

Trueb, R. M., Borelli, S., Schmid-Grendelmeier, P., Panizzon, R. G., & Burg, G. (1995). [Overlap of Sjogren-lupus erythematosus syndrome]. Hautarzt, 46(7), 467-471.

Trueb, R. M., Hurlimann, A. F., & Burg, G. (1995). [Periarteritis nodosa cutanea. 20 years follow-up with leg pain, Raynaud syndrome and nail changes]. Hautarzt, 46(8), 568-572.

Allmann, K. H., Leu, H., Burg, G., & Hodler, J. (1996). Hereditary sensory and autonomic neuropathy type I (Thevenard's disease). Skeletal Radiol, 25(5), 501-504.

Boni, R., Davis-Daneshfar, A., Burg, G., Fuchs, D., & Wood, G. S. (1996). No detection of HTLV-I proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T-cell lymphoma. Br J Dermatol, 134(2), 282-284.

Boni, R., Doguoglu, A., Burg, G., Muller, B., & Dummer, R. (1996). MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma. J Am Acad Dermatol, 35(3 Pt 1), 416-418.

Boni, R., Huch-Boni, R. A., Steinert, H., von Schulthess, G. K., & Burg, G. (1996). Early detection of melanoma metastasis using fludeoxyglucose F 18 positron emission tomography. Arch Dermatol, 132(8), 875-876.

Boni, R., Steinert, H., Boni, R. A., Lichtensteiger, W., Dummer, R., Hartman, D. S., . . . Westera, G. (1996). Lack of expression of dopamine D2 receptors in malignant melanoma: evidence for interaction of iodobenzofurans with melanin. Dermatology, 193(3), 198-202. doi:10.1159/000246245

Burg, G., Dummer, R., Nestle, F. O., Doebbeling, U., & Haeffner, A. (1996). Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol, 132(5), 567-572.

Dommann, S. N., Dommann-Scherrer, C. C., Dours-Zimmermann, M. T., Zimmermann, D. R., Kural-Serbes, B., & Burg, G. (1996). Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas. Arch Dermatol Res, 288(4), 163-167.

Dummer, R., Heald, P. W., Nestle, F. O., Ludwig, E., Laine, E., Hemmi, S., & Burg, G. (1996). Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood, 88(4), 1383-1389.

Dummer, R., Nestle, F. O., & Burg, G. (1996). [Modern tumor therapy as seen in melanoma]. Praxis (Bern 1994), 85(50), 1609-1614.

Dummer, R., Posseckert, G., Sugamura, K., Grundmann, H., & Burg, G. (1996). Circulating interleukin-2 receptors are a group of multimeric proteins with immunoreactivity for interleukin-2 receptor alpha, beta, and gamma chains. J Interferon Cytokine Res, 16(4), 315-320. doi:10.1089/jir.1996.16.315

Dummer, R., Potoczna, N., Haffner, A. C., Zimmermann, D. R., Gilardi, S., & Burg, G. (1996). A primary cutaneous non-T, non-B CD4+, CD56+ lymphoma. Arch Dermatol, 132(5), 550-553.

Haffner, A. C., Zepter, K., Elsner, P., & Burg, G. (1996). Isolated delayed-type hypersensitivity to latex rubber. Contact Dermatitis, 35(4), 247-248.

Hafner, J., Bounameaux, H., Burg, G., & Brunner, U. (1996). Management of venous leg ulcers. Vasa, 25(2), 161-167.

Hafner, J., Brunner, U., & Burg, G. (1996). [Treatment guidelines for venous leg ulcers: causal therapy initiation and local wound treatment]. Ther Umsch, 53(4), 304-308.

Hurlimann, A. F., Panizzon, R. G., & Burg, G. (1996). Eruptive vellus hair cyst and steatocystoma multiplex: hybrid cysts. Dermatology, 192(1), 64-66. doi:10.1159/000246319

Kagi, M. K., Trueb, R., Wuthrich, B., & Burg, G. (1996). Confluent and reticulated papillomatosis associated with atopy. Successful treatment with topical urea and tretinoin. Br J Dermatol, 134(2), 381-382.

Kleinhans, M., Schmid-Grendelmeier, P., & Burg, G. (1996). [Levodopa and malignant melanoma--case report and review of the literature. A contribution to causal relationship between levodopa and the development of malignant melanoma]. Hautarzt, 47(6), 432-437.

Lubbe, J., Kormann, A., Adams, V., Hassam, S., Gratz, K. W., Panizzon, R. G., & Burg, G. (1996). HPV-11- and HPV-16-associated oral verrucous carcinoma. Dermatology, 192(3), 217-221. doi:10.1159/000246369

Potoczna, N., Boehncke, W. H., Nestle, F. O., Kuenzlen, C., Sterry, W., Burg, G., & Dummer, R. (1996). T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin. J Cutan Pathol, 23(4), 298-305.

Rajan, G. P., Seifert, B., Prummer, O., Joller-Jemelka, H. I., Burg, G., & Dummer, R. (1996). Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA. Arch Dermatol Res, 288(9), 543-548.

Wood, G. S., Hardman, D. L., Boni, R., Dummer, R., Kim, Y. H., Smoller, B. R., . . . Burg, G. (1996). Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Blood, 88(5), 1765-1770.

Boni, R., Burg, G., Doguoglu, A., Ilg, E. C., Schafer, B. W., Muller, B., & Heizmann, C. W. (1997). Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol, 137(1), 39-43.

Boni, R., Lichtensteiger, W., Steinert, H. C., Boni, R. A., Fruh, H., Dummer, R., . . . Burg, G. (1997). D1 dopamine receptors are not expressed in human melanoma. Melanoma Res, 7(2), 117-119.

Boni, R., Steinert, H., Huch Boni, R., Von Schulthess, G. K., Meyer, J., Dummer, R., . . . Westera, G. (1997). Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and results in patients. Br J Dermatol, 137(1), 96-100.

Camacho, F. M., Burg, G., Moreno, J. C., Campora, R. G., & Villar, J. L. (1997). Granulomatous slack skin in childhood. Pediatr Dermatol, 14(3), 204-208.

Davis-Daneshfar, A., Boni, R., von Wussow, P., Joller, H., Burg, G., & Dummer, R. (1997). Adjuvant immunotherapy in malignant melanoma: impact of antibody formation against interferon-alpha on immunoparameters in vivo. J Immunother, 20(3), 208-213.

Dobbeling, U., Dummer, R., Hess Schmid, M., & Burg, G. (1997). Lack of expression of the recombination activating genes RAG-1 and RAG-2 in cutaneous T-cell lymphoma: pathogenic implications. Clin Exp Dermatol, 22(5), 230-233.

Dommann, S. N., Dommann-Scherrer, C. C., Ziegler, T., Meyer, J., Trueb, R. M., Kundig, T., . . . Burg, G. (1997). Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas. Am J Dermatopathol, 19(4), 391-395.

Hinnen, U., Elsner, P., Barraud, M., & Burg, G. (1997). Foreign body granuloma of the penis caused by occupational glass fibre exposure. Genitourin Med, 73(6), 577-578.

Lubbe, J., Nakazawa, H., & Burg, G. (1997). [Telomerase]. Hautarzt, 48(9), 615-621.

Mandt, N., Krasovec, M., Ellgehausen, P., & Burg, G. (1997). [Cutaneous artefacts]. Schweiz Med Wochenschr, 127(38), 1579.

Meyer, J. C., Hassam, S., Dummer, R., Muletta, S., Dobbeling, U., Dommann, S. N., & Burg, G. (1997). A realistic approach to the sensitivity of PCR-DGGE and its application as a sensitive tool for the detection of clonality in cutaneous T-cell proliferations. Exp Dermatol, 6(3), 122-127.

Nestle, F. O., Haffner, A. C., Schmid, M. H., Dummer, R., & Burg, G. (1997). [Current therapy concepts in cutaneous T-cell lymphomas]. Schweiz Med Wochenschr, 127(8), 311-320.

Seelentag, W. K., Boni, R., Gunthert, U., Futo, E., Burg, G., Heitz, P. U., & Roth, J. (1997). Expression of CD44 isoforms and beta 1,6-branched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with metastatic potential. J Cutan Pathol, 24(4), 206-211.

Trueb, R. M., Pericin, M., Hafner, J., & Burg, G. (1997). [Tufted hair folliculitis]. Hautarzt, 48(4), 266-269.

Trueb, R. M., Pericin, M., Kohler, E., Barandun, J., & Burg, G. (1997). Necrotizing granulomatosis of the breast. Br J Dermatol, 137(5), 799-803.

Trueb, R. M., Pericin, M., Winzeler, B., Wuthrich, B., & Burg, G. (1997). Eosinophilic myositis/perimyositis: frequency and spectrum of cutaneous manifestations. J Am Acad Dermatol, 37(3 Pt 1), 385-391.

van Vliet, J. J., Vaessen, H. A., van den Burg, G., & Schothorst, R. C. (1997). Twenty-four-hour duplicate diet study 1994; nitrate and nitrite: method development and intake per person per day. Cancer Lett, 114(1-2), 305-307.

Waldmann, V., Kempf, W., Burg, G., & Dummer, R. (1997). [Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid]. Hautarzt, 48(4), 262-265.

Wimmer, I., Meyer, J. C., Seifert, B., Dummer, R., Flace, A., & Burg, G. (1997). Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy. Cancer Res, 57(22), 5073-5076.

Yue, F. Y., Dummer, R., Geertsen, R., Hofbauer, G., Laine, E., Manolio, S., & Burg, G. (1997). Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer, 71(4), 630-637.

Boni, R., Bantschapp, O., Muller, B., & Burg, G. (1998). c-myc is not useful as prognostic immunohistochemical marker in cutaneous melanoma. Dermatology, 196(3), 288-291. doi:10.1159/000017922

Boni, R., Matt, D., Burg, G., Tronnier, M., Vortmeyer, A., & Zhuang, Z. (1998). Ultraviolet-induced acute histological changes in irradiated nevi are not associated with allelic loss. Arch Dermatol, 134(7), 853-856.

Boni, R., Matt, D., Voetmeyer, A., Burg, G., & Zhuang, Z. (1998). Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation. J Invest Dermatol, 110(3), 215-217. doi:10.1046/j.1523-1747.1998.00109.x

Boni, R., Vortmeyer, A. O., Burg, G., Hofbauer, G., & Zhuang, Z. (1998). The PTEN tumour suppressor gene and malignant melanoma. Melanoma Res, 8(4), 300-302.

Boni, R., Vortmeyer, A. O., Pack, S., Park, W. S., Burg, G., Hofbauer, G., . . . Zhuang, Z. (1998). Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic angiofibromas. J Invest Dermatol, 111(3), 539-540. doi:10.1046/j.1523-1747.1998.00317.x

Boni, R., Vortmeyer, A. O., Stern, J. B., Burg, G., Hofbauer, G., & Zhuang, Z. (1998). Concordance of genetic changes in basal cell carcinoma and associated clusters of squamous cells. J Invest Dermatol, 111(1), 173-174. doi:10.1046/j.1523-1747.1998.00247.x

Burg, G. (1998). [Dermatology 1997: immune intervention making progress]. Schweiz Med Wochenschr, 128(1-2), 18-20.

Burg, G., Kempf, W., Hochli, M., Huwyler, T., & Panizzon, R. G. (1998). 'Tubular' epithelioid cell nevus: a new variant of Spitz's nevus. J Cutan Pathol, 25(9), 475-478.

Dobbeling, U., Dummer, R., Laine, E., Potoczna, N., Qin, J. Z., & Burg, G. (1998). Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood, 92(1), 252-258.

Dummer, R., Geertsen, R., Ludwig, E., Niederer, E., & Burg, G. (1998). Sezary syndrome, T-helper 2 cytokines and accessory factor-1 (AF-1). Leuk Lymphoma, 28(5-6), 515-522. doi:10.3109/10428199809058359

Dummer, R., Graf, P., Greif, C., & Burg, G. (1998). Treatment of vascular lesions using the VersaPulse variable pulse width frequency doubled neodymium:YAG laser. Dermatology, 197(2), 158-161. doi:10.1159/000017989

Dummer, R., Hauschild, A., Henseler, T., & Burg, G. (1998). Combined interferon-alpha and interleukin-2 as adjuvant treatment for melanoma. Lancet, 352(9131), 908-909.

Dummer, R., Kempf, W., & Burg, G. (1998). Pseudo-melanoma after laser therapy. Dermatology, 197(1), 71-73. doi:10.1159/000017962

Dummer, R., Nestle, F. O., Hofbauer, G., Boni, R., & Burg, G. (1998). [Therapy of cutaneous melanoma]. Ther Umsch, 55(8), 509-514.

Dummer, R., Yue, F. Y., Pavlovic, J., Geertsen, R., Dohring, C., Moelling, K., & Burg, G. (1998). Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10. Br J Cancer, 77(9), 1413-1419.

Ellgehausen, P., Elsner, P., & Burg, G. (1998). Drug-induced lichen planus. Clin Dermatol, 16(3), 325-332.

Geertsen, R. C., Hofbauer, G. F., Yue, F. Y., Manolio, S., Burg, G., & Dummer, R. (1998). Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions. J Invest Dermatol, 111(3), 497-502. doi:10.1046/j.1523-1747.1998.00305.x

Grob, M., Wyss, M., Spycher, M. A., Dommann, S., Schinzel, A., Burg, G., & Trueb, R. M. (1998). Histopathologic and ultrastructural study of lupus-like skin lesions in a patient with Bloom syndrome. J Cutan Pathol, 25(5), 275-278.

Hafner, J., Keusch, G., Wahl, C., & Burg, G. (1998). Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. Vasa, 27(3), 137-143.

Hofbauer, G. F., Dummer, R., Laine, E., & Burg, G. (1998). Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA. Arch Dermatol Res, 290(8), 458-461.

Kamarashev, J., Burg, G., Kempf, W., Hess Schmid, M., & Dummer, R. (1998). Comparative analysis of histological and immunohistological features in mycosis fungoides and Sezary syndrome. J Cutan Pathol, 25(8), 407-412.

Kempf, W., Dummer, R., Schmid, M. H., Fritz, T., Wuthrich, B., & Burg, G. (1998). Intralesional cisplatin for the treatment of cutaneous B-cell lymphoma. Arch Dermatol, 134(11), 1343-1345.

Kempf, W., Haeffner, A. C., Mueller, B., Panizzon, R. G., & Burg, G. (1998). Experts and gold standards in dermatopathology: qualitative and quantitative analysis of the self-assessment slide seminar at the 17th colloquium of the International Society of Dermatopathology. Am J Dermatopathol, 20(5), 478-482.

Kerl, H., Burg, G., Sterry, W., & Wolff, H. H. (1998). [Problems, responsibility and goals in dermatopathology]. Hautarzt, 49(7), 533-535.

Kleeman, D., Kempf, W., Burg, G., & Hafner, J. (1998). Cutaneous polyarteritis nodosa. Vasa, 27(1), 54-57.

Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., . . . Schadendorf, D. (1998). Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med, 4(3), 328-332.

Nestle, F. O., & Burg, G. (1998). [Persistent facial swelling of uncertain origin]. Schweiz Med Wochenschr, 128(51-52), 2056.

Nestle, F. O., Filgueira, L., Nickoloff, B. J., & Burg, G. (1998). Human dermal dendritic cells process and present soluble protein antigens. J Invest Dermatol, 110(5), 762-766. doi:10.1046/j.1523-1747.1998.00189.x

Villeneuve, P., Hafner, J., Prenosil, J. E., Elsner, P., & Burg, G. (1998). A novel culturing and grafting system for the treatment of leg ulcers. Br J Dermatol, 138(5), 849-851.

Boni, R., & Burg, G. (1999). [The atypical nevus: a risk situation?]. Schweiz Med Wochenschr, 129(22), 825-832.

Boni, R., Vortmeyer, A. O., Huang, S., Burg, G., Hofbauer, G., & Zhuang, Z. (1999). Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma. Melanoma Res, 9(3), 249-252.

Burg, G. (1999). [Malignant melanoma]. Ther Umsch, 56(6), 285.

Dummer, R., Nestle, F. O., Hofbauer, G., & Burg, G. (1999). [Systemic therapy of metastatic melanoma]. Ther Umsch, 56(6), 330-333. doi:10.1024/0040-5930.56.6.330

Dummer, R., Nestle, F. O., Niederer, E., Ludwig, E., Laine, E., Grundmann, H., . . . Burg, G. (1999). Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sezary syndrome. Arch Dermatol Res, 291(6), 307-311.

Fritz, T. M., Burg, G., & Hafner, J. (1999). Eyebrow reconstruction with free skin and hair-bearing composite graft. J Am Acad Dermatol, 41(6), 1008-1010.

Fuchs, D., Querings, K., Burg, G., & Boni, R. (1999). [Persistent erythema after total CO2 skin resurfacing]. Schweiz Med Wochenschr, 129(21), 813-817.

Geertsen, R., Zenklusen, R., Kamarashev, J., Burg, G., & Dummer, R. (1999). Inverse regulation of neuronal cellular adhesion molecule (NCAM) by IFN-gamma in melanoma cell cultures established from CNS lesions. Int J Cancer, 83(1), 135-140.

Haffner, A. C., Zepter, K., Fritz, T., Dummer, R., Lejeune, F. J., & Burg, G. (1999). Complete remission of advanced cutaneous leiomyosarcoma following isolated limb perfusion with high-dose tumour necrosis factor-alpha and melphalan. Br J Dermatol, 141(5), 935-936.

Hafner, J., & Burg, G. (1999). [Dermatological aspects in prevention and treatment of the diabetic foot syndrome]. Praxis (Bern 1994), 88(27-28), 1170-1177.

Hess Schmid, M., Dummer, R., Kempf, W., Hilty, N., & Burg, G. (1999). Mycosis fungoides with mucinosis follicularis in childhood. Dermatology, 198(3), 284-287. doi:10.1159/000018131

Kempf, W., Adams, V., Kleinhans, M., Burg, G., Panizzon, R. G., Campadelli-Fiume, G., & Nestle, F. O. (1999). Pityriasis rosea is not associated with human herpesvirus 7. Arch Dermatol, 135(9), 1070-1072.

Krasovec, M., & Burg, G. (1999). Nodular fasciitis (pseudotumor of the skin). Dermatology, 198(4), 431-433.

Nestle, F. O., Hofbauer, G., & Burg, G. (1999). Necrobiotic xanthogranuloma with monoclonal gammopathy of the IgG lambda type. Dermatology, 198(4), 434-435.

Nestle, F. O., Tun Kyi, A., Gilliet, M., Dummer, R., & Burg, G. (1999). [Vaccination therapy of malignant melanoma]. Ther Umsch, 56(6), 334-337. doi:10.1024/0040-5930.56.6.334

Rogalski, C., Dummer, R., & Burg, G. (1999). Immunomodulators in the treatment of cutaneous lymphoma. J Eur Acad Dermatol Venereol, 13(2), 83-90.

Schmid, M. H., Bird, P., Dummer, R., Kempf, W., & Burg, G. (1999). Tumor burden index as a prognostic tool for cutaneous T-cell lymphoma: a new concept. Arch Dermatol, 135(10), 1204-1208.

Shephard, S. E., Zogg, M., Burg, G., & Panizzon, R. G. (1999). Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood. Arch Dermatol Res, 291(9), 491-499.

Trueb, R. M., Scheidegger, E. P., Pericin, M., Singh, A., Hoffmann, U., Sauvant, G., & Burg, G. (1999). Periarteritis nodosa presenting as a breast lesion: report of a case and review of the literature. Br J Dermatol, 141(6), 1117-1121.

Yue, F. Y., Geertsen, R., Hemmi, S., Burg, G., Pavlovic, J., Laine, E., & Dummer, R. (1999). IL-12 directly up-regulates the expression of HLA class I, HLA class II and ICAM-1 on human melanoma cells: a mechanism for its antitumor activity? Eur J Immunol, 29(6), 1762-1773. doi:10.1002/(SICI)1521-4141(199906)29:06<1762::AID-IMMU1762>3.0.CO;2-F

Bader, U., Banyai, M., Boni, R., Burg, G., & Hafner, J. (2000). Leg ulcers in patients with myeloproliferative disorders: disease- or treatment-related? Dermatology, 200(1), 45-48. doi:10.1159/000018315

Bernand, S., Scheidegger, E. P., Dummer, R., & Burg, G. (2000). Multifocal fixed drug eruption to paracetamol, tropisetron and ondansetron induced by interleukin 2. Dermatology, 201(2), 148-150. doi:10.1159/000018459

Boni, R., & Burg, G. (2000). [Aging skin: physiological bases, preventive measures and therapeutic modalities]. Schweiz Med Wochenschr, 130(36), 1272-1278.

Boni, R., Burg, G., & Wirth, H. P. (2000). [Helicobacter pylori and skin diseases--a (still) intact myth?]. Schweiz Med Wochenschr, 130(37), 1305-1308.

Boni, R., Kreyden, O. P., & Burg, G. (2000). Revival of the use of botulinum toxin: application in dermatology. Dermatology, 200(4), 287-291. doi:10.1159/000018389

Boni, R., Xin, H., Kamarashev, J., Utzinger, E., Dummer, R., Kempf, W., . . . Burg, G. (2000). Allelic deletion at 9p21-22 in primary cutaneous CD30(+) large cell lymphoma. J Invest Dermatol, 115(6), 1104-1107. doi:10.1038/jid.2000.4

Burg, G., & Dummer, R. (2000). Historical perspective on the use of retinoids in cutaneous T-cell lymphoma (CTCL). Clin Lymphoma, 1 Suppl 1, S41-44.

Carrozza, P., Hausermann, P., Nestle, F. O., Burg, G., & Boni, R. (2000). Clinical efficacy of narrow-band UVB (311 nm) combined with dithranol in psoriasis. An open pilot study. Dermatology, 200(1), 35-39. doi:10.1159/000018312

Dummer, R., Bergh, J., Karlsson, Y., Horowitz, J. A., Mulder, N. H., Huinink, D. T. B., . . . Osanto, S. (2000). Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors. Cancer Gene Ther, 7(7), 1069-1076. doi:10.1038/sj.cgt.7700214

Dummer, R., & Burg, G. (2000). What's new in the treatment of melanoma? J Eur Acad Dermatol Venereol, 14(5), 337-339.

Dummer, R., Heinzerling, L., Schmid, M. H., & Burg, G. (2000). [Immuno-intervention in cutaneous lymphomas]. Praxis (Bern 1994), 89(37), 1471-1476.

Dummer, R., Hess-Schmid, M., & Burg, G. (2000). Cutaneous T-cell lymphomas: prognosis and quality-of-life issues. Clin Lymphoma, 1 Suppl 1, S21-25.

Dummer, R., Nestle, F. O., & Burg, G. (2000). [Immunotherapy of melanoma]. Dtsch Med Wochenschr, 125(41), 1240-1242. doi:10.1055/s-2000-7722

Dummer, R., Willers, J., Kamarashev, J., Urosevic, M., Dobbeling, U., & Burg, G. (2000). Pathogenesis of cutaneous lymphomas. Semin Cutan Med Surg, 19(2), 78-86.

Fritz, T. M., Burg, G., & Boni, R. (2000). Carpal tunnel syndrome with ulcerous skin lesions. Dermatology, 201(2), 165-167. doi:10.1159/000018464

Hafner, J., Botonakis, I., & Burg, G. (2000). A comparison of multilayer bandage systems during rest, exercise, and over 2 days of wear time. Arch Dermatol, 136(7), 857-863.

Hafner, J., Luthi, W., Hanssle, H., Kammerlander, G., & Burg, G. (2000). Instruction of compression therapy by means of interface pressure measurement. Dermatol Surg, 26(5), 481-486; discussion 487.

Hafner, J., Schaad, I., Schneider, E., Seifert, B., Burg, G., & Cassina, P. C. (2000). Leg ulcers in peripheral arterial disease (arterial leg ulcers): impaired wound healing above the threshold of chronic critical limb ischemia. J Am Acad Dermatol, 43(6), 1001-1008. doi:10.1067/mjd.2000.108375

Hafner, J., Schneider, E., Burg, G., & Cassina, P. C. (2000). Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease. J Vasc Surg, 32(2), 322-329. doi:10.1067/mva.2000.106942

Heinzerling, L., Dummer, R., Kempf, W., Schmid, M. H., & Burg, G. (2000). Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma. Arch Dermatol, 136(3), 374-378.

Heinzerling, L., Dummer, R., Wildberger, H., & Burg, G. (2000). Cutaneous ulceration after injection of polyethylene-glycol-modified interferon alpha associated with visual disturbances in a melanoma patient. Dermatology, 201(2), 154-157. doi:10.1159/000018461

Heinzerling, L. M., Urbanek, M., Funk, J. O., Peker, S., Bleck, O., Neuber, K., . . . Dummer, R. (2000). Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma. Cancer, 89(8), 1835-1844.

Hofbauer, G. F., Burg, G., & Nestle, F. O. (2000). Cocaine-related Stevens-Johnson syndrome. Dermatology, 201(3), 258-260. doi:10.1159/000018500

Hofbauer, G. F., Burg, G., & Nestle, F. O. (2000). [Sporotrichoid infection with Mycobacterium marinum: successful therapy with oral tetracycline administration]. Hautarzt, 51(5), 349-352.

Kamarashev, J., Dummer, R., Schmidt, M. H., Kempf, W., Kurrer, M. O., & Burg, G. (2000). Primary cutaneous T-cell-rich B-cell lymphoma and Hodgkin's disease in a patient with Gardner's syndrome. Dermatology, 201(4), 362-365. doi:10.1159/000051557

Kempf, W., Adams, V. V., Burg, G., Panizzon, R. G., Campadelli-Fiume, G., & Nestle, F. O. (2000). Is pityriasis rosea skin healthier than healthy skin? Arch Dermatol, 136(7), 932-934.

Kempf, W., & Burg, G. (2000). Pityriasis rosea--a virus-induced skin disease? An update. Arch Virol, 145(8), 1509-1520.

Kreyden, O. P., Boni, R., & Burg, G. (2000). [Type A botulinum toxin: a new methods in treating focal hyperhidrosis. A summary of various possibilities in hyperhidrosis therapy with special emphasis type A botulinum toxin injections]. Praxis (Bern 1994), 89(21), 909-915.

Kreyden, O. P., & Burg, G. (2000). [Toxin treatment of sweat pearls. A review of the treatment of hyperhidrosis with a special view of a new therapy option using botulinum toxin A]. Schweiz Med Wochenschr, 130(29-30), 1084-1090.

Kreyden, O. P., Geiges, M. L., Boni, R., & Burg, G. (2000). [Botulinum toxin: from poison to drug. A historical review]. Hautarzt, 51(10), 733-737.

Laetsch, B., Haffner, A. C., Dobbeling, U., Seifert, B., Ludwig, E., Burg, G., & Dummer, R. (2000). CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas. J Invest Dermatol, 114(1), 107-111. doi:10.1046/j.1523-1747.2000.00818.x

Matt, D., Xin, H., Vortmeyer, A. O., Zhuang, Z., Burg, G., & Boni, R. (2000). Sporadic trichoepithelioma demonstrates deletions at 9q22.3. Arch Dermatol, 136(5), 657-660.

Santucci, M., Biggeri, A., Feller, A. C., & Burg, G. (2000). Accuracy, concordance, and reproducibility of histologic diagnosis in cutaneous T-cell lymphoma: an EORTC Cutaneous Lymphoma Project Group Study. European Organization for Research and Treatment of Cancer. Arch Dermatol, 136(4), 497-502.

Santucci, M., Biggeri, A., Feller, A. C., Massi, D., & Burg, G. (2000). Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. European Organization for Research and Treatment of Cancer. Am J Surg Pathol, 24(1), 40-50.

Schaerer, L., Schmid, M. H., Mueller, B., Dummer, R. G., Burg, G., & Kempf, W. (2000). Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas. Am J Dermatopathol, 22(2), 140-143.

Schmid-Grendelmeier, P., Masenga, E. J., Haeffner, A., & Burg, G. (2000). Teledermatology as a new tool in sub-saharan Africa: an experience from Tanzania. J Am Acad Dermatol, 42(5 Pt 1), 833-835.

Yue, F. Y., Cao, L., Hemmi, S., Geertsen, R., Laine, E., Burg, G., & Dummer, R. (2000). Upregulation of interleukin-12 receptor on peripheral blood mononuclear cells and HLA class I, HLA class II or ICAM-1 on melanoma cells by B7.1 and interleukin-12: a mechanism for immunostimulatory impact of melanoma cells adenovirally transfected with B7.1 and IL12? Melanoma Res, 10(4), 313-322.

Bogdan, I., Burg, G., & Boni, R. (2001). Spitz nevi display allelic deletions. Arch Dermatol, 137(11), 1417-1420.

Bogdan, I., Xin, H., Burg, G., & Boni, R. (2001). Heterogeneity of allelic deletions within melanoma metastases. Melanoma Res, 11(4), 349-354.

Boni, R., Kargl, A., Kreyden, O. P., & Burg, G. (2001). [Treatment of hyperfunctional facial lines with botulinum toxin]. Praxis (Bern 1994), 90(34), 1408-1412.

Boni, R., Xin, H., Hohl, D., Panizzon, R., & Burg, G. (2001). Syringocystadenoma papilliferum: a study of potential tumor suppressor genes. Am J Dermatopathol, 23(2), 87-89.

Burg, G., Dummer, R., Haeffner, A., Kempf, W., & Kadin, M. (2001). From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol, 137(7), 949-952.

Burg, G., Kempf, W., & Dummer, R. (2001). Diagnostic signs of cutaneous lymphomas. J Eur Acad Dermatol Venereol, 15(4), 358-360.

Dummer, R., Bosch, U., Panizzon, R., Bloch, P. H., Burg, G., & Task Force 'Skin Cancer'. Swiss National Program against Cancer. Swiss Cancer, L. (2001). Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology, 203(1), 75-80. doi:10.1159/000051710

Dummer, R., Dobbeling, U., Geertsen, R., Willers, J., Burg, G., & Pavlovic, J. (2001). Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication. Blood, 97(2), 523-527.

Dummer, R., Nestle, F. O., & Burg, G. (2001). Report on the Eighth World Congress on Cancers of the Skin 18-21 July 2001, Zurich, Switzerland. Melanoma Res, 11(5), 549-550.

Dummer, R., Willers, J., Dobbeling, U., & Burg, G. (2001). [Current pathogenetic aspects of Sezary syndrome and mycosis fungoides]. Hautarzt, 52(3), 189-192.

Fritz, T. M., Burg, G., & Krasovec, M. (2001). [Allergic contact dermatitis to cosmetics containing Melaleuca alternifolia (tea tree oil)]. Ann Dermatol Venereol, 128(2), 123-126.

Gerlini, G., Hefti, H. P., Kleinhans, M., Nickoloff, B. J., Burg, G., & Nestle, F. O. (2001). Cd1d is expressed on dermal dendritic cells and monocyte-derived dendritic cells. J Invest Dermatol, 117(3), 576-582. doi:10.1046/j.0022-202x.2001.01458.x

Hofbauer, G. F., Dummer, R., Hafner, J., Burg, G., Binswanger, U., & Kempf, W. (2001). Skin cancers in organ transplant recipients: two cases of virus-induced neoplasms. Dermatology, 202(4), 359-361. doi:10.1159/000051683

Hofbauer, G. F., Geertsen, R., Laine, E., Burg, G., & Dummer, R. (2001). Impact of interferons on the expression of melanoma-associated antigens in melanoma short-term cell cultures. Melanoma Res, 11(3), 213-218.

Hofbauer, G. F., Kamarachev, J., Kempf, W., Burg, G., Pestalozzi, B. C., & Dummer, R. (2001). A CD4+ CD56+ natural killer-like T-cell systemic lymphoma with haemorrhagic cutaneous manifestations. Br J Dermatol, 144(2), 432-434.

Hofbauer, G. F., Kessler, B., Kempf, W., Nestle, F. O., Burg, G., & Dummer, R. (2001). Multilesional primary cutaneous diffuse large B-cell lymphoma responsive to antibiotic treatment. Dermatology, 203(2), 168-170. doi:10.1159/000051735

Kamarashev, J., Burg, G., Mingari, M. C., Kempf, W., Hofbauer, G., & Dummer, R. (2001). Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas. Am J Pathol, 158(5), 1593-1598. doi:10.1016/S0002-9440(10)64114-4

Kamarashev, J., Ferrone, S., Seifert, B., Boni, R., Nestle, F. O., Burg, G., & Dummer, R. (2001). TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis. Int J Cancer, 95(1), 23-28.

Kamarashev, J., Schaerer, L., Burg, G., Schmid, M. H., Muller, B., & Kempf, W. (2001). Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders. J Cutan Pathol, 28(9), 448-452.

Kempf, W., Kadin, M. E., Kutzner, H., Lord, C. L., Burg, G., Letvin, N. L., & Koralnik, I. J. (2001). Lymphomatoid papulosis and human herpesviruses--A PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses. J Cutan Pathol, 28(1), 29-33.

Kempf, W., Kazakov, D. V., & Burg, G. (2001). Applications of molecular virology to modern dermatopathology. Curr Top Pathol, 94, 39-47.

Kreyden, O. P., Borradori, L., Trueb, R. M., Burg, G., & Nestle, F. O. (2001). [Successful therapy with tetracycline and nicotinamide in cicatricial pemphigoid]. Hautarzt, 52(3), 247-250.

Kreyden, O. P., Hafner, J., Burg, G., & Nestle, F. O. (2001). [Case report on therapy with granulocyte stimulating factor in diabetic foot]. Hautarzt, 52(4), 327-330.

Kreyden, O. P., Schmid-Grendelmeier, P., & Burg, G. (2001). Idiopathic localized unilateral hyperhidrosis: case report of successful treatment with botulinum toxin type A and review of the literature. Arch Dermatol, 137(12), 1622-1625.

Nestle, F. O., & Burg, G. (2001). Bilateral carpal tunnel syndrome as a clue for the diagnosis of systemic amyloidosis. Dermatology, 202(4), 353-355. doi:10.1159/000051681

Qin, J. Z., Kamarashev, J., Zhang, C. L., Dummer, R., Burg, G., & Dobbeling, U. (2001). Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. J Invest Dermatol, 117(3), 583-589. doi:10.1046/j.0022-202x.2001.01436.x

Qin, J. Z., Zhang, C. L., Kamarashev, J., Dummer, R., Burg, G., & Dobbeling, U. (2001). Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood, 98(9), 2778-2783.

Rogalski, C., Hurlimann, A., Burg, G., Wuthrich, B., & Kempf, W. (2001). [Drug reaction to terbinafine simulating an acute generalized exanthematous pustulosis]. Hautarzt, 52(5), 444-448.

Roos, J., Hennig, I., Schwaller, J., Zbaren, J., Dummer, R., Burg, G., . . . Borisch, B. (2001). Expression of TCL1 in hematologic disorders. Pathobiology, 69(2), 59-66. doi:10.1159/000048758

Schmook, T., Burg, G., & Hafner, J. (2001). Surgical pearl: mini-incisions for the extraction of steatocystoma multiplex. J Am Acad Dermatol, 44(6), 1041-1042. doi:10.1067/mjd.2001.112351

Schmook, T., Hofbauer, G., Kempf, W., Burg, G., & Dummer, R. (2001). [Granulomatous slack skin: partial remission following intralesional administration of interferon-alpha and PUVA]. Hautarzt, 52(10 Pt 2), 985-988.

Schnorf, M., Helfenstein, U., Blum, A., Ellwanger, U., Garbe, C., Burg, G., & Dummer, R. (2001). [Manifestations of the "pretherapeutic phase" of malignant melanoma of the skin in Switzerland 1996-1998]. Praxis (Bern 1994), 90(50), 2193-2198.

Senti, G., Schmid, M. H., & Burg, G. (2001). [Multiple miliary osteomata cutis. Excision with "front lift" approach]. Hautarzt, 52(6), 522-525.

Storz, M., Zepter, K., Kamarashev, J., Dummer, R., Burg, G., & Haffner, A. C. (2001). Coexpression of CD40 and CD40 ligand in cutaneous T-cell lymphoma (mycosis fungoides). Cancer Res, 61(2), 452-454.

Urosevic, M., Kurrer, M. O., Kamarashev, J., Mueller, B., Weder, W., Burg, G., . . . Trojan, A. (2001). Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol, 159(3), 817-824. doi:10.1016/S0002-9440(10)61756-7

Willers, J., Haffner, A., Zepter, K., Storz, M., Urosevic, M., Burg, G., & Dummer, R. (2001). The interferon inhibiting cytokine IK is overexpressed in cutaneous T cell lymphoma derived tumor cells that fail to upregulate major histocompatibility complex class II upon interferon-gamma stimulation. J Invest Dermatol, 116(6), 874-879. doi:10.1046/j.1523-1747.2001.01339.x

Willers, J., Urosevic, M., Laine, E., Geertsen, R., Kundig, T., Burg, G., & Dummer, R. (2001). Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression. J Invest Dermatol, 117(6), 1498-1504. doi:10.1046/j.0022-202x.2001.01586.x

Boni, R., Schuster, C., Nehrhoff, B., & Burg, G. (2002). Epidemiology of skin cancer. Neuro Endocrinol Lett, 23 Suppl 2, 48-51.

Burg, G. (2002). Public education in skin cancer world-wide. Recent Results Cancer Res, 160, 3-6.

Burg, G., Kempf, W., Haeffner, A., Dobbeling, U., Nestle, F. O., Boni, R., . . . Dummer, R. (2002). From inflammation to neoplasia: new concepts in the pathogenesis of cutaneous lymphomas. Recent Results Cancer Res, 160, 271-280.

Carrozza, P. M., Kempf, W., Kazakov, D. V., Dummer, R., & Burg, G. (2002). A case of Sezary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphoma. Br J Dermatol, 147(3), 582-586.

Carrozza, P. M., Merlani, G. M., Burg, G., & Hafner, J. (2002). CO(2) laser surgery for extensive, cauliflower-like anogenital condylomata acuminata: retrospective long-term study on 19 HIV-positive and 45 HIV-negative men. Dermatology, 205(3), 255-259. doi:10.1159/000065844

Dummer, R., Kamarashev, J., Kempf, W., Haffner, A. C., Hess-Schmid, M., & Burg, G. (2002). Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: a CD8+ variant of mycosis fungoides? Arch Dermatol, 138(2), 199-203.

Erdmann, I., Scheidegger, E. P., Koch, F. K., Heinzerling, L., Odermatt, B., Burg, G., . . . Kundig, T. M. (2002). Fucosyltransferase VII-deficient mice with defective E-, P-, and L-selectin ligands show impaired CD4+ and CD8+ T cell migration into the skin, but normal extravasation into visceral organs. J Immunol, 168(5), 2139-2146.

Farshad, A., Burg, G., Panizzon, R., & Dummer, R. (2002). A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays. Br J Dermatol, 146(6), 1042-1046.

Haffner, A. C., Tassis, A., Zepter, K., Storz, M., Tureci, O., Burg, G., & Nestle, F. O. (2002). Expression of cancer/testis antigens in cutaneous T cell lymphomas. Int J Cancer, 97(5), 668-670.

Heinzerling, L., Dummer, R., Burg, G., & Schmid-Grendelmeier, P. (2002). Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient. Eur J Dermatol, 12(2), 194-197.

Heinzerling, L., Dummer, R., Pavlovic, J., Schultz, J., Burg, G., & Moelling, K. (2002). Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice. Exp Dermatol, 11(3), 232-240.

Heinzerling, L. M., Dummer, R., Panizzon, R. G., Bloch, P. H., Barbezat, R., Burg, G., & Task force 'swiss cancer' of the swiss cancer, l. (2002). Prevention campaign against skin cancer. Dermatology, 205(3), 229-233. doi:10.1159/000065848

Hofbauer, G. F., Boehler, A., Speich, R., Burg, G., & Nestle, F. O. (2002). Painless erythema of the hands associated with non-Hodgkin's lymphoma in a lung transplant recipient. J Am Acad Dermatol, 46(5 Suppl), S159-160.

Hofbauer, G. F., Boni, R., Simmen, D., Mihic, D., Nestle, F. O., Burg, G., & Dummer, R. (2002). Histological, immunological and molecular features of a nasal mucosa primary melanoma associated with nasal melanosis. Melanoma Res, 12(1), 77-82.

Kamarashev, J., Lor, P., Forster, A., Heinzerling, L., Burg, G., & Nestle, F. O. (2002). Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept. Dermatology, 205(2), 213-216. doi:10.1159/000063919

Kazakov, D. V., Belousova, I. E., Muller, B., Palmedo, G., Samtsov, A. V., Burg, G., & Kempf, W. (2002). Primary cutaneous plasmacytoma: a clinicopathological study of two cases with a long-term follow-up and review of the literature. J Cutan Pathol, 29(4), 244-248.

Kazakov, D. V., Burg, G., Dummer, R., & Kempf, W. (2002). Cutaneous lymphomas and pseudolymphomas: newly described entities. Recent Results Cancer Res, 160, 283-293.

Kazakov, D. V., Burg, G., Dummer, R., Palmedo, G., Muller, B., & Kempf, W. (2002). Primary subcutaneous follicular centre cell lymphoma with involvement of the galea: a case report and short review of the literature. Br J Dermatol, 146(4), 663-666.

Kazakov, D. V., Burg, G., & Kempf, W. (2002). Primary cutaneous B-cell lymphomas and pseudolymphomas: review of histopathological features. Cesk Patol, 38(4), 147-154.

Kazakov, D. V., Kempf, W., Michaelis, S., Schmid, U., Cogliatti, S., Dummer, R., & Burg, G. (2002). T-zone lymphoma with cutaneous involvement: a case report and review of the literature. Br J Dermatol, 146(6), 1096-1100.

Kazakov, D. V., Kutzner, H., Rutten, A., Dummer, R., Burg, G., & Kempf, W. (2002). Trichogerminoma: a rare cutaneous adnexal tumor with differentiation toward the hair germ epithelium. Dermatology, 205(4), 405-408. doi:10.1159/000066427

Kazakov, D. V., Mentzel, T., Burg, G., & Kempf, W. (2002). Superficial acral fibromyxoma: report of two cases. Dermatology, 205(3), 285-288. doi:10.1159/000065853

Kazakov, D. V., Prinz, B. M., Michaelis, S., Schmid, M., Muller, B., Adams, V., . . . Kempf, W. (2002). Study of HHV-8 DNA sequences in archival biopsies from lesional skin of Kaposi's sarcoma, various mesenchymal tumors and related reactive conditions. J Cutan Pathol, 29(5), 279-281.

Kempf, W., Haeffner, A. C., Zepter, K., Sander, C. A., Flaig, M. J., Mueller, B., . . . Burg, G. (2002). Angiolymphoid hyperplasia with eosinophilia: evidence for a T-cell lymphoproliferative origin. Hum Pathol, 33(10), 1023-1029.

Kempf, W., Levi, E., Kamarashev, J., Kutzner, H., Pfeifer, W., Petrogiannis-Haliotis, T., . . . Kadin, M. E. (2002). Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. J Cutan Pathol, 29(5), 295-300.

Knobler, R., Burg, G., Whittaker, S., & Baila, L. (2002). EORTC cutaneous lymphoma task force. European Organisation for Research and Treatment of Cancer. Eur J Cancer, 38 Suppl 4, S60-64.

Lor, P., Krueger, U., Kempf, W., Burg, G., & Nestle, F. O. (2002). Monoclonal rearrangement of the T cell receptor gamma-chain in lichenoid pigmented purpuric dermatitis of gougerot-blum responding to topical corticosteroid therapy. Dermatology, 205(2), 191-193. doi:10.1159/000063912

Rubben, A., Bogdan, I., Grussendorf-Conen, E. I., Burg, G., & Boni, R. (2002). Loss of heterozygosity and microsatellite instability in acquired melanocytic nevi: towards a molecular definition of the dysplastic nevus. Recent Results Cancer Res, 160, 100-110.

Schwab, C., Willers, J., Niederer, E., Ludwig, E., Kundig, T., Grob, P., . . . Dummer, R. (2002). The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas. Br J Haematol, 118(4), 1019-1026.

Urosevic, M., Willers, J., Mueller, B., Kempf, W., Burg, G., & Dummer, R. (2002). HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood, 99(2), 609-617.

Vonderheid, E. C., Bernengo, M. G., Burg, G., Duvic, M., Heald, P., Laroche, L., . . . Iscl. (2002). Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol, 46(1), 95-106.

Bader, U., Cipolat, C., & Burg, G. (2003). Dermatology online with interactive technology (DOIT). Curr Probl Dermatol, 32, 176-181.

Bogdan, I., Smolle, J., Kerl, H., Burg, G., & Boni, R. (2003). Melanoma ex naevo: a study of the associated naevus. Melanoma Res, 13(2), 213-217. doi:10.1097/01.cmr.0000056226.78713.99

Burg, G. (2003). [Herr Professor and Dr. of Medicine Urs Walter Schnyder on his 80th birthday]. J Dtsch Dermatol Ges, 1(2), 157-158.

Burg, G., & Denz, M. (2003). The Telemedical Information Society: doctors' playground or a contribution to the evolution of healthcare? Curr Probl Dermatol, 32, 2-5.

Burg, G., Kempf, W., Kazakov, D. V., Dummer, R., Frosch, P. J., Lange-Ionescu, S., . . . Kadin, M. E. (2003). Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature. Br J Dermatol, 148(3), 580-586.

Cipolat, C., Bader, U., Rufli, T., & Burg, G. (2003). Teledermatology in Switzerland. Curr Probl Dermatol, 32, 257-260.

Dragieva, G., Stahel, H. U., Meyer, M., Kempf, W., Haffner, A., Burg, G., & Hafner, J. (2003). Proteus syndrome. Vasa, 32(3), 159-163. doi:10.1024/0301-1526.32.3.159

Dummer, R., Beyeler, M., Morcinek, J., & Burg, G. (2003). [Cutaneous neoplasms]. Praxis (Bern 1994), 92(36), 1470-1478. doi:10.1024/0369-8394.92.36.1470

Dummer, R., Ivanova, K., Scheidegger, E. P., & Burg, G. (2003). Clinical and therapeutic aspects of polymorphous light eruption. Dermatology, 207(1), 93-95. doi:10.1159/000070956

Dummer, R., Kempf, W., Hess Schmid, M., Haffner, A., & Burg, G. (2003). Therapy of cutaneous lymphoma--current practice and future developments. Onkologie, 26(4), 366-372. doi:10.1159/000072098

Dummer, R., Urosevic, M., Hoek, K., Haffner, A., & Burg, G. (2003). Exploring primary cutaneous B-cell lymphoma by microarray technology. J Invest Dermatol, 120(5), vii-viii. doi:10.1046/j.1523-1747.2003.12151.x

Dummer, R., Urosevic, M., Kempf, W., Hoek, K., Hafner, J., & Burg, G. (2003). Imiquimod in basal cell carcinoma: how does it work? Br J Dermatol, 149 Suppl 66, 57-58.

Dummer, R., Urosevic, M., Kempf, W., Kazakov, D., & Burg, G. (2003). Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides. Dermatology, 207(1), 116-118. doi:10.1159/000070962

Gilliet, M., Kleinhans, M., Lantelme, E., Schadendorf, D., Burg, G., & Nestle, F. O. (2003). Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen. Blood, 102(1), 36-42. doi:10.1182/blood-2002-07-2274

Hauschild, A., Weichenthal, M., Balda, B. R., Becker, J. C., Wolff, H. H., Tilgen, W., . . . Dummer, R. (2003). Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis. J Clin Oncol, 21(15), 2883-2888. doi:10.1200/JCO.2003.07.116

Kazakov, D. V., Mentzel, T., Burg, G., Dummer, R., & Kempf, W. (2003). Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more? Br J Dermatol, 149(4), 869-876.

Kazakov, D. V., Schmid, M., Adams, V., Cathomas, G., Muller, B., Burg, G., & Kempf, W. (2003). HHV-8 DNA sequences in the peripheral blood and skin lesions of an HIV-negative patient with multiple eruptive dermatofibromas: implications for the detection of HHV-8 as a diagnostic marker for Kaposi's sarcoma. Dermatology, 206(3), 217-221. doi:10.1159/000068896

Kempf, W., Kadin, M. E., Dvorak, A. M., Lord, C. C., Burg, G., Letvin, N. L., & Koralnik, I. J. (2003). Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin. Carcinogenesis, 24(2), 301-306.

Kempf, W., Kettelhack, N., Duvic, M., & Burg, G. (2003). Topical and systemic retinoid therapy for cutaneous T-cell lymphoma. Hematol Oncol Clin North Am, 17(6), 1405-1419.

Kempf, W., Reichlin, S., & Burg, G. (2003). HistoClinC: a Web-based telemedicine application for clinicopathologic correlations in dermatopathology. Curr Probl Dermatol, 32, 213-220.

Kleinhans, M., Tun-Kyi, A., Gilliet, M., Kadin, M. E., Dummer, R., Burg, G., & Nestle, F. O. (2003). Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood, 101(4), 1487-1493. doi:10.1182/blood-2002-02-0475

Kropf, R., Cipolat, C., & Burg, G. (2003). Telemedicine in Europe. Curr Probl Dermatol, 32, 247-251.

Kropf, R., Cipolat, C., & Burg, G. (2003). Teleteaching tools in dermatology on the Web. Curr Probl Dermatol, 32, 33-38.

Lauchli, S., & Burg, G. (2003). Treatment of hyperhidrosis with botulinum toxin A. Skin Therapy Lett, 8(7), 1-4.

Lauchli, S., Kempf, W., Dragieva, G., Burg, G., & Hafner, J. (2003). CO2 laser treatment of warts in immunosuppressed patients. Dermatology, 206(2), 148-152. doi:10.1159/000068459

Maier, T., Tun-Kyi, A., Tassis, A., Jungius, K. P., Burg, G., Dummer, R., & Nestle, F. O. (2003). Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells. Blood, 102(7), 2338-2344. doi:10.1182/blood-2002-08-2455

Michaelis, S., Kazakov, D. V., Schmid, M., Dummer, R., Burg, G., & Kempf, W. (2003). Hepatitis C and G viruses in B-cell lymphomas of the skin. J Cutan Pathol, 30(6), 369-372.

Papp, K. A., Guenther, L., Boyden, B., Larsen, F. G., Harvima, R. J., Guilhou, J. J., . . . Chu, A. (2003). Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol, 48(1), 48-54. doi:10.1067/mjd.2003.130

Roberts, A. A., Amano, M., Felten, C., Galvan, M., Sulur, G., Pinter-Brown, L., . . . Baum, L. G. (2003). Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation. Mod Pathol, 16(6), 543-551. doi:10.1097/01.MP.0000071840.84469.06

Urosevic, M., Maier, T., Benninghoff, B., Slade, H., Burg, G., & Dummer, R. (2003). Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol, 139(10), 1325-1332. doi:10.1001/archderm.139.10.1325

Willers, J., Dummer, R., Kempf, W., Kundig, T., Burg, G., & Kadin, M. E. (2003). Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand. Clin Cancer Res, 9(7), 2744-2754.

Zagrodnik, B., Kempf, W., Seifert, B., Muller, B., Burg, G., Urosevic, M., & Dummer, R. (2003). Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer, 98(12), 2708-2714. doi:10.1002/cncr.11798

Zhang, C. L., Kamarashev, J., Qin, J. Z., Burg, G., Dummer, R., & Dobbeling, U. (2003). Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells. J Pathol, 200(2), 249-254. doi:10.1002/path.1341

Beyeler, M., Burg, G., & Dummer, R. (2004). [Cutaneous lymphoma]. Hautarzt, 55(10), 1005-1016; quiz 1017. doi:10.1007/s00105-004-0816-2

Beyeler, M., Kempf, W., Hafner, J., Burg, G., & Dummer, R. (2004). The spectrum of mesenchymal skin neoplasms reflected by the new WHO classification. Onkologie, 27(4), 401-406. doi:10.1159/000079097

Cozzio, A., Hafner, J., Kempf, W., Haffner, A., Palmedo, G., Michaelis, S., . . . Burg, G. (2004). Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity? J Am Acad Dermatol, 51(6), 1014-1017. doi:10.1016/j.jaad.2004.06.009

Dragieva, G., Hafner, J., Dummer, R., Schmid-Grendelmeier, P., Roos, M., Prinz, B. M., . . . Kempf, W. (2004). Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation, 77(1), 115-121. doi:10.1097/01.TP.0000107284.04969.5C

Dragieva, G., Prinz, B. M., Hafner, J., Dummer, R., Burg, G., Binswanger, U., & Kempf, W. (2004). A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol, 151(1), 196-200. doi:10.1111/j.1365-2133.2004.06054.x

Dummer, R., Hassel, J. C., Fellenberg, F., Eichmuller, S., Maier, T., Slos, P., . . . Urosevic, M. (2004). Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas. Blood, 104(6), 1631-1638. doi:10.1182/blood-2004-01-0360

Gerlini, G., Tun-Kyi, A., Dudli, C., Burg, G., Pimpinelli, N., & Nestle, F. O. (2004). Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol, 165(6), 1853-1863. doi:10.1016/S0002-9440(10)63238-5

Gilliet, M., Conrad, C., Geiges, M., Cozzio, A., Thurlimann, W., Burg, G., . . . Dummer, R. (2004). Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol, 140(12), 1490-1495. doi:10.1001/archderm.140.12.1490

Hafner, J., Schmid, M. H., Kempf, W., Burg, G., Kunzi, W., Meuli-Simmen, C., . . . Steinert, H. (2004). Baseline staging in cutaneous malignant melanoma. Br J Dermatol, 150(4), 677-686. doi:10.1111/j.0007-0963.2004.05870.x

Hasse, U., Kropf, R., & Burg, G. (2004). [Telemedicine in dermatology 2003: a review]. J Dtsch Dermatol Ges, 2(4), 294-300; quiz 301-292.

Hassel, J. C., Meier, R., Joller-Jemelka, H., Burg, G., & Dummer, R. (2004). Serological immunomarkers in cutaneous T cell lymphoma. Dermatology, 209(4), 296-300. doi:10.1159/000080852

Hofbauer, G. F., Burkhart, A., Schuler, G., Dummer, R., Burg, G., & Nestle, F. O. (2004). High frequency of melanoma-associated antigen or HLA class I loss does not correlate with survival in primary melanoma. J Immunother, 27(1), 73-78.

Kazakov, D. V., Burg, G., & Kempf, W. (2004). Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol, 18(4), 397-415. doi:10.1111/j.1468-3083.2004.00937.x

Kazakov, D. V., Kutzner, H., Rutten, A., Michal, M., Requena, L., Burg, G., . . . Kempf, W. (2004). The anti-MAGE antibody B57 as a diagnostic marker in melanocytic lesions. Am J Dermatopathol, 26(2), 102-107.

Kempf, W., Cathomas, G., Burg, G., & Trueb, R. M. (2004). Micronodular Kaposi's sarcoma - a new variant of classic-sporadic Kaposi's sarcoma. Dermatology, 208(3), 255-258. doi:10.1159/000077313

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., & Smoller, B. R. (2004). International board certification in dermatopathology: paving the way for the future. Am J Dermatopathol, 26(5), 439-440.

Lauchli, S., Zortea-Caflisch, C., Nestle, F. O., Burg, G., & Kempf, W. (2004). Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis. Dermatology, 208(3), 278-280. doi:10.1159/000077321

Liu, J. Y., Hafner, J., Dragieva, G., & Burg, G. (2004). Bioreactor microcarrier cell culture system (Bio-MCCS) for large-scale production of autologous melanocytes. Cell Transplant, 13(7-8), 809-816.

Liu, J. Y., Hafner, J., Dragieva, G., Seifert, B., & Burg, G. (2004). Autologous cultured keratinocytes on porcine gelatin microbeads effectively heal chronic venous leg ulcers. Wound Repair Regen, 12(2), 148-156. doi:10.1111/j.1067-1927.2004.012205.x

Meier, S., Baumert, B. G., Maier, T., Wellis, G., Burg, G., Seifert, B., & Dummer, R. (2004). Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie, 27(2), 145-149. doi:10.1159/000076903

Michaelis, S., Cozzio, A., Kempf, W., Graf, P., Burg, G., & Dummer, R. (2004). Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoides. Dermatology, 209(1), 72-74. doi:10.1159/000078595

Murer, K., Urosevic, M., Willers, J., Selvam, P., Laine, E., Burg, G., & Dummer, R. (2004). Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients. Melanoma Res, 14(4), 257-262.

Prinz, B. M., Hafner, J., Dummer, R., Burg, G., Bruswanger, U., & Kempf, W. (2004). Treatment of Bowen's disease with imiquimod 5% cream in transplant recipients. Transplantation, 77(5), 790-791.

Prinz, B. M., Michaelis, S., Kettelhack, N., Mueller, B., Burg, G., & Kempf, W. (2004). Subcutaneous infection with Mycobacterium abscessus in a renal transplant recipient. Dermatology, 208(3), 259-261. doi:10.1159/000077314

Prinz, B. M., Vavricka, S. R., Graf, P., Burg, G., & Dummer, R. (2004). Efficacy of laser treatment of tattoos using lasers emitting wavelengths of 532 nm, 755 nm and 1064 nm. Br J Dermatol, 150(2), 245-251.

Requena, L., Burg, G., Cerroni, L., & Zelger, B. W. (2004). A progressive papular eruption on the chest and back. Am J Dermatopathol, 26(2), 162-165.

Rubben, A., Kempf, W., Kadin, M. E., Zimmermann, D. R., & Burg, G. (2004). Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma. Exp Dermatol, 13(8), 472-483. doi:10.1111/j.0906-6705.2004.00176.x

Schuster, C., & Burg, G. (2004). [The red face]. Praxis (Bern 1994), 93(42), 1727-1732. doi:10.1024/0369-8394.93.42.1727

Urosevic, M., Kamarashev, J., Burg, G., & Dummer, R. (2004). Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2. Blood, 103(5), 1796-1798. doi:10.1182/blood-2003-10-3372

Urosevic, M., Oberholzer, P. A., Maier, T., Hafner, J., Laine, E., Slade, H., . . . Dummer, R. (2004). Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha? Clin Cancer Res, 10(15), 4959-4970. doi:10.1158/1078-0432.CCR-04-0193

  • Burg, G., Dummer, R., & Kempf, W. (2005). Dyscrasias with "undetermined significance". Arch Dermatol, 141(3), 382-384.

Burg, G., Hasse, U., Cipolat, C., Kropf, R., Djamei, V., Soyer, H. P., & Chimenti, S. (2005). Teledermatology: just cool or a real tool? Dermatology, 210(2), 169-173. doi:10.1159/000082573

Burg, G., Kempf, W., Cozzio, A., Feit, J., Willemze, R., E, S. J., . . . Whittaker, S. (2005). WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol, 32(10), 647-674. doi:10.1111/j.0303-6987.2005.00495.x

Dummer, R., Panizzon, R., Bloch, P. H., Burg, G., & Task Force Skin, C. (2005). Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology, 210(1), 39-44. doi:10.1159/000081482

Feit, J., Kempf, W., Jedlickova, H., & Burg, G. (2005). Hypertext atlas of dermatopathology with expert system for epithelial tumors of the skin. J Cutan Pathol, 32(6), 433-437. doi:10.1111/j.0303-6987.2005.00291.x

Gilliet, M., Cozzio, A., Burg, G., & Nestle, F. O. (2005). Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis. Br J Dermatol, 152(3), 531-536. doi:10.1111/j.1365-2133.2005.06434.x

Greisser, J., Doebbeling, U., Roos, M., Mueller, B., Schmid, M., Burg, G., . . . Kempf, W. (2005). Apoptosis in CD30-positive lymphoproliferative disorders of the skin. Exp Dermatol, 14(5), 380-385. doi:10.1111/j.0906-6705.2005.00293.x

Heinzerling, L., Burg, G., Dummer, R., Maier, T., Oberholzer, P. A., Schultz, J., . . . Moelling, K. (2005). Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. Hum Gene Ther, 16(1), 35-48. doi:10.1089/hum.2005.16.35

Hofbauer, G. F., Hatta, N., Daigle, I., Hemmi, S., Spanaus Schlapbach, K., Willers, J., . . . Dummer, R. (2005). Fas ligand reduces viability in primary melanoma short-term cell cultures more than in metastatic melanoma short-term cell cultures. Dermatology, 211(4), 318-324. doi:10.1159/000088500

Kempf, W., Kutzner, H., Kettelhack, N., Palmedo, G., & Burg, G. (2005). Paraneoplastic pityriasis lichenoides in cutaneous lymphoma: case report and review of the literature on paraneoplastic reactions of the skin in lymphoma and leukaemia. Br J Dermatol, 152(6), 1327-1331. doi:10.1111/j.1365-2133.2005.06457.x

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., Kutzner, H., & Sanguenza, O. (2005). International Board certification dermatopathology: a worldwide effort to rise standards in dermatopathology. J Dtsch Dermatol Ges, 3(4), 309-311.

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., Kutzner, H., & Sangueza, O. (2005). International Board Certification in Dermatopathology: a worldwide effort to raise standards in dermatopathology. Am J Dermatopathol, 27(4), 357-359.

Laetsch, B., Hofbauer, G., Kempf, W., Burg, G., & Dummer, R. (2005). Atypical poorly differentiated cutaneous T-cell lymphoma with an angiocentric growth pattern presenting histologically as vasculitis. Dermatology, 210(4), 341-345. doi:10.1159/000084763

Liu, J. Y., & Burg, G. (2005). An improved organ culture for regeneration of pure autologous keratinocytes from small split-thickness skin specimens. Dermatology, 210(1), 45-48. doi:10.1159/000081483

Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., . . . Gilliet, M. (2005). Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med, 202(1), 135-143. doi:10.1084/jem.20050500

Pimpinelli, N., Olsen, E. A., Santucci, M., Vonderheid, E., Haeffner, A. C., Stevens, S., . . . International Society for Cutaneous, L. (2005). Defining early mycosis fungoides. J Am Acad Dermatol, 53(6), 1053-1063. doi:10.1016/j.jaad.2005.08.057

Schraner, C., Hasse, B., Hasse, U., Baumann, D., Faeh, A., Burg, G., . . . Gunthard, H. F. (2005). Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1. Clin Infect Dis, 40(12), e120-124. doi:10.1086/430444

Urosevic, M., Braun, B., Willers, J., Burg, G., & Dummer, R. (2005). Expression of melanoma-associated antigens in melanoma cell cultures. Exp Dermatol, 14(7), 491-497. doi:10.1111/j.0906-6705.2005.00305.x

Urosevic, M., Conrad, C., Kamarashev, J., Asagoe, K., Cozzio, A., Burg, G., & Dummer, R. (2005). CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Hum Pathol, 36(9), 1020-1024. doi:10.1016/j.humpath.2005.07.002

Urosevic, M., Dummer, R., Conrad, C., Beyeler, M., Laine, E., Burg, G., & Gilliet, M. (2005). Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. J Natl Cancer Inst, 97(15), 1143-1153. doi:10.1093/jnci/dji207

Urosevic, M., Kempf, W., Zagrodnik, B., Panizzon, R., Burg, G., & Dummer, R. (2005). HLA-G expression in basal cell carcinomas of the skin recurring after radiotherapy. Clin Exp Dermatol, 30(4), 422-425. doi:10.1111/j.1365-2230.2005.01790.x

Willemze, R., Jaffe, E. S., Burg, G., Cerroni, L., Berti, E., Swerdlow, S. H., . . . Meijer, C. J. (2005). WHO-EORTC classification for cutaneous lymphomas. Blood, 105(10), 3768-3785. doi:10.1182/blood-2004-09-3502

Beyeler, M., Waldispuhl, S., Strobel, K., Joller-Jemelka, H. I., Burg, G., & Dummer, R. (2006). Detection of melanoma relapse: first comparative analysis on imaging techniques versus S100 protein. Dermatology, 213(3), 187-191. doi:10.1159/000095034

Burg, G., Kempf, W., Cozzio, A., Dobbeling, U., Feit, J., Golling, P., . . . Dummer, R. (2006). Cutaneous malignant lymphomas: update 2006. J Dtsch Dermatol Ges, 4(11), 914-933. doi:10.1111/j.1610-0387.2006.06069.x

Cozzio, A., Kempf, W., Schmid-Meyer, R., Gilliet, M., Michaelis, S., Scharer, L., . . . Dummer, R. (2006). Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma. Leuk Lymphoma, 47(5), 865-869. doi:10.1080/10428190500399698

Dummer, R., Hauschild, A., Skalsky, J., Burg, G., & Weichenthal, M. (2006). Bexarotene and systemic disease progression in CTCL? J Am Acad Dermatol, 55(2), 365-366; author reply 366. doi:10.1016/j.jaad.2006.01.022

Dummer, R., Urosevic, M., Cozzio, A., Asagoe, K., Dobbeling, U., & Burg, G. (2006). [Perspective of cutaneous lymphoma reserach]. J Dtsch Dermatol Ges, 4(6), 492-495. doi:10.1111/j.1610-0387.2006.05986.x

Goldinger, S. M., Dummer, R., Schmid, P., Prinz Vavricka, M., Burg, G., & Lauchli, S. (2006). Excimer laser versus narrow-band UVB (311 nm) in the treatment of psoriasis vulgaris. Dermatology, 213(2), 134-139. doi:10.1159/000093852

Greisser, J., Palmedo, G., Sander, C., Kutzner, H., Kazakov, D. V., Roos, M., . . . Kempf, W. (2006). Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders. J Cutan Pathol, 33(11), 711-715. doi:10.1111/j.1600-0560.2006.00560.x

Kazakov, D. V., Kutzner, H., Palmedo, G., Boudova, L., Michaelis, S., Michal, M., . . . Kempf, W. (2006). Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement. Am J Dermatopathol, 28(5), 399-409. doi:10.1097/01.dad.0000211514.98230.ba

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., Kutzner, H., & Sangueza, O. (2006). International Board Certification in Dermatopathology: a worldwide effort to raise standards in dermatopathology. J Cutan Pathol, 33(2), 156-159. doi:10.1111/j.0303-6987.2006.00390.x

Liu, J. Y., Hafner, J., Dragieva, G., & Burg, G. (2006). High yields of autologous living dermal equivalents using porcine gelatin microbeads as microcarriers for autologous fibroblasts. Cell Transplant, 15(5), 445-451.

Liu, J. Y., Hafner, J., Dragieva, G., & Burg, G. (2006). A novel bioreactor microcarrier cell culture system for high yields of proliferating autologous human keratinocytes. Cell Transplant, 15(5), 435-443.

Michaelis, S., Kazakov, D. V., Burg, G., Dummer, R., & Kempf, W. (2006). Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sezary syndrome. Int J Dermatol, 45(3), 277-279. doi:10.1111/j.1365-4632.2006.02378.x

Schadendorf, D., Ugurel, S., Schuler-Thurner, B., Nestle, F. O., Enk, A., Brocker, E. B., . . . DeCOG, D. C. s. g. o. t. (2006). Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol, 17(4), 563-570. doi:10.1093/annonc/mdj138

Dummer, R., Asagoe, K., Cozzio, A., Burg, G., Doebbeling, U., Golling, P., . . . Urosevic, M. (2007). Recent advances in cutaneous lymphomas. J Dermatol Sci, 48(3), 157-167. doi:10.1016/j.jdermsci.2007.09.001

Gachter, T., Muhleisen, B., Scharer, L., Dummer, R., Burg, G., & Hofbauer, G. F. (2007). Weight of decision-making impairs clinical assessment of melanocytic lesions. J Cutan Med Surg, 11(1), 9-18. doi:10.2310/7750.2007.00007

Goldinger, S. M., Dummer, R., Schmid, P., Burg, G., Seifert, B., & Lauchli, S. (2007). Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo. J Eur Acad Dermatol Venereol, 21(4), 504-508. doi:10.1111/j.1468-3083.2006.02016.x

Hafner, J., Fritz, T., Lauchli, S., Bogdan, I., Burg, G., & French, L. E. (2007). [Eyebrow repair after skin cancer surgery: combined naked and hairbearing full thickness graft from the contralateral retroauricular donor site]. J Dtsch Dermatol Ges, 5(11), 1034-1035. doi:10.1111/j.1610-0387.2007.06564.x

Kamarashev, J., Theler, B., Dummer, R., & Burg, G. (2007). Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation. Int J Dermatol, 46(9), 930-935. doi:10.1111/j.1365-4632.2007.03149.x

Muehleisen, B., Schaerer, L., Dummer, R., Burg, G., & Hofbauer, G. F. (2007). Cancer/testis antigen MAGE-A4 expression pattern differs in epithelial skin tumors of organ-transplant recipients and immunocompetent patients. J Cutan Pathol, 34(1), 1-6. doi:10.1111/j.1600-0560.2006.00576.x

Olsen, E., Vonderheid, E., Pimpinelli, N., Willemze, R., Kim, Y., Knobler, R., . . . Iscl/Eortc. (2007). Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood, 110(6), 1713-1722. doi:10.1182/blood-2007-03-055749

Burg, G. (2008). [E-Learning in medicine: at the top or a flop]. J Dtsch Dermatol Ges, 6(6), 435. doi:10.1111/j.1610-0387.2008.06789.x

Hofbauer, G. F., Baur, T., Bonnet, M. C., Tartour, E., Burg, G., Berinstein, N. L., & Dummer, R. (2008). Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate. Melanoma Res, 18(2), 104-111. doi:10.1097/CMR.0b013e3282f702cf

Kempf, W., Ostheeren-Michaelis, S., Paulli, M., Lucioni, M., Wechsler, J., Audring, H., . . . Treatment of, C. (2008). Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). Arch Dermatol, 144(12), 1609-1617. doi:10.1001/archdermatol.2008.46

Valentini, J., Grotto, D., Paniz, C., Roehrs, M., Burg, G., & Garcia, S. C. (2008). The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients. Biomed Pharmacother, 62(6), 378-382. doi:10.1016/j.biopha.2007.10.017

Burg, G., Soyer, H. P., & Chimenti, S. (2009). Skin diseases in Europe. Teledermatology. Eur J Dermatol, 19(6), 656-658. doi:10.1684/ejd.2009.0800

Kerl, H., Cerio, R., Burg, G., Anadolu, R. Y., Chimenti, S., & Forsea, D. (2009). Dermatopathology. Eur J Dermatol, 19(5), 536-537. doi:10.1684/ejd.2009.0785

Hafner, J., Nobbe, S., Partsch, H., Lauchli, S., Mayer, D., Amann-Vesti, B., . . . French, L. E. (2010). Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol, 146(9), 961-968. doi:10.1001/archdermatol.2010.224

Olsen, E. A., Whittaker, S., Kim, Y. H., Duvic, M., Prince, H. M., Lessin, S. R., . . . Treatment of, C. (2011). Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol, 29(18), 2598-2607. doi:10.1200/JCO.2010.32.0630

Tremp, M., Knafla, I., Burg, G., Wuthrich, B., & Schmid-Grendelmeier, P. (2011). 'EASIdig'--a digital tool to document disease activity in atopic dermatitis. Dermatology, 223(1), 68-73. doi:10.1159/000330333

Burg, G. (2012). History of sexually transmitted infections (STI). G Ital Dermatol Venereol, 147(4), 329-340.

Burg, G., & French, L. E. (2012). [The age of Gutenberg is over: a consideration of medical education--past, present and future]. Hautarzt, 63 Suppl 1, 38-44. doi:10.1007/s00105-011-2301-z

Hafner, J., French, L. E., Burg, G., & Schnyder, U. W. (2012). [To Prof. Dr. Dr. h.c. mult. Otto Braun-Falco: Birthday wishes and expression of appreciation from the Swiss Society for Dermatology and Venereology (SGDV)]. Hautarzt, 63 Suppl 1, 17. doi:10.1007/s00105-011-2308-5

Burg, G., French, L., & Hafner, J. (2013). [In memoriam: Prof. Dr. Dr. h.c. Urs Walter Schnyder: 7 February 1923-21 October 2012]. Hautarzt, 64(1), 65-66. doi:10.1007/s00105-012-2500-2

Pimmer, C., Linxen, S., Grohbiel, U., Jha, A. K., & Burg, G. (2013). Mobile learning in resource-constrained environments: a case study of medical education. Med Teach, 35(5), e1157-1165. doi:10.3109/0142159X.2012.733454

Burg, G. (2015). Systemic involvement in mycosis fungoides. Clin Dermatol, 33(5), 563-571. doi:10.1016/j.clindermatol.2015.05.008

Robson, A., Assaf, C., Bagot, M., Burg, G., Calonje, E., Castillo, C., . . . Berti, E. (2015). Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop. Histopathology, 67(4), 425-441. doi:10.1111/his.12371

Burg, G., & Finlay, A. Y. (2016). Web-based education. J Eur Acad Dermatol Venereol, 30(12), e226-e227. doi:10.1111/jdv.13560

 

Burg, G. (1969). [Protoporhyrinemic photodermatosis simulating hydroa aestivalia]. Dtsch Med Wochenschr, 94(25), 1314-1325.

Burg, G. (1969). [Protoporhyrinemic photodermatosis simulating hydroa aestivalia]. Dtsch Med Wochenschr, 94(25), 1314-1325.

Burg, G., Rassner, G., & Braun-Falco, O. (1969). [The effect of cyclophosphamide (Endoxan) on acute and chronic inflammation in the guinea pig]. Arch Klin Exp Dermatol, 236(1), 61-71.

Burg, G., Rassner, G., & Braun-Falco, O. (1969). [The effect of cyclophosphamide (Endoxan) on acute and chronic inflammation in the guinea pig]. Arch Klin Exp Dermatol, 236(1), 61-71.

Zaun, H., & Burg, G. (1969). [True twisted hair (Galewsky-Ronchese) with involvement of eyebrows and lanugo]. Asthet Med (Berl), 18(5), 95-100.

Zaun, H., & Burg, G. (1969). [True twisted hair (Galewsky-Ronchese) with involvement of eyebrows and lanugo]. Asthet Med (Berl), 18(5), 95-100.

Braun-Falco, O., & Burg, G. (1970). [Cytostatics and immunosuppressive agents in dermatology]. Hautarzt, 21(9), 391-397.

Braun-Falco, O., & Burg, G. (1970). [Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol, 236(3), 297-314.

Braun-Falco, O., & Burg, G. (1970). [Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. Arch Klin Exp Dermatol, 239(3), 307-322.

Braun-Falco, O., & Burg, G. (1970). [Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol, 236(2), 173-189.

Braun-Falco, O., & Burg, G. (1970). [Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol, 236(2), 173-189.

Braun-Falco, O., & Burg, G. (1970). [Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. Arch Klin Exp Dermatol, 239(3), 307-322.

Braun-Falco, O., & Burg, G. (1970). [Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol, 236(3), 297-314.

Braun-Falco, O., & Burg, G. (1970). [Cytostatics and immunosuppressive agents in dermatology]. Hautarzt, 21(9), 391-397.

Braun-Falco, O., Schmidt, D., & Burg, G. (1970). [Protoperphyrinaemic photodermatosis of the Quinckes's edema type]. Munch Med Wochenschr, 112(32), 1443-1447.

Braun-Falco, O., Schmidt, D., & Burg, G. (1970). [Protoperphyrinaemic photodermatosis of the Quinckes's edema type]. Munch Med Wochenschr, 112(32), 1443-1447.

Burg, G. (1970). [Erythropoietic protoporphyrinemic light dermatosis. Contribution to optical fluorescence demonstration, pathogenesis and therapy]. Dtsch Med Wochenschr, 95(20), 1120-1123. doi:10.1055/s-0028-1108598

Burg, G. (1970). [Erythropoietic protoporphyrinemic light dermatosis. Contribution to optical fluorescence demonstration, pathogenesis and therapy]. Dtsch Med Wochenschr, 95(20), 1120-1123. doi:10.1055/s-0028-1108598

Braun-Falco, O., & Burg, G. (1971). [Cytostatic and immunosuppressive treatment of dermatologic diseases]. Ther Ggw, 110(4), 488-500.

Braun-Falco, O., & Burg, G. (1971). [Dynamics of skin reaction following horn layer stripping. Histochemical and cytochemical studies on guinea pig ears]. Arch Dermatol Forsch, 241(1), 1-14.

Braun-Falco, O., & Burg, G. (1971). [Dynamics of skin reaction following horn layer stripping. Histochemical and cytochemical studies on guinea pig ears]. Arch Dermatol Forsch, 241(1), 1-14.

Braun-Falco, O., & Burg, G. (1971). [Cytostatic and immunosuppressive treatment of dermatologic diseases]. Ther Ggw, 110(4), 488-500.

Braun-Falco, O., Burg, G., & Schoefinius, H. H. (1971). [The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations]. Arch Dermatol Forsch, 241(3), 217-236.

Braun-Falco, O., Burg, G., & Schoefinius, H. H. (1971). [The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations]. Arch Dermatol Forsch, 241(3), 217-236.

Burg, G. (1971). [Therapy of porphyrias]. Dtsch Med Wochenschr, 96(21), 914-915. doi:10.1055/s-0028-1108358

Burg, G. (1971). [Therapy of porphyrias]. Dtsch Med Wochenschr, 96(21), 914-915. doi:10.1055/s-0028-1108358

Braun-Falco, O., Burg, G., & Farber, E. M. (1972). [Psoriasis. A questionnaire study of 536 patients]. Munch Med Wochenschr, 114(23), 1105-1110.

Braun-Falco, O., Burg, G., & Farber, E. M. (1972). [Psoriasis. A questionnaire study of 536 patients]. Munch Med Wochenschr, 114(23), 1105-1110.

Burg, G. (1972). [Therapy of porphyrias]. Minerva Med, 63(31), 1813-1815.

Burg, G. (1972). [Therapy of porphyrias]. Minerva Med, 63(31), 1813-1815.

Burg, G., & Braun-Falco, O. (1972). [Cytochemical studies on cellular stroma reaction in melanoma]. Arch Dermatol Forsch, 244, 261-264.

Burg, G., & Braun-Falco, O. (1972). The cellular stromal reaction in malignant melanoma. A cytochemical investigation. Arch Dermatol Forsch, 245(4), 318-333.

Burg, G., & Braun-Falco, O. (1972). The cellular stromal reaction in malignant melanoma. A cytochemical investigation. Arch Dermatol Forsch, 245(4), 318-333.

Burg, G., & Braun-Falco, O. (1972). [Cytochemical studies on cellular stroma reaction in melanoma]. Arch Dermatol Forsch, 244, 261-264.

Burg, G., & Plewig, G. (1972). [Seasonal pruritus as a symptom of erythropoietic protoporphyrinemic photodermatosis (EPL)]. Hautarzt, 23(12), 553-555.

Burg, G., & Plewig, G. (1972). [Seasonal pruritus as a symptom of erythropoietic protoporphyrinemic photodermatosis (EPL)]. Hautarzt, 23(12), 553-555.

Burg, G., & Robins, P. (1972). [Chemosurgery. Surgical removal of chemically fixed tumor tissue with microscopic control]. Hautarzt, 23(1), 16-20.

Burg, G., & Robins, P. (1972). [Chemosurgery. Surgical removal of chemically fixed tumor tissue with microscopic control]. Hautarzt, 23(1), 16-20.

Kolomiichenko, A. I., Kharshak, E. M., Lifanov, V. L., Burg, G. M., & Moroz, B. S. (1972). [Mobile audiometric laboratory]. Zh Ushn Nos Gorl Bolezn, 32(1), 103-104.

Kolomiichenko, A. I., Kharshak, E. M., Lifanov, V. L., Burg, G. M., & Moroz, B. S. (1972). [Mobile audiometric laboratory]. Zh Ushn Nos Gorl Bolezn, 32(1), 103-104.

Braun-Falco, O., & Burg, G. (1973). [Enzyme histochemistry of malignant melanoma. Investigations on primary tumors and metastases (author's transl)]. Arch Dermatol Forsch, 246(4), 303-316.

Braun-Falco, O., & Burg, G. (1973). [Enzyme histochemistry of malignant melanoma. Investigations on primary tumors and metastases (author's transl)]. Arch Dermatol Forsch, 246(4), 303-316.

Burg, G. (1973). [Erythropoetic, protoporphyrinemic light dermatosis with secondary cutaneous hyalinosis]. Hautarzt, 24(12), 564.

Burg, G. (1973). [Erythropoetic, protoporphyrinemic light dermatosis with secondary cutaneous hyalinosis]. Hautarzt, 24(12), 564.

Huhn, D., Burg, G., & Mempel, W. (1973). [Specific cutaneous changes in Hodgkin's disease (author's transl)]. Dtsch Med Wochenschr, 98(52), 2469-2472. doi:10.1055/s-0028-1107281

Huhn, D., Burg, G., & Mempel, W. (1973). [Specific cutaneous changes in Hodgkin's disease (author's transl)]. Dtsch Med Wochenschr, 98(52), 2469-2472. doi:10.1055/s-0028-1107281

Braun-Falco, O., & Burg, G. (1974). [Cellular infiltrate and capillaries in atopic dermatitis. Quantitative enzyme-cytochemical and histochemical investigations (author's transl)]. Arch Dermatol Forsch, 249(2), 113-124.

Braun-Falco, O., & Burg, G. (1974). [Cellular infiltrate and capillaries in atopic dermatitis. Quantitative enzyme-cytochemical and histochemical investigations (author's transl)]. Arch Dermatol Forsch, 249(2), 113-124.

Burg, G., & Braun-Falco, O. (1974). [Qualitative and quantitative aspects of the cellular reaction in the skin and blood in mycosis fungoides. A cytochemical study]. Hautarzt, 25(4), 178-187.

Burg, G., & Braun-Falco, O. (1974). [Advances in cytochemical differentiation of cellular infiltrates into the skin]. Hautarzt, 25(1), 1-8.

Burg, G., & Braun-Falco, O. (1974). [Advances in cytochemical differentiation of cellular infiltrates into the skin]. Hautarzt, 25(1), 1-8.

Burg, G., & Braun-Falco, O. (1974). [Qualitative and quantitative aspects of the cellular reaction in the skin and blood in mycosis fungoides. A cytochemical study]. Hautarzt, 25(4), 178-187.

Burg, G., & Dorn, M. (1974). [Chemosurgery of basaliomas]. Z Hautkr, 49(17), 713-714.

Burg, G., & Dorn, M. (1974). [Chemosurgery of basaliomas]. Z Hautkr, 49(17), 713-714.

Kerl, H., Burg, G., & Braun-Falco, O. (1974). Quantitative and qualitative dynamics of the epidermal and cellular inflammatory reaction in primary toxic and allergic dinitrochlorobenzene contact dermatitis in guinea pigs. Arch Dermatol Forsch, 249(3), 207-226.

Kerl, H., Burg, G., & Braun-Falco, O. (1974). Quantitative and qualitative dynamics of the epidermal and cellular inflammatory reaction in primary toxic and allergic dinitrochlorobenzene contact dermatitis in guinea pigs. Arch Dermatol Forsch, 249(3), 207-226.

Burg, G. (1975). [Procceedings: Hereditary onycholysis mit scleronychia]. Hautarzt, 26(7), 386.

Burg, G., & Braun-Falco, O. (1975). [T and B lymphocytes in skin changes of cutaneous lymphoma (author's transl)]. Dtsch Med Wochenschr, 100(50), 2562-2564. doi:10.1055/s-0028-1106585

Burg, G., & Braun-Falco, O. (1975). Classification and differentiation of cutaneous lymphomas. Enzyme-cytochemical and immunocytological studies. Br J Dermatol, 93(5), 597-599.

Burg, G., Hirsch, R. D., Konz, B., & Braun-Falco, O. (1975). Histographic surgery: accuracy of visual assessment of the margins of basal-cell epithelioma. J Dermatol Surg, 1(3), 21-24.

Falco, O. B., & Burg, G. (1975). [Lymphoreticular proliferations in the skin. Cytochemical and immunocytological studies in lymphadenosis benigna cutis]. Hautarzt, 26(3), 124-132.

Kerl, H., & Burg, G. (1975). [Acquired (postinflammatory) dermatchalasis, dermatitis herpetiformis Duhring, celiac syndrome, dermatochalasis]. Hautarzt, 26(4), 191-196.

Weber, K., Burg, G., Wolff, H. H., Braun-Falco, O., & Ehlers, G. (1975). [Sezary's syndrome. Case report]. Hautarzt, 26(5), 255-259.

Braun-Falco, O., & Burg, G. (1976). Proceedings: Enzyme cytochemical and immunocytological characterization of cutaneous lymphomas. Br J Dermatol, 95 Suppl 14, 9-10.

Braun-Falco, O., Burg, G., & Wolff, H. H. (1976). [Cutaneous lymphomas, and pseudolymphomas. Immunocytological, enzymocytochemical and electron microscopical studies (authors transl)]. Ther Umsch, 33(8), 543-550.

Burg, G. (1976). [Progress in the diagnosis of cutaneous lymphomas. Enzyme cytochemical and immunocytological studies]. Fortschr Med, 94(18), 1089-1098.

Burg, G., & Braun-Falco, O. (1977). [1-Chloro-2,4-dinitrobenzene ointment for sensitization, testing and therapy of malignant melanoma patients]. Dtsch Med Wochenschr, 102(6), 210-211.

Burg, G., & Braun-Falco, O. (1977). Morphological and functional differentiation and classification of cutaneous lymphomas. Bull Cancer, 64(2), 225-240.

Burg, G., & Braun-Falco, O. (1977). [Enzyme cytochemical and immunocytologic studies of mycosis fungoides]. Acta Histochem Suppl, Suppl 18, 209-214.

Burg, G., Rodt, H., Grosse-Wilde, H., Netzel, B., Fateh-Moghadam, A., & Braun-Falco, O. (1977). Enzymecytochemical and immunocytological studies as a basis for the revaluation of the histology of cutaneous B-cell and T-cell lymphomas. Haematol Blood Transfus, 20, 179-187.

Hofmann, C., Burg, G., Plewig, G., & Braun-Falco, O. (1977). [Photochemotherapy of cutaneous lymphoma: oral and local 8-MOP-UVA treatment (author's transl)]. Dtsch Med Wochenschr, 102(18), 675-679. doi:10.1055/s-0028-1104951

Schmoeckel, C., Burg, G., Wolf, H. H., & Braun-Falco, O. (1977). The ultrastructure of lymphadenosis benigna cutis (pseudolymphoma cutis). Arch Dermatol Res, 258(2), 161-167.

Bode, U., & Burg, G. (1978). [The acquired digital fibrokeratoma]. Hautarzt, 29(12), 659-660.

Braun-Falco, O., Guggenberger, K., Burg, G., & Fateh-Moghadam, A. (1978). [Immunocytoma simulating chronic acrodermatitis atrophicans]. Hautarzt, 29(12), 644-647.

Burg, G., & Braun-Falco, O. (1978). Cutaneous non-Hodgkin lymphoma: re-evaluation of histology using enzymecytochemical and immunologic studies. Int J Dermatol, 17(6), 496-505.

Burg, G., Braun-Falco, O., Hoffmann-Fezer, G., Rodt, H., & Schmoeckel, C. (1978). Patterns of cutaneous lymphomas. Histological, enzyme cytochemical, and immunological typing of lymphoreticular proliferations in the skin. Dermatologica, 157(5), 282-291.

Burg, G., Braun-Falco, O., & Schmoeckel, C. (1978). [Cutaneous T-cell lymphomas]. Fortschr Med, 96(5), 199-205.

Burg, G., Rodt, H., Grosse-Wilde, H., & Braun-Falco, O. (1978). Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sezary's syndrome. J Invest Dermatol, 70(5), 257-259.

Burg, G., Schmoeckel, C., Braun-Falco, O., & Wolff, H. H. (1978). Monocytic leukemia. Clinically appearing as 'malignant reticulosis of the skin'. Arch Dermatol, 114(3), 418-420.

Bonniger, F., & Burg, G. (1979). [Multiple keratoacanthomas]. Hautarzt, 30(2), 92-94.

Braun-Falco, O., Schmoeckel, C., Burg, G., & Ryckmanns, F. (1979). Pagetoid reticulosis. A further case report with a review of the literature. Acta Derm Venereol Suppl (Stockh), 59(85), 11-21.

Burg, G. (1979). [Reticuloses and lymphomas of the skin from the present viewpoint]. Hautarzt, 30(3), 167-168.

Butenschon, H., Burg, G., & Lentze, M. (1979). [LEOPARD syndrome]. Z Hautkr, 54(13), 613-618.

Kerl, H., & Burg, G. (1979). [Immunocytomas and immunoblastic lymphomas of the skin]. Hautarzt, 30(12), 666-672.

Kienitz, T., Burg, G., Schmoeckel, C., Weitz, H., & Braun-Falco, O. (1979). High-grade malignant lymphoma arising from Sezary's syndrome. A case report. Dermatologica, 158(2), 126-136.

Schmoeckel, C., Burg, G., & Braun-Falco, O. (1979). Quantitative analysis of lymphoid cells in cutaneous low-grade malignant B-cell lymphomas. Arch Dermatol Res, 266(3), 239-251.

Schmoeckel, C., Burg, G., & Braun-Falco, O. (1979). Quantitative analysis of lymphoid cells in myocosis fungoides, Sezary's syndrome and parapsoriasis en plaques. Arch Dermatol Res, 264(1), 17-28.

von Liebe, V., Karge, H. J., & Burg, G. (1979). [Contact urticaria]. Hautarzt, 30(10), 544-546.

Braun-Falco, O., Burg, G., Hoffmann-Fezer, G., Fateh-Moghadam, A., & Herterich, J. (1980). [Reticulosis of the skin - a heterogenic group of diseases]. Acta Histochem Suppl, 21, 57-69.

Braun-Falco, O., Burg, G., Selzle, D., & Schmoeckel, C. (1980). [Diffuse congenital melanosis]. Hautarzt, 31(6), 324-327.

Burg, G. (1980). [Enzyme cytochemical and immunological procedures for diagnosis of pseudolymphomas and skin lymphomas]. Z Hautkr, 55(20), 1351-1366.

Burg, G., Guggenberger, K., Schmoeckel, C., & Braun-Falco, O. (1980). [Therapy of mycosis fungoides]. Ther Ggw, 119(7), 773-790.

Kolz, R., Lonsdorf, G., & Burg, G. (1980). [Intolerance reactions following parenteral administration of vitamin B]. Hautarzt, 31(12), 657-659.

Schmoeckel, C., Braun-Falco, O., & Burg, G. (1980). [Atypical fibroxanthoma]. Hautarzt, 31(4), 213-215.

Braun-Falco, O., Burg, G., & Schmoeckel, C. (1981). Recent advances in the understanding of cutaneous lymphoma. Clin Exp Dermatol, 6(1), 89-109.

Burg, G. (1981). Malignant histiocytic disorders of the skin. Haematol Blood Transfus, 27, 221-224.

Burg, G., Hoffmann-Fezer, G., Nikolowski, J., Schmoeckel, C., Braun-Falco, O., & Stunkel, K. (1981). Lymphomatoid papulosis: a cutaneous T-cell pseudolymphoma. Acta Derm Venereol, 61(6), 491-496.

Landthaler, M., Burg, G., & Zirbs, S. (1981). [Dye and nickel allergy in the hairdressing salon]. Hautarzt, 32(6), 281-284.

Schmoeckel, C., Burg, G., Braun-Falco, O., & Klingmuller, G. (1981). [High-grade malignant mycosis fungoides with cytological transformation (author's transl)]. Ann Dermatol Venereol, 108(3), 231-236, 239-241.

Forg, T., Burg, G., & Zirbs, S. (1982). [Frequency of contact allergy in housewives (author's transl)]. Derm Beruf Umwelt, 30(2), 48-50.

Ring, J., Lonsdorf, G., Schury, W., & Burg, G. (1982). [Bee and wasp venom allergy. Clinical aspects, prevention and therapy]. MMW Munch Med Wochenschr, 124(24), 587-590.

Schmoeckel, C., Burg, G., Hoffmann-Fezer, G., Stolz, W., Weitz, H., Lohrs, U., & Braun-Falco, O. (1982). Cutaneous immunoblastic T-cell lymphoma. Arch Dermatol Res, 274(1-2), 141-154.

Braun-Falco, O., & Burg, G. (1983). [Malignant lymphomas of the skin]. Internist (Berl), 24(6), 306-320.

Braun-Falco, O., Nikolowski, J., Burg, G., & Schmoeckel, C. (1983). [Lymphomatoid papulosis. Review and personal observation of 4 patients]. Hautarzt, 34(2), 59-65.

Hoffmann, R., van de Graaff, S., & Burg, G. (1983). [Spread of tuberculosis in ornamental fishes]. Tierarztl Prax, 11(2), 261-267.

Kerl, H., Burg, G., & Hashimoto, K. (1983). Fatal, penicillin-induced, generalized, postinflammatory elastolysis (cutis laxa). Am J Dermatopathol, 5(3), 267-276.

Oehlschlaegel, G., Marquart, K. H., Steuer, G., & Burg, G. (1983). [Iatrogenic pseudotumor of the skin induced by polyvinyl pyrrolidone]. Hautarzt, 34(11), 555-560.

Przybilla, B., Burg, G., Schmoeckel, C., & Braun-Falco, O. (1983). Treatment of cutaneous T-cell lymphomas with TP-5. Evaluation of the clinical effect in 8 patients. Acta Derm Venereol, 63(6), 524-529.

Przybilla, B., Burg, G., & Thieme, C. (1983). Evaluation of the immune status in vivo by the 2,4-dinitro-1-chlorobenzene contact allergy time (DNCB-CAT). Dermatologica, 167(1), 1-5.

Przybilla, B., Ring, J., & Burg, G. (1983). [Anaphylaxis following ingestion of coffee, chronic urticaria and analgesics idiosyncrasy]. Hautarzt, 34(2), 73-76.

Ring, J., Bode, U., Kadach, U., Stix, E., & Burg, G. (1983). [Gammaglobulins and allergy. Clinical results of a controlled study with standard human IgG and placebo in pollinosis]. MMW Munch Med Wochenschr, 125(14), 289-292.

Stolz, W., Schmoeckel, C., Burg, G., & Braun-Falco, O. (1983). Circulating Sezary cells in the diagnosis of Sezary syndrome (quantitative and morphometric analyses). J Invest Dermatol, 81(4), 314-319.

Burg, G., Kerl, H., Kaudewitz, P., Braun-Falco, O., & Mason, D. Y. (1984). Immunoenzymatic typing of lymphoplasmacytoid skin infiltrates. J Dermatol Surg Oncol, 10(4), 284-290.

Burg, G., Kerl, H., Przybilla, B., & Braun-Falco, O. (1984). Some statistical data, diagnosis, and staging of cutaneous B-cell lymphomas. J Dermatol Surg Oncol, 10(4), 256-262.

Burg, G., Kerl, H., & Schmoeckel, C. (1984). Differentiation between malignant B-cell lymphomas and pseudolymphomas of the skin. J Dermatol Surg Oncol, 10(4), 271-275.

Eberth-Willershausen, W., Steger, O., Barran, W., Burg, G., Ryckmanns, F., & Kaudewitz, P. (1984). [Histiocytosis X. An oligosymptomatic form of Hand-Schuller-Christian disease with a new form and possibilities of diagnosis]. Hautarzt, 35(10), 539-542.

Geerts, M. L., Burg, G., Schmoeckel, C., & Braun-Falco, O. (1984). Alkaline phosphatase activity in non-Hodgkin's lymphomas and pseudolymphomas of the skin. J Dermatol Surg Oncol, 10(4), 306-312.

Geerts, M. L., Burg, G., Schmoeckel, C., & Braun-Falco, O. (1984). Alkaline phosphatase positive lymphoma. Dermatologica, 169(6), 342-347.

Kaudewitz, P., Burg, G., Klepzig, K., Munker, R., Rieber, P., & Braun-Falco, O. (1984). Cells reactive with anti-T-cell monoclonal antibodies in malignant cutaneous B-cell lymphomas and pseudolymphomas. J Dermatol Surg Oncol, 10(4), 313-314.

Kerl, H., & Burg, G. (1984). Histomorphology and cytomorphology of cutaneous B-cell lymphomas. J Dermatol Surg Oncol, 10(4), 266-270.

Burg, G., Kaudewitz, P., Klepzig, K., Przybilla, B., & Braun-Falco, O. (1985). Cutaneous B-cell lymphoma. Dermatol Clin, 3(4), 689-704.

Kaudewitz, P., Burg, G., Stein, H., Klepzig, K., Mason, D. Y., & Braun-Falco, O. (1985). Monoclonal antibody patterns in lymphomatoid papulosis. Dermatol Clin, 3(4), 749-757.

Maier, H., Schmoeckel, C., Burg, G., & Braun-Falco, O. (1985). Primary cutaneous atypical histiocytosis with possible dissemination. Am J Dermatopathol, 7(4), 373-382.

Schanne, R., Burg, G., & Braun-Falco, O. (1985). [Nosologic relation of dyskeratosis follicularis (Darier) and pemphigus benignus chronicus familiaris (Hailey-Hailey). Position based on a case report]. Hautarzt, 36(9), 504-508.

Smolle, J., Kaudewitz, P., Burg, G., Kresbach, H., & Kerl, H. (1985). Significance of non-lymphoid ('accessory') cells in malignant lymphomas and pseudolymphomas of the skin. Br J Dermatol, 113(6), 677-685.

Burg, G. (1986). [Pagetoid skin infiltrates]. Pathologe, 7(4), 199-206.

Burg, G., Klepzig, K., Kaudewitz, P., Wolf, H., & Braun-Falco, O. (1986). Acyclovir in lymphomatoid papulosis and mycosis fungoides. JAMA, 256(2), 214-215.

Burg, G., Klepzig, K., Kaudewitz, P., Wolff, H., & Braun-Falco, O. (1986). [Acyclovir in mycosis fungoides and lymphomatoid papulosis]. Hautarzt, 37(10), 533-536.

Hofmann, C., Burg, G., & Jung, C. (1986). [Cutaneous side effects of gold therapy. Clinical and histologic results]. Z Rheumatol, 45(3), 100-106.

Imai, S., Burg, G., & Braun-Falco, O. (1986). Mycosis fungoides and Sezary's syndrome show distinct histomorphological features. Dermatologica, 173(3), 131-135.

Kaudewitz, P., Burg, G., Smolle, J., & Braun-Falco, O. (1986). [Immunologic phenotyping of cutaneous lymphomas]. Hautarzt, 37(12), 647-655.

Kaudewitz, P., Soldner, R., Burg, G., Bieber, T., Berger, C., Edelson, R., . . . Braun-Falco, O. (1986). Reactivity of monoclonal antibody BE 2 in different stages of mycosis fungoides and in benign dermal infiltrates. Arch Dermatol Res, 279(2), 83-88.

Kaudewitz, P., Stein, H., Burg, G., Mason, D. Y., & Braun-Falco, O. (1986). Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1. J Invest Dermatol, 86(4), 350-354.

Bieber, T., Ruzicka, T., & Burg, G. (1987). [Erosive pustulous dermatitis of the scalp]. Hautarzt, 38(11), 687-689.

Burg, G., Stunkel, K. G., Bieber, T., Opitz, U., & Kaudewitz, P. (1987). Cutaneous infiltrates of histiocytosis X contain plasminogen activator-bearing epidermotropic dendritic cells different from Langerhans cells. Arch Dermatol Res, 279 Suppl, S88-91.

Hofmann, C., Richter, W., Hiller, C., & Burg, G. (1987). [Urticaria vasculitis]. Z Rheumatol, 46(5), 233-236.

Kaudewitz, P., Burg, G., Majiewski, G., Gerdes, J., Schwarting, R., & Braun-Falco, O. (1987). Cell populations in pagetoid reticulosis: an immunological study using cell activation associated monoclonal antibodies. Acta Derm Venereol, 67(1), 24-29.

Ruzicka, T., & Burg, G. (1987). Effects of chronic intracutaneous administration of arachidonic acid and its metabolites. Induction of leukocytoclastic vasculitis by leukotriene B4 and 12-hydroxyeicosatetraenoic acid and its prevention by prostaglandin E2. J Invest Dermatol, 88(2), 120-123.

Smolle, J., Kaudewitz, P., Aberer, E., Torne, R., Burg, G., & Kerl, H. (1987). [Immunohistochemical classification of cutaneous lymphomas and pseudolymphomas]. Hautarzt, 38(8), 461-466.

Burg, G., Bieber, T., & Langecker, P. (1988). [Localized neutrophilic eccrine hydradenitis in mitoxantrone therapy: a typical side-effect of cytostatic drugs]. Hautarzt, 39(4), 233-236.

Burg, G., & Landthaler, M. (1988). [Proliferating tricholemmal tumor]. Hautarzt, 39(2), 117-119.

Burg, G., von der Helm, D., Kaudewitz, P., Klepzig, K., & Braun-Falco, O. (1988). Antihuman T-cell leukemia/lymphoma virus antibodies in three patients with primary cutaneous B-cell lymphoma. J Dermatol Surg Oncol, 14(6), 653-656.

Eckert, F., Burg, G., Braun-Falco, O., Schmid, U., & Gloor, F. (1988). Immunostaining in atypical fibroxanthoma of the skin. Pathol Res Pract, 184(1), 27-34. doi:10.1016/S0344-0338(88)80187-0

Eckert, F., Hein, R., Krieg, T., & Burg, G. (1988). [Local recurrent centroblastic lymphoma of the skin]. Hautarzt, 39(12), 791-794.

Enders, F., Przybilla, B., Ring, J., Burg, G., & Braun-Falco, O. (1988). [Epicutaneous testing with a standard series. Results in 12,026 patients]. Hautarzt, 39(12), 779-786.

Gollhausen, R., Enders, F., Przybilla, B., Burg, G., & Ring, J. (1988). Trends in allergic contact sensitization. Contact Dermatitis, 18(3), 147-154.

Kampgen, E., Burg, G., & Wank, R. (1988). Association of herpes simplex virus-induced erythema multiforme with the human leukocyte antigen DQw3. Arch Dermatol, 124(9), 1372-1375.

Schmoeckel, C., & Burg, G. (1988). Congenital spiradenoma. Am J Dermatopathol, 10(6), 541-545.

Schrallhammer, K., Burg, G., Stolz, W., & Braun-Falco, O. (1988). [Congenital poikiloderma with verrucous hyperkeratosis. An unusual form of Thomson's syndrome?]. Hautarzt, 39(3), 143-148.

von der Helm, D., von der Helm, K., Burg, G., Braun-Falco, O., & Deinhardt, F. (1988). [Antibodies against HTLV I in T-lymphoproliferative diseases of the skin]. Hautarzt, 39(6), 348-350.

Burg, G., & Bergner, T. (1989). Pigmentary disorders associated with nutritional deficiency states. Clin Dermatol, 7(2), 36-43.

Burg, G., Vieluf, D., Stolz, W., Landthaler, M., & Braun-Falco, O. (1989). [Malignant atrophic papulosis (Kohlmeier-Degos disease)]. Hautarzt, 40(8), 480-485.

Eckert, F., Schmid, U., Kaudewitz, P., Burg, G., & Braun-Falco, O. (1989). Follicular lymphoid hyperplasia of the skin with high content of Ki-1 positive lymphocytes. Am J Dermatopathol, 11(4), 345-352.

Hackel, H., Burg, G., Lechner, W., Stolz, W., Ring, J., & Braun-Falco, O. (1989). [Keratoacanthoma centrifugum marginatum]. Hautarzt, 40(12), 763-766.

Hartmann, A. A., & Burg, G. (1989). [Fulminant acne in Klinefelter syndrome treated with testosterone. A side effect of anti-tallness therapy]. Monatsschr Kinderheilkd, 137(8), 466-467.

Kaudewitz, P., Stein, H., Dallenbach, F., Eckert, F., Bieber, K., Burg, G., & Braun-Falco, O. (1989). Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics. Am J Pathol, 135(2), 359-367.

Kleber, R., Landthaler, M., & Burg, G. (1989). [Post-zoster granuloma anulare]. Hautarzt, 40(2), 110-111.

Pierard-Franchimont, C., Burg, G., Grosshans, E., Kerl, H., & Pierard, G. E. (1989). [Prevalence of skin cancers in the Mosane region and in European countries of the same latitude]. Rev Med Liege, 44(18), 541-545.

Stolz, W., Graubner, U., Gerstmeier, J., Burg, G., & Belohradsky, B. H. (1989). Chediak-Higashi syndrome: approaches in diagnosis and treatment. Curr Probl Dermatol, 18, 93-100.

Braun-Falco, O., Burg, G., & Vieluf, D. (1990). [History of the Munich Dermatology Society]. Hautarzt, 41(5), 290-294.

Burg, G., & Kaudewitz, P. (1990). Where are we today in the diagnosis of cutaneous lymphoma? Curr Probl Dermatol, 19, 90-104.

Burg, G., & Sobetzko, R. (1990). [Florid oral papillomatosis: an indication for etretinate?]. Hautarzt, 41(6), 314-316.

Cavey, D., Bouclier, M., Burg, G., Delamadeleine, F., & Hensby, C. N. (1990). The pharmacological modulation of delayed type hypersensitivity (DTH) reactions to topical oxazolone in mouse skin. Agents Actions, 29(1-2), 65-67.

Dummer, R., Welters, H., Keilholz, U., Tilgen, W., & Burg, G. (1990). [Interleukin 2: immunologic background and clinical use in tumor therapy]. Hautarzt, 41(2), 53-55.

Elsner, P., Hartmann, A. A., & Burg, G. (1990). [Experiences with oxytetracycline treatment of non-gonorrhea urethritis caused by Ureaplasma urealyticum]. Hautarzt, 41(2), 94-97.

Encke, A., Hermanek, P., & Burg, G. (1990). [News on TNM consultation activity of the German Language Committee]. Leber Magen Darm, 20(1), 47.

Hackel, H., Hartmann, A. A., Elsner, P., & Burg, G. (1990). Prevalence of Ureaplasma urealyticum in the urethra of men without urethritis in relation to clinical diagnosis. Dermatologica, 180(2), 76-78.

Hackel, H., Zillikens, D., Lechner, W., & Burg, G. (1990). [Unusual manifestation of scleroderma of the trunk]. Hautarzt, 41(2), 91-93.

Kaudewitz, P., Burg, G., & Stein, H. (1990). Ki-1 (CD30) positive cutaneous anaplastic large cell lymphomas. Curr Probl Dermatol, 19, 150-156.

Kaudewitz, P., Stein, H., Plewig, G., Schwarting, R., Gerdes, J., Burg, G., . . . Braun-Falco, O. (1990). Hodgkin's disease followed by lymphomatoid papulosis. Immunophenotypic evidence for a close relationship between lymphomatoid papulosis and Hodgkin's disease. J Am Acad Dermatol, 22(6 Pt 1), 999-1006.

Sepp, N., Schuler, G., Romani, N., Geissler, D., Gattringer, C., Burg, G., . . . Fritsch, P. (1990). "Intravascular lymphomatosis" (angioendotheliomatosis): evidence for a T-cell origin in two cases. Hum Pathol, 21(10), 1051-1058.

Stolz, W., Vogt, T., Braun-Falco, O., Abmayr, W., Eckert, F., Kaudewitz, P., . . . Burg, G. (1990). Differentiation between lymphomas and pseudolymphomas of the skin by computerized DNA-image cytometry. J Invest Dermatol, 94(2), 254-260.

Weiss, J., Garbe, C., Bertz, J., Biltz, H., Burg, G., Hennes, B., . . . et al. (1990). [Risk factors for the development of malignant melanoma in West Germany. Results of a multicenter-case control study]. Hautarzt, 41(6), 309-313.

Zillikens, D., Miller, K., Hartmann, A. A., & Burg, G. (1990). IgA pemphigus foliaceus: a case report. Dermatologica, 181(4), 304-307.

Bastian, B. C., & Burg, G. (1991). [Computer networks in clinical practice--a histology data bank system]. Hautarzt, 42(6), 376-379.

Bastian, B. C., Romisch, J., Paques, E. P., & Burg, G. (1991). [Lipocortins and phospholipases: new aspects in the physiology of glucocorticosteroid effect]. Hautarzt, 42(7), 417-423.

Becker, J. C., Dummer, R., Hartmann, A. A., Burg, G., & Schmidt, R. E. (1991). Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol, 147(12), 4398-4401.

Burg, G., Dummer, R., Wilhelm, M., Nestle, F., Ott, M. M., Feller, A., . . . Wiede, J. (1991). A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med, 325(15), 1078-1081. doi:10.1056/NEJM199110103251506

Burg, G., & Kerl, H. (1991). Seminars in diagnostic pathology. Introduction. Semin Diagn Pathol, 8(2), 53-54.

Dummer, R., Muller, W., Nestle, F., Wiede, J., Dues, J., Lechner, W., . . . Burg, G. (1991). Formation of neutralizing antibodies against natural interferon-beta, but not against recombinant interferon-gamma during adjuvant therapy for high-risk malignant melanoma patients. Cancer, 67(9), 2300-2304.

Dummer, R., Schafer, E., Eilles, C., Borner, W., & Burg, G. (1991). Lymphokine-activated killer-cell traffic in metastatic melanoma. Lancet, 338(8764), 456-457.

Dunkel, F. G., Elsner, P., & Burg, G. (1991). Contact allergies to topical corticosteroids: 10 cases of contact dermatitis. Contact Dermatitis, 25(2), 97-103.

Goldstein, R. K., Bastian, B. C., Elsner, P., & Burg, G. (1991). Giant lichenification of the vulva with marked ulcerations. A case report. J Reprod Med, 36(4), 309-311.

Goldstein, R. K., Zillikens, D., Miller, K., Elsner, P., & Burg, G. (1991). [Local treatment of disseminated granuloma anulare with a vitamin E emulsion]. Hautarzt, 42(3), 176-178.

Hackel, H., Hartmann, A. A., & Burg, G. (1991). Vulvitis granulomatosa and anoperineitis granulomatosa. Dermatologica, 182(2), 128-131.

Hackel, H., Hartmann, A. A., Elsner, P., Martius, J., Engel, C., & Burg, G. (1991). [The value of Gardnerella-vaginalis-culture in bacterial-vaginitis- score-confirmed bacterial vaginosis]. Hautarzt, 42(3), 173-175.

Hackel, H., Miller, K., Elsner, P., & Burg, G. (1991). Unusual combined sensitization to palladium and other metals. Contact Dermatitis, 24(2), 131-132.

Kaudewitz, P., & Burg, G. (1991). Lymphomatoid papulosis and Ki-1 (CD30)-positive cutaneous large cell lymphomas. Semin Diagn Pathol, 8(2), 117-124.

Kerl, H., Cerroni, L., & Burg, G. (1991). The morphologic spectrum of T-cell lymphomas of the skin: a proposal for a new classification. Semin Diagn Pathol, 8(2), 55-61.

Ostmeier, H., Schumann, J., Otto, F., Krieg, V., Fuchs, B., Biess, B., . . . Suter, L. (1991). The relationship between characteristics of the tumor cells and sex of the patients in primary malignant melanomas. J Cancer Res Clin Oncol, 117(4), 364-366.

Schulz, A., Elsner, P., & Burg, G. (1991). Quantification of irritant contact dermatitis in vivo: comparison of the Dermatest system with the evaporimeter. Contact Dermatitis, 24(3), 235-237.

Vogt, T., Stolz, W., Braun-Falco, O., Kaudewitz, P., Eckert, F., Abmayr, W., . . . Burg, G. (1991). Prognostic significance of DNA cytometry in cutaneous malignant lymphomas. Cancer, 68(5), 1095-1100.

Zillikens, D., Bammel, A., Lurz, C., Elsner, P., & Burg, G. (1991). [Eosinophilia-myalgia syndrome after L-tryptophan intake]. Hautarzt, 42(3), 154-157.

Zillikens, D., Mehringer, A., Lechner, W., & Burg, G. (1991). Hypo- and hyperpigmented areas in incontinentia pigmenti. Light and electron microscopic studies. Am J Dermatopathol, 13(1), 57-62.

Ambach, A., Zillikens, D., Klingert, B., Hartmann, A. A., & Burg, G. (1992). [Immune phenotyping of mononuclear infiltrate in bullous pemphigoid]. Hautarzt, 43(2), 81-85.

Baumgartner, R., Trueb, R., Bruckner, L., Schmid, U., Speiser, P., & Burg, G. (1992). [Recurrent eyelid tumor in necrotizing panniculitis]. Klin Monbl Augenheilkd, 200(5), 529-531. doi:10.1055/s-2008-1045816

Becker, J. C., Dummer, R., Schmidt, R. E., Burg, G., & Hartmann, A. A. (1992). [Shedding of soluble intercellular adhesion molecule 1 (ICAM-1) from melanoma cells and the effect on cellular cytotoxicity]. Immun Infekt, 20(2), 62-63.

Becker, J. C., Dummer, R., Schwinn, A., Hartmann, A. A., & Burg, G. (1992). Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy. J Immunother (1991), 12(2), 147-150.

Becker, J. C., Dummer, R., Von Wussow, P., Burg, G., & Schmidt, R. E. (1992). Non-MHC-restricted T-cell interaction with B cells: role of the T-cell receptor. Scand J Immunol, 36(2), 177-181.

Boyera, N., Cavey, D., Bouclier, M., Burg, G., Rossio, P., & Hensby, C. (1992). Repeated application of dinitrochlorobenzene to the ears of sensitized guinea pigs: a preliminary characterization of a potential new animal model for contact eczema in humans. Skin Pharmacol, 5(3), 184-188.

Burg, G. (1992). [The First Bruno Bloch Memorial Lecture]. Hautarzt, 43(6), 390.

Burg, G. (1992). Disseminated granuloma anulare: therapy with vitamin E topically. Dermatology, 184(4), 308-309. doi:10.1159/000247580

Burg, G., & Dummer, R. (1992). [Current treatment methods in skin tumors]. Schweiz Rundsch Med Prax, 81(19), 610-614.

Burg, G., & Schmockel, C. (1992). Syringolymphoid hyperplasia with alopecia--a syringotropic cutaneous T-cell lymphoma? Dermatology, 184(4), 306-307. doi:10.1159/000247579

Cavegn, B., Puppin, D., Jr., & Burg, G. (1992). [Controversial aspects of stage I skin melanomas]. Schweiz Med Wochenschr, 122(49), 1883-1888.

Dummer, R., Becker, J. C., Boser, B., Hartmann, A. A., & Burg, G. (1992). Successful therapy of metastatic eccrine poroma using perilesional interferon alfa and interleukin 2. Arch Dermatol, 128(8), 1127-1128.

Dummer, R., Posseckert, G., Nestle, F., Witzgall, R., Burger, M., Becker, J. C., . . . Burg, G. (1992). Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo? J Invest Dermatol, 98(1), 50-54.

Dummer, R., Roger, J., Vogt, T., Becker, J., Hefner, H., Sindermann, H., & Burg, G. (1992). Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas. Prog Exp Tumor Res, 34, 160-169.

Dunkel, F. G., & Burg, G. (1992). [The pathogenesis of psoriasis--new results]. Fortschr Med, 110(25), 457-460.

Elder, D. E., Freeman, R. G., Bergfeld, W. F., Ackerman, A. B., Azar, H. A., Fechner, R. E., . . . et al. (1992). Do you use the term "dysplasia"? If so, what do you mean by it, and if not, why not? Am J Dermatopathol, 14(5), 462-486.

Goldstein, R. K., Augustin, A., Milz, J., Burg, G., & Lutz, J. (1992). Influence of free radical scavengers on myeloperoxidase activity and lipid peroxidation in acute skin grafts. Adv Exp Med Biol, 316, 253-258.

Haffner, A. C., Garbe, C., Burg, G., Buttner, P., Orfanos, C. E., & Rassner, G. (1992). The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients. Br J Cancer, 66(5), 856-861.

Hafner, J., Enderlin, A., Seger, R. A., Wuthrich, B., Bruckner-Tudermann, L., Panizzoni, P., & Burg, G. (1992). Discoid lupus erythematosus-like lesions in carriers of X-linked chronic granulomatous disease. Br J Dermatol, 127(4), 446-447.

Hermanek, P., Encke, A., & Burg, G. (1992). [Histologic study of lymph nodes in tumor resections--results of a survey of the German TNM Committee]. Chirurg, 63(6), Suppl 93-97.

Trueb, R., & Burg, G. (1992). [Drug reaction to amoxicillin simulating toxic pustular dermatosis]. Hautarzt, 43(9), 595-596.

Trueb, R. M., & Burg, G. (1992). [Loose anagen hair]. Hautarzt, 43(8), 505-508.

Wilhelm, M., Meyer, P., Batram, C., Tony, H. P., Dummer, R., Nestle, F., . . . Wilms, K. (1992). Gamma/delta receptor-expressing T-cell clones from a cutaneous T-cell lymphoma suppress hematopoiesis. Ann Hematol, 65(3), 111-115.

Zillikens, D., Ambach, A., Schuessler, M., Dummer, R., Hartmann, A. A., & Burg, G. (1992). The interleukin-2 receptor in lesions and serum of bullous pemphigoid. Arch Dermatol Res, 284(3), 141-145.

Zillikens, D., Blum, C., Dummer, R., Hartmann, A. A., & Burg, G. (1992). Serum levels of soluble interleukin-2 receptor in systemic and circumscribed scleroderma. Dermatology, 184(3), 233-234. doi:10.1159/000247555

Zillikens, D., Mehringer, A., Lechner, W., & Burg, G. (1992). Hypo- and hyperpigmented areas in incontinentia pigmenti. Reply by Zillikens et al. Am J Dermatopathol, 14(3), 288-289.

Ballmer-Weber, B. K., Widmer, M., & Burg, G. (1993). [Acetylsalicylic acid-induced generalized pustulosis]. Schweiz Med Wochenschr, 123(12), 542-546.

Becker, J. C., Schwinn, A., Dummer, R., Burg, G., & Brocker, E. B. (1993). Lesion-specific activation of cloned human tumor-infiltrating lymphocytes by autologous tumor cells: induction of proliferation and cytokine production. J Invest Dermatol, 101(1), 15-21.

Becker, J. C., Schwinn, A., Dummer, R., Burg, G., & Brocker, E. B. (1993). Tumour-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expression. Clin Exp Immunol, 91(1), 121-125.

Blum, C., Zillikens, D., Tony, H. P., Hartmann, A. A., & Burg, G. (1993). [Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus]. Hautarzt, 44(5), 290-295.

Burg, G. (1993). Collision dermatosis: angiolymphoid hyperplasia with eosinophilia developing within a congenital port wine nevus. Dermatology, 187(4), 293-295. doi:10.1159/000247272

Burg, G., Dommann, S., & Dummer, R. (1993). [Malignant lymphoma of the skin]. Ther Umsch, 50(12), 828-834.

Burg, G., Dummer, R., Cavegn, B., & Panizzon, R. (1993). [Malignant melanoma of the skin]. Ther Umsch, 50(12), 822-827.

Dummer, R., Becker, J. C., Eilles, C., Schafer, E., Borner, W., & Burg, G. (1993). T cells migrate to tumour sites after extracorporeal interleukin 2 stimulation and reinfusion in a patient with metastatic melanoma. Br J Dermatol, 128(4), 399-403.

Dummer, R., Burg, G., Nestle, F., & Kohl, O. (1993). Soluble interleukin-2 receptors and cutaneous T-cell lymphoma. Cancer, 71(11), 3793-3795.

Dummer, R., Kohl, O., Gillessen, J., Kagi, M., & Burg, G. (1993). Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation. Arch Dermatol, 129(4), 433-436.

Dummer, R., Krasovec, M., Roger, J., Sindermann, H., & Burg, G. (1993). Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study. J Am Acad Dermatol, 29(6), 963-970.

Dummer, R., Meyer, J. C., Ballmer-Weber, B. K., Muletta, S., Panizzon, R., & Burg, G. (1993). UVA suppresses shedding of ICAM-1 from interferon-gamma (IFN-gamma)-pretreated transformed keratinocytes. Arch Dermatol Res, 285(4), 230-232.

Elsner, P., & Burg, G. (1993). Irritant reactivity is a better risk marker for nickel sensitization than atopy. Acta Derm Venereol, 73(3), 214-216.

Encke, A., Hermanek, P., & Burg, G. (1993). [Report of the German-Speaking TNM Committee]. Zentralbl Chir, 118(5), 310.

Hafner, J., Panizzon, R., Bruckner-Tuderman, L., Wuthrich, B., Seger, R. A., & Burg, G. (1993). [Lupus erythematosus discoid-like dermatosis in a carrier of septic granulomatosis]. Hautarzt, 44(7), 452-456.

Krasovec, M., Elsner, P., & Burg, G. (1993). Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors. Dermatology, 186(4), 248-252. doi:10.1159/000247363

Krasovec, M., Widmer, M., Gilliet, F., & Burg, G. (1993). [A case from practice (275). Lupus vulgaris with scar-forming alopecia in florid pulmonary tuberculosis]. Schweiz Rundsch Med Prax, 82(33), 893-895.

Trueb, R. M., Bruckner-Tuderman, L., & Burg, G. (1993). Ectrodactyly-ectodermal dysplasia-clefting syndrome with scalp dermatitis. J Am Acad Dermatol, 29(3), 505-506.

Trueb, R. M., & Burg, G. (1993). [Unilateral "nevoid" spider nevi]. Vasa, 22(1), 82-85.

Trueb, R. M., & Burg, G. (1993). Acute generalized exanthematous pustulosis due to doxycycline. Dermatology, 186(1), 75-78. doi:10.1159/000247308

Trueb, R. M., & Burg, G. (1993). Idiopathic middermal elastolysis. Dermatology, 187(1), 62-66. doi:10.1159/000247201

Trueb, R. M., Elsner, P., & Burg, G. (1993). [Pseudomonas aeruginosa folliculitis after epilation]. Hautarzt, 44(2), 103-105.

Trueb, R. M., Panizzon, R. G., & Burg, G. (1993). Cutaneous ossification in Albright's hereditary osteodystrophy. Dermatology, 186(3), 205-209. doi:10.1159/000247347

Widmer, M., Reverdin, E., Kung, E., Vesti, B., Bollinger, A., Linke, R. P., & Burg, G. (1993). [Amyloidosis cutis nodularis atrophicans (Gottron)]. Hautarzt, 44(5), 319-323.

Wyss, M., Elsner, P., Wuthrich, B., & Burg, G. (1993). Allergic contact dermatitis from natural latex without contact urticaria. Contact Dermatitis, 28(3), 154-156.

Zillikens, D., Ambach, A., Zentner, A., Dummer, R., Schussler, M., Burg, G., & Brocker, E. B. (1993). Evidence for cell-mediated immune mechanisms in the pathology of pemphigus. Br J Dermatol, 128(6), 636-643.

Zillikens, D., Zentner, A., Burger, M., Hartmann, A. A., & Burg, G. (1993). [Pemphigus foliaceus caused by penicillamine]. Hautarzt, 44(3), 167-171.

Burg, G., Dummer, R., & Kerl, H. (1994). Classification of cutaneous lymphomas. Dermatol Clin, 12(2), 213-217.

Burg, G., Dummer, R., & Nestle, F. (1994). Distinct subtypes of subcutaneous T-cell lymphoma. Arch Dermatol, 130(8), 1073.

Burg, G., Schmid, M. H., Kung, E., Dommann, S., & Dummer, R. (1994). Semimalignant ("pseudolymphomatous") cutaneous B-cell lymphomas. Dermatol Clin, 12(2), 399-407.

Burg, G., Wursch, T., Fah, J., & Elsner, P. (1994). Eruptive hamartomatous clear-cell acanthomas. Dermatology, 189(4), 437-439. doi:10.1159/000246904

Burg, G., Zwingers, T., Staegemeir, E., & Santucci, M. (1994). Interrater and intrarater variabilities in the evaluation of cutaneous lymphoproliferative T-cell infiltrates. EORTC-Cutaneous Lymphoma Project Group. Dermatol Clin, 12(2), 311-314.

Dommann, S. N., Widmer, M., Dommann-Scherrer, C., Bernasconi, E., & Burg, G. (1994). [Actinobacillus actinomycetemcomitans isolated from a mycetoma (of the forearm)]. Hautarzt, 45(6), 402-405.

Dummer, R., Sigg-Zemann, S., Kalthof, K., Muletta, S., Meyer, J. C., & Burg, G. (1994). Various cytokines modulate ICAM-1 shedding on melanoma- and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sezary cell line by interferon-gamma. Dermatology, 189(2), 120-124. doi:10.1159/000246813

Jorg, B., Kerl, H., Thiers, B. H., Brocker, E. B., & Burg, G. (1994). Therapeutic approaches in cutaneous lymphoma. Dermatol Clin, 12(2), 433-441.

Lubbe, J., Kleihues, P., & Burg, G. (1994). [The tumor suppressor gene p53 and its significance for dermatology]. Hautarzt, 45(11), 741-745.

Lubbe, J., Reichel, M., Burg, G., & Kleihues, P. (1994). Absence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol, 102(5), 819-821.

Santucci, M., Burg, G., & Feller, A. C. (1994). Interrater and intrarater reliability of histologic criteria in early cutaneous T-cell lymphoma. An EORTC Cutaneous Lymphoma Project Group study. Dermatol Clin, 12(2), 323-327.

Schneider-Yin, X., Schafer, B. W., Mohr, P., Burg, G., & Minder, E. I. (1994). Molecular defects in erythropoietic protoporphyria with terminal liver failure. Hum Genet, 93(6), 711-713.

Schultz, E. S., Dummer, R., Becker, J. C., Zillikens, D., & Burg, G. (1994). Influence of various cytokines on the interleukin-2-dependent lysis of melanoma cells in vitro. Arch Dermatol Res, 286(2), 73-76.

Trueb, R., Burg, G., Bottani, A., & Schinzel, A. (1994). Ectodermal dysplasia with corkscrew hairs: observation of probable autosomal dominant tricho-odonto-onychodysplasia with syndactyly. J Am Acad Dermatol, 30(2 Pt 1), 289-290.

Trueb, R. M., Spycher, M. A., Schumacher, F., & Burg, G. (1994). [Pili torti et canaliculi in ectodermal dysplasia]. Hautarzt, 45(6), 372-377.

Widmer, J., Elsner, P., & Burg, G. (1994). Skin irritant reactivity following experimental cumulative irritant contact dermatitis. Contact Dermatitis, 30(1), 35-39.

Adams, V., Kempf, W., Schmid, M., Muller, B., Briner, J., & Burg, G. (1995). Absence of herpesvirus-like DNA sequences in skin cancers of non-immunosuppressed patients. Lancet, 346(8991-8992), 1715-1716.

Boni, R., Dummer, R., & Burg, G. (1995). [Are skin tumors on the increase?]. Schweiz Med Wochenschr, 125(35), 1619-1624.

Boni, R., Dummer, R., Dommann-Scherrer, C., Dommann, S., Zimmermann, D. R., Joller-Jemelka, H., & Burg, G. (1995). Necrotizing herpes zoster mimicking relapse of vasculitis in angioimmunoblastic lymphadenopathy with dysproteinaemia. Br J Dermatol, 133(6), 978-982.

Burg, G. (1995). Report from the president (V) 1992-1994. Am J Dermatopathol, 17(5), 534-537.

Burg, G., Dummer, R., Dommann, S., Nestle, F., & Nickoloff, B. (1995). Pathology of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am, 9(5), 961-995.

Buttner, P., Garbe, C., Bertz, J., Burg, G., d'Hoedt, B., Drepper, H., . . . et al. (1995). Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer, 75(10), 2499-2506.

Dommann, S. N., Dommann-Scherrer, C. C., Zimmerman, D., Dours-Zimmermann, M. T., Hassam, S., & Burg, G. (1995). Primary cutaneous T-cell-rich B-cell lymphoma. A case report with a 13-year follow-up. Am J Dermatopathol, 17(6), 618-624.

Dommann, S. N., Ziegler, T., Dommann-Schener, C. C., Meyer, J., Panizzon, R., & Burg, G. (1995). CD44v6 is a marker for systemic spread in cutaneous T-cell lymphomas. A comparative study between nodal and cutaneous lymphomas. J Cutan Pathol, 22(5), 407-412.

Dummer, R., Davis-Daneshfar, A., Dohring, C., Dobbeling, U., & Burg, G. (1995). [Strategies for gene therapy of melanoma]. Hautarzt, 46(5), 305-308.

Garbe, C., Buttner, P., Bertz, J., Burg, G., d'Hoedt, B., Drepper, H., . . . et al. (1995). Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer, 75(10), 2492-2498.

Garbe, C., Buttner, P., Bertz, J., Burg, G., d'Hoedt, B., Drepper, H., . . . et al. (1995). Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer, 75(10), 2484-2491.

Hafner, J., Haenseler, E., Ossent, P., Burg, G., & Panizzon, R. G. (1995). Benzidine stain for the histochemical detection of hemoglobin in splinter hemorrhage (subungual hematoma) and black heel. Am J Dermatopathol, 17(4), 362-367.

Hinnen, U., Elsner, P., & Burg, G. (1995). Assessment of skin irritancy by 2 short tests compared to acute irritation induced by sodium lauryl sulfate. Contact Dermatitis, 33(4), 236-239.

Krasovec, M., Elsner, P., & Burg, G. (1995). [Cowden's syndrome]. Hautarzt, 46(7), 472-476.

Lubbe, J., Schlupen, E. M., Fierz, W., Panizzon, R. G., & Burg, G. (1995). Identification of Borrelia afzelii in a juxta-articular fibroid nodule from a human immunodeficiency virus-positive patient with acrodermatitis chronica atrophicans. Arch Dermatol, 131(11), 1341-1342.

Steinert, H. C., Huch Boni, R. A., Buck, A., Boni, R., Berthold, T., Marincek, B., . . . von Schulthess, G. K. (1995). Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology, 195(3), 705-709. doi:10.1148/radiology.195.3.7753998

Trueb, R. M., Becker-Wegerich, P., Hafner, J., Wuthrich, B., & Burg, G. (1995). Relapsing eosinophilic perimyositis. Br J Dermatol, 133(1), 109-114.

Trueb, R. M., Borelli, S., Schmid-Grendelmeier, P., Panizzon, R. G., & Burg, G. (1995). [Overlap of Sjogren-lupus erythematosus syndrome]. Hautarzt, 46(7), 467-471.

Trueb, R. M., Hurlimann, A. F., & Burg, G. (1995). [Periarteritis nodosa cutanea. 20 years follow-up with leg pain, Raynaud syndrome and nail changes]. Hautarzt, 46(8), 568-572.

Allmann, K. H., Leu, H., Burg, G., & Hodler, J. (1996). Hereditary sensory and autonomic neuropathy type I (Thevenard's disease). Skeletal Radiol, 25(5), 501-504.

Boni, R., Davis-Daneshfar, A., Burg, G., Fuchs, D., & Wood, G. S. (1996). No detection of HTLV-I proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T-cell lymphoma. Br J Dermatol, 134(2), 282-284.

Boni, R., Doguoglu, A., Burg, G., Muller, B., & Dummer, R. (1996). MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma. J Am Acad Dermatol, 35(3 Pt 1), 416-418.

Boni, R., Huch-Boni, R. A., Steinert, H., von Schulthess, G. K., & Burg, G. (1996). Early detection of melanoma metastasis using fludeoxyglucose F 18 positron emission tomography. Arch Dermatol, 132(8), 875-876.

Boni, R., Steinert, H., Boni, R. A., Lichtensteiger, W., Dummer, R., Hartman, D. S., . . . Westera, G. (1996). Lack of expression of dopamine D2 receptors in malignant melanoma: evidence for interaction of iodobenzofurans with melanin. Dermatology, 193(3), 198-202. doi:10.1159/000246245

Burg, G., Dummer, R., Nestle, F. O., Doebbeling, U., & Haeffner, A. (1996). Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol, 132(5), 567-572.

Dommann, S. N., Dommann-Scherrer, C. C., Dours-Zimmermann, M. T., Zimmermann, D. R., Kural-Serbes, B., & Burg, G. (1996). Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas. Arch Dermatol Res, 288(4), 163-167.

Dummer, R., Heald, P. W., Nestle, F. O., Ludwig, E., Laine, E., Hemmi, S., & Burg, G. (1996). Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood, 88(4), 1383-1389.

Dummer, R., Nestle, F. O., & Burg, G. (1996). [Modern tumor therapy as seen in melanoma]. Praxis (Bern 1994), 85(50), 1609-1614.

Dummer, R., Posseckert, G., Sugamura, K., Grundmann, H., & Burg, G. (1996). Circulating interleukin-2 receptors are a group of multimeric proteins with immunoreactivity for interleukin-2 receptor alpha, beta, and gamma chains. J Interferon Cytokine Res, 16(4), 315-320. doi:10.1089/jir.1996.16.315

Dummer, R., Potoczna, N., Haffner, A. C., Zimmermann, D. R., Gilardi, S., & Burg, G. (1996). A primary cutaneous non-T, non-B CD4+, CD56+ lymphoma. Arch Dermatol, 132(5), 550-553.

Haffner, A. C., Zepter, K., Elsner, P., & Burg, G. (1996). Isolated delayed-type hypersensitivity to latex rubber. Contact Dermatitis, 35(4), 247-248.

Hafner, J., Bounameaux, H., Burg, G., & Brunner, U. (1996). Management of venous leg ulcers. Vasa, 25(2), 161-167.

Hafner, J., Brunner, U., & Burg, G. (1996). [Treatment guidelines for venous leg ulcers: causal therapy initiation and local wound treatment]. Ther Umsch, 53(4), 304-308.

Hurlimann, A. F., Panizzon, R. G., & Burg, G. (1996). Eruptive vellus hair cyst and steatocystoma multiplex: hybrid cysts. Dermatology, 192(1), 64-66. doi:10.1159/000246319

Kagi, M. K., Trueb, R., Wuthrich, B., & Burg, G. (1996). Confluent and reticulated papillomatosis associated with atopy. Successful treatment with topical urea and tretinoin. Br J Dermatol, 134(2), 381-382.

Kleinhans, M., Schmid-Grendelmeier, P., & Burg, G. (1996). [Levodopa and malignant melanoma--case report and review of the literature. A contribution to causal relationship between levodopa and the development of malignant melanoma]. Hautarzt, 47(6), 432-437.

Lubbe, J., Kormann, A., Adams, V., Hassam, S., Gratz, K. W., Panizzon, R. G., & Burg, G. (1996). HPV-11- and HPV-16-associated oral verrucous carcinoma. Dermatology, 192(3), 217-221. doi:10.1159/000246369

Potoczna, N., Boehncke, W. H., Nestle, F. O., Kuenzlen, C., Sterry, W., Burg, G., & Dummer, R. (1996). T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin. J Cutan Pathol, 23(4), 298-305.

Rajan, G. P., Seifert, B., Prummer, O., Joller-Jemelka, H. I., Burg, G., & Dummer, R. (1996). Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA. Arch Dermatol Res, 288(9), 543-548.

Wood, G. S., Hardman, D. L., Boni, R., Dummer, R., Kim, Y. H., Smoller, B. R., . . . Burg, G. (1996). Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Blood, 88(5), 1765-1770.

Boni, R., Burg, G., Doguoglu, A., Ilg, E. C., Schafer, B. W., Muller, B., & Heizmann, C. W. (1997). Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol, 137(1), 39-43.

Boni, R., Lichtensteiger, W., Steinert, H. C., Boni, R. A., Fruh, H., Dummer, R., . . . Burg, G. (1997). D1 dopamine receptors are not expressed in human melanoma. Melanoma Res, 7(2), 117-119.

Boni, R., Steinert, H., Huch Boni, R., Von Schulthess, G. K., Meyer, J., Dummer, R., . . . Westera, G. (1997). Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and results in patients. Br J Dermatol, 137(1), 96-100.

Camacho, F. M., Burg, G., Moreno, J. C., Campora, R. G., & Villar, J. L. (1997). Granulomatous slack skin in childhood. Pediatr Dermatol, 14(3), 204-208.

Davis-Daneshfar, A., Boni, R., von Wussow, P., Joller, H., Burg, G., & Dummer, R. (1997). Adjuvant immunotherapy in malignant melanoma: impact of antibody formation against interferon-alpha on immunoparameters in vivo. J Immunother, 20(3), 208-213.

Dobbeling, U., Dummer, R., Hess Schmid, M., & Burg, G. (1997). Lack of expression of the recombination activating genes RAG-1 and RAG-2 in cutaneous T-cell lymphoma: pathogenic implications. Clin Exp Dermatol, 22(5), 230-233.

Dommann, S. N., Dommann-Scherrer, C. C., Ziegler, T., Meyer, J., Trueb, R. M., Kundig, T., . . . Burg, G. (1997). Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas. Am J Dermatopathol, 19(4), 391-395.

Hinnen, U., Elsner, P., Barraud, M., & Burg, G. (1997). Foreign body granuloma of the penis caused by occupational glass fibre exposure. Genitourin Med, 73(6), 577-578.

Lubbe, J., Nakazawa, H., & Burg, G. (1997). [Telomerase]. Hautarzt, 48(9), 615-621.

Mandt, N., Krasovec, M., Ellgehausen, P., & Burg, G. (1997). [Cutaneous artefacts]. Schweiz Med Wochenschr, 127(38), 1579.

Meyer, J. C., Hassam, S., Dummer, R., Muletta, S., Dobbeling, U., Dommann, S. N., & Burg, G. (1997). A realistic approach to the sensitivity of PCR-DGGE and its application as a sensitive tool for the detection of clonality in cutaneous T-cell proliferations. Exp Dermatol, 6(3), 122-127.

Nestle, F. O., Haffner, A. C., Schmid, M. H., Dummer, R., & Burg, G. (1997). [Current therapy concepts in cutaneous T-cell lymphomas]. Schweiz Med Wochenschr, 127(8), 311-320.

Seelentag, W. K., Boni, R., Gunthert, U., Futo, E., Burg, G., Heitz, P. U., & Roth, J. (1997). Expression of CD44 isoforms and beta 1,6-branched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with metastatic potential. J Cutan Pathol, 24(4), 206-211.

Trueb, R. M., Pericin, M., Hafner, J., & Burg, G. (1997). [Tufted hair folliculitis]. Hautarzt, 48(4), 266-269.

Trueb, R. M., Pericin, M., Kohler, E., Barandun, J., & Burg, G. (1997). Necrotizing granulomatosis of the breast. Br J Dermatol, 137(5), 799-803.

Trueb, R. M., Pericin, M., Winzeler, B., Wuthrich, B., & Burg, G. (1997). Eosinophilic myositis/perimyositis: frequency and spectrum of cutaneous manifestations. J Am Acad Dermatol, 37(3 Pt 1), 385-391.

van Vliet, J. J., Vaessen, H. A., van den Burg, G., & Schothorst, R. C. (1997). Twenty-four-hour duplicate diet study 1994; nitrate and nitrite: method development and intake per person per day. Cancer Lett, 114(1-2), 305-307.

Waldmann, V., Kempf, W., Burg, G., & Dummer, R. (1997). [Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid]. Hautarzt, 48(4), 262-265.

Wimmer, I., Meyer, J. C., Seifert, B., Dummer, R., Flace, A., & Burg, G. (1997). Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy. Cancer Res, 57(22), 5073-5076.

Yue, F. Y., Dummer, R., Geertsen, R., Hofbauer, G., Laine, E., Manolio, S., & Burg, G. (1997). Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer, 71(4), 630-637.

Boni, R., Bantschapp, O., Muller, B., & Burg, G. (1998). c-myc is not useful as prognostic immunohistochemical marker in cutaneous melanoma. Dermatology, 196(3), 288-291. doi:10.1159/000017922

Boni, R., Matt, D., Burg, G., Tronnier, M., Vortmeyer, A., & Zhuang, Z. (1998). Ultraviolet-induced acute histological changes in irradiated nevi are not associated with allelic loss. Arch Dermatol, 134(7), 853-856.

Boni, R., Matt, D., Voetmeyer, A., Burg, G., & Zhuang, Z. (1998). Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation. J Invest Dermatol, 110(3), 215-217. doi:10.1046/j.1523-1747.1998.00109.x

Boni, R., Vortmeyer, A. O., Burg, G., Hofbauer, G., & Zhuang, Z. (1998). The PTEN tumour suppressor gene and malignant melanoma. Melanoma Res, 8(4), 300-302.

Boni, R., Vortmeyer, A. O., Pack, S., Park, W. S., Burg, G., Hofbauer, G., . . . Zhuang, Z. (1998). Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic angiofibromas. J Invest Dermatol, 111(3), 539-540. doi:10.1046/j.1523-1747.1998.00317.x

Boni, R., Vortmeyer, A. O., Stern, J. B., Burg, G., Hofbauer, G., & Zhuang, Z. (1998). Concordance of genetic changes in basal cell carcinoma and associated clusters of squamous cells. J Invest Dermatol, 111(1), 173-174. doi:10.1046/j.1523-1747.1998.00247.x

Burg, G. (1998). [Dermatology 1997: immune intervention making progress]. Schweiz Med Wochenschr, 128(1-2), 18-20.

Burg, G., Kempf, W., Hochli, M., Huwyler, T., & Panizzon, R. G. (1998). 'Tubular' epithelioid cell nevus: a new variant of Spitz's nevus. J Cutan Pathol, 25(9), 475-478.

Dobbeling, U., Dummer, R., Laine, E., Potoczna, N., Qin, J. Z., & Burg, G. (1998). Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood, 92(1), 252-258.

Dummer, R., Geertsen, R., Ludwig, E., Niederer, E., & Burg, G. (1998). Sezary syndrome, T-helper 2 cytokines and accessory factor-1 (AF-1). Leuk Lymphoma, 28(5-6), 515-522. doi:10.3109/10428199809058359

Dummer, R., Graf, P., Greif, C., & Burg, G. (1998). Treatment of vascular lesions using the VersaPulse variable pulse width frequency doubled neodymium:YAG laser. Dermatology, 197(2), 158-161. doi:10.1159/000017989

Dummer, R., Hauschild, A., Henseler, T., & Burg, G. (1998). Combined interferon-alpha and interleukin-2 as adjuvant treatment for melanoma. Lancet, 352(9131), 908-909.

Dummer, R., Kempf, W., & Burg, G. (1998). Pseudo-melanoma after laser therapy. Dermatology, 197(1), 71-73. doi:10.1159/000017962

Dummer, R., Nestle, F. O., Hofbauer, G., Boni, R., & Burg, G. (1998). [Therapy of cutaneous melanoma]. Ther Umsch, 55(8), 509-514.

Dummer, R., Yue, F. Y., Pavlovic, J., Geertsen, R., Dohring, C., Moelling, K., & Burg, G. (1998). Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10. Br J Cancer, 77(9), 1413-1419.

Ellgehausen, P., Elsner, P., & Burg, G. (1998). Drug-induced lichen planus. Clin Dermatol, 16(3), 325-332.

Geertsen, R. C., Hofbauer, G. F., Yue, F. Y., Manolio, S., Burg, G., & Dummer, R. (1998). Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions. J Invest Dermatol, 111(3), 497-502. doi:10.1046/j.1523-1747.1998.00305.x

Grob, M., Wyss, M., Spycher, M. A., Dommann, S., Schinzel, A., Burg, G., & Trueb, R. M. (1998). Histopathologic and ultrastructural study of lupus-like skin lesions in a patient with Bloom syndrome. J Cutan Pathol, 25(5), 275-278.

Hafner, J., Keusch, G., Wahl, C., & Burg, G. (1998). Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. Vasa, 27(3), 137-143.

Hofbauer, G. F., Dummer, R., Laine, E., & Burg, G. (1998). Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA. Arch Dermatol Res, 290(8), 458-461.

Kamarashev, J., Burg, G., Kempf, W., Hess Schmid, M., & Dummer, R. (1998). Comparative analysis of histological and immunohistological features in mycosis fungoides and Sezary syndrome. J Cutan Pathol, 25(8), 407-412.

Kempf, W., Dummer, R., Schmid, M. H., Fritz, T., Wuthrich, B., & Burg, G. (1998). Intralesional cisplatin for the treatment of cutaneous B-cell lymphoma. Arch Dermatol, 134(11), 1343-1345.

Kempf, W., Haeffner, A. C., Mueller, B., Panizzon, R. G., & Burg, G. (1998). Experts and gold standards in dermatopathology: qualitative and quantitative analysis of the self-assessment slide seminar at the 17th colloquium of the International Society of Dermatopathology. Am J Dermatopathol, 20(5), 478-482.

Kerl, H., Burg, G., Sterry, W., & Wolff, H. H. (1998). [Problems, responsibility and goals in dermatopathology]. Hautarzt, 49(7), 533-535.

Kleeman, D., Kempf, W., Burg, G., & Hafner, J. (1998). Cutaneous polyarteritis nodosa. Vasa, 27(1), 54-57.

Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., . . . Schadendorf, D. (1998). Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med, 4(3), 328-332.

Nestle, F. O., & Burg, G. (1998). [Persistent facial swelling of uncertain origin]. Schweiz Med Wochenschr, 128(51-52), 2056.

Nestle, F. O., Filgueira, L., Nickoloff, B. J., & Burg, G. (1998). Human dermal dendritic cells process and present soluble protein antigens. J Invest Dermatol, 110(5), 762-766. doi:10.1046/j.1523-1747.1998.00189.x

Villeneuve, P., Hafner, J., Prenosil, J. E., Elsner, P., & Burg, G. (1998). A novel culturing and grafting system for the treatment of leg ulcers. Br J Dermatol, 138(5), 849-851.

Boni, R., & Burg, G. (1999). [The atypical nevus: a risk situation?]. Schweiz Med Wochenschr, 129(22), 825-832.

Boni, R., Vortmeyer, A. O., Huang, S., Burg, G., Hofbauer, G., & Zhuang, Z. (1999). Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma. Melanoma Res, 9(3), 249-252.

Burg, G. (1999). [Malignant melanoma]. Ther Umsch, 56(6), 285.

Dummer, R., Nestle, F. O., Hofbauer, G., & Burg, G. (1999). [Systemic therapy of metastatic melanoma]. Ther Umsch, 56(6), 330-333. doi:10.1024/0040-5930.56.6.330

Dummer, R., Nestle, F. O., Niederer, E., Ludwig, E., Laine, E., Grundmann, H., . . . Burg, G. (1999). Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sezary syndrome. Arch Dermatol Res, 291(6), 307-311.

Fritz, T. M., Burg, G., & Hafner, J. (1999). Eyebrow reconstruction with free skin and hair-bearing composite graft. J Am Acad Dermatol, 41(6), 1008-1010.

Fuchs, D., Querings, K., Burg, G., & Boni, R. (1999). [Persistent erythema after total CO2 skin resurfacing]. Schweiz Med Wochenschr, 129(21), 813-817.

Geertsen, R., Zenklusen, R., Kamarashev, J., Burg, G., & Dummer, R. (1999). Inverse regulation of neuronal cellular adhesion molecule (NCAM) by IFN-gamma in melanoma cell cultures established from CNS lesions. Int J Cancer, 83(1), 135-140.

Haffner, A. C., Zepter, K., Fritz, T., Dummer, R., Lejeune, F. J., & Burg, G. (1999). Complete remission of advanced cutaneous leiomyosarcoma following isolated limb perfusion with high-dose tumour necrosis factor-alpha and melphalan. Br J Dermatol, 141(5), 935-936.

Hafner, J., & Burg, G. (1999). [Dermatological aspects in prevention and treatment of the diabetic foot syndrome]. Praxis (Bern 1994), 88(27-28), 1170-1177.

Hess Schmid, M., Dummer, R., Kempf, W., Hilty, N., & Burg, G. (1999). Mycosis fungoides with mucinosis follicularis in childhood. Dermatology, 198(3), 284-287. doi:10.1159/000018131

Kempf, W., Adams, V., Kleinhans, M., Burg, G., Panizzon, R. G., Campadelli-Fiume, G., & Nestle, F. O. (1999). Pityriasis rosea is not associated with human herpesvirus 7. Arch Dermatol, 135(9), 1070-1072.

Krasovec, M., & Burg, G. (1999). Nodular fasciitis (pseudotumor of the skin). Dermatology, 198(4), 431-433.

Nestle, F. O., Hofbauer, G., & Burg, G. (1999). Necrobiotic xanthogranuloma with monoclonal gammopathy of the IgG lambda type. Dermatology, 198(4), 434-435.

Nestle, F. O., Tun Kyi, A., Gilliet, M., Dummer, R., & Burg, G. (1999). [Vaccination therapy of malignant melanoma]. Ther Umsch, 56(6), 334-337. doi:10.1024/0040-5930.56.6.334

Rogalski, C., Dummer, R., & Burg, G. (1999). Immunomodulators in the treatment of cutaneous lymphoma. J Eur Acad Dermatol Venereol, 13(2), 83-90.

Schmid, M. H., Bird, P., Dummer, R., Kempf, W., & Burg, G. (1999). Tumor burden index as a prognostic tool for cutaneous T-cell lymphoma: a new concept. Arch Dermatol, 135(10), 1204-1208.

Shephard, S. E., Zogg, M., Burg, G., & Panizzon, R. G. (1999). Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood. Arch Dermatol Res, 291(9), 491-499.

Trueb, R. M., Scheidegger, E. P., Pericin, M., Singh, A., Hoffmann, U., Sauvant, G., & Burg, G. (1999). Periarteritis nodosa presenting as a breast lesion: report of a case and review of the literature. Br J Dermatol, 141(6), 1117-1121.

Yue, F. Y., Geertsen, R., Hemmi, S., Burg, G., Pavlovic, J., Laine, E., & Dummer, R. (1999). IL-12 directly up-regulates the expression of HLA class I, HLA class II and ICAM-1 on human melanoma cells: a mechanism for its antitumor activity? Eur J Immunol, 29(6), 1762-1773. doi:10.1002/(SICI)1521-4141(199906)29:06<1762::AID-IMMU1762>3.0.CO;2-F

Bader, U., Banyai, M., Boni, R., Burg, G., & Hafner, J. (2000). Leg ulcers in patients with myeloproliferative disorders: disease- or treatment-related? Dermatology, 200(1), 45-48. doi:10.1159/000018315

Bernand, S., Scheidegger, E. P., Dummer, R., & Burg, G. (2000). Multifocal fixed drug eruption to paracetamol, tropisetron and ondansetron induced by interleukin 2. Dermatology, 201(2), 148-150. doi:10.1159/000018459

Boni, R., & Burg, G. (2000). [Aging skin: physiological bases, preventive measures and therapeutic modalities]. Schweiz Med Wochenschr, 130(36), 1272-1278.

Boni, R., Burg, G., & Wirth, H. P. (2000). [Helicobacter pylori and skin diseases--a (still) intact myth?]. Schweiz Med Wochenschr, 130(37), 1305-1308.

Boni, R., Kreyden, O. P., & Burg, G. (2000). Revival of the use of botulinum toxin: application in dermatology. Dermatology, 200(4), 287-291. doi:10.1159/000018389

Boni, R., Xin, H., Kamarashev, J., Utzinger, E., Dummer, R., Kempf, W., . . . Burg, G. (2000). Allelic deletion at 9p21-22 in primary cutaneous CD30(+) large cell lymphoma. J Invest Dermatol, 115(6), 1104-1107. doi:10.1038/jid.2000.4

Burg, G., & Dummer, R. (2000). Historical perspective on the use of retinoids in cutaneous T-cell lymphoma (CTCL). Clin Lymphoma, 1 Suppl 1, S41-44.

Carrozza, P., Hausermann, P., Nestle, F. O., Burg, G., & Boni, R. (2000). Clinical efficacy of narrow-band UVB (311 nm) combined with dithranol in psoriasis. An open pilot study. Dermatology, 200(1), 35-39. doi:10.1159/000018312

Dummer, R., Bergh, J., Karlsson, Y., Horowitz, J. A., Mulder, N. H., Huinink, D. T. B., . . . Osanto, S. (2000). Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors. Cancer Gene Ther, 7(7), 1069-1076. doi:10.1038/sj.cgt.7700214

Dummer, R., & Burg, G. (2000). What's new in the treatment of melanoma? J Eur Acad Dermatol Venereol, 14(5), 337-339.

Dummer, R., Heinzerling, L., Schmid, M. H., & Burg, G. (2000). [Immuno-intervention in cutaneous lymphomas]. Praxis (Bern 1994), 89(37), 1471-1476.

Dummer, R., Hess-Schmid, M., & Burg, G. (2000). Cutaneous T-cell lymphomas: prognosis and quality-of-life issues. Clin Lymphoma, 1 Suppl 1, S21-25.

Dummer, R., Nestle, F. O., & Burg, G. (2000). [Immunotherapy of melanoma]. Dtsch Med Wochenschr, 125(41), 1240-1242. doi:10.1055/s-2000-7722

Dummer, R., Willers, J., Kamarashev, J., Urosevic, M., Dobbeling, U., & Burg, G. (2000). Pathogenesis of cutaneous lymphomas. Semin Cutan Med Surg, 19(2), 78-86.

Fritz, T. M., Burg, G., & Boni, R. (2000). Carpal tunnel syndrome with ulcerous skin lesions. Dermatology, 201(2), 165-167. doi:10.1159/000018464

Hafner, J., Botonakis, I., & Burg, G. (2000). A comparison of multilayer bandage systems during rest, exercise, and over 2 days of wear time. Arch Dermatol, 136(7), 857-863.

Hafner, J., Luthi, W., Hanssle, H., Kammerlander, G., & Burg, G. (2000). Instruction of compression therapy by means of interface pressure measurement. Dermatol Surg, 26(5), 481-486; discussion 487.

Hafner, J., Schaad, I., Schneider, E., Seifert, B., Burg, G., & Cassina, P. C. (2000). Leg ulcers in peripheral arterial disease (arterial leg ulcers): impaired wound healing above the threshold of chronic critical limb ischemia. J Am Acad Dermatol, 43(6), 1001-1008. doi:10.1067/mjd.2000.108375

Hafner, J., Schneider, E., Burg, G., & Cassina, P. C. (2000). Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease. J Vasc Surg, 32(2), 322-329. doi:10.1067/mva.2000.106942

Heinzerling, L., Dummer, R., Kempf, W., Schmid, M. H., & Burg, G. (2000). Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma. Arch Dermatol, 136(3), 374-378.

Heinzerling, L., Dummer, R., Wildberger, H., & Burg, G. (2000). Cutaneous ulceration after injection of polyethylene-glycol-modified interferon alpha associated with visual disturbances in a melanoma patient. Dermatology, 201(2), 154-157. doi:10.1159/000018461

Heinzerling, L. M., Urbanek, M., Funk, J. O., Peker, S., Bleck, O., Neuber, K., . . . Dummer, R. (2000). Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma. Cancer, 89(8), 1835-1844.

Hofbauer, G. F., Burg, G., & Nestle, F. O. (2000). Cocaine-related Stevens-Johnson syndrome. Dermatology, 201(3), 258-260. doi:10.1159/000018500

Hofbauer, G. F., Burg, G., & Nestle, F. O. (2000). [Sporotrichoid infection with Mycobacterium marinum: successful therapy with oral tetracycline administration]. Hautarzt, 51(5), 349-352.

Kamarashev, J., Dummer, R., Schmidt, M. H., Kempf, W., Kurrer, M. O., & Burg, G. (2000). Primary cutaneous T-cell-rich B-cell lymphoma and Hodgkin's disease in a patient with Gardner's syndrome. Dermatology, 201(4), 362-365. doi:10.1159/000051557

Kempf, W., Adams, V. V., Burg, G., Panizzon, R. G., Campadelli-Fiume, G., & Nestle, F. O. (2000). Is pityriasis rosea skin healthier than healthy skin? Arch Dermatol, 136(7), 932-934.

Kempf, W., & Burg, G. (2000). Pityriasis rosea--a virus-induced skin disease? An update. Arch Virol, 145(8), 1509-1520.

Kreyden, O. P., Boni, R., & Burg, G. (2000). [Type A botulinum toxin: a new methods in treating focal hyperhidrosis. A summary of various possibilities in hyperhidrosis therapy with special emphasis type A botulinum toxin injections]. Praxis (Bern 1994), 89(21), 909-915.

Kreyden, O. P., & Burg, G. (2000). [Toxin treatment of sweat pearls. A review of the treatment of hyperhidrosis with a special view of a new therapy option using botulinum toxin A]. Schweiz Med Wochenschr, 130(29-30), 1084-1090.

Kreyden, O. P., Geiges, M. L., Boni, R., & Burg, G. (2000). [Botulinum toxin: from poison to drug. A historical review]. Hautarzt, 51(10), 733-737.

Laetsch, B., Haffner, A. C., Dobbeling, U., Seifert, B., Ludwig, E., Burg, G., & Dummer, R. (2000). CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas. J Invest Dermatol, 114(1), 107-111. doi:10.1046/j.1523-1747.2000.00818.x

Matt, D., Xin, H., Vortmeyer, A. O., Zhuang, Z., Burg, G., & Boni, R. (2000). Sporadic trichoepithelioma demonstrates deletions at 9q22.3. Arch Dermatol, 136(5), 657-660.

Santucci, M., Biggeri, A., Feller, A. C., & Burg, G. (2000). Accuracy, concordance, and reproducibility of histologic diagnosis in cutaneous T-cell lymphoma: an EORTC Cutaneous Lymphoma Project Group Study. European Organization for Research and Treatment of Cancer. Arch Dermatol, 136(4), 497-502.

Santucci, M., Biggeri, A., Feller, A. C., Massi, D., & Burg, G. (2000). Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. European Organization for Research and Treatment of Cancer. Am J Surg Pathol, 24(1), 40-50.

Schaerer, L., Schmid, M. H., Mueller, B., Dummer, R. G., Burg, G., & Kempf, W. (2000). Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas. Am J Dermatopathol, 22(2), 140-143.

Schmid-Grendelmeier, P., Masenga, E. J., Haeffner, A., & Burg, G. (2000). Teledermatology as a new tool in sub-saharan Africa: an experience from Tanzania. J Am Acad Dermatol, 42(5 Pt 1), 833-835.

Yue, F. Y., Cao, L., Hemmi, S., Geertsen, R., Laine, E., Burg, G., & Dummer, R. (2000). Upregulation of interleukin-12 receptor on peripheral blood mononuclear cells and HLA class I, HLA class II or ICAM-1 on melanoma cells by B7.1 and interleukin-12: a mechanism for immunostimulatory impact of melanoma cells adenovirally transfected with B7.1 and IL12? Melanoma Res, 10(4), 313-322.

Bogdan, I., Burg, G., & Boni, R. (2001). Spitz nevi display allelic deletions. Arch Dermatol, 137(11), 1417-1420.

Bogdan, I., Xin, H., Burg, G., & Boni, R. (2001). Heterogeneity of allelic deletions within melanoma metastases. Melanoma Res, 11(4), 349-354.

Boni, R., Kargl, A., Kreyden, O. P., & Burg, G. (2001). [Treatment of hyperfunctional facial lines with botulinum toxin]. Praxis (Bern 1994), 90(34), 1408-1412.

Boni, R., Xin, H., Hohl, D., Panizzon, R., & Burg, G. (2001). Syringocystadenoma papilliferum: a study of potential tumor suppressor genes. Am J Dermatopathol, 23(2), 87-89.

Burg, G., Dummer, R., Haeffner, A., Kempf, W., & Kadin, M. (2001). From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol, 137(7), 949-952.

Burg, G., Kempf, W., & Dummer, R. (2001). Diagnostic signs of cutaneous lymphomas. J Eur Acad Dermatol Venereol, 15(4), 358-360.

Dummer, R., Bosch, U., Panizzon, R., Bloch, P. H., Burg, G., & Task Force 'Skin Cancer'. Swiss National Program against Cancer. Swiss Cancer, L. (2001). Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology, 203(1), 75-80. doi:10.1159/000051710

Dummer, R., Dobbeling, U., Geertsen, R., Willers, J., Burg, G., & Pavlovic, J. (2001). Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication. Blood, 97(2), 523-527.

Dummer, R., Nestle, F. O., & Burg, G. (2001). Report on the Eighth World Congress on Cancers of the Skin 18-21 July 2001, Zurich, Switzerland. Melanoma Res, 11(5), 549-550.

Dummer, R., Willers, J., Dobbeling, U., & Burg, G. (2001). [Current pathogenetic aspects of Sezary syndrome and mycosis fungoides]. Hautarzt, 52(3), 189-192.

Fritz, T. M., Burg, G., & Krasovec, M. (2001). [Allergic contact dermatitis to cosmetics containing Melaleuca alternifolia (tea tree oil)]. Ann Dermatol Venereol, 128(2), 123-126.

Gerlini, G., Hefti, H. P., Kleinhans, M., Nickoloff, B. J., Burg, G., & Nestle, F. O. (2001). Cd1d is expressed on dermal dendritic cells and monocyte-derived dendritic cells. J Invest Dermatol, 117(3), 576-582. doi:10.1046/j.0022-202x.2001.01458.x

Hofbauer, G. F., Dummer, R., Hafner, J., Burg, G., Binswanger, U., & Kempf, W. (2001). Skin cancers in organ transplant recipients: two cases of virus-induced neoplasms. Dermatology, 202(4), 359-361. doi:10.1159/000051683

Hofbauer, G. F., Geertsen, R., Laine, E., Burg, G., & Dummer, R. (2001). Impact of interferons on the expression of melanoma-associated antigens in melanoma short-term cell cultures. Melanoma Res, 11(3), 213-218.

Hofbauer, G. F., Kamarachev, J., Kempf, W., Burg, G., Pestalozzi, B. C., & Dummer, R. (2001). A CD4+ CD56+ natural killer-like T-cell systemic lymphoma with haemorrhagic cutaneous manifestations. Br J Dermatol, 144(2), 432-434.

Hofbauer, G. F., Kessler, B., Kempf, W., Nestle, F. O., Burg, G., & Dummer, R. (2001). Multilesional primary cutaneous diffuse large B-cell lymphoma responsive to antibiotic treatment. Dermatology, 203(2), 168-170. doi:10.1159/000051735

Kamarashev, J., Burg, G., Mingari, M. C., Kempf, W., Hofbauer, G., & Dummer, R. (2001). Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas. Am J Pathol, 158(5), 1593-1598. doi:10.1016/S0002-9440(10)64114-4

Kamarashev, J., Ferrone, S., Seifert, B., Boni, R., Nestle, F. O., Burg, G., & Dummer, R. (2001). TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis. Int J Cancer, 95(1), 23-28.

Kamarashev, J., Schaerer, L., Burg, G., Schmid, M. H., Muller, B., & Kempf, W. (2001). Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders. J Cutan Pathol, 28(9), 448-452.

Kempf, W., Kadin, M. E., Kutzner, H., Lord, C. L., Burg, G., Letvin, N. L., & Koralnik, I. J. (2001). Lymphomatoid papulosis and human herpesviruses--A PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses. J Cutan Pathol, 28(1), 29-33.

Kempf, W., Kazakov, D. V., & Burg, G. (2001). Applications of molecular virology to modern dermatopathology. Curr Top Pathol, 94, 39-47.

Kreyden, O. P., Borradori, L., Trueb, R. M., Burg, G., & Nestle, F. O. (2001). [Successful therapy with tetracycline and nicotinamide in cicatricial pemphigoid]. Hautarzt, 52(3), 247-250.

Kreyden, O. P., Hafner, J., Burg, G., & Nestle, F. O. (2001). [Case report on therapy with granulocyte stimulating factor in diabetic foot]. Hautarzt, 52(4), 327-330.

Kreyden, O. P., Schmid-Grendelmeier, P., & Burg, G. (2001). Idiopathic localized unilateral hyperhidrosis: case report of successful treatment with botulinum toxin type A and review of the literature. Arch Dermatol, 137(12), 1622-1625.

Nestle, F. O., & Burg, G. (2001). Bilateral carpal tunnel syndrome as a clue for the diagnosis of systemic amyloidosis. Dermatology, 202(4), 353-355. doi:10.1159/000051681

Qin, J. Z., Kamarashev, J., Zhang, C. L., Dummer, R., Burg, G., & Dobbeling, U. (2001). Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. J Invest Dermatol, 117(3), 583-589. doi:10.1046/j.0022-202x.2001.01436.x

Qin, J. Z., Zhang, C. L., Kamarashev, J., Dummer, R., Burg, G., & Dobbeling, U. (2001). Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood, 98(9), 2778-2783.

Rogalski, C., Hurlimann, A., Burg, G., Wuthrich, B., & Kempf, W. (2001). [Drug reaction to terbinafine simulating an acute generalized exanthematous pustulosis]. Hautarzt, 52(5), 444-448.

Roos, J., Hennig, I., Schwaller, J., Zbaren, J., Dummer, R., Burg, G., . . . Borisch, B. (2001). Expression of TCL1 in hematologic disorders. Pathobiology, 69(2), 59-66. doi:10.1159/000048758

Schmook, T., Burg, G., & Hafner, J. (2001). Surgical pearl: mini-incisions for the extraction of steatocystoma multiplex. J Am Acad Dermatol, 44(6), 1041-1042. doi:10.1067/mjd.2001.112351

Schmook, T., Hofbauer, G., Kempf, W., Burg, G., & Dummer, R. (2001). [Granulomatous slack skin: partial remission following intralesional administration of interferon-alpha and PUVA]. Hautarzt, 52(10 Pt 2), 985-988.

Schnorf, M., Helfenstein, U., Blum, A., Ellwanger, U., Garbe, C., Burg, G., & Dummer, R. (2001). [Manifestations of the "pretherapeutic phase" of malignant melanoma of the skin in Switzerland 1996-1998]. Praxis (Bern 1994), 90(50), 2193-2198.

Senti, G., Schmid, M. H., & Burg, G. (2001). [Multiple miliary osteomata cutis. Excision with "front lift" approach]. Hautarzt, 52(6), 522-525.

Storz, M., Zepter, K., Kamarashev, J., Dummer, R., Burg, G., & Haffner, A. C. (2001). Coexpression of CD40 and CD40 ligand in cutaneous T-cell lymphoma (mycosis fungoides). Cancer Res, 61(2), 452-454.

Urosevic, M., Kurrer, M. O., Kamarashev, J., Mueller, B., Weder, W., Burg, G., . . . Trojan, A. (2001). Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol, 159(3), 817-824. doi:10.1016/S0002-9440(10)61756-7

Willers, J., Haffner, A., Zepter, K., Storz, M., Urosevic, M., Burg, G., & Dummer, R. (2001). The interferon inhibiting cytokine IK is overexpressed in cutaneous T cell lymphoma derived tumor cells that fail to upregulate major histocompatibility complex class II upon interferon-gamma stimulation. J Invest Dermatol, 116(6), 874-879. doi:10.1046/j.1523-1747.2001.01339.x

Willers, J., Urosevic, M., Laine, E., Geertsen, R., Kundig, T., Burg, G., & Dummer, R. (2001). Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression. J Invest Dermatol, 117(6), 1498-1504. doi:10.1046/j.0022-202x.2001.01586.x

Boni, R., Schuster, C., Nehrhoff, B., & Burg, G. (2002). Epidemiology of skin cancer. Neuro Endocrinol Lett, 23 Suppl 2, 48-51.

Burg, G. (2002). Public education in skin cancer world-wide. Recent Results Cancer Res, 160, 3-6.

Burg, G., Kempf, W., Haeffner, A., Dobbeling, U., Nestle, F. O., Boni, R., . . . Dummer, R. (2002). From inflammation to neoplasia: new concepts in the pathogenesis of cutaneous lymphomas. Recent Results Cancer Res, 160, 271-280.

Carrozza, P. M., Kempf, W., Kazakov, D. V., Dummer, R., & Burg, G. (2002). A case of Sezary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphoma. Br J Dermatol, 147(3), 582-586.

Carrozza, P. M., Merlani, G. M., Burg, G., & Hafner, J. (2002). CO(2) laser surgery for extensive, cauliflower-like anogenital condylomata acuminata: retrospective long-term study on 19 HIV-positive and 45 HIV-negative men. Dermatology, 205(3), 255-259. doi:10.1159/000065844

Dummer, R., Kamarashev, J., Kempf, W., Haffner, A. C., Hess-Schmid, M., & Burg, G. (2002). Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: a CD8+ variant of mycosis fungoides? Arch Dermatol, 138(2), 199-203.

Erdmann, I., Scheidegger, E. P., Koch, F. K., Heinzerling, L., Odermatt, B., Burg, G., . . . Kundig, T. M. (2002). Fucosyltransferase VII-deficient mice with defective E-, P-, and L-selectin ligands show impaired CD4+ and CD8+ T cell migration into the skin, but normal extravasation into visceral organs. J Immunol, 168(5), 2139-2146.

Farshad, A., Burg, G., Panizzon, R., & Dummer, R. (2002). A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays. Br J Dermatol, 146(6), 1042-1046.

Haffner, A. C., Tassis, A., Zepter, K., Storz, M., Tureci, O., Burg, G., & Nestle, F. O. (2002). Expression of cancer/testis antigens in cutaneous T cell lymphomas. Int J Cancer, 97(5), 668-670.

Heinzerling, L., Dummer, R., Burg, G., & Schmid-Grendelmeier, P. (2002). Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient. Eur J Dermatol, 12(2), 194-197.

Heinzerling, L., Dummer, R., Pavlovic, J., Schultz, J., Burg, G., & Moelling, K. (2002). Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice. Exp Dermatol, 11(3), 232-240.

Heinzerling, L. M., Dummer, R., Panizzon, R. G., Bloch, P. H., Barbezat, R., Burg, G., & Task force 'swiss cancer' of the swiss cancer, l. (2002). Prevention campaign against skin cancer. Dermatology, 205(3), 229-233. doi:10.1159/000065848

Hofbauer, G. F., Boehler, A., Speich, R., Burg, G., & Nestle, F. O. (2002). Painless erythema of the hands associated with non-Hodgkin's lymphoma in a lung transplant recipient. J Am Acad Dermatol, 46(5 Suppl), S159-160.

Hofbauer, G. F., Boni, R., Simmen, D., Mihic, D., Nestle, F. O., Burg, G., & Dummer, R. (2002). Histological, immunological and molecular features of a nasal mucosa primary melanoma associated with nasal melanosis. Melanoma Res, 12(1), 77-82.

Kamarashev, J., Lor, P., Forster, A., Heinzerling, L., Burg, G., & Nestle, F. O. (2002). Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept. Dermatology, 205(2), 213-216. doi:10.1159/000063919

Kazakov, D. V., Belousova, I. E., Muller, B., Palmedo, G., Samtsov, A. V., Burg, G., & Kempf, W. (2002). Primary cutaneous plasmacytoma: a clinicopathological study of two cases with a long-term follow-up and review of the literature. J Cutan Pathol, 29(4), 244-248.

Kazakov, D. V., Burg, G., Dummer, R., & Kempf, W. (2002). Cutaneous lymphomas and pseudolymphomas: newly described entities. Recent Results Cancer Res, 160, 283-293.

Kazakov, D. V., Burg, G., Dummer, R., Palmedo, G., Muller, B., & Kempf, W. (2002). Primary subcutaneous follicular centre cell lymphoma with involvement of the galea: a case report and short review of the literature. Br J Dermatol, 146(4), 663-666.

Kazakov, D. V., Burg, G., & Kempf, W. (2002). Primary cutaneous B-cell lymphomas and pseudolymphomas: review of histopathological features. Cesk Patol, 38(4), 147-154.

Kazakov, D. V., Kempf, W., Michaelis, S., Schmid, U., Cogliatti, S., Dummer, R., & Burg, G. (2002). T-zone lymphoma with cutaneous involvement: a case report and review of the literature. Br J Dermatol, 146(6), 1096-1100.

Kazakov, D. V., Kutzner, H., Rutten, A., Dummer, R., Burg, G., & Kempf, W. (2002). Trichogerminoma: a rare cutaneous adnexal tumor with differentiation toward the hair germ epithelium. Dermatology, 205(4), 405-408. doi:10.1159/000066427

Kazakov, D. V., Mentzel, T., Burg, G., & Kempf, W. (2002). Superficial acral fibromyxoma: report of two cases. Dermatology, 205(3), 285-288. doi:10.1159/000065853

Kazakov, D. V., Prinz, B. M., Michaelis, S., Schmid, M., Muller, B., Adams, V., . . . Kempf, W. (2002). Study of HHV-8 DNA sequences in archival biopsies from lesional skin of Kaposi's sarcoma, various mesenchymal tumors and related reactive conditions. J Cutan Pathol, 29(5), 279-281.

Kempf, W., Haeffner, A. C., Zepter, K., Sander, C. A., Flaig, M. J., Mueller, B., . . . Burg, G. (2002). Angiolymphoid hyperplasia with eosinophilia: evidence for a T-cell lymphoproliferative origin. Hum Pathol, 33(10), 1023-1029.

Kempf, W., Levi, E., Kamarashev, J., Kutzner, H., Pfeifer, W., Petrogiannis-Haliotis, T., . . . Kadin, M. E. (2002). Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. J Cutan Pathol, 29(5), 295-300.

Knobler, R., Burg, G., Whittaker, S., & Baila, L. (2002). EORTC cutaneous lymphoma task force. European Organisation for Research and Treatment of Cancer. Eur J Cancer, 38 Suppl 4, S60-64.

Lor, P., Krueger, U., Kempf, W., Burg, G., & Nestle, F. O. (2002). Monoclonal rearrangement of the T cell receptor gamma-chain in lichenoid pigmented purpuric dermatitis of gougerot-blum responding to topical corticosteroid therapy. Dermatology, 205(2), 191-193. doi:10.1159/000063912

Rubben, A., Bogdan, I., Grussendorf-Conen, E. I., Burg, G., & Boni, R. (2002). Loss of heterozygosity and microsatellite instability in acquired melanocytic nevi: towards a molecular definition of the dysplastic nevus. Recent Results Cancer Res, 160, 100-110.

Schwab, C., Willers, J., Niederer, E., Ludwig, E., Kundig, T., Grob, P., . . . Dummer, R. (2002). The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas. Br J Haematol, 118(4), 1019-1026.

Urosevic, M., Willers, J., Mueller, B., Kempf, W., Burg, G., & Dummer, R. (2002). HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood, 99(2), 609-617.

Vonderheid, E. C., Bernengo, M. G., Burg, G., Duvic, M., Heald, P., Laroche, L., . . . Iscl. (2002). Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol, 46(1), 95-106.

Bader, U., Cipolat, C., & Burg, G. (2003). Dermatology online with interactive technology (DOIT). Curr Probl Dermatol, 32, 176-181.

Bogdan, I., Smolle, J., Kerl, H., Burg, G., & Boni, R. (2003). Melanoma ex naevo: a study of the associated naevus. Melanoma Res, 13(2), 213-217. doi:10.1097/01.cmr.0000056226.78713.99

Burg, G. (2003). [Herr Professor and Dr. of Medicine Urs Walter Schnyder on his 80th birthday]. J Dtsch Dermatol Ges, 1(2), 157-158.

Burg, G., & Denz, M. (2003). The Telemedical Information Society: doctors' playground or a contribution to the evolution of healthcare? Curr Probl Dermatol, 32, 2-5.

Burg, G., Kempf, W., Kazakov, D. V., Dummer, R., Frosch, P. J., Lange-Ionescu, S., . . . Kadin, M. E. (2003). Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature. Br J Dermatol, 148(3), 580-586.

Cipolat, C., Bader, U., Rufli, T., & Burg, G. (2003). Teledermatology in Switzerland. Curr Probl Dermatol, 32, 257-260.

Dragieva, G., Stahel, H. U., Meyer, M., Kempf, W., Haffner, A., Burg, G., & Hafner, J. (2003). Proteus syndrome. Vasa, 32(3), 159-163. doi:10.1024/0301-1526.32.3.159

Dummer, R., Beyeler, M., Morcinek, J., & Burg, G. (2003). [Cutaneous neoplasms]. Praxis (Bern 1994), 92(36), 1470-1478. doi:10.1024/0369-8394.92.36.1470

Dummer, R., Ivanova, K., Scheidegger, E. P., & Burg, G. (2003). Clinical and therapeutic aspects of polymorphous light eruption. Dermatology, 207(1), 93-95. doi:10.1159/000070956

Dummer, R., Kempf, W., Hess Schmid, M., Haffner, A., & Burg, G. (2003). Therapy of cutaneous lymphoma--current practice and future developments. Onkologie, 26(4), 366-372. doi:10.1159/000072098

Dummer, R., Urosevic, M., Hoek, K., Haffner, A., & Burg, G. (2003). Exploring primary cutaneous B-cell lymphoma by microarray technology. J Invest Dermatol, 120(5), vii-viii. doi:10.1046/j.1523-1747.2003.12151.x

Dummer, R., Urosevic, M., Kempf, W., Hoek, K., Hafner, J., & Burg, G. (2003). Imiquimod in basal cell carcinoma: how does it work? Br J Dermatol, 149 Suppl 66, 57-58.

Dummer, R., Urosevic, M., Kempf, W., Kazakov, D., & Burg, G. (2003). Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides. Dermatology, 207(1), 116-118. doi:10.1159/000070962

Gilliet, M., Kleinhans, M., Lantelme, E., Schadendorf, D., Burg, G., & Nestle, F. O. (2003). Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen. Blood, 102(1), 36-42. doi:10.1182/blood-2002-07-2274

Hauschild, A., Weichenthal, M., Balda, B. R., Becker, J. C., Wolff, H. H., Tilgen, W., . . . Dummer, R. (2003). Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis. J Clin Oncol, 21(15), 2883-2888. doi:10.1200/JCO.2003.07.116

Kazakov, D. V., Mentzel, T., Burg, G., Dummer, R., & Kempf, W. (2003). Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more? Br J Dermatol, 149(4), 869-876.

Kazakov, D. V., Schmid, M., Adams, V., Cathomas, G., Muller, B., Burg, G., & Kempf, W. (2003). HHV-8 DNA sequences in the peripheral blood and skin lesions of an HIV-negative patient with multiple eruptive dermatofibromas: implications for the detection of HHV-8 as a diagnostic marker for Kaposi's sarcoma. Dermatology, 206(3), 217-221. doi:10.1159/000068896

Kempf, W., Kadin, M. E., Dvorak, A. M., Lord, C. C., Burg, G., Letvin, N. L., & Koralnik, I. J. (2003). Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin. Carcinogenesis, 24(2), 301-306.

Kempf, W., Kettelhack, N., Duvic, M., & Burg, G. (2003). Topical and systemic retinoid therapy for cutaneous T-cell lymphoma. Hematol Oncol Clin North Am, 17(6), 1405-1419.

Kempf, W., Reichlin, S., & Burg, G. (2003). HistoClinC: a Web-based telemedicine application for clinicopathologic correlations in dermatopathology. Curr Probl Dermatol, 32, 213-220.

Kleinhans, M., Tun-Kyi, A., Gilliet, M., Kadin, M. E., Dummer, R., Burg, G., & Nestle, F. O. (2003). Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood, 101(4), 1487-1493. doi:10.1182/blood-2002-02-0475

Kropf, R., Cipolat, C., & Burg, G. (2003). Telemedicine in Europe. Curr Probl Dermatol, 32, 247-251.

Kropf, R., Cipolat, C., & Burg, G. (2003). Teleteaching tools in dermatology on the Web. Curr Probl Dermatol, 32, 33-38.

Lauchli, S., & Burg, G. (2003). Treatment of hyperhidrosis with botulinum toxin A. Skin Therapy Lett, 8(7), 1-4.

Lauchli, S., Kempf, W., Dragieva, G., Burg, G., & Hafner, J. (2003). CO2 laser treatment of warts in immunosuppressed patients. Dermatology, 206(2), 148-152. doi:10.1159/000068459

Maier, T., Tun-Kyi, A., Tassis, A., Jungius, K. P., Burg, G., Dummer, R., & Nestle, F. O. (2003). Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells. Blood, 102(7), 2338-2344. doi:10.1182/blood-2002-08-2455

Michaelis, S., Kazakov, D. V., Schmid, M., Dummer, R., Burg, G., & Kempf, W. (2003). Hepatitis C and G viruses in B-cell lymphomas of the skin. J Cutan Pathol, 30(6), 369-372.

Papp, K. A., Guenther, L., Boyden, B., Larsen, F. G., Harvima, R. J., Guilhou, J. J., . . . Chu, A. (2003). Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol, 48(1), 48-54. doi:10.1067/mjd.2003.130

Roberts, A. A., Amano, M., Felten, C., Galvan, M., Sulur, G., Pinter-Brown, L., . . . Baum, L. G. (2003). Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation. Mod Pathol, 16(6), 543-551. doi:10.1097/01.MP.0000071840.84469.06

Urosevic, M., Maier, T., Benninghoff, B., Slade, H., Burg, G., & Dummer, R. (2003). Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol, 139(10), 1325-1332. doi:10.1001/archderm.139.10.1325

Willers, J., Dummer, R., Kempf, W., Kundig, T., Burg, G., & Kadin, M. E. (2003). Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand. Clin Cancer Res, 9(7), 2744-2754.

Zagrodnik, B., Kempf, W., Seifert, B., Muller, B., Burg, G., Urosevic, M., & Dummer, R. (2003). Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer, 98(12), 2708-2714. doi:10.1002/cncr.11798

Zhang, C. L., Kamarashev, J., Qin, J. Z., Burg, G., Dummer, R., & Dobbeling, U. (2003). Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells. J Pathol, 200(2), 249-254. doi:10.1002/path.1341

Beyeler, M., Burg, G., & Dummer, R. (2004). [Cutaneous lymphoma]. Hautarzt, 55(10), 1005-1016; quiz 1017. doi:10.1007/s00105-004-0816-2

Beyeler, M., Kempf, W., Hafner, J., Burg, G., & Dummer, R. (2004). The spectrum of mesenchymal skin neoplasms reflected by the new WHO classification. Onkologie, 27(4), 401-406. doi:10.1159/000079097

Cozzio, A., Hafner, J., Kempf, W., Haffner, A., Palmedo, G., Michaelis, S., . . . Burg, G. (2004). Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity? J Am Acad Dermatol, 51(6), 1014-1017. doi:10.1016/j.jaad.2004.06.009

Dragieva, G., Hafner, J., Dummer, R., Schmid-Grendelmeier, P., Roos, M., Prinz, B. M., . . . Kempf, W. (2004). Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation, 77(1), 115-121. doi:10.1097/01.TP.0000107284.04969.5C

Dragieva, G., Prinz, B. M., Hafner, J., Dummer, R., Burg, G., Binswanger, U., & Kempf, W. (2004). A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol, 151(1), 196-200. doi:10.1111/j.1365-2133.2004.06054.x

Dummer, R., Hassel, J. C., Fellenberg, F., Eichmuller, S., Maier, T., Slos, P., . . . Urosevic, M. (2004). Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas. Blood, 104(6), 1631-1638. doi:10.1182/blood-2004-01-0360

Gerlini, G., Tun-Kyi, A., Dudli, C., Burg, G., Pimpinelli, N., & Nestle, F. O. (2004). Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol, 165(6), 1853-1863. doi:10.1016/S0002-9440(10)63238-5

Gilliet, M., Conrad, C., Geiges, M., Cozzio, A., Thurlimann, W., Burg, G., . . . Dummer, R. (2004). Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol, 140(12), 1490-1495. doi:10.1001/archderm.140.12.1490

Hafner, J., Schmid, M. H., Kempf, W., Burg, G., Kunzi, W., Meuli-Simmen, C., . . . Steinert, H. (2004). Baseline staging in cutaneous malignant melanoma. Br J Dermatol, 150(4), 677-686. doi:10.1111/j.0007-0963.2004.05870.x

Hasse, U., Kropf, R., & Burg, G. (2004). [Telemedicine in dermatology 2003: a review]. J Dtsch Dermatol Ges, 2(4), 294-300; quiz 301-292.

Hassel, J. C., Meier, R., Joller-Jemelka, H., Burg, G., & Dummer, R. (2004). Serological immunomarkers in cutaneous T cell lymphoma. Dermatology, 209(4), 296-300. doi:10.1159/000080852

Hofbauer, G. F., Burkhart, A., Schuler, G., Dummer, R., Burg, G., & Nestle, F. O. (2004). High frequency of melanoma-associated antigen or HLA class I loss does not correlate with survival in primary melanoma. J Immunother, 27(1), 73-78.

Kazakov, D. V., Burg, G., & Kempf, W. (2004). Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol, 18(4), 397-415. doi:10.1111/j.1468-3083.2004.00937.x

Kazakov, D. V., Kutzner, H., Rutten, A., Michal, M., Requena, L., Burg, G., . . . Kempf, W. (2004). The anti-MAGE antibody B57 as a diagnostic marker in melanocytic lesions. Am J Dermatopathol, 26(2), 102-107.

Kempf, W., Cathomas, G., Burg, G., & Trueb, R. M. (2004). Micronodular Kaposi's sarcoma - a new variant of classic-sporadic Kaposi's sarcoma. Dermatology, 208(3), 255-258. doi:10.1159/000077313

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., & Smoller, B. R. (2004). International board certification in dermatopathology: paving the way for the future. Am J Dermatopathol, 26(5), 439-440.

Lauchli, S., Zortea-Caflisch, C., Nestle, F. O., Burg, G., & Kempf, W. (2004). Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis. Dermatology, 208(3), 278-280. doi:10.1159/000077321

Liu, J. Y., Hafner, J., Dragieva, G., & Burg, G. (2004). Bioreactor microcarrier cell culture system (Bio-MCCS) for large-scale production of autologous melanocytes. Cell Transplant, 13(7-8), 809-816.

Liu, J. Y., Hafner, J., Dragieva, G., Seifert, B., & Burg, G. (2004). Autologous cultured keratinocytes on porcine gelatin microbeads effectively heal chronic venous leg ulcers. Wound Repair Regen, 12(2), 148-156. doi:10.1111/j.1067-1927.2004.012205.x

Meier, S., Baumert, B. G., Maier, T., Wellis, G., Burg, G., Seifert, B., & Dummer, R. (2004). Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie, 27(2), 145-149. doi:10.1159/000076903

Michaelis, S., Cozzio, A., Kempf, W., Graf, P., Burg, G., & Dummer, R. (2004). Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoides. Dermatology, 209(1), 72-74. doi:10.1159/000078595

Murer, K., Urosevic, M., Willers, J., Selvam, P., Laine, E., Burg, G., & Dummer, R. (2004). Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients. Melanoma Res, 14(4), 257-262.

Prinz, B. M., Hafner, J., Dummer, R., Burg, G., Bruswanger, U., & Kempf, W. (2004). Treatment of Bowen's disease with imiquimod 5% cream in transplant recipients. Transplantation, 77(5), 790-791.

Prinz, B. M., Michaelis, S., Kettelhack, N., Mueller, B., Burg, G., & Kempf, W. (2004). Subcutaneous infection with Mycobacterium abscessus in a renal transplant recipient. Dermatology, 208(3), 259-261. doi:10.1159/000077314

Prinz, B. M., Vavricka, S. R., Graf, P., Burg, G., & Dummer, R. (2004). Efficacy of laser treatment of tattoos using lasers emitting wavelengths of 532 nm, 755 nm and 1064 nm. Br J Dermatol, 150(2), 245-251.

Requena, L., Burg, G., Cerroni, L., & Zelger, B. W. (2004). A progressive papular eruption on the chest and back. Am J Dermatopathol, 26(2), 162-165.

Rubben, A., Kempf, W., Kadin, M. E., Zimmermann, D. R., & Burg, G. (2004). Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma. Exp Dermatol, 13(8), 472-483. doi:10.1111/j.0906-6705.2004.00176.x

Schuster, C., & Burg, G. (2004). [The red face]. Praxis (Bern 1994), 93(42), 1727-1732. doi:10.1024/0369-8394.93.42.1727

Urosevic, M., Kamarashev, J., Burg, G., & Dummer, R. (2004). Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2. Blood, 103(5), 1796-1798. doi:10.1182/blood-2003-10-3372

Urosevic, M., Oberholzer, P. A., Maier, T., Hafner, J., Laine, E., Slade, H., . . . Dummer, R. (2004). Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha? Clin Cancer Res, 10(15), 4959-4970. doi:10.1158/1078-0432.CCR-04-0193

  • Burg, G., Dummer, R., & Kempf, W. (2005). Dyscrasias with "undetermined significance". Arch Dermatol, 141(3), 382-384.

Burg, G., Hasse, U., Cipolat, C., Kropf, R., Djamei, V., Soyer, H. P., & Chimenti, S. (2005). Teledermatology: just cool or a real tool? Dermatology, 210(2), 169-173. doi:10.1159/000082573

Burg, G., Kempf, W., Cozzio, A., Feit, J., Willemze, R., E, S. J., . . . Whittaker, S. (2005). WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol, 32(10), 647-674. doi:10.1111/j.0303-6987.2005.00495.x

Dummer, R., Panizzon, R., Bloch, P. H., Burg, G., & Task Force Skin, C. (2005). Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology, 210(1), 39-44. doi:10.1159/000081482

Feit, J., Kempf, W., Jedlickova, H., & Burg, G. (2005). Hypertext atlas of dermatopathology with expert system for epithelial tumors of the skin. J Cutan Pathol, 32(6), 433-437. doi:10.1111/j.0303-6987.2005.00291.x

Gilliet, M., Cozzio, A., Burg, G., & Nestle, F. O. (2005). Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis. Br J Dermatol, 152(3), 531-536. doi:10.1111/j.1365-2133.2005.06434.x

Greisser, J., Doebbeling, U., Roos, M., Mueller, B., Schmid, M., Burg, G., . . . Kempf, W. (2005). Apoptosis in CD30-positive lymphoproliferative disorders of the skin. Exp Dermatol, 14(5), 380-385. doi:10.1111/j.0906-6705.2005.00293.x

Heinzerling, L., Burg, G., Dummer, R., Maier, T., Oberholzer, P. A., Schultz, J., . . . Moelling, K. (2005). Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. Hum Gene Ther, 16(1), 35-48. doi:10.1089/hum.2005.16.35

Hofbauer, G. F., Hatta, N., Daigle, I., Hemmi, S., Spanaus Schlapbach, K., Willers, J., . . . Dummer, R. (2005). Fas ligand reduces viability in primary melanoma short-term cell cultures more than in metastatic melanoma short-term cell cultures. Dermatology, 211(4), 318-324. doi:10.1159/000088500

Kempf, W., Kutzner, H., Kettelhack, N., Palmedo, G., & Burg, G. (2005). Paraneoplastic pityriasis lichenoides in cutaneous lymphoma: case report and review of the literature on paraneoplastic reactions of the skin in lymphoma and leukaemia. Br J Dermatol, 152(6), 1327-1331. doi:10.1111/j.1365-2133.2005.06457.x

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., Kutzner, H., & Sanguenza, O. (2005). International Board certification dermatopathology: a worldwide effort to rise standards in dermatopathology. J Dtsch Dermatol Ges, 3(4), 309-311.

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., Kutzner, H., & Sangueza, O. (2005). International Board Certification in Dermatopathology: a worldwide effort to raise standards in dermatopathology. Am J Dermatopathol, 27(4), 357-359.

Laetsch, B., Hofbauer, G., Kempf, W., Burg, G., & Dummer, R. (2005). Atypical poorly differentiated cutaneous T-cell lymphoma with an angiocentric growth pattern presenting histologically as vasculitis. Dermatology, 210(4), 341-345. doi:10.1159/000084763

Liu, J. Y., & Burg, G. (2005). An improved organ culture for regeneration of pure autologous keratinocytes from small split-thickness skin specimens. Dermatology, 210(1), 45-48. doi:10.1159/000081483

Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., . . . Gilliet, M. (2005). Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med, 202(1), 135-143. doi:10.1084/jem.20050500

Pimpinelli, N., Olsen, E. A., Santucci, M., Vonderheid, E., Haeffner, A. C., Stevens, S., . . . International Society for Cutaneous, L. (2005). Defining early mycosis fungoides. J Am Acad Dermatol, 53(6), 1053-1063. doi:10.1016/j.jaad.2005.08.057

Schraner, C., Hasse, B., Hasse, U., Baumann, D., Faeh, A., Burg, G., . . . Gunthard, H. F. (2005). Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1. Clin Infect Dis, 40(12), e120-124. doi:10.1086/430444

Urosevic, M., Braun, B., Willers, J., Burg, G., & Dummer, R. (2005). Expression of melanoma-associated antigens in melanoma cell cultures. Exp Dermatol, 14(7), 491-497. doi:10.1111/j.0906-6705.2005.00305.x

Urosevic, M., Conrad, C., Kamarashev, J., Asagoe, K., Cozzio, A., Burg, G., & Dummer, R. (2005). CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Hum Pathol, 36(9), 1020-1024. doi:10.1016/j.humpath.2005.07.002

Urosevic, M., Dummer, R., Conrad, C., Beyeler, M., Laine, E., Burg, G., & Gilliet, M. (2005). Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. J Natl Cancer Inst, 97(15), 1143-1153. doi:10.1093/jnci/dji207

Urosevic, M., Kempf, W., Zagrodnik, B., Panizzon, R., Burg, G., & Dummer, R. (2005). HLA-G expression in basal cell carcinomas of the skin recurring after radiotherapy. Clin Exp Dermatol, 30(4), 422-425. doi:10.1111/j.1365-2230.2005.01790.x

Willemze, R., Jaffe, E. S., Burg, G., Cerroni, L., Berti, E., Swerdlow, S. H., . . . Meijer, C. J. (2005). WHO-EORTC classification for cutaneous lymphomas. Blood, 105(10), 3768-3785. doi:10.1182/blood-2004-09-3502

Beyeler, M., Waldispuhl, S., Strobel, K., Joller-Jemelka, H. I., Burg, G., & Dummer, R. (2006). Detection of melanoma relapse: first comparative analysis on imaging techniques versus S100 protein. Dermatology, 213(3), 187-191. doi:10.1159/000095034

Burg, G., Kempf, W., Cozzio, A., Dobbeling, U., Feit, J., Golling, P., . . . Dummer, R. (2006). Cutaneous malignant lymphomas: update 2006. J Dtsch Dermatol Ges, 4(11), 914-933. doi:10.1111/j.1610-0387.2006.06069.x

Cozzio, A., Kempf, W., Schmid-Meyer, R., Gilliet, M., Michaelis, S., Scharer, L., . . . Dummer, R. (2006). Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma. Leuk Lymphoma, 47(5), 865-869. doi:10.1080/10428190500399698

Dummer, R., Hauschild, A., Skalsky, J., Burg, G., & Weichenthal, M. (2006). Bexarotene and systemic disease progression in CTCL? J Am Acad Dermatol, 55(2), 365-366; author reply 366. doi:10.1016/j.jaad.2006.01.022

Dummer, R., Urosevic, M., Cozzio, A., Asagoe, K., Dobbeling, U., & Burg, G. (2006). [Perspective of cutaneous lymphoma reserach]. J Dtsch Dermatol Ges, 4(6), 492-495. doi:10.1111/j.1610-0387.2006.05986.x

Goldinger, S. M., Dummer, R., Schmid, P., Prinz Vavricka, M., Burg, G., & Lauchli, S. (2006). Excimer laser versus narrow-band UVB (311 nm) in the treatment of psoriasis vulgaris. Dermatology, 213(2), 134-139. doi:10.1159/000093852

Greisser, J., Palmedo, G., Sander, C., Kutzner, H., Kazakov, D. V., Roos, M., . . . Kempf, W. (2006). Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders. J Cutan Pathol, 33(11), 711-715. doi:10.1111/j.1600-0560.2006.00560.x

Kazakov, D. V., Kutzner, H., Palmedo, G., Boudova, L., Michaelis, S., Michal, M., . . . Kempf, W. (2006). Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement. Am J Dermatopathol, 28(5), 399-409. doi:10.1097/01.dad.0000211514.98230.ba

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., Kutzner, H., & Sangueza, O. (2006). International Board Certification in Dermatopathology: a worldwide effort to raise standards in dermatopathology. J Cutan Pathol, 33(2), 156-159. doi:10.1111/j.0303-6987.2006.00390.x

Liu, J. Y., Hafner, J., Dragieva, G., & Burg, G. (2006). High yields of autologous living dermal equivalents using porcine gelatin microbeads as microcarriers for autologous fibroblasts. Cell Transplant, 15(5), 445-451.

Liu, J. Y., Hafner, J., Dragieva, G., & Burg, G. (2006). A novel bioreactor microcarrier cell culture system for high yields of proliferating autologous human keratinocytes. Cell Transplant, 15(5), 435-443.

Michaelis, S., Kazakov, D. V., Burg, G., Dummer, R., & Kempf, W. (2006). Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sezary syndrome. Int J Dermatol, 45(3), 277-279. doi:10.1111/j.1365-4632.2006.02378.x

Schadendorf, D., Ugurel, S., Schuler-Thurner, B., Nestle, F. O., Enk, A., Brocker, E. B., . . . DeCOG, D. C. s. g. o. t. (2006). Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol, 17(4), 563-570. doi:10.1093/annonc/mdj138

Dummer, R., Asagoe, K., Cozzio, A., Burg, G., Doebbeling, U., Golling, P., . . . Urosevic, M. (2007). Recent advances in cutaneous lymphomas. J Dermatol Sci, 48(3), 157-167. doi:10.1016/j.jdermsci.2007.09.001

Gachter, T., Muhleisen, B., Scharer, L., Dummer, R., Burg, G., & Hofbauer, G. F. (2007). Weight of decision-making impairs clinical assessment of melanocytic lesions. J Cutan Med Surg, 11(1), 9-18. doi:10.2310/7750.2007.00007

Goldinger, S. M., Dummer, R., Schmid, P., Burg, G., Seifert, B., & Lauchli, S. (2007). Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo. J Eur Acad Dermatol Venereol, 21(4), 504-508. doi:10.1111/j.1468-3083.2006.02016.x

Hafner, J., Fritz, T., Lauchli, S., Bogdan, I., Burg, G., & French, L. E. (2007). [Eyebrow repair after skin cancer surgery: combined naked and hairbearing full thickness graft from the contralateral retroauricular donor site]. J Dtsch Dermatol Ges, 5(11), 1034-1035. doi:10.1111/j.1610-0387.2007.06564.x

Kamarashev, J., Theler, B., Dummer, R., & Burg, G. (2007). Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation. Int J Dermatol, 46(9), 930-935. doi:10.1111/j.1365-4632.2007.03149.x

Muehleisen, B., Schaerer, L., Dummer, R., Burg, G., & Hofbauer, G. F. (2007). Cancer/testis antigen MAGE-A4 expression pattern differs in epithelial skin tumors of organ-transplant recipients and immunocompetent patients. J Cutan Pathol, 34(1), 1-6. doi:10.1111/j.1600-0560.2006.00576.x

Olsen, E., Vonderheid, E., Pimpinelli, N., Willemze, R., Kim, Y., Knobler, R., . . . Iscl/Eortc. (2007). Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood, 110(6), 1713-1722. doi:10.1182/blood-2007-03-055749

Burg, G. (2008). [E-Learning in medicine: at the top or a flop]. J Dtsch Dermatol Ges, 6(6), 435. doi:10.1111/j.1610-0387.2008.06789.x

Hofbauer, G. F., Baur, T., Bonnet, M. C., Tartour, E., Burg, G., Berinstein, N. L., & Dummer, R. (2008). Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate. Melanoma Res, 18(2), 104-111. doi:10.1097/CMR.0b013e3282f702cf

Kempf, W., Ostheeren-Michaelis, S., Paulli, M., Lucioni, M., Wechsler, J., Audring, H., . . . Treatment of, C. (2008). Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). Arch Dermatol, 144(12), 1609-1617. doi:10.1001/archdermatol.2008.46

Valentini, J., Grotto, D., Paniz, C., Roehrs, M., Burg, G., & Garcia, S. C. (2008). The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients. Biomed Pharmacother, 62(6), 378-382. doi:10.1016/j.biopha.2007.10.017

Burg, G., Soyer, H. P., & Chimenti, S. (2009). Skin diseases in Europe. Teledermatology. Eur J Dermatol, 19(6), 656-658. doi:10.1684/ejd.2009.0800

Kerl, H., Cerio, R., Burg, G., Anadolu, R. Y., Chimenti, S., & Forsea, D. (2009). Dermatopathology. Eur J Dermatol, 19(5), 536-537. doi:10.1684/ejd.2009.0785

Hafner, J., Nobbe, S., Partsch, H., Lauchli, S., Mayer, D., Amann-Vesti, B., . . . French, L. E. (2010). Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol, 146(9), 961-968. doi:10.1001/archdermatol.2010.224

Olsen, E. A., Whittaker, S., Kim, Y. H., Duvic, M., Prince, H. M., Lessin, S. R., . . . Treatment of, C. (2011). Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol, 29(18), 2598-2607. doi:10.1200/JCO.2010.32.0630

Tremp, M., Knafla, I., Burg, G., Wuthrich, B., & Schmid-Grendelmeier, P. (2011). 'EASIdig'--a digital tool to document disease activity in atopic dermatitis. Dermatology, 223(1), 68-73. doi:10.1159/000330333

Burg, G. (2012). History of sexually transmitted infections (STI). G Ital Dermatol Venereol, 147(4), 329-340.

Burg, G., & French, L. E. (2012). [The age of Gutenberg is over: a consideration of medical education--past, present and future]. Hautarzt, 63 Suppl 1, 38-44. doi:10.1007/s00105-011-2301-z

Hafner, J., French, L. E., Burg, G., & Schnyder, U. W. (2012). [To Prof. Dr. Dr. h.c. mult. Otto Braun-Falco: Birthday wishes and expression of appreciation from the Swiss Society for Dermatology and Venereology (SGDV)]. Hautarzt, 63 Suppl 1, 17. doi:10.1007/s00105-011-2308-5

Burg, G., French, L., & Hafner, J. (2013). [In memoriam: Prof. Dr. Dr. h.c. Urs Walter Schnyder: 7 February 1923-21 October 2012]. Hautarzt, 64(1), 65-66. doi:10.1007/s00105-012-2500-2

Pimmer, C., Linxen, S., Grohbiel, U., Jha, A. K., & Burg, G. (2013). Mobile learning in resource-constrained environments: a case study of medical education. Med Teach, 35(5), e1157-1165. doi:10.3109/0142159X.2012.733454

Burg, G. (2015). Systemic involvement in mycosis fungoides. Clin Dermatol, 33(5), 563-571. doi:10.1016/j.clindermatol.2015.05.008

Robson, A., Assaf, C., Bagot, M., Burg, G., Calonje, E., Castillo, C., . . . Berti, E. (2015). Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop. Histopathology, 67(4), 425-441. doi:10.1111/his.12371

Burg, G., & Finlay, A. Y. (2016). Web-based education. J Eur Acad Dermatol Venereol, 30(12), e226-e227. doi:10.1111/jdv.13560

 

Burg, G. (1969). [Protoporhyrinemic photodermatosis simulating hydroa aestivalia]. Dtsch Med Wochenschr, 94(25), 1314-1325.

Burg, G. (1969). [Protoporhyrinemic photodermatosis simulating hydroa aestivalia]. Dtsch Med Wochenschr, 94(25), 1314-1325.

Burg, G., Rassner, G., & Braun-Falco, O. (1969). [The effect of cyclophosphamide (Endoxan) on acute and chronic inflammation in the guinea pig]. Arch Klin Exp Dermatol, 236(1), 61-71.

Burg, G., Rassner, G., & Braun-Falco, O. (1969). [The effect of cyclophosphamide (Endoxan) on acute and chronic inflammation in the guinea pig]. Arch Klin Exp Dermatol, 236(1), 61-71.

Zaun, H., & Burg, G. (1969). [True twisted hair (Galewsky-Ronchese) with involvement of eyebrows and lanugo]. Asthet Med (Berl), 18(5), 95-100.

Zaun, H., & Burg, G. (1969). [True twisted hair (Galewsky-Ronchese) with involvement of eyebrows and lanugo]. Asthet Med (Berl), 18(5), 95-100.

Braun-Falco, O., & Burg, G. (1970). [Cytostatics and immunosuppressive agents in dermatology]. Hautarzt, 21(9), 391-397.

Braun-Falco, O., & Burg, G. (1970). [Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol, 236(3), 297-314.

Braun-Falco, O., & Burg, G. (1970). [Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. Arch Klin Exp Dermatol, 239(3), 307-322.

Braun-Falco, O., & Burg, G. (1970). [Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol, 236(2), 173-189.

Braun-Falco, O., & Burg, G. (1970). [Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol, 236(2), 173-189.

Braun-Falco, O., & Burg, G. (1970). [Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. Arch Klin Exp Dermatol, 239(3), 307-322.

Braun-Falco, O., & Burg, G. (1970). [Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol, 236(3), 297-314.

Braun-Falco, O., & Burg, G. (1970). [Cytostatics and immunosuppressive agents in dermatology]. Hautarzt, 21(9), 391-397.

Braun-Falco, O., Schmidt, D., & Burg, G. (1970). [Protoperphyrinaemic photodermatosis of the Quinckes's edema type]. Munch Med Wochenschr, 112(32), 1443-1447.

Braun-Falco, O., Schmidt, D., & Burg, G. (1970). [Protoperphyrinaemic photodermatosis of the Quinckes's edema type]. Munch Med Wochenschr, 112(32), 1443-1447.

Burg, G. (1970). [Erythropoietic protoporphyrinemic light dermatosis. Contribution to optical fluorescence demonstration, pathogenesis and therapy]. Dtsch Med Wochenschr, 95(20), 1120-1123. doi:10.1055/s-0028-1108598

Burg, G. (1970). [Erythropoietic protoporphyrinemic light dermatosis. Contribution to optical fluorescence demonstration, pathogenesis and therapy]. Dtsch Med Wochenschr, 95(20), 1120-1123. doi:10.1055/s-0028-1108598

Braun-Falco, O., & Burg, G. (1971). [Cytostatic and immunosuppressive treatment of dermatologic diseases]. Ther Ggw, 110(4), 488-500.

Braun-Falco, O., & Burg, G. (1971). [Dynamics of skin reaction following horn layer stripping. Histochemical and cytochemical studies on guinea pig ears]. Arch Dermatol Forsch, 241(1), 1-14.

Braun-Falco, O., & Burg, G. (1971). [Dynamics of skin reaction following horn layer stripping. Histochemical and cytochemical studies on guinea pig ears]. Arch Dermatol Forsch, 241(1), 1-14.

Braun-Falco, O., & Burg, G. (1971). [Cytostatic and immunosuppressive treatment of dermatologic diseases]. Ther Ggw, 110(4), 488-500.

Braun-Falco, O., Burg, G., & Schoefinius, H. H. (1971). [The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations]. Arch Dermatol Forsch, 241(3), 217-236.

Braun-Falco, O., Burg, G., & Schoefinius, H. H. (1971). [The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations]. Arch Dermatol Forsch, 241(3), 217-236.

Burg, G. (1971). [Therapy of porphyrias]. Dtsch Med Wochenschr, 96(21), 914-915. doi:10.1055/s-0028-1108358

Burg, G. (1971). [Therapy of porphyrias]. Dtsch Med Wochenschr, 96(21), 914-915. doi:10.1055/s-0028-1108358

Braun-Falco, O., Burg, G., & Farber, E. M. (1972). [Psoriasis. A questionnaire study of 536 patients]. Munch Med Wochenschr, 114(23), 1105-1110.

Braun-Falco, O., Burg, G., & Farber, E. M. (1972). [Psoriasis. A questionnaire study of 536 patients]. Munch Med Wochenschr, 114(23), 1105-1110.

Burg, G. (1972). [Therapy of porphyrias]. Minerva Med, 63(31), 1813-1815.

Burg, G. (1972). [Therapy of porphyrias]. Minerva Med, 63(31), 1813-1815.

Burg, G., & Braun-Falco, O. (1972). [Cytochemical studies on cellular stroma reaction in melanoma]. Arch Dermatol Forsch, 244, 261-264.

Burg, G., & Braun-Falco, O. (1972). The cellular stromal reaction in malignant melanoma. A cytochemical investigation. Arch Dermatol Forsch, 245(4), 318-333.

Burg, G., & Braun-Falco, O. (1972). The cellular stromal reaction in malignant melanoma. A cytochemical investigation. Arch Dermatol Forsch, 245(4), 318-333.

Burg, G., & Braun-Falco, O. (1972). [Cytochemical studies on cellular stroma reaction in melanoma]. Arch Dermatol Forsch, 244, 261-264.

Burg, G., & Plewig, G. (1972). [Seasonal pruritus as a symptom of erythropoietic protoporphyrinemic photodermatosis (EPL)]. Hautarzt, 23(12), 553-555.

Burg, G., & Plewig, G. (1972). [Seasonal pruritus as a symptom of erythropoietic protoporphyrinemic photodermatosis (EPL)]. Hautarzt, 23(12), 553-555.

Burg, G., & Robins, P. (1972). [Chemosurgery. Surgical removal of chemically fixed tumor tissue with microscopic control]. Hautarzt, 23(1), 16-20.

Burg, G., & Robins, P. (1972). [Chemosurgery. Surgical removal of chemically fixed tumor tissue with microscopic control]. Hautarzt, 23(1), 16-20.

Kolomiichenko, A. I., Kharshak, E. M., Lifanov, V. L., Burg, G. M., & Moroz, B. S. (1972). [Mobile audiometric laboratory]. Zh Ushn Nos Gorl Bolezn, 32(1), 103-104.

Kolomiichenko, A. I., Kharshak, E. M., Lifanov, V. L., Burg, G. M., & Moroz, B. S. (1972). [Mobile audiometric laboratory]. Zh Ushn Nos Gorl Bolezn, 32(1), 103-104.

Braun-Falco, O., & Burg, G. (1973). [Enzyme histochemistry of malignant melanoma. Investigations on primary tumors and metastases (author's transl)]. Arch Dermatol Forsch, 246(4), 303-316.

Braun-Falco, O., & Burg, G. (1973). [Enzyme histochemistry of malignant melanoma. Investigations on primary tumors and metastases (author's transl)]. Arch Dermatol Forsch, 246(4), 303-316.

Burg, G. (1973). [Erythropoetic, protoporphyrinemic light dermatosis with secondary cutaneous hyalinosis]. Hautarzt, 24(12), 564.

Burg, G. (1973). [Erythropoetic, protoporphyrinemic light dermatosis with secondary cutaneous hyalinosis]. Hautarzt, 24(12), 564.

Huhn, D., Burg, G., & Mempel, W. (1973). [Specific cutaneous changes in Hodgkin's disease (author's transl)]. Dtsch Med Wochenschr, 98(52), 2469-2472. doi:10.1055/s-0028-1107281

Huhn, D., Burg, G., & Mempel, W. (1973). [Specific cutaneous changes in Hodgkin's disease (author's transl)]. Dtsch Med Wochenschr, 98(52), 2469-2472. doi:10.1055/s-0028-1107281

Braun-Falco, O., & Burg, G. (1974). [Cellular infiltrate and capillaries in atopic dermatitis. Quantitative enzyme-cytochemical and histochemical investigations (author's transl)]. Arch Dermatol Forsch, 249(2), 113-124.

Braun-Falco, O., & Burg, G. (1974). [Cellular infiltrate and capillaries in atopic dermatitis. Quantitative enzyme-cytochemical and histochemical investigations (author's transl)]. Arch Dermatol Forsch, 249(2), 113-124.

Burg, G., & Braun-Falco, O. (1974). [Qualitative and quantitative aspects of the cellular reaction in the skin and blood in mycosis fungoides. A cytochemical study]. Hautarzt, 25(4), 178-187.

Burg, G., & Braun-Falco, O. (1974). [Advances in cytochemical differentiation of cellular infiltrates into the skin]. Hautarzt, 25(1), 1-8.

Burg, G., & Braun-Falco, O. (1974). [Advances in cytochemical differentiation of cellular infiltrates into the skin]. Hautarzt, 25(1), 1-8.

Burg, G., & Braun-Falco, O. (1974). [Qualitative and quantitative aspects of the cellular reaction in the skin and blood in mycosis fungoides. A cytochemical study]. Hautarzt, 25(4), 178-187.

Burg, G., & Dorn, M. (1974). [Chemosurgery of basaliomas]. Z Hautkr, 49(17), 713-714.

Burg, G., & Dorn, M. (1974). [Chemosurgery of basaliomas]. Z Hautkr, 49(17), 713-714.

Kerl, H., Burg, G., & Braun-Falco, O. (1974). Quantitative and qualitative dynamics of the epidermal and cellular inflammatory reaction in primary toxic and allergic dinitrochlorobenzene contact dermatitis in guinea pigs. Arch Dermatol Forsch, 249(3), 207-226.

Kerl, H., Burg, G., & Braun-Falco, O. (1974). Quantitative and qualitative dynamics of the epidermal and cellular inflammatory reaction in primary toxic and allergic dinitrochlorobenzene contact dermatitis in guinea pigs. Arch Dermatol Forsch, 249(3), 207-226.

Burg, G. (1975). [Procceedings: Hereditary onycholysis mit scleronychia]. Hautarzt, 26(7), 386.

Burg, G., & Braun-Falco, O. (1975). [T and B lymphocytes in skin changes of cutaneous lymphoma (author's transl)]. Dtsch Med Wochenschr, 100(50), 2562-2564. doi:10.1055/s-0028-1106585

Burg, G., & Braun-Falco, O. (1975). Classification and differentiation of cutaneous lymphomas. Enzyme-cytochemical and immunocytological studies. Br J Dermatol, 93(5), 597-599.

Burg, G., Hirsch, R. D., Konz, B., & Braun-Falco, O. (1975). Histographic surgery: accuracy of visual assessment of the margins of basal-cell epithelioma. J Dermatol Surg, 1(3), 21-24.

Falco, O. B., & Burg, G. (1975). [Lymphoreticular proliferations in the skin. Cytochemical and immunocytological studies in lymphadenosis benigna cutis]. Hautarzt, 26(3), 124-132.

Kerl, H., & Burg, G. (1975). [Acquired (postinflammatory) dermatchalasis, dermatitis herpetiformis Duhring, celiac syndrome, dermatochalasis]. Hautarzt, 26(4), 191-196.

Weber, K., Burg, G., Wolff, H. H., Braun-Falco, O., & Ehlers, G. (1975). [Sezary's syndrome. Case report]. Hautarzt, 26(5), 255-259.

Braun-Falco, O., & Burg, G. (1976). Proceedings: Enzyme cytochemical and immunocytological characterization of cutaneous lymphomas. Br J Dermatol, 95 Suppl 14, 9-10.

Braun-Falco, O., Burg, G., & Wolff, H. H. (1976). [Cutaneous lymphomas, and pseudolymphomas. Immunocytological, enzymocytochemical and electron microscopical studies (authors transl)]. Ther Umsch, 33(8), 543-550.

Burg, G. (1976). [Progress in the diagnosis of cutaneous lymphomas. Enzyme cytochemical and immunocytological studies]. Fortschr Med, 94(18), 1089-1098.

Burg, G., & Braun-Falco, O. (1977). [1-Chloro-2,4-dinitrobenzene ointment for sensitization, testing and therapy of malignant melanoma patients]. Dtsch Med Wochenschr, 102(6), 210-211.

Burg, G., & Braun-Falco, O. (1977). Morphological and functional differentiation and classification of cutaneous lymphomas. Bull Cancer, 64(2), 225-240.

Burg, G., & Braun-Falco, O. (1977). [Enzyme cytochemical and immunocytologic studies of mycosis fungoides]. Acta Histochem Suppl, Suppl 18, 209-214.

Burg, G., Rodt, H., Grosse-Wilde, H., Netzel, B., Fateh-Moghadam, A., & Braun-Falco, O. (1977). Enzymecytochemical and immunocytological studies as a basis for the revaluation of the histology of cutaneous B-cell and T-cell lymphomas. Haematol Blood Transfus, 20, 179-187.

Hofmann, C., Burg, G., Plewig, G., & Braun-Falco, O. (1977). [Photochemotherapy of cutaneous lymphoma: oral and local 8-MOP-UVA treatment (author's transl)]. Dtsch Med Wochenschr, 102(18), 675-679. doi:10.1055/s-0028-1104951

Schmoeckel, C., Burg, G., Wolf, H. H., & Braun-Falco, O. (1977). The ultrastructure of lymphadenosis benigna cutis (pseudolymphoma cutis). Arch Dermatol Res, 258(2), 161-167.

Bode, U., & Burg, G. (1978). [The acquired digital fibrokeratoma]. Hautarzt, 29(12), 659-660.

Braun-Falco, O., Guggenberger, K., Burg, G., & Fateh-Moghadam, A. (1978). [Immunocytoma simulating chronic acrodermatitis atrophicans]. Hautarzt, 29(12), 644-647.

Burg, G., & Braun-Falco, O. (1978). Cutaneous non-Hodgkin lymphoma: re-evaluation of histology using enzymecytochemical and immunologic studies. Int J Dermatol, 17(6), 496-505.

Burg, G., Braun-Falco, O., Hoffmann-Fezer, G., Rodt, H., & Schmoeckel, C. (1978). Patterns of cutaneous lymphomas. Histological, enzyme cytochemical, and immunological typing of lymphoreticular proliferations in the skin. Dermatologica, 157(5), 282-291.

Burg, G., Braun-Falco, O., & Schmoeckel, C. (1978). [Cutaneous T-cell lymphomas]. Fortschr Med, 96(5), 199-205.

Burg, G., Rodt, H., Grosse-Wilde, H., & Braun-Falco, O. (1978). Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sezary's syndrome. J Invest Dermatol, 70(5), 257-259.

Burg, G., Schmoeckel, C., Braun-Falco, O., & Wolff, H. H. (1978). Monocytic leukemia. Clinically appearing as 'malignant reticulosis of the skin'. Arch Dermatol, 114(3), 418-420.

Bonniger, F., & Burg, G. (1979). [Multiple keratoacanthomas]. Hautarzt, 30(2), 92-94.

Braun-Falco, O., Schmoeckel, C., Burg, G., & Ryckmanns, F. (1979). Pagetoid reticulosis. A further case report with a review of the literature. Acta Derm Venereol Suppl (Stockh), 59(85), 11-21.

Burg, G. (1979). [Reticuloses and lymphomas of the skin from the present viewpoint]. Hautarzt, 30(3), 167-168.

Butenschon, H., Burg, G., & Lentze, M. (1979). [LEOPARD syndrome]. Z Hautkr, 54(13), 613-618.

Kerl, H., & Burg, G. (1979). [Immunocytomas and immunoblastic lymphomas of the skin]. Hautarzt, 30(12), 666-672.

Kienitz, T., Burg, G., Schmoeckel, C., Weitz, H., & Braun-Falco, O. (1979). High-grade malignant lymphoma arising from Sezary's syndrome. A case report. Dermatologica, 158(2), 126-136.

Schmoeckel, C., Burg, G., & Braun-Falco, O. (1979). Quantitative analysis of lymphoid cells in cutaneous low-grade malignant B-cell lymphomas. Arch Dermatol Res, 266(3), 239-251.

Schmoeckel, C., Burg, G., & Braun-Falco, O. (1979). Quantitative analysis of lymphoid cells in myocosis fungoides, Sezary's syndrome and parapsoriasis en plaques. Arch Dermatol Res, 264(1), 17-28.

von Liebe, V., Karge, H. J., & Burg, G. (1979). [Contact urticaria]. Hautarzt, 30(10), 544-546.

Braun-Falco, O., Burg, G., Hoffmann-Fezer, G., Fateh-Moghadam, A., & Herterich, J. (1980). [Reticulosis of the skin - a heterogenic group of diseases]. Acta Histochem Suppl, 21, 57-69.

Braun-Falco, O., Burg, G., Selzle, D., & Schmoeckel, C. (1980). [Diffuse congenital melanosis]. Hautarzt, 31(6), 324-327.

Burg, G. (1980). [Enzyme cytochemical and immunological procedures for diagnosis of pseudolymphomas and skin lymphomas]. Z Hautkr, 55(20), 1351-1366.

Burg, G., Guggenberger, K., Schmoeckel, C., & Braun-Falco, O. (1980). [Therapy of mycosis fungoides]. Ther Ggw, 119(7), 773-790.

Kolz, R., Lonsdorf, G., & Burg, G. (1980). [Intolerance reactions following parenteral administration of vitamin B]. Hautarzt, 31(12), 657-659.

Schmoeckel, C., Braun-Falco, O., & Burg, G. (1980). [Atypical fibroxanthoma]. Hautarzt, 31(4), 213-215.

Braun-Falco, O., Burg, G., & Schmoeckel, C. (1981). Recent advances in the understanding of cutaneous lymphoma. Clin Exp Dermatol, 6(1), 89-109.

Burg, G. (1981). Malignant histiocytic disorders of the skin. Haematol Blood Transfus, 27, 221-224.

Burg, G., Hoffmann-Fezer, G., Nikolowski, J., Schmoeckel, C., Braun-Falco, O., & Stunkel, K. (1981). Lymphomatoid papulosis: a cutaneous T-cell pseudolymphoma. Acta Derm Venereol, 61(6), 491-496.

Landthaler, M., Burg, G., & Zirbs, S. (1981). [Dye and nickel allergy in the hairdressing salon]. Hautarzt, 32(6), 281-284.

Schmoeckel, C., Burg, G., Braun-Falco, O., & Klingmuller, G. (1981). [High-grade malignant mycosis fungoides with cytological transformation (author's transl)]. Ann Dermatol Venereol, 108(3), 231-236, 239-241.

Forg, T., Burg, G., & Zirbs, S. (1982). [Frequency of contact allergy in housewives (author's transl)]. Derm Beruf Umwelt, 30(2), 48-50.

Ring, J., Lonsdorf, G., Schury, W., & Burg, G. (1982). [Bee and wasp venom allergy. Clinical aspects, prevention and therapy]. MMW Munch Med Wochenschr, 124(24), 587-590.

Schmoeckel, C., Burg, G., Hoffmann-Fezer, G., Stolz, W., Weitz, H., Lohrs, U., & Braun-Falco, O. (1982). Cutaneous immunoblastic T-cell lymphoma. Arch Dermatol Res, 274(1-2), 141-154.

Braun-Falco, O., & Burg, G. (1983). [Malignant lymphomas of the skin]. Internist (Berl), 24(6), 306-320.

Braun-Falco, O., Nikolowski, J., Burg, G., & Schmoeckel, C. (1983). [Lymphomatoid papulosis. Review and personal observation of 4 patients]. Hautarzt, 34(2), 59-65.

Hoffmann, R., van de Graaff, S., & Burg, G. (1983). [Spread of tuberculosis in ornamental fishes]. Tierarztl Prax, 11(2), 261-267.

Kerl, H., Burg, G., & Hashimoto, K. (1983). Fatal, penicillin-induced, generalized, postinflammatory elastolysis (cutis laxa). Am J Dermatopathol, 5(3), 267-276.

Oehlschlaegel, G., Marquart, K. H., Steuer, G., & Burg, G. (1983). [Iatrogenic pseudotumor of the skin induced by polyvinyl pyrrolidone]. Hautarzt, 34(11), 555-560.

Przybilla, B., Burg, G., Schmoeckel, C., & Braun-Falco, O. (1983). Treatment of cutaneous T-cell lymphomas with TP-5. Evaluation of the clinical effect in 8 patients. Acta Derm Venereol, 63(6), 524-529.

Przybilla, B., Burg, G., & Thieme, C. (1983). Evaluation of the immune status in vivo by the 2,4-dinitro-1-chlorobenzene contact allergy time (DNCB-CAT). Dermatologica, 167(1), 1-5.

Przybilla, B., Ring, J., & Burg, G. (1983). [Anaphylaxis following ingestion of coffee, chronic urticaria and analgesics idiosyncrasy]. Hautarzt, 34(2), 73-76.

Ring, J., Bode, U., Kadach, U., Stix, E., & Burg, G. (1983). [Gammaglobulins and allergy. Clinical results of a controlled study with standard human IgG and placebo in pollinosis]. MMW Munch Med Wochenschr, 125(14), 289-292.

Stolz, W., Schmoeckel, C., Burg, G., & Braun-Falco, O. (1983). Circulating Sezary cells in the diagnosis of Sezary syndrome (quantitative and morphometric analyses). J Invest Dermatol, 81(4), 314-319.

Burg, G., Kerl, H., Kaudewitz, P., Braun-Falco, O., & Mason, D. Y. (1984). Immunoenzymatic typing of lymphoplasmacytoid skin infiltrates. J Dermatol Surg Oncol, 10(4), 284-290.

Burg, G., Kerl, H., Przybilla, B., & Braun-Falco, O. (1984). Some statistical data, diagnosis, and staging of cutaneous B-cell lymphomas. J Dermatol Surg Oncol, 10(4), 256-262.

Burg, G., Kerl, H., & Schmoeckel, C. (1984). Differentiation between malignant B-cell lymphomas and pseudolymphomas of the skin. J Dermatol Surg Oncol, 10(4), 271-275.

Eberth-Willershausen, W., Steger, O., Barran, W., Burg, G., Ryckmanns, F., & Kaudewitz, P. (1984). [Histiocytosis X. An oligosymptomatic form of Hand-Schuller-Christian disease with a new form and possibilities of diagnosis]. Hautarzt, 35(10), 539-542.

Geerts, M. L., Burg, G., Schmoeckel, C., & Braun-Falco, O. (1984). Alkaline phosphatase activity in non-Hodgkin's lymphomas and pseudolymphomas of the skin. J Dermatol Surg Oncol, 10(4), 306-312.

Geerts, M. L., Burg, G., Schmoeckel, C., & Braun-Falco, O. (1984). Alkaline phosphatase positive lymphoma. Dermatologica, 169(6), 342-347.

Kaudewitz, P., Burg, G., Klepzig, K., Munker, R., Rieber, P., & Braun-Falco, O. (1984). Cells reactive with anti-T-cell monoclonal antibodies in malignant cutaneous B-cell lymphomas and pseudolymphomas. J Dermatol Surg Oncol, 10(4), 313-314.

Kerl, H., & Burg, G. (1984). Histomorphology and cytomorphology of cutaneous B-cell lymphomas. J Dermatol Surg Oncol, 10(4), 266-270.

Burg, G., Kaudewitz, P., Klepzig, K., Przybilla, B., & Braun-Falco, O. (1985). Cutaneous B-cell lymphoma. Dermatol Clin, 3(4), 689-704.

Kaudewitz, P., Burg, G., Stein, H., Klepzig, K., Mason, D. Y., & Braun-Falco, O. (1985). Monoclonal antibody patterns in lymphomatoid papulosis. Dermatol Clin, 3(4), 749-757.

Maier, H., Schmoeckel, C., Burg, G., & Braun-Falco, O. (1985). Primary cutaneous atypical histiocytosis with possible dissemination. Am J Dermatopathol, 7(4), 373-382.

Schanne, R., Burg, G., & Braun-Falco, O. (1985). [Nosologic relation of dyskeratosis follicularis (Darier) and pemphigus benignus chronicus familiaris (Hailey-Hailey). Position based on a case report]. Hautarzt, 36(9), 504-508.

Smolle, J., Kaudewitz, P., Burg, G., Kresbach, H., & Kerl, H. (1985). Significance of non-lymphoid ('accessory') cells in malignant lymphomas and pseudolymphomas of the skin. Br J Dermatol, 113(6), 677-685.

Burg, G. (1986). [Pagetoid skin infiltrates]. Pathologe, 7(4), 199-206.

Burg, G., Klepzig, K., Kaudewitz, P., Wolf, H., & Braun-Falco, O. (1986). Acyclovir in lymphomatoid papulosis and mycosis fungoides. JAMA, 256(2), 214-215.

Burg, G., Klepzig, K., Kaudewitz, P., Wolff, H., & Braun-Falco, O. (1986). [Acyclovir in mycosis fungoides and lymphomatoid papulosis]. Hautarzt, 37(10), 533-536.

Hofmann, C., Burg, G., & Jung, C. (1986). [Cutaneous side effects of gold therapy. Clinical and histologic results]. Z Rheumatol, 45(3), 100-106.

Imai, S., Burg, G., & Braun-Falco, O. (1986). Mycosis fungoides and Sezary's syndrome show distinct histomorphological features. Dermatologica, 173(3), 131-135.

Kaudewitz, P., Burg, G., Smolle, J., & Braun-Falco, O. (1986). [Immunologic phenotyping of cutaneous lymphomas]. Hautarzt, 37(12), 647-655.

Kaudewitz, P., Soldner, R., Burg, G., Bieber, T., Berger, C., Edelson, R., . . . Braun-Falco, O. (1986). Reactivity of monoclonal antibody BE 2 in different stages of mycosis fungoides and in benign dermal infiltrates. Arch Dermatol Res, 279(2), 83-88.

Kaudewitz, P., Stein, H., Burg, G., Mason, D. Y., & Braun-Falco, O. (1986). Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1. J Invest Dermatol, 86(4), 350-354.

Bieber, T., Ruzicka, T., & Burg, G. (1987). [Erosive pustulous dermatitis of the scalp]. Hautarzt, 38(11), 687-689.

Burg, G., Stunkel, K. G., Bieber, T., Opitz, U., & Kaudewitz, P. (1987). Cutaneous infiltrates of histiocytosis X contain plasminogen activator-bearing epidermotropic dendritic cells different from Langerhans cells. Arch Dermatol Res, 279 Suppl, S88-91.

Hofmann, C., Richter, W., Hiller, C., & Burg, G. (1987). [Urticaria vasculitis]. Z Rheumatol, 46(5), 233-236.

Kaudewitz, P., Burg, G., Majiewski, G., Gerdes, J., Schwarting, R., & Braun-Falco, O. (1987). Cell populations in pagetoid reticulosis: an immunological study using cell activation associated monoclonal antibodies. Acta Derm Venereol, 67(1), 24-29.

Ruzicka, T., & Burg, G. (1987). Effects of chronic intracutaneous administration of arachidonic acid and its metabolites. Induction of leukocytoclastic vasculitis by leukotriene B4 and 12-hydroxyeicosatetraenoic acid and its prevention by prostaglandin E2. J Invest Dermatol, 88(2), 120-123.

Smolle, J., Kaudewitz, P., Aberer, E., Torne, R., Burg, G., & Kerl, H. (1987). [Immunohistochemical classification of cutaneous lymphomas and pseudolymphomas]. Hautarzt, 38(8), 461-466.

Burg, G., Bieber, T., & Langecker, P. (1988). [Localized neutrophilic eccrine hydradenitis in mitoxantrone therapy: a typical side-effect of cytostatic drugs]. Hautarzt, 39(4), 233-236.

Burg, G., & Landthaler, M. (1988). [Proliferating tricholemmal tumor]. Hautarzt, 39(2), 117-119.

Burg, G., von der Helm, D., Kaudewitz, P., Klepzig, K., & Braun-Falco, O. (1988). Antihuman T-cell leukemia/lymphoma virus antibodies in three patients with primary cutaneous B-cell lymphoma. J Dermatol Surg Oncol, 14(6), 653-656.

Eckert, F., Burg, G., Braun-Falco, O., Schmid, U., & Gloor, F. (1988). Immunostaining in atypical fibroxanthoma of the skin. Pathol Res Pract, 184(1), 27-34. doi:10.1016/S0344-0338(88)80187-0

Eckert, F., Hein, R., Krieg, T., & Burg, G. (1988). [Local recurrent centroblastic lymphoma of the skin]. Hautarzt, 39(12), 791-794.

Enders, F., Przybilla, B., Ring, J., Burg, G., & Braun-Falco, O. (1988). [Epicutaneous testing with a standard series. Results in 12,026 patients]. Hautarzt, 39(12), 779-786.

Gollhausen, R., Enders, F., Przybilla, B., Burg, G., & Ring, J. (1988). Trends in allergic contact sensitization. Contact Dermatitis, 18(3), 147-154.

Kampgen, E., Burg, G., & Wank, R. (1988). Association of herpes simplex virus-induced erythema multiforme with the human leukocyte antigen DQw3. Arch Dermatol, 124(9), 1372-1375.

Schmoeckel, C., & Burg, G. (1988). Congenital spiradenoma. Am J Dermatopathol, 10(6), 541-545.

Schrallhammer, K., Burg, G., Stolz, W., & Braun-Falco, O. (1988). [Congenital poikiloderma with verrucous hyperkeratosis. An unusual form of Thomson's syndrome?]. Hautarzt, 39(3), 143-148.

von der Helm, D., von der Helm, K., Burg, G., Braun-Falco, O., & Deinhardt, F. (1988). [Antibodies against HTLV I in T-lymphoproliferative diseases of the skin]. Hautarzt, 39(6), 348-350.

Burg, G., & Bergner, T. (1989). Pigmentary disorders associated with nutritional deficiency states. Clin Dermatol, 7(2), 36-43.

Burg, G., Vieluf, D., Stolz, W., Landthaler, M., & Braun-Falco, O. (1989). [Malignant atrophic papulosis (Kohlmeier-Degos disease)]. Hautarzt, 40(8), 480-485.

Eckert, F., Schmid, U., Kaudewitz, P., Burg, G., & Braun-Falco, O. (1989). Follicular lymphoid hyperplasia of the skin with high content of Ki-1 positive lymphocytes. Am J Dermatopathol, 11(4), 345-352.

Hackel, H., Burg, G., Lechner, W., Stolz, W., Ring, J., & Braun-Falco, O. (1989). [Keratoacanthoma centrifugum marginatum]. Hautarzt, 40(12), 763-766.

Hartmann, A. A., & Burg, G. (1989). [Fulminant acne in Klinefelter syndrome treated with testosterone. A side effect of anti-tallness therapy]. Monatsschr Kinderheilkd, 137(8), 466-467.

Kaudewitz, P., Stein, H., Dallenbach, F., Eckert, F., Bieber, K., Burg, G., & Braun-Falco, O. (1989). Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics. Am J Pathol, 135(2), 359-367.

Kleber, R., Landthaler, M., & Burg, G. (1989). [Post-zoster granuloma anulare]. Hautarzt, 40(2), 110-111.

Pierard-Franchimont, C., Burg, G., Grosshans, E., Kerl, H., & Pierard, G. E. (1989). [Prevalence of skin cancers in the Mosane region and in European countries of the same latitude]. Rev Med Liege, 44(18), 541-545.

Stolz, W., Graubner, U., Gerstmeier, J., Burg, G., & Belohradsky, B. H. (1989). Chediak-Higashi syndrome: approaches in diagnosis and treatment. Curr Probl Dermatol, 18, 93-100.

Braun-Falco, O., Burg, G., & Vieluf, D. (1990). [History of the Munich Dermatology Society]. Hautarzt, 41(5), 290-294.

Burg, G., & Kaudewitz, P. (1990). Where are we today in the diagnosis of cutaneous lymphoma? Curr Probl Dermatol, 19, 90-104.

Burg, G., & Sobetzko, R. (1990). [Florid oral papillomatosis: an indication for etretinate?]. Hautarzt, 41(6), 314-316.

Cavey, D., Bouclier, M., Burg, G., Delamadeleine, F., & Hensby, C. N. (1990). The pharmacological modulation of delayed type hypersensitivity (DTH) reactions to topical oxazolone in mouse skin. Agents Actions, 29(1-2), 65-67.

Dummer, R., Welters, H., Keilholz, U., Tilgen, W., & Burg, G. (1990). [Interleukin 2: immunologic background and clinical use in tumor therapy]. Hautarzt, 41(2), 53-55.

Elsner, P., Hartmann, A. A., & Burg, G. (1990). [Experiences with oxytetracycline treatment of non-gonorrhea urethritis caused by Ureaplasma urealyticum]. Hautarzt, 41(2), 94-97.

Encke, A., Hermanek, P., & Burg, G. (1990). [News on TNM consultation activity of the German Language Committee]. Leber Magen Darm, 20(1), 47.

Hackel, H., Hartmann, A. A., Elsner, P., & Burg, G. (1990). Prevalence of Ureaplasma urealyticum in the urethra of men without urethritis in relation to clinical diagnosis. Dermatologica, 180(2), 76-78.

Hackel, H., Zillikens, D., Lechner, W., & Burg, G. (1990). [Unusual manifestation of scleroderma of the trunk]. Hautarzt, 41(2), 91-93.

Kaudewitz, P., Burg, G., & Stein, H. (1990). Ki-1 (CD30) positive cutaneous anaplastic large cell lymphomas. Curr Probl Dermatol, 19, 150-156.

Kaudewitz, P., Stein, H., Plewig, G., Schwarting, R., Gerdes, J., Burg, G., . . . Braun-Falco, O. (1990). Hodgkin's disease followed by lymphomatoid papulosis. Immunophenotypic evidence for a close relationship between lymphomatoid papulosis and Hodgkin's disease. J Am Acad Dermatol, 22(6 Pt 1), 999-1006.

Sepp, N., Schuler, G., Romani, N., Geissler, D., Gattringer, C., Burg, G., . . . Fritsch, P. (1990). "Intravascular lymphomatosis" (angioendotheliomatosis): evidence for a T-cell origin in two cases. Hum Pathol, 21(10), 1051-1058.

Stolz, W., Vogt, T., Braun-Falco, O., Abmayr, W., Eckert, F., Kaudewitz, P., . . . Burg, G. (1990). Differentiation between lymphomas and pseudolymphomas of the skin by computerized DNA-image cytometry. J Invest Dermatol, 94(2), 254-260.

Weiss, J., Garbe, C., Bertz, J., Biltz, H., Burg, G., Hennes, B., . . . et al. (1990). [Risk factors for the development of malignant melanoma in West Germany. Results of a multicenter-case control study]. Hautarzt, 41(6), 309-313.

Zillikens, D., Miller, K., Hartmann, A. A., & Burg, G. (1990). IgA pemphigus foliaceus: a case report. Dermatologica, 181(4), 304-307.

Bastian, B. C., & Burg, G. (1991). [Computer networks in clinical practice--a histology data bank system]. Hautarzt, 42(6), 376-379.

Bastian, B. C., Romisch, J., Paques, E. P., & Burg, G. (1991). [Lipocortins and phospholipases: new aspects in the physiology of glucocorticosteroid effect]. Hautarzt, 42(7), 417-423.

Becker, J. C., Dummer, R., Hartmann, A. A., Burg, G., & Schmidt, R. E. (1991). Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol, 147(12), 4398-4401.

Burg, G., Dummer, R., Wilhelm, M., Nestle, F., Ott, M. M., Feller, A., . . . Wiede, J. (1991). A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med, 325(15), 1078-1081. doi:10.1056/NEJM199110103251506

Burg, G., & Kerl, H. (1991). Seminars in diagnostic pathology. Introduction. Semin Diagn Pathol, 8(2), 53-54.

Dummer, R., Muller, W., Nestle, F., Wiede, J., Dues, J., Lechner, W., . . . Burg, G. (1991). Formation of neutralizing antibodies against natural interferon-beta, but not against recombinant interferon-gamma during adjuvant therapy for high-risk malignant melanoma patients. Cancer, 67(9), 2300-2304.

Dummer, R., Schafer, E., Eilles, C., Borner, W., & Burg, G. (1991). Lymphokine-activated killer-cell traffic in metastatic melanoma. Lancet, 338(8764), 456-457.

Dunkel, F. G., Elsner, P., & Burg, G. (1991). Contact allergies to topical corticosteroids: 10 cases of contact dermatitis. Contact Dermatitis, 25(2), 97-103.

Goldstein, R. K., Bastian, B. C., Elsner, P., & Burg, G. (1991). Giant lichenification of the vulva with marked ulcerations. A case report. J Reprod Med, 36(4), 309-311.

Goldstein, R. K., Zillikens, D., Miller, K., Elsner, P., & Burg, G. (1991). [Local treatment of disseminated granuloma anulare with a vitamin E emulsion]. Hautarzt, 42(3), 176-178.

Hackel, H., Hartmann, A. A., & Burg, G. (1991). Vulvitis granulomatosa and anoperineitis granulomatosa. Dermatologica, 182(2), 128-131.

Hackel, H., Hartmann, A. A., Elsner, P., Martius, J., Engel, C., & Burg, G. (1991). [The value of Gardnerella-vaginalis-culture in bacterial-vaginitis- score-confirmed bacterial vaginosis]. Hautarzt, 42(3), 173-175.

Hackel, H., Miller, K., Elsner, P., & Burg, G. (1991). Unusual combined sensitization to palladium and other metals. Contact Dermatitis, 24(2), 131-132.

Kaudewitz, P., & Burg, G. (1991). Lymphomatoid papulosis and Ki-1 (CD30)-positive cutaneous large cell lymphomas. Semin Diagn Pathol, 8(2), 117-124.

Kerl, H., Cerroni, L., & Burg, G. (1991). The morphologic spectrum of T-cell lymphomas of the skin: a proposal for a new classification. Semin Diagn Pathol, 8(2), 55-61.

Ostmeier, H., Schumann, J., Otto, F., Krieg, V., Fuchs, B., Biess, B., . . . Suter, L. (1991). The relationship between characteristics of the tumor cells and sex of the patients in primary malignant melanomas. J Cancer Res Clin Oncol, 117(4), 364-366.

Schulz, A., Elsner, P., & Burg, G. (1991). Quantification of irritant contact dermatitis in vivo: comparison of the Dermatest system with the evaporimeter. Contact Dermatitis, 24(3), 235-237.

Vogt, T., Stolz, W., Braun-Falco, O., Kaudewitz, P., Eckert, F., Abmayr, W., . . . Burg, G. (1991). Prognostic significance of DNA cytometry in cutaneous malignant lymphomas. Cancer, 68(5), 1095-1100.

Zillikens, D., Bammel, A., Lurz, C., Elsner, P., & Burg, G. (1991). [Eosinophilia-myalgia syndrome after L-tryptophan intake]. Hautarzt, 42(3), 154-157.

Zillikens, D., Mehringer, A., Lechner, W., & Burg, G. (1991). Hypo- and hyperpigmented areas in incontinentia pigmenti. Light and electron microscopic studies. Am J Dermatopathol, 13(1), 57-62.

Ambach, A., Zillikens, D., Klingert, B., Hartmann, A. A., & Burg, G. (1992). [Immune phenotyping of mononuclear infiltrate in bullous pemphigoid]. Hautarzt, 43(2), 81-85.

Baumgartner, R., Trueb, R., Bruckner, L., Schmid, U., Speiser, P., & Burg, G. (1992). [Recurrent eyelid tumor in necrotizing panniculitis]. Klin Monbl Augenheilkd, 200(5), 529-531. doi:10.1055/s-2008-1045816

Becker, J. C., Dummer, R., Schmidt, R. E., Burg, G., & Hartmann, A. A. (1992). [Shedding of soluble intercellular adhesion molecule 1 (ICAM-1) from melanoma cells and the effect on cellular cytotoxicity]. Immun Infekt, 20(2), 62-63.

Becker, J. C., Dummer, R., Schwinn, A., Hartmann, A. A., & Burg, G. (1992). Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy. J Immunother (1991), 12(2), 147-150.

Becker, J. C., Dummer, R., Von Wussow, P., Burg, G., & Schmidt, R. E. (1992). Non-MHC-restricted T-cell interaction with B cells: role of the T-cell receptor. Scand J Immunol, 36(2), 177-181.

Boyera, N., Cavey, D., Bouclier, M., Burg, G., Rossio, P., & Hensby, C. (1992). Repeated application of dinitrochlorobenzene to the ears of sensitized guinea pigs: a preliminary characterization of a potential new animal model for contact eczema in humans. Skin Pharmacol, 5(3), 184-188.

Burg, G. (1992). [The First Bruno Bloch Memorial Lecture]. Hautarzt, 43(6), 390.

Burg, G. (1992). Disseminated granuloma anulare: therapy with vitamin E topically. Dermatology, 184(4), 308-309. doi:10.1159/000247580

Burg, G., & Dummer, R. (1992). [Current treatment methods in skin tumors]. Schweiz Rundsch Med Prax, 81(19), 610-614.

Burg, G., & Schmockel, C. (1992). Syringolymphoid hyperplasia with alopecia--a syringotropic cutaneous T-cell lymphoma? Dermatology, 184(4), 306-307. doi:10.1159/000247579

Cavegn, B., Puppin, D., Jr., & Burg, G. (1992). [Controversial aspects of stage I skin melanomas]. Schweiz Med Wochenschr, 122(49), 1883-1888.

Dummer, R., Becker, J. C., Boser, B., Hartmann, A. A., & Burg, G. (1992). Successful therapy of metastatic eccrine poroma using perilesional interferon alfa and interleukin 2. Arch Dermatol, 128(8), 1127-1128.

Dummer, R., Posseckert, G., Nestle, F., Witzgall, R., Burger, M., Becker, J. C., . . . Burg, G. (1992). Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo? J Invest Dermatol, 98(1), 50-54.

Dummer, R., Roger, J., Vogt, T., Becker, J., Hefner, H., Sindermann, H., & Burg, G. (1992). Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas. Prog Exp Tumor Res, 34, 160-169.

Dunkel, F. G., & Burg, G. (1992). [The pathogenesis of psoriasis--new results]. Fortschr Med, 110(25), 457-460.

Elder, D. E., Freeman, R. G., Bergfeld, W. F., Ackerman, A. B., Azar, H. A., Fechner, R. E., . . . et al. (1992). Do you use the term "dysplasia"? If so, what do you mean by it, and if not, why not? Am J Dermatopathol, 14(5), 462-486.

Goldstein, R. K., Augustin, A., Milz, J., Burg, G., & Lutz, J. (1992). Influence of free radical scavengers on myeloperoxidase activity and lipid peroxidation in acute skin grafts. Adv Exp Med Biol, 316, 253-258.

Haffner, A. C., Garbe, C., Burg, G., Buttner, P., Orfanos, C. E., & Rassner, G. (1992). The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients. Br J Cancer, 66(5), 856-861.

Hafner, J., Enderlin, A., Seger, R. A., Wuthrich, B., Bruckner-Tudermann, L., Panizzoni, P., & Burg, G. (1992). Discoid lupus erythematosus-like lesions in carriers of X-linked chronic granulomatous disease. Br J Dermatol, 127(4), 446-447.

Hermanek, P., Encke, A., & Burg, G. (1992). [Histologic study of lymph nodes in tumor resections--results of a survey of the German TNM Committee]. Chirurg, 63(6), Suppl 93-97.

Trueb, R., & Burg, G. (1992). [Drug reaction to amoxicillin simulating toxic pustular dermatosis]. Hautarzt, 43(9), 595-596.

Trueb, R. M., & Burg, G. (1992). [Loose anagen hair]. Hautarzt, 43(8), 505-508.

Wilhelm, M., Meyer, P., Batram, C., Tony, H. P., Dummer, R., Nestle, F., . . . Wilms, K. (1992). Gamma/delta receptor-expressing T-cell clones from a cutaneous T-cell lymphoma suppress hematopoiesis. Ann Hematol, 65(3), 111-115.

Zillikens, D., Ambach, A., Schuessler, M., Dummer, R., Hartmann, A. A., & Burg, G. (1992). The interleukin-2 receptor in lesions and serum of bullous pemphigoid. Arch Dermatol Res, 284(3), 141-145.

Zillikens, D., Blum, C., Dummer, R., Hartmann, A. A., & Burg, G. (1992). Serum levels of soluble interleukin-2 receptor in systemic and circumscribed scleroderma. Dermatology, 184(3), 233-234. doi:10.1159/000247555

Zillikens, D., Mehringer, A., Lechner, W., & Burg, G. (1992). Hypo- and hyperpigmented areas in incontinentia pigmenti. Reply by Zillikens et al. Am J Dermatopathol, 14(3), 288-289.

Ballmer-Weber, B. K., Widmer, M., & Burg, G. (1993). [Acetylsalicylic acid-induced generalized pustulosis]. Schweiz Med Wochenschr, 123(12), 542-546.

Becker, J. C., Schwinn, A., Dummer, R., Burg, G., & Brocker, E. B. (1993). Lesion-specific activation of cloned human tumor-infiltrating lymphocytes by autologous tumor cells: induction of proliferation and cytokine production. J Invest Dermatol, 101(1), 15-21.

Becker, J. C., Schwinn, A., Dummer, R., Burg, G., & Brocker, E. B. (1993). Tumour-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expression. Clin Exp Immunol, 91(1), 121-125.

Blum, C., Zillikens, D., Tony, H. P., Hartmann, A. A., & Burg, G. (1993). [Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus]. Hautarzt, 44(5), 290-295.

Burg, G. (1993). Collision dermatosis: angiolymphoid hyperplasia with eosinophilia developing within a congenital port wine nevus. Dermatology, 187(4), 293-295. doi:10.1159/000247272

Burg, G., Dommann, S., & Dummer, R. (1993). [Malignant lymphoma of the skin]. Ther Umsch, 50(12), 828-834.

Burg, G., Dummer, R., Cavegn, B., & Panizzon, R. (1993). [Malignant melanoma of the skin]. Ther Umsch, 50(12), 822-827.

Dummer, R., Becker, J. C., Eilles, C., Schafer, E., Borner, W., & Burg, G. (1993). T cells migrate to tumour sites after extracorporeal interleukin 2 stimulation and reinfusion in a patient with metastatic melanoma. Br J Dermatol, 128(4), 399-403.

Dummer, R., Burg, G., Nestle, F., & Kohl, O. (1993). Soluble interleukin-2 receptors and cutaneous T-cell lymphoma. Cancer, 71(11), 3793-3795.

Dummer, R., Kohl, O., Gillessen, J., Kagi, M., & Burg, G. (1993). Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation. Arch Dermatol, 129(4), 433-436.

Dummer, R., Krasovec, M., Roger, J., Sindermann, H., & Burg, G. (1993). Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study. J Am Acad Dermatol, 29(6), 963-970.

Dummer, R., Meyer, J. C., Ballmer-Weber, B. K., Muletta, S., Panizzon, R., & Burg, G. (1993). UVA suppresses shedding of ICAM-1 from interferon-gamma (IFN-gamma)-pretreated transformed keratinocytes. Arch Dermatol Res, 285(4), 230-232.

Elsner, P., & Burg, G. (1993). Irritant reactivity is a better risk marker for nickel sensitization than atopy. Acta Derm Venereol, 73(3), 214-216.

Encke, A., Hermanek, P., & Burg, G. (1993). [Report of the German-Speaking TNM Committee]. Zentralbl Chir, 118(5), 310.

Hafner, J., Panizzon, R., Bruckner-Tuderman, L., Wuthrich, B., Seger, R. A., & Burg, G. (1993). [Lupus erythematosus discoid-like dermatosis in a carrier of septic granulomatosis]. Hautarzt, 44(7), 452-456.

Krasovec, M., Elsner, P., & Burg, G. (1993). Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors. Dermatology, 186(4), 248-252. doi:10.1159/000247363

Krasovec, M., Widmer, M., Gilliet, F., & Burg, G. (1993). [A case from practice (275). Lupus vulgaris with scar-forming alopecia in florid pulmonary tuberculosis]. Schweiz Rundsch Med Prax, 82(33), 893-895.

Trueb, R. M., Bruckner-Tuderman, L., & Burg, G. (1993). Ectrodactyly-ectodermal dysplasia-clefting syndrome with scalp dermatitis. J Am Acad Dermatol, 29(3), 505-506.

Trueb, R. M., & Burg, G. (1993). [Unilateral "nevoid" spider nevi]. Vasa, 22(1), 82-85.

Trueb, R. M., & Burg, G. (1993). Acute generalized exanthematous pustulosis due to doxycycline. Dermatology, 186(1), 75-78. doi:10.1159/000247308

Trueb, R. M., & Burg, G. (1993). Idiopathic middermal elastolysis. Dermatology, 187(1), 62-66. doi:10.1159/000247201

Trueb, R. M., Elsner, P., & Burg, G. (1993). [Pseudomonas aeruginosa folliculitis after epilation]. Hautarzt, 44(2), 103-105.

Trueb, R. M., Panizzon, R. G., & Burg, G. (1993). Cutaneous ossification in Albright's hereditary osteodystrophy. Dermatology, 186(3), 205-209. doi:10.1159/000247347

Widmer, M., Reverdin, E., Kung, E., Vesti, B., Bollinger, A., Linke, R. P., & Burg, G. (1993). [Amyloidosis cutis nodularis atrophicans (Gottron)]. Hautarzt, 44(5), 319-323.

Wyss, M., Elsner, P., Wuthrich, B., & Burg, G. (1993). Allergic contact dermatitis from natural latex without contact urticaria. Contact Dermatitis, 28(3), 154-156.

Zillikens, D., Ambach, A., Zentner, A., Dummer, R., Schussler, M., Burg, G., & Brocker, E. B. (1993). Evidence for cell-mediated immune mechanisms in the pathology of pemphigus. Br J Dermatol, 128(6), 636-643.

Zillikens, D., Zentner, A., Burger, M., Hartmann, A. A., & Burg, G. (1993). [Pemphigus foliaceus caused by penicillamine]. Hautarzt, 44(3), 167-171.

Burg, G., Dummer, R., & Kerl, H. (1994). Classification of cutaneous lymphomas. Dermatol Clin, 12(2), 213-217.

Burg, G., Dummer, R., & Nestle, F. (1994). Distinct subtypes of subcutaneous T-cell lymphoma. Arch Dermatol, 130(8), 1073.

Burg, G., Schmid, M. H., Kung, E., Dommann, S., & Dummer, R. (1994). Semimalignant ("pseudolymphomatous") cutaneous B-cell lymphomas. Dermatol Clin, 12(2), 399-407.

Burg, G., Wursch, T., Fah, J., & Elsner, P. (1994). Eruptive hamartomatous clear-cell acanthomas. Dermatology, 189(4), 437-439. doi:10.1159/000246904

Burg, G., Zwingers, T., Staegemeir, E., & Santucci, M. (1994). Interrater and intrarater variabilities in the evaluation of cutaneous lymphoproliferative T-cell infiltrates. EORTC-Cutaneous Lymphoma Project Group. Dermatol Clin, 12(2), 311-314.

Dommann, S. N., Widmer, M., Dommann-Scherrer, C., Bernasconi, E., & Burg, G. (1994). [Actinobacillus actinomycetemcomitans isolated from a mycetoma (of the forearm)]. Hautarzt, 45(6), 402-405.

Dummer, R., Sigg-Zemann, S., Kalthof, K., Muletta, S., Meyer, J. C., & Burg, G. (1994). Various cytokines modulate ICAM-1 shedding on melanoma- and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sezary cell line by interferon-gamma. Dermatology, 189(2), 120-124. doi:10.1159/000246813

Jorg, B., Kerl, H., Thiers, B. H., Brocker, E. B., & Burg, G. (1994). Therapeutic approaches in cutaneous lymphoma. Dermatol Clin, 12(2), 433-441.

Lubbe, J., Kleihues, P., & Burg, G. (1994). [The tumor suppressor gene p53 and its significance for dermatology]. Hautarzt, 45(11), 741-745.

Lubbe, J., Reichel, M., Burg, G., & Kleihues, P. (1994). Absence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol, 102(5), 819-821.

Santucci, M., Burg, G., & Feller, A. C. (1994). Interrater and intrarater reliability of histologic criteria in early cutaneous T-cell lymphoma. An EORTC Cutaneous Lymphoma Project Group study. Dermatol Clin, 12(2), 323-327.

Schneider-Yin, X., Schafer, B. W., Mohr, P., Burg, G., & Minder, E. I. (1994). Molecular defects in erythropoietic protoporphyria with terminal liver failure. Hum Genet, 93(6), 711-713.

Schultz, E. S., Dummer, R., Becker, J. C., Zillikens, D., & Burg, G. (1994). Influence of various cytokines on the interleukin-2-dependent lysis of melanoma cells in vitro. Arch Dermatol Res, 286(2), 73-76.

Trueb, R., Burg, G., Bottani, A., & Schinzel, A. (1994). Ectodermal dysplasia with corkscrew hairs: observation of probable autosomal dominant tricho-odonto-onychodysplasia with syndactyly. J Am Acad Dermatol, 30(2 Pt 1), 289-290.

Trueb, R. M., Spycher, M. A., Schumacher, F., & Burg, G. (1994). [Pili torti et canaliculi in ectodermal dysplasia]. Hautarzt, 45(6), 372-377.

Widmer, J., Elsner, P., & Burg, G. (1994). Skin irritant reactivity following experimental cumulative irritant contact dermatitis. Contact Dermatitis, 30(1), 35-39.

Adams, V., Kempf, W., Schmid, M., Muller, B., Briner, J., & Burg, G. (1995). Absence of herpesvirus-like DNA sequences in skin cancers of non-immunosuppressed patients. Lancet, 346(8991-8992), 1715-1716.

Boni, R., Dummer, R., & Burg, G. (1995). [Are skin tumors on the increase?]. Schweiz Med Wochenschr, 125(35), 1619-1624.

Boni, R., Dummer, R., Dommann-Scherrer, C., Dommann, S., Zimmermann, D. R., Joller-Jemelka, H., & Burg, G. (1995). Necrotizing herpes zoster mimicking relapse of vasculitis in angioimmunoblastic lymphadenopathy with dysproteinaemia. Br J Dermatol, 133(6), 978-982.

Burg, G. (1995). Report from the president (V) 1992-1994. Am J Dermatopathol, 17(5), 534-537.

Burg, G., Dummer, R., Dommann, S., Nestle, F., & Nickoloff, B. (1995). Pathology of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am, 9(5), 961-995.

Buttner, P., Garbe, C., Bertz, J., Burg, G., d'Hoedt, B., Drepper, H., . . . et al. (1995). Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer, 75(10), 2499-2506.

Dommann, S. N., Dommann-Scherrer, C. C., Zimmerman, D., Dours-Zimmermann, M. T., Hassam, S., & Burg, G. (1995). Primary cutaneous T-cell-rich B-cell lymphoma. A case report with a 13-year follow-up. Am J Dermatopathol, 17(6), 618-624.

Dommann, S. N., Ziegler, T., Dommann-Schener, C. C., Meyer, J., Panizzon, R., & Burg, G. (1995). CD44v6 is a marker for systemic spread in cutaneous T-cell lymphomas. A comparative study between nodal and cutaneous lymphomas. J Cutan Pathol, 22(5), 407-412.

Dummer, R., Davis-Daneshfar, A., Dohring, C., Dobbeling, U., & Burg, G. (1995). [Strategies for gene therapy of melanoma]. Hautarzt, 46(5), 305-308.

Garbe, C., Buttner, P., Bertz, J., Burg, G., d'Hoedt, B., Drepper, H., . . . et al. (1995). Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer, 75(10), 2492-2498.

Garbe, C., Buttner, P., Bertz, J., Burg, G., d'Hoedt, B., Drepper, H., . . . et al. (1995). Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer, 75(10), 2484-2491.

Hafner, J., Haenseler, E., Ossent, P., Burg, G., & Panizzon, R. G. (1995). Benzidine stain for the histochemical detection of hemoglobin in splinter hemorrhage (subungual hematoma) and black heel. Am J Dermatopathol, 17(4), 362-367.

Hinnen, U., Elsner, P., & Burg, G. (1995). Assessment of skin irritancy by 2 short tests compared to acute irritation induced by sodium lauryl sulfate. Contact Dermatitis, 33(4), 236-239.

Krasovec, M., Elsner, P., & Burg, G. (1995). [Cowden's syndrome]. Hautarzt, 46(7), 472-476.

Lubbe, J., Schlupen, E. M., Fierz, W., Panizzon, R. G., & Burg, G. (1995). Identification of Borrelia afzelii in a juxta-articular fibroid nodule from a human immunodeficiency virus-positive patient with acrodermatitis chronica atrophicans. Arch Dermatol, 131(11), 1341-1342.

Steinert, H. C., Huch Boni, R. A., Buck, A., Boni, R., Berthold, T., Marincek, B., . . . von Schulthess, G. K. (1995). Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology, 195(3), 705-709. doi:10.1148/radiology.195.3.7753998

Trueb, R. M., Becker-Wegerich, P., Hafner, J., Wuthrich, B., & Burg, G. (1995). Relapsing eosinophilic perimyositis. Br J Dermatol, 133(1), 109-114.

Trueb, R. M., Borelli, S., Schmid-Grendelmeier, P., Panizzon, R. G., & Burg, G. (1995). [Overlap of Sjogren-lupus erythematosus syndrome]. Hautarzt, 46(7), 467-471.

Trueb, R. M., Hurlimann, A. F., & Burg, G. (1995). [Periarteritis nodosa cutanea. 20 years follow-up with leg pain, Raynaud syndrome and nail changes]. Hautarzt, 46(8), 568-572.

Allmann, K. H., Leu, H., Burg, G., & Hodler, J. (1996). Hereditary sensory and autonomic neuropathy type I (Thevenard's disease). Skeletal Radiol, 25(5), 501-504.

Boni, R., Davis-Daneshfar, A., Burg, G., Fuchs, D., & Wood, G. S. (1996). No detection of HTLV-I proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T-cell lymphoma. Br J Dermatol, 134(2), 282-284.

Boni, R., Doguoglu, A., Burg, G., Muller, B., & Dummer, R. (1996). MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma. J Am Acad Dermatol, 35(3 Pt 1), 416-418.

Boni, R., Huch-Boni, R. A., Steinert, H., von Schulthess, G. K., & Burg, G. (1996). Early detection of melanoma metastasis using fludeoxyglucose F 18 positron emission tomography. Arch Dermatol, 132(8), 875-876.

Boni, R., Steinert, H., Boni, R. A., Lichtensteiger, W., Dummer, R., Hartman, D. S., . . . Westera, G. (1996). Lack of expression of dopamine D2 receptors in malignant melanoma: evidence for interaction of iodobenzofurans with melanin. Dermatology, 193(3), 198-202. doi:10.1159/000246245

Burg, G., Dummer, R., Nestle, F. O., Doebbeling, U., & Haeffner, A. (1996). Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol, 132(5), 567-572.

Dommann, S. N., Dommann-Scherrer, C. C., Dours-Zimmermann, M. T., Zimmermann, D. R., Kural-Serbes, B., & Burg, G. (1996). Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas. Arch Dermatol Res, 288(4), 163-167.

Dummer, R., Heald, P. W., Nestle, F. O., Ludwig, E., Laine, E., Hemmi, S., & Burg, G. (1996). Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood, 88(4), 1383-1389.

Dummer, R., Nestle, F. O., & Burg, G. (1996). [Modern tumor therapy as seen in melanoma]. Praxis (Bern 1994), 85(50), 1609-1614.

Dummer, R., Posseckert, G., Sugamura, K., Grundmann, H., & Burg, G. (1996). Circulating interleukin-2 receptors are a group of multimeric proteins with immunoreactivity for interleukin-2 receptor alpha, beta, and gamma chains. J Interferon Cytokine Res, 16(4), 315-320. doi:10.1089/jir.1996.16.315

Dummer, R., Potoczna, N., Haffner, A. C., Zimmermann, D. R., Gilardi, S., & Burg, G. (1996). A primary cutaneous non-T, non-B CD4+, CD56+ lymphoma. Arch Dermatol, 132(5), 550-553.

Haffner, A. C., Zepter, K., Elsner, P., & Burg, G. (1996). Isolated delayed-type hypersensitivity to latex rubber. Contact Dermatitis, 35(4), 247-248.

Hafner, J., Bounameaux, H., Burg, G., & Brunner, U. (1996). Management of venous leg ulcers. Vasa, 25(2), 161-167.

Hafner, J., Brunner, U., & Burg, G. (1996). [Treatment guidelines for venous leg ulcers: causal therapy initiation and local wound treatment]. Ther Umsch, 53(4), 304-308.

Hurlimann, A. F., Panizzon, R. G., & Burg, G. (1996). Eruptive vellus hair cyst and steatocystoma multiplex: hybrid cysts. Dermatology, 192(1), 64-66. doi:10.1159/000246319

Kagi, M. K., Trueb, R., Wuthrich, B., & Burg, G. (1996). Confluent and reticulated papillomatosis associated with atopy. Successful treatment with topical urea and tretinoin. Br J Dermatol, 134(2), 381-382.

Kleinhans, M., Schmid-Grendelmeier, P., & Burg, G. (1996). [Levodopa and malignant melanoma--case report and review of the literature. A contribution to causal relationship between levodopa and the development of malignant melanoma]. Hautarzt, 47(6), 432-437.

Lubbe, J., Kormann, A., Adams, V., Hassam, S., Gratz, K. W., Panizzon, R. G., & Burg, G. (1996). HPV-11- and HPV-16-associated oral verrucous carcinoma. Dermatology, 192(3), 217-221. doi:10.1159/000246369

Potoczna, N., Boehncke, W. H., Nestle, F. O., Kuenzlen, C., Sterry, W., Burg, G., & Dummer, R. (1996). T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin. J Cutan Pathol, 23(4), 298-305.

Rajan, G. P., Seifert, B., Prummer, O., Joller-Jemelka, H. I., Burg, G., & Dummer, R. (1996). Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA. Arch Dermatol Res, 288(9), 543-548.

Wood, G. S., Hardman, D. L., Boni, R., Dummer, R., Kim, Y. H., Smoller, B. R., . . . Burg, G. (1996). Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Blood, 88(5), 1765-1770.

Boni, R., Burg, G., Doguoglu, A., Ilg, E. C., Schafer, B. W., Muller, B., & Heizmann, C. W. (1997). Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol, 137(1), 39-43.

Boni, R., Lichtensteiger, W., Steinert, H. C., Boni, R. A., Fruh, H., Dummer, R., . . . Burg, G. (1997). D1 dopamine receptors are not expressed in human melanoma. Melanoma Res, 7(2), 117-119.

Boni, R., Steinert, H., Huch Boni, R., Von Schulthess, G. K., Meyer, J., Dummer, R., . . . Westera, G. (1997). Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and results in patients. Br J Dermatol, 137(1), 96-100.

Camacho, F. M., Burg, G., Moreno, J. C., Campora, R. G., & Villar, J. L. (1997). Granulomatous slack skin in childhood. Pediatr Dermatol, 14(3), 204-208.

Davis-Daneshfar, A., Boni, R., von Wussow, P., Joller, H., Burg, G., & Dummer, R. (1997). Adjuvant immunotherapy in malignant melanoma: impact of antibody formation against interferon-alpha on immunoparameters in vivo. J Immunother, 20(3), 208-213.

Dobbeling, U., Dummer, R., Hess Schmid, M., & Burg, G. (1997). Lack of expression of the recombination activating genes RAG-1 and RAG-2 in cutaneous T-cell lymphoma: pathogenic implications. Clin Exp Dermatol, 22(5), 230-233.

Dommann, S. N., Dommann-Scherrer, C. C., Ziegler, T., Meyer, J., Trueb, R. M., Kundig, T., . . . Burg, G. (1997). Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas. Am J Dermatopathol, 19(4), 391-395.

Hinnen, U., Elsner, P., Barraud, M., & Burg, G. (1997). Foreign body granuloma of the penis caused by occupational glass fibre exposure. Genitourin Med, 73(6), 577-578.

Lubbe, J., Nakazawa, H., & Burg, G. (1997). [Telomerase]. Hautarzt, 48(9), 615-621.

Mandt, N., Krasovec, M., Ellgehausen, P., & Burg, G. (1997). [Cutaneous artefacts]. Schweiz Med Wochenschr, 127(38), 1579.

Meyer, J. C., Hassam, S., Dummer, R., Muletta, S., Dobbeling, U., Dommann, S. N., & Burg, G. (1997). A realistic approach to the sensitivity of PCR-DGGE and its application as a sensitive tool for the detection of clonality in cutaneous T-cell proliferations. Exp Dermatol, 6(3), 122-127.

Nestle, F. O., Haffner, A. C., Schmid, M. H., Dummer, R., & Burg, G. (1997). [Current therapy concepts in cutaneous T-cell lymphomas]. Schweiz Med Wochenschr, 127(8), 311-320.

Seelentag, W. K., Boni, R., Gunthert, U., Futo, E., Burg, G., Heitz, P. U., & Roth, J. (1997). Expression of CD44 isoforms and beta 1,6-branched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with metastatic potential. J Cutan Pathol, 24(4), 206-211.

Trueb, R. M., Pericin, M., Hafner, J., & Burg, G. (1997). [Tufted hair folliculitis]. Hautarzt, 48(4), 266-269.

Trueb, R. M., Pericin, M., Kohler, E., Barandun, J., & Burg, G. (1997). Necrotizing granulomatosis of the breast. Br J Dermatol, 137(5), 799-803.

Trueb, R. M., Pericin, M., Winzeler, B., Wuthrich, B., & Burg, G. (1997). Eosinophilic myositis/perimyositis: frequency and spectrum of cutaneous manifestations. J Am Acad Dermatol, 37(3 Pt 1), 385-391.

van Vliet, J. J., Vaessen, H. A., van den Burg, G., & Schothorst, R. C. (1997). Twenty-four-hour duplicate diet study 1994; nitrate and nitrite: method development and intake per person per day. Cancer Lett, 114(1-2), 305-307.

Waldmann, V., Kempf, W., Burg, G., & Dummer, R. (1997). [Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid]. Hautarzt, 48(4), 262-265.

Wimmer, I., Meyer, J. C., Seifert, B., Dummer, R., Flace, A., & Burg, G. (1997). Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy. Cancer Res, 57(22), 5073-5076.

Yue, F. Y., Dummer, R., Geertsen, R., Hofbauer, G., Laine, E., Manolio, S., & Burg, G. (1997). Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer, 71(4), 630-637.

Boni, R., Bantschapp, O., Muller, B., & Burg, G. (1998). c-myc is not useful as prognostic immunohistochemical marker in cutaneous melanoma. Dermatology, 196(3), 288-291. doi:10.1159/000017922

Boni, R., Matt, D., Burg, G., Tronnier, M., Vortmeyer, A., & Zhuang, Z. (1998). Ultraviolet-induced acute histological changes in irradiated nevi are not associated with allelic loss. Arch Dermatol, 134(7), 853-856.

Boni, R., Matt, D., Voetmeyer, A., Burg, G., & Zhuang, Z. (1998). Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation. J Invest Dermatol, 110(3), 215-217. doi:10.1046/j.1523-1747.1998.00109.x

Boni, R., Vortmeyer, A. O., Burg, G., Hofbauer, G., & Zhuang, Z. (1998). The PTEN tumour suppressor gene and malignant melanoma. Melanoma Res, 8(4), 300-302.

Boni, R., Vortmeyer, A. O., Pack, S., Park, W. S., Burg, G., Hofbauer, G., . . . Zhuang, Z. (1998). Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic angiofibromas. J Invest Dermatol, 111(3), 539-540. doi:10.1046/j.1523-1747.1998.00317.x

Boni, R., Vortmeyer, A. O., Stern, J. B., Burg, G., Hofbauer, G., & Zhuang, Z. (1998). Concordance of genetic changes in basal cell carcinoma and associated clusters of squamous cells. J Invest Dermatol, 111(1), 173-174. doi:10.1046/j.1523-1747.1998.00247.x

Burg, G. (1998). [Dermatology 1997: immune intervention making progress]. Schweiz Med Wochenschr, 128(1-2), 18-20.

Burg, G., Kempf, W., Hochli, M., Huwyler, T., & Panizzon, R. G. (1998). 'Tubular' epithelioid cell nevus: a new variant of Spitz's nevus. J Cutan Pathol, 25(9), 475-478.

Dobbeling, U., Dummer, R., Laine, E., Potoczna, N., Qin, J. Z., & Burg, G. (1998). Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood, 92(1), 252-258.

Dummer, R., Geertsen, R., Ludwig, E., Niederer, E., & Burg, G. (1998). Sezary syndrome, T-helper 2 cytokines and accessory factor-1 (AF-1). Leuk Lymphoma, 28(5-6), 515-522. doi:10.3109/10428199809058359

Dummer, R., Graf, P., Greif, C., & Burg, G. (1998). Treatment of vascular lesions using the VersaPulse variable pulse width frequency doubled neodymium:YAG laser. Dermatology, 197(2), 158-161. doi:10.1159/000017989

Dummer, R., Hauschild, A., Henseler, T., & Burg, G. (1998). Combined interferon-alpha and interleukin-2 as adjuvant treatment for melanoma. Lancet, 352(9131), 908-909.

Dummer, R., Kempf, W., & Burg, G. (1998). Pseudo-melanoma after laser therapy. Dermatology, 197(1), 71-73. doi:10.1159/000017962

Dummer, R., Nestle, F. O., Hofbauer, G., Boni, R., & Burg, G. (1998). [Therapy of cutaneous melanoma]. Ther Umsch, 55(8), 509-514.

Dummer, R., Yue, F. Y., Pavlovic, J., Geertsen, R., Dohring, C., Moelling, K., & Burg, G. (1998). Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10. Br J Cancer, 77(9), 1413-1419.

Ellgehausen, P., Elsner, P., & Burg, G. (1998). Drug-induced lichen planus. Clin Dermatol, 16(3), 325-332.

Geertsen, R. C., Hofbauer, G. F., Yue, F. Y., Manolio, S., Burg, G., & Dummer, R. (1998). Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions. J Invest Dermatol, 111(3), 497-502. doi:10.1046/j.1523-1747.1998.00305.x

Grob, M., Wyss, M., Spycher, M. A., Dommann, S., Schinzel, A., Burg, G., & Trueb, R. M. (1998). Histopathologic and ultrastructural study of lupus-like skin lesions in a patient with Bloom syndrome. J Cutan Pathol, 25(5), 275-278.

Hafner, J., Keusch, G., Wahl, C., & Burg, G. (1998). Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. Vasa, 27(3), 137-143.

Hofbauer, G. F., Dummer, R., Laine, E., & Burg, G. (1998). Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA. Arch Dermatol Res, 290(8), 458-461.

Kamarashev, J., Burg, G., Kempf, W., Hess Schmid, M., & Dummer, R. (1998). Comparative analysis of histological and immunohistological features in mycosis fungoides and Sezary syndrome. J Cutan Pathol, 25(8), 407-412.

Kempf, W., Dummer, R., Schmid, M. H., Fritz, T., Wuthrich, B., & Burg, G. (1998). Intralesional cisplatin for the treatment of cutaneous B-cell lymphoma. Arch Dermatol, 134(11), 1343-1345.

Kempf, W., Haeffner, A. C., Mueller, B., Panizzon, R. G., & Burg, G. (1998). Experts and gold standards in dermatopathology: qualitative and quantitative analysis of the self-assessment slide seminar at the 17th colloquium of the International Society of Dermatopathology. Am J Dermatopathol, 20(5), 478-482.

Kerl, H., Burg, G., Sterry, W., & Wolff, H. H. (1998). [Problems, responsibility and goals in dermatopathology]. Hautarzt, 49(7), 533-535.

Kleeman, D., Kempf, W., Burg, G., & Hafner, J. (1998). Cutaneous polyarteritis nodosa. Vasa, 27(1), 54-57.

Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., . . . Schadendorf, D. (1998). Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med, 4(3), 328-332.

Nestle, F. O., & Burg, G. (1998). [Persistent facial swelling of uncertain origin]. Schweiz Med Wochenschr, 128(51-52), 2056.

Nestle, F. O., Filgueira, L., Nickoloff, B. J., & Burg, G. (1998). Human dermal dendritic cells process and present soluble protein antigens. J Invest Dermatol, 110(5), 762-766. doi:10.1046/j.1523-1747.1998.00189.x

Villeneuve, P., Hafner, J., Prenosil, J. E., Elsner, P., & Burg, G. (1998). A novel culturing and grafting system for the treatment of leg ulcers. Br J Dermatol, 138(5), 849-851.

Boni, R., & Burg, G. (1999). [The atypical nevus: a risk situation?]. Schweiz Med Wochenschr, 129(22), 825-832.

Boni, R., Vortmeyer, A. O., Huang, S., Burg, G., Hofbauer, G., & Zhuang, Z. (1999). Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma. Melanoma Res, 9(3), 249-252.

Burg, G. (1999). [Malignant melanoma]. Ther Umsch, 56(6), 285.

Dummer, R., Nestle, F. O., Hofbauer, G., & Burg, G. (1999). [Systemic therapy of metastatic melanoma]. Ther Umsch, 56(6), 330-333. doi:10.1024/0040-5930.56.6.330

Dummer, R., Nestle, F. O., Niederer, E., Ludwig, E., Laine, E., Grundmann, H., . . . Burg, G. (1999). Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sezary syndrome. Arch Dermatol Res, 291(6), 307-311.

Fritz, T. M., Burg, G., & Hafner, J. (1999). Eyebrow reconstruction with free skin and hair-bearing composite graft. J Am Acad Dermatol, 41(6), 1008-1010.

Fuchs, D., Querings, K., Burg, G., & Boni, R. (1999). [Persistent erythema after total CO2 skin resurfacing]. Schweiz Med Wochenschr, 129(21), 813-817.

Geertsen, R., Zenklusen, R., Kamarashev, J., Burg, G., & Dummer, R. (1999). Inverse regulation of neuronal cellular adhesion molecule (NCAM) by IFN-gamma in melanoma cell cultures established from CNS lesions. Int J Cancer, 83(1), 135-140.

Haffner, A. C., Zepter, K., Fritz, T., Dummer, R., Lejeune, F. J., & Burg, G. (1999). Complete remission of advanced cutaneous leiomyosarcoma following isolated limb perfusion with high-dose tumour necrosis factor-alpha and melphalan. Br J Dermatol, 141(5), 935-936.

Hafner, J., & Burg, G. (1999). [Dermatological aspects in prevention and treatment of the diabetic foot syndrome]. Praxis (Bern 1994), 88(27-28), 1170-1177.

Hess Schmid, M., Dummer, R., Kempf, W., Hilty, N., & Burg, G. (1999). Mycosis fungoides with mucinosis follicularis in childhood. Dermatology, 198(3), 284-287. doi:10.1159/000018131

Kempf, W., Adams, V., Kleinhans, M., Burg, G., Panizzon, R. G., Campadelli-Fiume, G., & Nestle, F. O. (1999). Pityriasis rosea is not associated with human herpesvirus 7. Arch Dermatol, 135(9), 1070-1072.

Krasovec, M., & Burg, G. (1999). Nodular fasciitis (pseudotumor of the skin). Dermatology, 198(4), 431-433.

Nestle, F. O., Hofbauer, G., & Burg, G. (1999). Necrobiotic xanthogranuloma with monoclonal gammopathy of the IgG lambda type. Dermatology, 198(4), 434-435.

Nestle, F. O., Tun Kyi, A., Gilliet, M., Dummer, R., & Burg, G. (1999). [Vaccination therapy of malignant melanoma]. Ther Umsch, 56(6), 334-337. doi:10.1024/0040-5930.56.6.334

Rogalski, C., Dummer, R., & Burg, G. (1999). Immunomodulators in the treatment of cutaneous lymphoma. J Eur Acad Dermatol Venereol, 13(2), 83-90.

Schmid, M. H., Bird, P., Dummer, R., Kempf, W., & Burg, G. (1999). Tumor burden index as a prognostic tool for cutaneous T-cell lymphoma: a new concept. Arch Dermatol, 135(10), 1204-1208.

Shephard, S. E., Zogg, M., Burg, G., & Panizzon, R. G. (1999). Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood. Arch Dermatol Res, 291(9), 491-499.

Trueb, R. M., Scheidegger, E. P., Pericin, M., Singh, A., Hoffmann, U., Sauvant, G., & Burg, G. (1999). Periarteritis nodosa presenting as a breast lesion: report of a case and review of the literature. Br J Dermatol, 141(6), 1117-1121.

Yue, F. Y., Geertsen, R., Hemmi, S., Burg, G., Pavlovic, J., Laine, E., & Dummer, R. (1999). IL-12 directly up-regulates the expression of HLA class I, HLA class II and ICAM-1 on human melanoma cells: a mechanism for its antitumor activity? Eur J Immunol, 29(6), 1762-1773. doi:10.1002/(SICI)1521-4141(199906)29:06<1762::AID-IMMU1762>3.0.CO;2-F

Bader, U., Banyai, M., Boni, R., Burg, G., & Hafner, J. (2000). Leg ulcers in patients with myeloproliferative disorders: disease- or treatment-related? Dermatology, 200(1), 45-48. doi:10.1159/000018315

Bernand, S., Scheidegger, E. P., Dummer, R., & Burg, G. (2000). Multifocal fixed drug eruption to paracetamol, tropisetron and ondansetron induced by interleukin 2. Dermatology, 201(2), 148-150. doi:10.1159/000018459

Boni, R., & Burg, G. (2000). [Aging skin: physiological bases, preventive measures and therapeutic modalities]. Schweiz Med Wochenschr, 130(36), 1272-1278.

Boni, R., Burg, G., & Wirth, H. P. (2000). [Helicobacter pylori and skin diseases--a (still) intact myth?]. Schweiz Med Wochenschr, 130(37), 1305-1308.

Boni, R., Kreyden, O. P., & Burg, G. (2000). Revival of the use of botulinum toxin: application in dermatology. Dermatology, 200(4), 287-291. doi:10.1159/000018389

Boni, R., Xin, H., Kamarashev, J., Utzinger, E., Dummer, R., Kempf, W., . . . Burg, G. (2000). Allelic deletion at 9p21-22 in primary cutaneous CD30(+) large cell lymphoma. J Invest Dermatol, 115(6), 1104-1107. doi:10.1038/jid.2000.4

Burg, G., & Dummer, R. (2000). Historical perspective on the use of retinoids in cutaneous T-cell lymphoma (CTCL). Clin Lymphoma, 1 Suppl 1, S41-44.

Carrozza, P., Hausermann, P., Nestle, F. O., Burg, G., & Boni, R. (2000). Clinical efficacy of narrow-band UVB (311 nm) combined with dithranol in psoriasis. An open pilot study. Dermatology, 200(1), 35-39. doi:10.1159/000018312

Dummer, R., Bergh, J., Karlsson, Y., Horowitz, J. A., Mulder, N. H., Huinink, D. T. B., . . . Osanto, S. (2000). Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors. Cancer Gene Ther, 7(7), 1069-1076. doi:10.1038/sj.cgt.7700214

Dummer, R., & Burg, G. (2000). What's new in the treatment of melanoma? J Eur Acad Dermatol Venereol, 14(5), 337-339.

Dummer, R., Heinzerling, L., Schmid, M. H., & Burg, G. (2000). [Immuno-intervention in cutaneous lymphomas]. Praxis (Bern 1994), 89(37), 1471-1476.

Dummer, R., Hess-Schmid, M., & Burg, G. (2000). Cutaneous T-cell lymphomas: prognosis and quality-of-life issues. Clin Lymphoma, 1 Suppl 1, S21-25.

Dummer, R., Nestle, F. O., & Burg, G. (2000). [Immunotherapy of melanoma]. Dtsch Med Wochenschr, 125(41), 1240-1242. doi:10.1055/s-2000-7722

Dummer, R., Willers, J., Kamarashev, J., Urosevic, M., Dobbeling, U., & Burg, G. (2000). Pathogenesis of cutaneous lymphomas. Semin Cutan Med Surg, 19(2), 78-86.

Fritz, T. M., Burg, G., & Boni, R. (2000). Carpal tunnel syndrome with ulcerous skin lesions. Dermatology, 201(2), 165-167. doi:10.1159/000018464

Hafner, J., Botonakis, I., & Burg, G. (2000). A comparison of multilayer bandage systems during rest, exercise, and over 2 days of wear time. Arch Dermatol, 136(7), 857-863.

Hafner, J., Luthi, W., Hanssle, H., Kammerlander, G., & Burg, G. (2000). Instruction of compression therapy by means of interface pressure measurement. Dermatol Surg, 26(5), 481-486; discussion 487.

Hafner, J., Schaad, I., Schneider, E., Seifert, B., Burg, G., & Cassina, P. C. (2000). Leg ulcers in peripheral arterial disease (arterial leg ulcers): impaired wound healing above the threshold of chronic critical limb ischemia. J Am Acad Dermatol, 43(6), 1001-1008. doi:10.1067/mjd.2000.108375

Hafner, J., Schneider, E., Burg, G., & Cassina, P. C. (2000). Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease. J Vasc Surg, 32(2), 322-329. doi:10.1067/mva.2000.106942

Heinzerling, L., Dummer, R., Kempf, W., Schmid, M. H., & Burg, G. (2000). Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma. Arch Dermatol, 136(3), 374-378.

Heinzerling, L., Dummer, R., Wildberger, H., & Burg, G. (2000). Cutaneous ulceration after injection of polyethylene-glycol-modified interferon alpha associated with visual disturbances in a melanoma patient. Dermatology, 201(2), 154-157. doi:10.1159/000018461

Heinzerling, L. M., Urbanek, M., Funk, J. O., Peker, S., Bleck, O., Neuber, K., . . . Dummer, R. (2000). Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma. Cancer, 89(8), 1835-1844.

Hofbauer, G. F., Burg, G., & Nestle, F. O. (2000). Cocaine-related Stevens-Johnson syndrome. Dermatology, 201(3), 258-260. doi:10.1159/000018500

Hofbauer, G. F., Burg, G., & Nestle, F. O. (2000). [Sporotrichoid infection with Mycobacterium marinum: successful therapy with oral tetracycline administration]. Hautarzt, 51(5), 349-352.

Kamarashev, J., Dummer, R., Schmidt, M. H., Kempf, W., Kurrer, M. O., & Burg, G. (2000). Primary cutaneous T-cell-rich B-cell lymphoma and Hodgkin's disease in a patient with Gardner's syndrome. Dermatology, 201(4), 362-365. doi:10.1159/000051557

Kempf, W., Adams, V. V., Burg, G., Panizzon, R. G., Campadelli-Fiume, G., & Nestle, F. O. (2000). Is pityriasis rosea skin healthier than healthy skin? Arch Dermatol, 136(7), 932-934.

Kempf, W., & Burg, G. (2000). Pityriasis rosea--a virus-induced skin disease? An update. Arch Virol, 145(8), 1509-1520.

Kreyden, O. P., Boni, R., & Burg, G. (2000). [Type A botulinum toxin: a new methods in treating focal hyperhidrosis. A summary of various possibilities in hyperhidrosis therapy with special emphasis type A botulinum toxin injections]. Praxis (Bern 1994), 89(21), 909-915.

Kreyden, O. P., & Burg, G. (2000). [Toxin treatment of sweat pearls. A review of the treatment of hyperhidrosis with a special view of a new therapy option using botulinum toxin A]. Schweiz Med Wochenschr, 130(29-30), 1084-1090.

Kreyden, O. P., Geiges, M. L., Boni, R., & Burg, G. (2000). [Botulinum toxin: from poison to drug. A historical review]. Hautarzt, 51(10), 733-737.

Laetsch, B., Haffner, A. C., Dobbeling, U., Seifert, B., Ludwig, E., Burg, G., & Dummer, R. (2000). CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas. J Invest Dermatol, 114(1), 107-111. doi:10.1046/j.1523-1747.2000.00818.x

Matt, D., Xin, H., Vortmeyer, A. O., Zhuang, Z., Burg, G., & Boni, R. (2000). Sporadic trichoepithelioma demonstrates deletions at 9q22.3. Arch Dermatol, 136(5), 657-660.

Santucci, M., Biggeri, A., Feller, A. C., & Burg, G. (2000). Accuracy, concordance, and reproducibility of histologic diagnosis in cutaneous T-cell lymphoma: an EORTC Cutaneous Lymphoma Project Group Study. European Organization for Research and Treatment of Cancer. Arch Dermatol, 136(4), 497-502.

Santucci, M., Biggeri, A., Feller, A. C., Massi, D., & Burg, G. (2000). Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. European Organization for Research and Treatment of Cancer. Am J Surg Pathol, 24(1), 40-50.

Schaerer, L., Schmid, M. H., Mueller, B., Dummer, R. G., Burg, G., & Kempf, W. (2000). Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas. Am J Dermatopathol, 22(2), 140-143.

Schmid-Grendelmeier, P., Masenga, E. J., Haeffner, A., & Burg, G. (2000). Teledermatology as a new tool in sub-saharan Africa: an experience from Tanzania. J Am Acad Dermatol, 42(5 Pt 1), 833-835.

Yue, F. Y., Cao, L., Hemmi, S., Geertsen, R., Laine, E., Burg, G., & Dummer, R. (2000). Upregulation of interleukin-12 receptor on peripheral blood mononuclear cells and HLA class I, HLA class II or ICAM-1 on melanoma cells by B7.1 and interleukin-12: a mechanism for immunostimulatory impact of melanoma cells adenovirally transfected with B7.1 and IL12? Melanoma Res, 10(4), 313-322.

Bogdan, I., Burg, G., & Boni, R. (2001). Spitz nevi display allelic deletions. Arch Dermatol, 137(11), 1417-1420.

Bogdan, I., Xin, H., Burg, G., & Boni, R. (2001). Heterogeneity of allelic deletions within melanoma metastases. Melanoma Res, 11(4), 349-354.

Boni, R., Kargl, A., Kreyden, O. P., & Burg, G. (2001). [Treatment of hyperfunctional facial lines with botulinum toxin]. Praxis (Bern 1994), 90(34), 1408-1412.

Boni, R., Xin, H., Hohl, D., Panizzon, R., & Burg, G. (2001). Syringocystadenoma papilliferum: a study of potential tumor suppressor genes. Am J Dermatopathol, 23(2), 87-89.

Burg, G., Dummer, R., Haeffner, A., Kempf, W., & Kadin, M. (2001). From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol, 137(7), 949-952.

Burg, G., Kempf, W., & Dummer, R. (2001). Diagnostic signs of cutaneous lymphomas. J Eur Acad Dermatol Venereol, 15(4), 358-360.

Dummer, R., Bosch, U., Panizzon, R., Bloch, P. H., Burg, G., & Task Force 'Skin Cancer'. Swiss National Program against Cancer. Swiss Cancer, L. (2001). Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology, 203(1), 75-80. doi:10.1159/000051710

Dummer, R., Dobbeling, U., Geertsen, R., Willers, J., Burg, G., & Pavlovic, J. (2001). Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication. Blood, 97(2), 523-527.

Dummer, R., Nestle, F. O., & Burg, G. (2001). Report on the Eighth World Congress on Cancers of the Skin 18-21 July 2001, Zurich, Switzerland. Melanoma Res, 11(5), 549-550.

Dummer, R., Willers, J., Dobbeling, U., & Burg, G. (2001). [Current pathogenetic aspects of Sezary syndrome and mycosis fungoides]. Hautarzt, 52(3), 189-192.

Fritz, T. M., Burg, G., & Krasovec, M. (2001). [Allergic contact dermatitis to cosmetics containing Melaleuca alternifolia (tea tree oil)]. Ann Dermatol Venereol, 128(2), 123-126.

Gerlini, G., Hefti, H. P., Kleinhans, M., Nickoloff, B. J., Burg, G., & Nestle, F. O. (2001). Cd1d is expressed on dermal dendritic cells and monocyte-derived dendritic cells. J Invest Dermatol, 117(3), 576-582. doi:10.1046/j.0022-202x.2001.01458.x

Hofbauer, G. F., Dummer, R., Hafner, J., Burg, G., Binswanger, U., & Kempf, W. (2001). Skin cancers in organ transplant recipients: two cases of virus-induced neoplasms. Dermatology, 202(4), 359-361. doi:10.1159/000051683

Hofbauer, G. F., Geertsen, R., Laine, E., Burg, G., & Dummer, R. (2001). Impact of interferons on the expression of melanoma-associated antigens in melanoma short-term cell cultures. Melanoma Res, 11(3), 213-218.

Hofbauer, G. F., Kamarachev, J., Kempf, W., Burg, G., Pestalozzi, B. C., & Dummer, R. (2001). A CD4+ CD56+ natural killer-like T-cell systemic lymphoma with haemorrhagic cutaneous manifestations. Br J Dermatol, 144(2), 432-434.

Hofbauer, G. F., Kessler, B., Kempf, W., Nestle, F. O., Burg, G., & Dummer, R. (2001). Multilesional primary cutaneous diffuse large B-cell lymphoma responsive to antibiotic treatment. Dermatology, 203(2), 168-170. doi:10.1159/000051735

Kamarashev, J., Burg, G., Mingari, M. C., Kempf, W., Hofbauer, G., & Dummer, R. (2001). Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas. Am J Pathol, 158(5), 1593-1598. doi:10.1016/S0002-9440(10)64114-4

Kamarashev, J., Ferrone, S., Seifert, B., Boni, R., Nestle, F. O., Burg, G., & Dummer, R. (2001). TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis. Int J Cancer, 95(1), 23-28.

Kamarashev, J., Schaerer, L., Burg, G., Schmid, M. H., Muller, B., & Kempf, W. (2001). Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders. J Cutan Pathol, 28(9), 448-452.

Kempf, W., Kadin, M. E., Kutzner, H., Lord, C. L., Burg, G., Letvin, N. L., & Koralnik, I. J. (2001). Lymphomatoid papulosis and human herpesviruses--A PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses. J Cutan Pathol, 28(1), 29-33.

Kempf, W., Kazakov, D. V., & Burg, G. (2001). Applications of molecular virology to modern dermatopathology. Curr Top Pathol, 94, 39-47.

Kreyden, O. P., Borradori, L., Trueb, R. M., Burg, G., & Nestle, F. O. (2001). [Successful therapy with tetracycline and nicotinamide in cicatricial pemphigoid]. Hautarzt, 52(3), 247-250.

Kreyden, O. P., Hafner, J., Burg, G., & Nestle, F. O. (2001). [Case report on therapy with granulocyte stimulating factor in diabetic foot]. Hautarzt, 52(4), 327-330.

Kreyden, O. P., Schmid-Grendelmeier, P., & Burg, G. (2001). Idiopathic localized unilateral hyperhidrosis: case report of successful treatment with botulinum toxin type A and review of the literature. Arch Dermatol, 137(12), 1622-1625.

Nestle, F. O., & Burg, G. (2001). Bilateral carpal tunnel syndrome as a clue for the diagnosis of systemic amyloidosis. Dermatology, 202(4), 353-355. doi:10.1159/000051681

Qin, J. Z., Kamarashev, J., Zhang, C. L., Dummer, R., Burg, G., & Dobbeling, U. (2001). Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. J Invest Dermatol, 117(3), 583-589. doi:10.1046/j.0022-202x.2001.01436.x

Qin, J. Z., Zhang, C. L., Kamarashev, J., Dummer, R., Burg, G., & Dobbeling, U. (2001). Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood, 98(9), 2778-2783.

Rogalski, C., Hurlimann, A., Burg, G., Wuthrich, B., & Kempf, W. (2001). [Drug reaction to terbinafine simulating an acute generalized exanthematous pustulosis]. Hautarzt, 52(5), 444-448.

Roos, J., Hennig, I., Schwaller, J., Zbaren, J., Dummer, R., Burg, G., . . . Borisch, B. (2001). Expression of TCL1 in hematologic disorders. Pathobiology, 69(2), 59-66. doi:10.1159/000048758

Schmook, T., Burg, G., & Hafner, J. (2001). Surgical pearl: mini-incisions for the extraction of steatocystoma multiplex. J Am Acad Dermatol, 44(6), 1041-1042. doi:10.1067/mjd.2001.112351

Schmook, T., Hofbauer, G., Kempf, W., Burg, G., & Dummer, R. (2001). [Granulomatous slack skin: partial remission following intralesional administration of interferon-alpha and PUVA]. Hautarzt, 52(10 Pt 2), 985-988.

Schnorf, M., Helfenstein, U., Blum, A., Ellwanger, U., Garbe, C., Burg, G., & Dummer, R. (2001). [Manifestations of the "pretherapeutic phase" of malignant melanoma of the skin in Switzerland 1996-1998]. Praxis (Bern 1994), 90(50), 2193-2198.

Senti, G., Schmid, M. H., & Burg, G. (2001). [Multiple miliary osteomata cutis. Excision with "front lift" approach]. Hautarzt, 52(6), 522-525.

Storz, M., Zepter, K., Kamarashev, J., Dummer, R., Burg, G., & Haffner, A. C. (2001). Coexpression of CD40 and CD40 ligand in cutaneous T-cell lymphoma (mycosis fungoides). Cancer Res, 61(2), 452-454.

Urosevic, M., Kurrer, M. O., Kamarashev, J., Mueller, B., Weder, W., Burg, G., . . . Trojan, A. (2001). Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol, 159(3), 817-824. doi:10.1016/S0002-9440(10)61756-7

Willers, J., Haffner, A., Zepter, K., Storz, M., Urosevic, M., Burg, G., & Dummer, R. (2001). The interferon inhibiting cytokine IK is overexpressed in cutaneous T cell lymphoma derived tumor cells that fail to upregulate major histocompatibility complex class II upon interferon-gamma stimulation. J Invest Dermatol, 116(6), 874-879. doi:10.1046/j.1523-1747.2001.01339.x

Willers, J., Urosevic, M., Laine, E., Geertsen, R., Kundig, T., Burg, G., & Dummer, R. (2001). Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression. J Invest Dermatol, 117(6), 1498-1504. doi:10.1046/j.0022-202x.2001.01586.x

Boni, R., Schuster, C., Nehrhoff, B., & Burg, G. (2002). Epidemiology of skin cancer. Neuro Endocrinol Lett, 23 Suppl 2, 48-51.

Burg, G. (2002). Public education in skin cancer world-wide. Recent Results Cancer Res, 160, 3-6.

Burg, G., Kempf, W., Haeffner, A., Dobbeling, U., Nestle, F. O., Boni, R., . . . Dummer, R. (2002). From inflammation to neoplasia: new concepts in the pathogenesis of cutaneous lymphomas. Recent Results Cancer Res, 160, 271-280.

Carrozza, P. M., Kempf, W., Kazakov, D. V., Dummer, R., & Burg, G. (2002). A case of Sezary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphoma. Br J Dermatol, 147(3), 582-586.

Carrozza, P. M., Merlani, G. M., Burg, G., & Hafner, J. (2002). CO(2) laser surgery for extensive, cauliflower-like anogenital condylomata acuminata: retrospective long-term study on 19 HIV-positive and 45 HIV-negative men. Dermatology, 205(3), 255-259. doi:10.1159/000065844

Dummer, R., Kamarashev, J., Kempf, W., Haffner, A. C., Hess-Schmid, M., & Burg, G. (2002). Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: a CD8+ variant of mycosis fungoides? Arch Dermatol, 138(2), 199-203.

Erdmann, I., Scheidegger, E. P., Koch, F. K., Heinzerling, L., Odermatt, B., Burg, G., . . . Kundig, T. M. (2002). Fucosyltransferase VII-deficient mice with defective E-, P-, and L-selectin ligands show impaired CD4+ and CD8+ T cell migration into the skin, but normal extravasation into visceral organs. J Immunol, 168(5), 2139-2146.

Farshad, A., Burg, G., Panizzon, R., & Dummer, R. (2002). A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays. Br J Dermatol, 146(6), 1042-1046.

Haffner, A. C., Tassis, A., Zepter, K., Storz, M., Tureci, O., Burg, G., & Nestle, F. O. (2002). Expression of cancer/testis antigens in cutaneous T cell lymphomas. Int J Cancer, 97(5), 668-670.

Heinzerling, L., Dummer, R., Burg, G., & Schmid-Grendelmeier, P. (2002). Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient. Eur J Dermatol, 12(2), 194-197.

Heinzerling, L., Dummer, R., Pavlovic, J., Schultz, J., Burg, G., & Moelling, K. (2002). Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice. Exp Dermatol, 11(3), 232-240.

Heinzerling, L. M., Dummer, R., Panizzon, R. G., Bloch, P. H., Barbezat, R., Burg, G., & Task force 'swiss cancer' of the swiss cancer, l. (2002). Prevention campaign against skin cancer. Dermatology, 205(3), 229-233. doi:10.1159/000065848

Hofbauer, G. F., Boehler, A., Speich, R., Burg, G., & Nestle, F. O. (2002). Painless erythema of the hands associated with non-Hodgkin's lymphoma in a lung transplant recipient. J Am Acad Dermatol, 46(5 Suppl), S159-160.

Hofbauer, G. F., Boni, R., Simmen, D., Mihic, D., Nestle, F. O., Burg, G., & Dummer, R. (2002). Histological, immunological and molecular features of a nasal mucosa primary melanoma associated with nasal melanosis. Melanoma Res, 12(1), 77-82.

Kamarashev, J., Lor, P., Forster, A., Heinzerling, L., Burg, G., & Nestle, F. O. (2002). Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept. Dermatology, 205(2), 213-216. doi:10.1159/000063919

Kazakov, D. V., Belousova, I. E., Muller, B., Palmedo, G., Samtsov, A. V., Burg, G., & Kempf, W. (2002). Primary cutaneous plasmacytoma: a clinicopathological study of two cases with a long-term follow-up and review of the literature. J Cutan Pathol, 29(4), 244-248.

Kazakov, D. V., Burg, G., Dummer, R., & Kempf, W. (2002). Cutaneous lymphomas and pseudolymphomas: newly described entities. Recent Results Cancer Res, 160, 283-293.

Kazakov, D. V., Burg, G., Dummer, R., Palmedo, G., Muller, B., & Kempf, W. (2002). Primary subcutaneous follicular centre cell lymphoma with involvement of the galea: a case report and short review of the literature. Br J Dermatol, 146(4), 663-666.

Kazakov, D. V., Burg, G., & Kempf, W. (2002). Primary cutaneous B-cell lymphomas and pseudolymphomas: review of histopathological features. Cesk Patol, 38(4), 147-154.

Kazakov, D. V., Kempf, W., Michaelis, S., Schmid, U., Cogliatti, S., Dummer, R., & Burg, G. (2002). T-zone lymphoma with cutaneous involvement: a case report and review of the literature. Br J Dermatol, 146(6), 1096-1100.

Kazakov, D. V., Kutzner, H., Rutten, A., Dummer, R., Burg, G., & Kempf, W. (2002). Trichogerminoma: a rare cutaneous adnexal tumor with differentiation toward the hair germ epithelium. Dermatology, 205(4), 405-408. doi:10.1159/000066427

Kazakov, D. V., Mentzel, T., Burg, G., & Kempf, W. (2002). Superficial acral fibromyxoma: report of two cases. Dermatology, 205(3), 285-288. doi:10.1159/000065853

Kazakov, D. V., Prinz, B. M., Michaelis, S., Schmid, M., Muller, B., Adams, V., . . . Kempf, W. (2002). Study of HHV-8 DNA sequences in archival biopsies from lesional skin of Kaposi's sarcoma, various mesenchymal tumors and related reactive conditions. J Cutan Pathol, 29(5), 279-281.

Kempf, W., Haeffner, A. C., Zepter, K., Sander, C. A., Flaig, M. J., Mueller, B., . . . Burg, G. (2002). Angiolymphoid hyperplasia with eosinophilia: evidence for a T-cell lymphoproliferative origin. Hum Pathol, 33(10), 1023-1029.

Kempf, W., Levi, E., Kamarashev, J., Kutzner, H., Pfeifer, W., Petrogiannis-Haliotis, T., . . . Kadin, M. E. (2002). Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. J Cutan Pathol, 29(5), 295-300.

Knobler, R., Burg, G., Whittaker, S., & Baila, L. (2002). EORTC cutaneous lymphoma task force. European Organisation for Research and Treatment of Cancer. Eur J Cancer, 38 Suppl 4, S60-64.

Lor, P., Krueger, U., Kempf, W., Burg, G., & Nestle, F. O. (2002). Monoclonal rearrangement of the T cell receptor gamma-chain in lichenoid pigmented purpuric dermatitis of gougerot-blum responding to topical corticosteroid therapy. Dermatology, 205(2), 191-193. doi:10.1159/000063912

Rubben, A., Bogdan, I., Grussendorf-Conen, E. I., Burg, G., & Boni, R. (2002). Loss of heterozygosity and microsatellite instability in acquired melanocytic nevi: towards a molecular definition of the dysplastic nevus. Recent Results Cancer Res, 160, 100-110.

Schwab, C., Willers, J., Niederer, E., Ludwig, E., Kundig, T., Grob, P., . . . Dummer, R. (2002). The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas. Br J Haematol, 118(4), 1019-1026.

Urosevic, M., Willers, J., Mueller, B., Kempf, W., Burg, G., & Dummer, R. (2002). HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood, 99(2), 609-617.

Vonderheid, E. C., Bernengo, M. G., Burg, G., Duvic, M., Heald, P., Laroche, L., . . . Iscl. (2002). Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol, 46(1), 95-106.

Bader, U., Cipolat, C., & Burg, G. (2003). Dermatology online with interactive technology (DOIT). Curr Probl Dermatol, 32, 176-181.

Bogdan, I., Smolle, J., Kerl, H., Burg, G., & Boni, R. (2003). Melanoma ex naevo: a study of the associated naevus. Melanoma Res, 13(2), 213-217. doi:10.1097/01.cmr.0000056226.78713.99

Burg, G. (2003). [Herr Professor and Dr. of Medicine Urs Walter Schnyder on his 80th birthday]. J Dtsch Dermatol Ges, 1(2), 157-158.

Burg, G., & Denz, M. (2003). The Telemedical Information Society: doctors' playground or a contribution to the evolution of healthcare? Curr Probl Dermatol, 32, 2-5.

Burg, G., Kempf, W., Kazakov, D. V., Dummer, R., Frosch, P. J., Lange-Ionescu, S., . . . Kadin, M. E. (2003). Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature. Br J Dermatol, 148(3), 580-586.

Cipolat, C., Bader, U., Rufli, T., & Burg, G. (2003). Teledermatology in Switzerland. Curr Probl Dermatol, 32, 257-260.

Dragieva, G., Stahel, H. U., Meyer, M., Kempf, W., Haffner, A., Burg, G., & Hafner, J. (2003). Proteus syndrome. Vasa, 32(3), 159-163. doi:10.1024/0301-1526.32.3.159

Dummer, R., Beyeler, M., Morcinek, J., & Burg, G. (2003). [Cutaneous neoplasms]. Praxis (Bern 1994), 92(36), 1470-1478. doi:10.1024/0369-8394.92.36.1470

Dummer, R., Ivanova, K., Scheidegger, E. P., & Burg, G. (2003). Clinical and therapeutic aspects of polymorphous light eruption. Dermatology, 207(1), 93-95. doi:10.1159/000070956

Dummer, R., Kempf, W., Hess Schmid, M., Haffner, A., & Burg, G. (2003). Therapy of cutaneous lymphoma--current practice and future developments. Onkologie, 26(4), 366-372. doi:10.1159/000072098

Dummer, R., Urosevic, M., Hoek, K., Haffner, A., & Burg, G. (2003). Exploring primary cutaneous B-cell lymphoma by microarray technology. J Invest Dermatol, 120(5), vii-viii. doi:10.1046/j.1523-1747.2003.12151.x

Dummer, R., Urosevic, M., Kempf, W., Hoek, K., Hafner, J., & Burg, G. (2003). Imiquimod in basal cell carcinoma: how does it work? Br J Dermatol, 149 Suppl 66, 57-58.

Dummer, R., Urosevic, M., Kempf, W., Kazakov, D., & Burg, G. (2003). Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides. Dermatology, 207(1), 116-118. doi:10.1159/000070962

Gilliet, M., Kleinhans, M., Lantelme, E., Schadendorf, D., Burg, G., & Nestle, F. O. (2003). Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen. Blood, 102(1), 36-42. doi:10.1182/blood-2002-07-2274

Hauschild, A., Weichenthal, M., Balda, B. R., Becker, J. C., Wolff, H. H., Tilgen, W., . . . Dummer, R. (2003). Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis. J Clin Oncol, 21(15), 2883-2888. doi:10.1200/JCO.2003.07.116

Kazakov, D. V., Mentzel, T., Burg, G., Dummer, R., & Kempf, W. (2003). Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more? Br J Dermatol, 149(4), 869-876.

Kazakov, D. V., Schmid, M., Adams, V., Cathomas, G., Muller, B., Burg, G., & Kempf, W. (2003). HHV-8 DNA sequences in the peripheral blood and skin lesions of an HIV-negative patient with multiple eruptive dermatofibromas: implications for the detection of HHV-8 as a diagnostic marker for Kaposi's sarcoma. Dermatology, 206(3), 217-221. doi:10.1159/000068896

Kempf, W., Kadin, M. E., Dvorak, A. M., Lord, C. C., Burg, G., Letvin, N. L., & Koralnik, I. J. (2003). Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin. Carcinogenesis, 24(2), 301-306.

Kempf, W., Kettelhack, N., Duvic, M., & Burg, G. (2003). Topical and systemic retinoid therapy for cutaneous T-cell lymphoma. Hematol Oncol Clin North Am, 17(6), 1405-1419.

Kempf, W., Reichlin, S., & Burg, G. (2003). HistoClinC: a Web-based telemedicine application for clinicopathologic correlations in dermatopathology. Curr Probl Dermatol, 32, 213-220.

Kleinhans, M., Tun-Kyi, A., Gilliet, M., Kadin, M. E., Dummer, R., Burg, G., & Nestle, F. O. (2003). Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood, 101(4), 1487-1493. doi:10.1182/blood-2002-02-0475

Kropf, R., Cipolat, C., & Burg, G. (2003). Telemedicine in Europe. Curr Probl Dermatol, 32, 247-251.

Kropf, R., Cipolat, C., & Burg, G. (2003). Teleteaching tools in dermatology on the Web. Curr Probl Dermatol, 32, 33-38.

Lauchli, S., & Burg, G. (2003). Treatment of hyperhidrosis with botulinum toxin A. Skin Therapy Lett, 8(7), 1-4.

Lauchli, S., Kempf, W., Dragieva, G., Burg, G., & Hafner, J. (2003). CO2 laser treatment of warts in immunosuppressed patients. Dermatology, 206(2), 148-152. doi:10.1159/000068459

Maier, T., Tun-Kyi, A., Tassis, A., Jungius, K. P., Burg, G., Dummer, R., & Nestle, F. O. (2003). Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells. Blood, 102(7), 2338-2344. doi:10.1182/blood-2002-08-2455

Michaelis, S., Kazakov, D. V., Schmid, M., Dummer, R., Burg, G., & Kempf, W. (2003). Hepatitis C and G viruses in B-cell lymphomas of the skin. J Cutan Pathol, 30(6), 369-372.

Papp, K. A., Guenther, L., Boyden, B., Larsen, F. G., Harvima, R. J., Guilhou, J. J., . . . Chu, A. (2003). Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol, 48(1), 48-54. doi:10.1067/mjd.2003.130

Roberts, A. A., Amano, M., Felten, C., Galvan, M., Sulur, G., Pinter-Brown, L., . . . Baum, L. G. (2003). Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation. Mod Pathol, 16(6), 543-551. doi:10.1097/01.MP.0000071840.84469.06

Urosevic, M., Maier, T., Benninghoff, B., Slade, H., Burg, G., & Dummer, R. (2003). Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol, 139(10), 1325-1332. doi:10.1001/archderm.139.10.1325

Willers, J., Dummer, R., Kempf, W., Kundig, T., Burg, G., & Kadin, M. E. (2003). Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand. Clin Cancer Res, 9(7), 2744-2754.

Zagrodnik, B., Kempf, W., Seifert, B., Muller, B., Burg, G., Urosevic, M., & Dummer, R. (2003). Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer, 98(12), 2708-2714. doi:10.1002/cncr.11798

Zhang, C. L., Kamarashev, J., Qin, J. Z., Burg, G., Dummer, R., & Dobbeling, U. (2003). Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells. J Pathol, 200(2), 249-254. doi:10.1002/path.1341

Beyeler, M., Burg, G., & Dummer, R. (2004). [Cutaneous lymphoma]. Hautarzt, 55(10), 1005-1016; quiz 1017. doi:10.1007/s00105-004-0816-2

Beyeler, M., Kempf, W., Hafner, J., Burg, G., & Dummer, R. (2004). The spectrum of mesenchymal skin neoplasms reflected by the new WHO classification. Onkologie, 27(4), 401-406. doi:10.1159/000079097

Cozzio, A., Hafner, J., Kempf, W., Haffner, A., Palmedo, G., Michaelis, S., . . . Burg, G. (2004). Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity? J Am Acad Dermatol, 51(6), 1014-1017. doi:10.1016/j.jaad.2004.06.009

Dragieva, G., Hafner, J., Dummer, R., Schmid-Grendelmeier, P., Roos, M., Prinz, B. M., . . . Kempf, W. (2004). Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation, 77(1), 115-121. doi:10.1097/01.TP.0000107284.04969.5C

Dragieva, G., Prinz, B. M., Hafner, J., Dummer, R., Burg, G., Binswanger, U., & Kempf, W. (2004). A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol, 151(1), 196-200. doi:10.1111/j.1365-2133.2004.06054.x

Dummer, R., Hassel, J. C., Fellenberg, F., Eichmuller, S., Maier, T., Slos, P., . . . Urosevic, M. (2004). Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas. Blood, 104(6), 1631-1638. doi:10.1182/blood-2004-01-0360

Gerlini, G., Tun-Kyi, A., Dudli, C., Burg, G., Pimpinelli, N., & Nestle, F. O. (2004). Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol, 165(6), 1853-1863. doi:10.1016/S0002-9440(10)63238-5

Gilliet, M., Conrad, C., Geiges, M., Cozzio, A., Thurlimann, W., Burg, G., . . . Dummer, R. (2004). Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol, 140(12), 1490-1495. doi:10.1001/archderm.140.12.1490

Hafner, J., Schmid, M. H., Kempf, W., Burg, G., Kunzi, W., Meuli-Simmen, C., . . . Steinert, H. (2004). Baseline staging in cutaneous malignant melanoma. Br J Dermatol, 150(4), 677-686. doi:10.1111/j.0007-0963.2004.05870.x

Hasse, U., Kropf, R., & Burg, G. (2004). [Telemedicine in dermatology 2003: a review]. J Dtsch Dermatol Ges, 2(4), 294-300; quiz 301-292.

Hassel, J. C., Meier, R., Joller-Jemelka, H., Burg, G., & Dummer, R. (2004). Serological immunomarkers in cutaneous T cell lymphoma. Dermatology, 209(4), 296-300. doi:10.1159/000080852

Hofbauer, G. F., Burkhart, A., Schuler, G., Dummer, R., Burg, G., & Nestle, F. O. (2004). High frequency of melanoma-associated antigen or HLA class I loss does not correlate with survival in primary melanoma. J Immunother, 27(1), 73-78.

Kazakov, D. V., Burg, G., & Kempf, W. (2004). Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol, 18(4), 397-415. doi:10.1111/j.1468-3083.2004.00937.x

Kazakov, D. V., Kutzner, H., Rutten, A., Michal, M., Requena, L., Burg, G., . . . Kempf, W. (2004). The anti-MAGE antibody B57 as a diagnostic marker in melanocytic lesions. Am J Dermatopathol, 26(2), 102-107.

Kempf, W., Cathomas, G., Burg, G., & Trueb, R. M. (2004). Micronodular Kaposi's sarcoma - a new variant of classic-sporadic Kaposi's sarcoma. Dermatology, 208(3), 255-258. doi:10.1159/000077313

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., & Smoller, B. R. (2004). International board certification in dermatopathology: paving the way for the future. Am J Dermatopathol, 26(5), 439-440.

Lauchli, S., Zortea-Caflisch, C., Nestle, F. O., Burg, G., & Kempf, W. (2004). Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis. Dermatology, 208(3), 278-280. doi:10.1159/000077321

Liu, J. Y., Hafner, J., Dragieva, G., & Burg, G. (2004). Bioreactor microcarrier cell culture system (Bio-MCCS) for large-scale production of autologous melanocytes. Cell Transplant, 13(7-8), 809-816.

Liu, J. Y., Hafner, J., Dragieva, G., Seifert, B., & Burg, G. (2004). Autologous cultured keratinocytes on porcine gelatin microbeads effectively heal chronic venous leg ulcers. Wound Repair Regen, 12(2), 148-156. doi:10.1111/j.1067-1927.2004.012205.x

Meier, S., Baumert, B. G., Maier, T., Wellis, G., Burg, G., Seifert, B., & Dummer, R. (2004). Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie, 27(2), 145-149. doi:10.1159/000076903

Michaelis, S., Cozzio, A., Kempf, W., Graf, P., Burg, G., & Dummer, R. (2004). Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoides. Dermatology, 209(1), 72-74. doi:10.1159/000078595

Murer, K., Urosevic, M., Willers, J., Selvam, P., Laine, E., Burg, G., & Dummer, R. (2004). Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients. Melanoma Res, 14(4), 257-262.

Prinz, B. M., Hafner, J., Dummer, R., Burg, G., Bruswanger, U., & Kempf, W. (2004). Treatment of Bowen's disease with imiquimod 5% cream in transplant recipients. Transplantation, 77(5), 790-791.

Prinz, B. M., Michaelis, S., Kettelhack, N., Mueller, B., Burg, G., & Kempf, W. (2004). Subcutaneous infection with Mycobacterium abscessus in a renal transplant recipient. Dermatology, 208(3), 259-261. doi:10.1159/000077314

Prinz, B. M., Vavricka, S. R., Graf, P., Burg, G., & Dummer, R. (2004). Efficacy of laser treatment of tattoos using lasers emitting wavelengths of 532 nm, 755 nm and 1064 nm. Br J Dermatol, 150(2), 245-251.

Requena, L., Burg, G., Cerroni, L., & Zelger, B. W. (2004). A progressive papular eruption on the chest and back. Am J Dermatopathol, 26(2), 162-165.

Rubben, A., Kempf, W., Kadin, M. E., Zimmermann, D. R., & Burg, G. (2004). Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma. Exp Dermatol, 13(8), 472-483. doi:10.1111/j.0906-6705.2004.00176.x

Schuster, C., & Burg, G. (2004). [The red face]. Praxis (Bern 1994), 93(42), 1727-1732. doi:10.1024/0369-8394.93.42.1727

Urosevic, M., Kamarashev, J., Burg, G., & Dummer, R. (2004). Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2. Blood, 103(5), 1796-1798. doi:10.1182/blood-2003-10-3372

Urosevic, M., Oberholzer, P. A., Maier, T., Hafner, J., Laine, E., Slade, H., . . . Dummer, R. (2004). Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha? Clin Cancer Res, 10(15), 4959-4970. doi:10.1158/1078-0432.CCR-04-0193

  • Burg, G., Dummer, R., & Kempf, W. (2005). Dyscrasias with "undetermined significance". Arch Dermatol, 141(3), 382-384.

Burg, G., Hasse, U., Cipolat, C., Kropf, R., Djamei, V., Soyer, H. P., & Chimenti, S. (2005). Teledermatology: just cool or a real tool? Dermatology, 210(2), 169-173. doi:10.1159/000082573

Burg, G., Kempf, W., Cozzio, A., Feit, J., Willemze, R., E, S. J., . . . Whittaker, S. (2005). WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol, 32(10), 647-674. doi:10.1111/j.0303-6987.2005.00495.x

Dummer, R., Panizzon, R., Bloch, P. H., Burg, G., & Task Force Skin, C. (2005). Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology, 210(1), 39-44. doi:10.1159/000081482

Feit, J., Kempf, W., Jedlickova, H., & Burg, G. (2005). Hypertext atlas of dermatopathology with expert system for epithelial tumors of the skin. J Cutan Pathol, 32(6), 433-437. doi:10.1111/j.0303-6987.2005.00291.x

Gilliet, M., Cozzio, A., Burg, G., & Nestle, F. O. (2005). Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis. Br J Dermatol, 152(3), 531-536. doi:10.1111/j.1365-2133.2005.06434.x

Greisser, J., Doebbeling, U., Roos, M., Mueller, B., Schmid, M., Burg, G., . . . Kempf, W. (2005). Apoptosis in CD30-positive lymphoproliferative disorders of the skin. Exp Dermatol, 14(5), 380-385. doi:10.1111/j.0906-6705.2005.00293.x

Heinzerling, L., Burg, G., Dummer, R., Maier, T., Oberholzer, P. A., Schultz, J., . . . Moelling, K. (2005). Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. Hum Gene Ther, 16(1), 35-48. doi:10.1089/hum.2005.16.35

Hofbauer, G. F., Hatta, N., Daigle, I., Hemmi, S., Spanaus Schlapbach, K., Willers, J., . . . Dummer, R. (2005). Fas ligand reduces viability in primary melanoma short-term cell cultures more than in metastatic melanoma short-term cell cultures. Dermatology, 211(4), 318-324. doi:10.1159/000088500

Kempf, W., Kutzner, H., Kettelhack, N., Palmedo, G., & Burg, G. (2005). Paraneoplastic pityriasis lichenoides in cutaneous lymphoma: case report and review of the literature on paraneoplastic reactions of the skin in lymphoma and leukaemia. Br J Dermatol, 152(6), 1327-1331. doi:10.1111/j.1365-2133.2005.06457.x

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., Kutzner, H., & Sanguenza, O. (2005). International Board certification dermatopathology: a worldwide effort to rise standards in dermatopathology. J Dtsch Dermatol Ges, 3(4), 309-311.

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., Kutzner, H., & Sangueza, O. (2005). International Board Certification in Dermatopathology: a worldwide effort to raise standards in dermatopathology. Am J Dermatopathol, 27(4), 357-359.

Laetsch, B., Hofbauer, G., Kempf, W., Burg, G., & Dummer, R. (2005). Atypical poorly differentiated cutaneous T-cell lymphoma with an angiocentric growth pattern presenting histologically as vasculitis. Dermatology, 210(4), 341-345. doi:10.1159/000084763

Liu, J. Y., & Burg, G. (2005). An improved organ culture for regeneration of pure autologous keratinocytes from small split-thickness skin specimens. Dermatology, 210(1), 45-48. doi:10.1159/000081483

Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., . . . Gilliet, M. (2005). Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med, 202(1), 135-143. doi:10.1084/jem.20050500

Pimpinelli, N., Olsen, E. A., Santucci, M., Vonderheid, E., Haeffner, A. C., Stevens, S., . . . International Society for Cutaneous, L. (2005). Defining early mycosis fungoides. J Am Acad Dermatol, 53(6), 1053-1063. doi:10.1016/j.jaad.2005.08.057

Schraner, C., Hasse, B., Hasse, U., Baumann, D., Faeh, A., Burg, G., . . . Gunthard, H. F. (2005). Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1. Clin Infect Dis, 40(12), e120-124. doi:10.1086/430444

Urosevic, M., Braun, B., Willers, J., Burg, G., & Dummer, R. (2005). Expression of melanoma-associated antigens in melanoma cell cultures. Exp Dermatol, 14(7), 491-497. doi:10.1111/j.0906-6705.2005.00305.x

Urosevic, M., Conrad, C., Kamarashev, J., Asagoe, K., Cozzio, A., Burg, G., & Dummer, R. (2005). CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Hum Pathol, 36(9), 1020-1024. doi:10.1016/j.humpath.2005.07.002

Urosevic, M., Dummer, R., Conrad, C., Beyeler, M., Laine, E., Burg, G., & Gilliet, M. (2005). Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. J Natl Cancer Inst, 97(15), 1143-1153. doi:10.1093/jnci/dji207

Urosevic, M., Kempf, W., Zagrodnik, B., Panizzon, R., Burg, G., & Dummer, R. (2005). HLA-G expression in basal cell carcinomas of the skin recurring after radiotherapy. Clin Exp Dermatol, 30(4), 422-425. doi:10.1111/j.1365-2230.2005.01790.x

Willemze, R., Jaffe, E. S., Burg, G., Cerroni, L., Berti, E., Swerdlow, S. H., . . . Meijer, C. J. (2005). WHO-EORTC classification for cutaneous lymphomas. Blood, 105(10), 3768-3785. doi:10.1182/blood-2004-09-3502

Beyeler, M., Waldispuhl, S., Strobel, K., Joller-Jemelka, H. I., Burg, G., & Dummer, R. (2006). Detection of melanoma relapse: first comparative analysis on imaging techniques versus S100 protein. Dermatology, 213(3), 187-191. doi:10.1159/000095034

Burg, G., Kempf, W., Cozzio, A., Dobbeling, U., Feit, J., Golling, P., . . . Dummer, R. (2006). Cutaneous malignant lymphomas: update 2006. J Dtsch Dermatol Ges, 4(11), 914-933. doi:10.1111/j.1610-0387.2006.06069.x

Cozzio, A., Kempf, W., Schmid-Meyer, R., Gilliet, M., Michaelis, S., Scharer, L., . . . Dummer, R. (2006). Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma. Leuk Lymphoma, 47(5), 865-869. doi:10.1080/10428190500399698

Dummer, R., Hauschild, A., Skalsky, J., Burg, G., & Weichenthal, M. (2006). Bexarotene and systemic disease progression in CTCL? J Am Acad Dermatol, 55(2), 365-366; author reply 366. doi:10.1016/j.jaad.2006.01.022

Dummer, R., Urosevic, M., Cozzio, A., Asagoe, K., Dobbeling, U., & Burg, G. (2006). [Perspective of cutaneous lymphoma reserach]. J Dtsch Dermatol Ges, 4(6), 492-495. doi:10.1111/j.1610-0387.2006.05986.x

Goldinger, S. M., Dummer, R., Schmid, P., Prinz Vavricka, M., Burg, G., & Lauchli, S. (2006). Excimer laser versus narrow-band UVB (311 nm) in the treatment of psoriasis vulgaris. Dermatology, 213(2), 134-139. doi:10.1159/000093852

Greisser, J., Palmedo, G., Sander, C., Kutzner, H., Kazakov, D. V., Roos, M., . . . Kempf, W. (2006). Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders. J Cutan Pathol, 33(11), 711-715. doi:10.1111/j.1600-0560.2006.00560.x

Kazakov, D. V., Kutzner, H., Palmedo, G., Boudova, L., Michaelis, S., Michal, M., . . . Kempf, W. (2006). Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement. Am J Dermatopathol, 28(5), 399-409. doi:10.1097/01.dad.0000211514.98230.ba

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., Kutzner, H., & Sangueza, O. (2006). International Board Certification in Dermatopathology: a worldwide effort to raise standards in dermatopathology. J Cutan Pathol, 33(2), 156-159. doi:10.1111/j.0303-6987.2006.00390.x

Liu, J. Y., Hafner, J., Dragieva, G., & Burg, G. (2006). High yields of autologous living dermal equivalents using porcine gelatin microbeads as microcarriers for autologous fibroblasts. Cell Transplant, 15(5), 445-451.

Liu, J. Y., Hafner, J., Dragieva, G., & Burg, G. (2006). A novel bioreactor microcarrier cell culture system for high yields of proliferating autologous human keratinocytes. Cell Transplant, 15(5), 435-443.

Michaelis, S., Kazakov, D. V., Burg, G., Dummer, R., & Kempf, W. (2006). Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sezary syndrome. Int J Dermatol, 45(3), 277-279. doi:10.1111/j.1365-4632.2006.02378.x

Schadendorf, D., Ugurel, S., Schuler-Thurner, B., Nestle, F. O., Enk, A., Brocker, E. B., . . . DeCOG, D. C. s. g. o. t. (2006). Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol, 17(4), 563-570. doi:10.1093/annonc/mdj138

Dummer, R., Asagoe, K., Cozzio, A., Burg, G., Doebbeling, U., Golling, P., . . . Urosevic, M. (2007). Recent advances in cutaneous lymphomas. J Dermatol Sci, 48(3), 157-167. doi:10.1016/j.jdermsci.2007.09.001

Gachter, T., Muhleisen, B., Scharer, L., Dummer, R., Burg, G., & Hofbauer, G. F. (2007). Weight of decision-making impairs clinical assessment of melanocytic lesions. J Cutan Med Surg, 11(1), 9-18. doi:10.2310/7750.2007.00007

Goldinger, S. M., Dummer, R., Schmid, P., Burg, G., Seifert, B., & Lauchli, S. (2007). Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo. J Eur Acad Dermatol Venereol, 21(4), 504-508. doi:10.1111/j.1468-3083.2006.02016.x

Hafner, J., Fritz, T., Lauchli, S., Bogdan, I., Burg, G., & French, L. E. (2007). [Eyebrow repair after skin cancer surgery: combined naked and hairbearing full thickness graft from the contralateral retroauricular donor site]. J Dtsch Dermatol Ges, 5(11), 1034-1035. doi:10.1111/j.1610-0387.2007.06564.x

Kamarashev, J., Theler, B., Dummer, R., & Burg, G. (2007). Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation. Int J Dermatol, 46(9), 930-935. doi:10.1111/j.1365-4632.2007.03149.x

Muehleisen, B., Schaerer, L., Dummer, R., Burg, G., & Hofbauer, G. F. (2007). Cancer/testis antigen MAGE-A4 expression pattern differs in epithelial skin tumors of organ-transplant recipients and immunocompetent patients. J Cutan Pathol, 34(1), 1-6. doi:10.1111/j.1600-0560.2006.00576.x

Olsen, E., Vonderheid, E., Pimpinelli, N., Willemze, R., Kim, Y., Knobler, R., . . . Iscl/Eortc. (2007). Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood, 110(6), 1713-1722. doi:10.1182/blood-2007-03-055749

Burg, G. (2008). [E-Learning in medicine: at the top or a flop]. J Dtsch Dermatol Ges, 6(6), 435. doi:10.1111/j.1610-0387.2008.06789.x

Hofbauer, G. F., Baur, T., Bonnet, M. C., Tartour, E., Burg, G., Berinstein, N. L., & Dummer, R. (2008). Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate. Melanoma Res, 18(2), 104-111. doi:10.1097/CMR.0b013e3282f702cf

Kempf, W., Ostheeren-Michaelis, S., Paulli, M., Lucioni, M., Wechsler, J., Audring, H., . . . Treatment of, C. (2008). Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). Arch Dermatol, 144(12), 1609-1617. doi:10.1001/archdermatol.2008.46

Valentini, J., Grotto, D., Paniz, C., Roehrs, M., Burg, G., & Garcia, S. C. (2008). The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients. Biomed Pharmacother, 62(6), 378-382. doi:10.1016/j.biopha.2007.10.017

Burg, G., Soyer, H. P., & Chimenti, S. (2009). Skin diseases in Europe. Teledermatology. Eur J Dermatol, 19(6), 656-658. doi:10.1684/ejd.2009.0800

Kerl, H., Cerio, R., Burg, G., Anadolu, R. Y., Chimenti, S., & Forsea, D. (2009). Dermatopathology. Eur J Dermatol, 19(5), 536-537. doi:10.1684/ejd.2009.0785

Hafner, J., Nobbe, S., Partsch, H., Lauchli, S., Mayer, D., Amann-Vesti, B., . . . French, L. E. (2010). Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol, 146(9), 961-968. doi:10.1001/archdermatol.2010.224

Olsen, E. A., Whittaker, S., Kim, Y. H., Duvic, M., Prince, H. M., Lessin, S. R., . . . Treatment of, C. (2011). Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol, 29(18), 2598-2607. doi:10.1200/JCO.2010.32.0630

Tremp, M., Knafla, I., Burg, G., Wuthrich, B., & Schmid-Grendelmeier, P. (2011). 'EASIdig'--a digital tool to document disease activity in atopic dermatitis. Dermatology, 223(1), 68-73. doi:10.1159/000330333

Burg, G. (2012). History of sexually transmitted infections (STI). G Ital Dermatol Venereol, 147(4), 329-340.

Burg, G., & French, L. E. (2012). [The age of Gutenberg is over: a consideration of medical education--past, present and future]. Hautarzt, 63 Suppl 1, 38-44. doi:10.1007/s00105-011-2301-z

Hafner, J., French, L. E., Burg, G., & Schnyder, U. W. (2012). [To Prof. Dr. Dr. h.c. mult. Otto Braun-Falco: Birthday wishes and expression of appreciation from the Swiss Society for Dermatology and Venereology (SGDV)]. Hautarzt, 63 Suppl 1, 17. doi:10.1007/s00105-011-2308-5

Burg, G., French, L., & Hafner, J. (2013). [In memoriam: Prof. Dr. Dr. h.c. Urs Walter Schnyder: 7 February 1923-21 October 2012]. Hautarzt, 64(1), 65-66. doi:10.1007/s00105-012-2500-2

Pimmer, C., Linxen, S., Grohbiel, U., Jha, A. K., & Burg, G. (2013). Mobile learning in resource-constrained environments: a case study of medical education. Med Teach, 35(5), e1157-1165. doi:10.3109/0142159X.2012.733454

Burg, G. (2015). Systemic involvement in mycosis fungoides. Clin Dermatol, 33(5), 563-571. doi:10.1016/j.clindermatol.2015.05.008

Robson, A., Assaf, C., Bagot, M., Burg, G., Calonje, E., Castillo, C., . . . Berti, E. (2015). Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop. Histopathology, 67(4), 425-441. doi:10.1111/his.12371

Burg, G., & Finlay, A. Y. (2016). Web-based education. J Eur Acad Dermatol Venereol, 30(12), e226-e227. doi:10.1111/jdv.13560

 

Burg, G. (1969). [Protoporhyrinemic photodermatosis simulating hydroa aestivalia]. Dtsch Med Wochenschr, 94(25), 1314-1325.

Burg, G. (1969). [Protoporhyrinemic photodermatosis simulating hydroa aestivalia]. Dtsch Med Wochenschr, 94(25), 1314-1325.

Burg, G., Rassner, G., & Braun-Falco, O. (1969). [The effect of cyclophosphamide (Endoxan) on acute and chronic inflammation in the guinea pig]. Arch Klin Exp Dermatol, 236(1), 61-71.

Burg, G., Rassner, G., & Braun-Falco, O. (1969). [The effect of cyclophosphamide (Endoxan) on acute and chronic inflammation in the guinea pig]. Arch Klin Exp Dermatol, 236(1), 61-71.

Zaun, H., & Burg, G. (1969). [True twisted hair (Galewsky-Ronchese) with involvement of eyebrows and lanugo]. Asthet Med (Berl), 18(5), 95-100.

Zaun, H., & Burg, G. (1969). [True twisted hair (Galewsky-Ronchese) with involvement of eyebrows and lanugo]. Asthet Med (Berl), 18(5), 95-100.

Braun-Falco, O., & Burg, G. (1970). [Cytostatics and immunosuppressive agents in dermatology]. Hautarzt, 21(9), 391-397.

Braun-Falco, O., & Burg, G. (1970). [Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol, 236(3), 297-314.

Braun-Falco, O., & Burg, G. (1970). [Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. Arch Klin Exp Dermatol, 239(3), 307-322.

Braun-Falco, O., & Burg, G. (1970). [Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol, 236(2), 173-189.

Braun-Falco, O., & Burg, G. (1970). [Histochemistry of capillaries in psoriasis vulgaris]. Arch Klin Exp Dermatol, 236(2), 173-189.

Braun-Falco, O., & Burg, G. (1970). [Histochemical and cytochemical investigations in allergic DNCB-contact dermatitis of the guinea pig]. Arch Klin Exp Dermatol, 239(3), 307-322.

Braun-Falco, O., & Burg, G. (1970). [Inflammatory infiltrate in psoriasis vulgaris. A cytochemical study]. Arch Klin Exp Dermatol, 236(3), 297-314.

Braun-Falco, O., & Burg, G. (1970). [Cytostatics and immunosuppressive agents in dermatology]. Hautarzt, 21(9), 391-397.

Braun-Falco, O., Schmidt, D., & Burg, G. (1970). [Protoperphyrinaemic photodermatosis of the Quinckes's edema type]. Munch Med Wochenschr, 112(32), 1443-1447.

Braun-Falco, O., Schmidt, D., & Burg, G. (1970). [Protoperphyrinaemic photodermatosis of the Quinckes's edema type]. Munch Med Wochenschr, 112(32), 1443-1447.

Burg, G. (1970). [Erythropoietic protoporphyrinemic light dermatosis. Contribution to optical fluorescence demonstration, pathogenesis and therapy]. Dtsch Med Wochenschr, 95(20), 1120-1123. doi:10.1055/s-0028-1108598

Burg, G. (1970). [Erythropoietic protoporphyrinemic light dermatosis. Contribution to optical fluorescence demonstration, pathogenesis and therapy]. Dtsch Med Wochenschr, 95(20), 1120-1123. doi:10.1055/s-0028-1108598

Braun-Falco, O., & Burg, G. (1971). [Cytostatic and immunosuppressive treatment of dermatologic diseases]. Ther Ggw, 110(4), 488-500.

Braun-Falco, O., & Burg, G. (1971). [Dynamics of skin reaction following horn layer stripping. Histochemical and cytochemical studies on guinea pig ears]. Arch Dermatol Forsch, 241(1), 1-14.

Braun-Falco, O., & Burg, G. (1971). [Dynamics of skin reaction following horn layer stripping. Histochemical and cytochemical studies on guinea pig ears]. Arch Dermatol Forsch, 241(1), 1-14.

Braun-Falco, O., & Burg, G. (1971). [Cytostatic and immunosuppressive treatment of dermatologic diseases]. Ther Ggw, 110(4), 488-500.

Braun-Falco, O., Burg, G., & Schoefinius, H. H. (1971). [The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations]. Arch Dermatol Forsch, 241(3), 217-236.

Braun-Falco, O., Burg, G., & Schoefinius, H. H. (1971). [The effect of dithranol in psoriasis fulgaris. Cyto- and histochemical investigations]. Arch Dermatol Forsch, 241(3), 217-236.

Burg, G. (1971). [Therapy of porphyrias]. Dtsch Med Wochenschr, 96(21), 914-915. doi:10.1055/s-0028-1108358

Burg, G. (1971). [Therapy of porphyrias]. Dtsch Med Wochenschr, 96(21), 914-915. doi:10.1055/s-0028-1108358

Braun-Falco, O., Burg, G., & Farber, E. M. (1972). [Psoriasis. A questionnaire study of 536 patients]. Munch Med Wochenschr, 114(23), 1105-1110.

Braun-Falco, O., Burg, G., & Farber, E. M. (1972). [Psoriasis. A questionnaire study of 536 patients]. Munch Med Wochenschr, 114(23), 1105-1110.

Burg, G. (1972). [Therapy of porphyrias]. Minerva Med, 63(31), 1813-1815.

Burg, G. (1972). [Therapy of porphyrias]. Minerva Med, 63(31), 1813-1815.

Burg, G., & Braun-Falco, O. (1972). [Cytochemical studies on cellular stroma reaction in melanoma]. Arch Dermatol Forsch, 244, 261-264.

Burg, G., & Braun-Falco, O. (1972). The cellular stromal reaction in malignant melanoma. A cytochemical investigation. Arch Dermatol Forsch, 245(4), 318-333.

Burg, G., & Braun-Falco, O. (1972). The cellular stromal reaction in malignant melanoma. A cytochemical investigation. Arch Dermatol Forsch, 245(4), 318-333.

Burg, G., & Braun-Falco, O. (1972). [Cytochemical studies on cellular stroma reaction in melanoma]. Arch Dermatol Forsch, 244, 261-264.

Burg, G., & Plewig, G. (1972). [Seasonal pruritus as a symptom of erythropoietic protoporphyrinemic photodermatosis (EPL)]. Hautarzt, 23(12), 553-555.

Burg, G., & Plewig, G. (1972). [Seasonal pruritus as a symptom of erythropoietic protoporphyrinemic photodermatosis (EPL)]. Hautarzt, 23(12), 553-555.

Burg, G., & Robins, P. (1972). [Chemosurgery. Surgical removal of chemically fixed tumor tissue with microscopic control]. Hautarzt, 23(1), 16-20.

Burg, G., & Robins, P. (1972). [Chemosurgery. Surgical removal of chemically fixed tumor tissue with microscopic control]. Hautarzt, 23(1), 16-20.

Kolomiichenko, A. I., Kharshak, E. M., Lifanov, V. L., Burg, G. M., & Moroz, B. S. (1972). [Mobile audiometric laboratory]. Zh Ushn Nos Gorl Bolezn, 32(1), 103-104.

Kolomiichenko, A. I., Kharshak, E. M., Lifanov, V. L., Burg, G. M., & Moroz, B. S. (1972). [Mobile audiometric laboratory]. Zh Ushn Nos Gorl Bolezn, 32(1), 103-104.

Braun-Falco, O., & Burg, G. (1973). [Enzyme histochemistry of malignant melanoma. Investigations on primary tumors and metastases (author's transl)]. Arch Dermatol Forsch, 246(4), 303-316.

Braun-Falco, O., & Burg, G. (1973). [Enzyme histochemistry of malignant melanoma. Investigations on primary tumors and metastases (author's transl)]. Arch Dermatol Forsch, 246(4), 303-316.

Burg, G. (1973). [Erythropoetic, protoporphyrinemic light dermatosis with secondary cutaneous hyalinosis]. Hautarzt, 24(12), 564.

Burg, G. (1973). [Erythropoetic, protoporphyrinemic light dermatosis with secondary cutaneous hyalinosis]. Hautarzt, 24(12), 564.

Huhn, D., Burg, G., & Mempel, W. (1973). [Specific cutaneous changes in Hodgkin's disease (author's transl)]. Dtsch Med Wochenschr, 98(52), 2469-2472. doi:10.1055/s-0028-1107281

Huhn, D., Burg, G., & Mempel, W. (1973). [Specific cutaneous changes in Hodgkin's disease (author's transl)]. Dtsch Med Wochenschr, 98(52), 2469-2472. doi:10.1055/s-0028-1107281

Braun-Falco, O., & Burg, G. (1974). [Cellular infiltrate and capillaries in atopic dermatitis. Quantitative enzyme-cytochemical and histochemical investigations (author's transl)]. Arch Dermatol Forsch, 249(2), 113-124.

Braun-Falco, O., & Burg, G. (1974). [Cellular infiltrate and capillaries in atopic dermatitis. Quantitative enzyme-cytochemical and histochemical investigations (author's transl)]. Arch Dermatol Forsch, 249(2), 113-124.

Burg, G., & Braun-Falco, O. (1974). [Qualitative and quantitative aspects of the cellular reaction in the skin and blood in mycosis fungoides. A cytochemical study]. Hautarzt, 25(4), 178-187.

Burg, G., & Braun-Falco, O. (1974). [Advances in cytochemical differentiation of cellular infiltrates into the skin]. Hautarzt, 25(1), 1-8.

Burg, G., & Braun-Falco, O. (1974). [Advances in cytochemical differentiation of cellular infiltrates into the skin]. Hautarzt, 25(1), 1-8.

Burg, G., & Braun-Falco, O. (1974). [Qualitative and quantitative aspects of the cellular reaction in the skin and blood in mycosis fungoides. A cytochemical study]. Hautarzt, 25(4), 178-187.

Burg, G., & Dorn, M. (1974). [Chemosurgery of basaliomas]. Z Hautkr, 49(17), 713-714.

Burg, G., & Dorn, M. (1974). [Chemosurgery of basaliomas]. Z Hautkr, 49(17), 713-714.

Kerl, H., Burg, G., & Braun-Falco, O. (1974). Quantitative and qualitative dynamics of the epidermal and cellular inflammatory reaction in primary toxic and allergic dinitrochlorobenzene contact dermatitis in guinea pigs. Arch Dermatol Forsch, 249(3), 207-226.

Kerl, H., Burg, G., & Braun-Falco, O. (1974). Quantitative and qualitative dynamics of the epidermal and cellular inflammatory reaction in primary toxic and allergic dinitrochlorobenzene contact dermatitis in guinea pigs. Arch Dermatol Forsch, 249(3), 207-226.

Burg, G. (1975). [Procceedings: Hereditary onycholysis mit scleronychia]. Hautarzt, 26(7), 386.

Burg, G., & Braun-Falco, O. (1975). [T and B lymphocytes in skin changes of cutaneous lymphoma (author's transl)]. Dtsch Med Wochenschr, 100(50), 2562-2564. doi:10.1055/s-0028-1106585

Burg, G., & Braun-Falco, O. (1975). Classification and differentiation of cutaneous lymphomas. Enzyme-cytochemical and immunocytological studies. Br J Dermatol, 93(5), 597-599.

Burg, G., Hirsch, R. D., Konz, B., & Braun-Falco, O. (1975). Histographic surgery: accuracy of visual assessment of the margins of basal-cell epithelioma. J Dermatol Surg, 1(3), 21-24.

Falco, O. B., & Burg, G. (1975). [Lymphoreticular proliferations in the skin. Cytochemical and immunocytological studies in lymphadenosis benigna cutis]. Hautarzt, 26(3), 124-132.

Kerl, H., & Burg, G. (1975). [Acquired (postinflammatory) dermatchalasis, dermatitis herpetiformis Duhring, celiac syndrome, dermatochalasis]. Hautarzt, 26(4), 191-196.

Weber, K., Burg, G., Wolff, H. H., Braun-Falco, O., & Ehlers, G. (1975). [Sezary's syndrome. Case report]. Hautarzt, 26(5), 255-259.

Braun-Falco, O., & Burg, G. (1976). Proceedings: Enzyme cytochemical and immunocytological characterization of cutaneous lymphomas. Br J Dermatol, 95 Suppl 14, 9-10.

Braun-Falco, O., Burg, G., & Wolff, H. H. (1976). [Cutaneous lymphomas, and pseudolymphomas. Immunocytological, enzymocytochemical and electron microscopical studies (authors transl)]. Ther Umsch, 33(8), 543-550.

Burg, G. (1976). [Progress in the diagnosis of cutaneous lymphomas. Enzyme cytochemical and immunocytological studies]. Fortschr Med, 94(18), 1089-1098.

Burg, G., & Braun-Falco, O. (1977). [1-Chloro-2,4-dinitrobenzene ointment for sensitization, testing and therapy of malignant melanoma patients]. Dtsch Med Wochenschr, 102(6), 210-211.

Burg, G., & Braun-Falco, O. (1977). Morphological and functional differentiation and classification of cutaneous lymphomas. Bull Cancer, 64(2), 225-240.

Burg, G., & Braun-Falco, O. (1977). [Enzyme cytochemical and immunocytologic studies of mycosis fungoides]. Acta Histochem Suppl, Suppl 18, 209-214.

Burg, G., Rodt, H., Grosse-Wilde, H., Netzel, B., Fateh-Moghadam, A., & Braun-Falco, O. (1977). Enzymecytochemical and immunocytological studies as a basis for the revaluation of the histology of cutaneous B-cell and T-cell lymphomas. Haematol Blood Transfus, 20, 179-187.

Hofmann, C., Burg, G., Plewig, G., & Braun-Falco, O. (1977). [Photochemotherapy of cutaneous lymphoma: oral and local 8-MOP-UVA treatment (author's transl)]. Dtsch Med Wochenschr, 102(18), 675-679. doi:10.1055/s-0028-1104951

Schmoeckel, C., Burg, G., Wolf, H. H., & Braun-Falco, O. (1977). The ultrastructure of lymphadenosis benigna cutis (pseudolymphoma cutis). Arch Dermatol Res, 258(2), 161-167.

Bode, U., & Burg, G. (1978). [The acquired digital fibrokeratoma]. Hautarzt, 29(12), 659-660.

Braun-Falco, O., Guggenberger, K., Burg, G., & Fateh-Moghadam, A. (1978). [Immunocytoma simulating chronic acrodermatitis atrophicans]. Hautarzt, 29(12), 644-647.

Burg, G., & Braun-Falco, O. (1978). Cutaneous non-Hodgkin lymphoma: re-evaluation of histology using enzymecytochemical and immunologic studies. Int J Dermatol, 17(6), 496-505.

Burg, G., Braun-Falco, O., Hoffmann-Fezer, G., Rodt, H., & Schmoeckel, C. (1978). Patterns of cutaneous lymphomas. Histological, enzyme cytochemical, and immunological typing of lymphoreticular proliferations in the skin. Dermatologica, 157(5), 282-291.

Burg, G., Braun-Falco, O., & Schmoeckel, C. (1978). [Cutaneous T-cell lymphomas]. Fortschr Med, 96(5), 199-205.

Burg, G., Rodt, H., Grosse-Wilde, H., & Braun-Falco, O. (1978). Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sezary's syndrome. J Invest Dermatol, 70(5), 257-259.

Burg, G., Schmoeckel, C., Braun-Falco, O., & Wolff, H. H. (1978). Monocytic leukemia. Clinically appearing as 'malignant reticulosis of the skin'. Arch Dermatol, 114(3), 418-420.

Bonniger, F., & Burg, G. (1979). [Multiple keratoacanthomas]. Hautarzt, 30(2), 92-94.

Braun-Falco, O., Schmoeckel, C., Burg, G., & Ryckmanns, F. (1979). Pagetoid reticulosis. A further case report with a review of the literature. Acta Derm Venereol Suppl (Stockh), 59(85), 11-21.

Burg, G. (1979). [Reticuloses and lymphomas of the skin from the present viewpoint]. Hautarzt, 30(3), 167-168.

Butenschon, H., Burg, G., & Lentze, M. (1979). [LEOPARD syndrome]. Z Hautkr, 54(13), 613-618.

Kerl, H., & Burg, G. (1979). [Immunocytomas and immunoblastic lymphomas of the skin]. Hautarzt, 30(12), 666-672.

Kienitz, T., Burg, G., Schmoeckel, C., Weitz, H., & Braun-Falco, O. (1979). High-grade malignant lymphoma arising from Sezary's syndrome. A case report. Dermatologica, 158(2), 126-136.

Schmoeckel, C., Burg, G., & Braun-Falco, O. (1979). Quantitative analysis of lymphoid cells in cutaneous low-grade malignant B-cell lymphomas. Arch Dermatol Res, 266(3), 239-251.

Schmoeckel, C., Burg, G., & Braun-Falco, O. (1979). Quantitative analysis of lymphoid cells in myocosis fungoides, Sezary's syndrome and parapsoriasis en plaques. Arch Dermatol Res, 264(1), 17-28.

von Liebe, V., Karge, H. J., & Burg, G. (1979). [Contact urticaria]. Hautarzt, 30(10), 544-546.

Braun-Falco, O., Burg, G., Hoffmann-Fezer, G., Fateh-Moghadam, A., & Herterich, J. (1980). [Reticulosis of the skin - a heterogenic group of diseases]. Acta Histochem Suppl, 21, 57-69.

Braun-Falco, O., Burg, G., Selzle, D., & Schmoeckel, C. (1980). [Diffuse congenital melanosis]. Hautarzt, 31(6), 324-327.

Burg, G. (1980). [Enzyme cytochemical and immunological procedures for diagnosis of pseudolymphomas and skin lymphomas]. Z Hautkr, 55(20), 1351-1366.

Burg, G., Guggenberger, K., Schmoeckel, C., & Braun-Falco, O. (1980). [Therapy of mycosis fungoides]. Ther Ggw, 119(7), 773-790.

Kolz, R., Lonsdorf, G., & Burg, G. (1980). [Intolerance reactions following parenteral administration of vitamin B]. Hautarzt, 31(12), 657-659.

Schmoeckel, C., Braun-Falco, O., & Burg, G. (1980). [Atypical fibroxanthoma]. Hautarzt, 31(4), 213-215.

Braun-Falco, O., Burg, G., & Schmoeckel, C. (1981). Recent advances in the understanding of cutaneous lymphoma. Clin Exp Dermatol, 6(1), 89-109.

Burg, G. (1981). Malignant histiocytic disorders of the skin. Haematol Blood Transfus, 27, 221-224.

Burg, G., Hoffmann-Fezer, G., Nikolowski, J., Schmoeckel, C., Braun-Falco, O., & Stunkel, K. (1981). Lymphomatoid papulosis: a cutaneous T-cell pseudolymphoma. Acta Derm Venereol, 61(6), 491-496.

Landthaler, M., Burg, G., & Zirbs, S. (1981). [Dye and nickel allergy in the hairdressing salon]. Hautarzt, 32(6), 281-284.

Schmoeckel, C., Burg, G., Braun-Falco, O., & Klingmuller, G. (1981). [High-grade malignant mycosis fungoides with cytological transformation (author's transl)]. Ann Dermatol Venereol, 108(3), 231-236, 239-241.

Forg, T., Burg, G., & Zirbs, S. (1982). [Frequency of contact allergy in housewives (author's transl)]. Derm Beruf Umwelt, 30(2), 48-50.

Ring, J., Lonsdorf, G., Schury, W., & Burg, G. (1982). [Bee and wasp venom allergy. Clinical aspects, prevention and therapy]. MMW Munch Med Wochenschr, 124(24), 587-590.

Schmoeckel, C., Burg, G., Hoffmann-Fezer, G., Stolz, W., Weitz, H., Lohrs, U., & Braun-Falco, O. (1982). Cutaneous immunoblastic T-cell lymphoma. Arch Dermatol Res, 274(1-2), 141-154.

Braun-Falco, O., & Burg, G. (1983). [Malignant lymphomas of the skin]. Internist (Berl), 24(6), 306-320.

Braun-Falco, O., Nikolowski, J., Burg, G., & Schmoeckel, C. (1983). [Lymphomatoid papulosis. Review and personal observation of 4 patients]. Hautarzt, 34(2), 59-65.

Hoffmann, R., van de Graaff, S., & Burg, G. (1983). [Spread of tuberculosis in ornamental fishes]. Tierarztl Prax, 11(2), 261-267.

Kerl, H., Burg, G., & Hashimoto, K. (1983). Fatal, penicillin-induced, generalized, postinflammatory elastolysis (cutis laxa). Am J Dermatopathol, 5(3), 267-276.

Oehlschlaegel, G., Marquart, K. H., Steuer, G., & Burg, G. (1983). [Iatrogenic pseudotumor of the skin induced by polyvinyl pyrrolidone]. Hautarzt, 34(11), 555-560.

Przybilla, B., Burg, G., Schmoeckel, C., & Braun-Falco, O. (1983). Treatment of cutaneous T-cell lymphomas with TP-5. Evaluation of the clinical effect in 8 patients. Acta Derm Venereol, 63(6), 524-529.

Przybilla, B., Burg, G., & Thieme, C. (1983). Evaluation of the immune status in vivo by the 2,4-dinitro-1-chlorobenzene contact allergy time (DNCB-CAT). Dermatologica, 167(1), 1-5.

Przybilla, B., Ring, J., & Burg, G. (1983). [Anaphylaxis following ingestion of coffee, chronic urticaria and analgesics idiosyncrasy]. Hautarzt, 34(2), 73-76.

Ring, J., Bode, U., Kadach, U., Stix, E., & Burg, G. (1983). [Gammaglobulins and allergy. Clinical results of a controlled study with standard human IgG and placebo in pollinosis]. MMW Munch Med Wochenschr, 125(14), 289-292.

Stolz, W., Schmoeckel, C., Burg, G., & Braun-Falco, O. (1983). Circulating Sezary cells in the diagnosis of Sezary syndrome (quantitative and morphometric analyses). J Invest Dermatol, 81(4), 314-319.

Burg, G., Kerl, H., Kaudewitz, P., Braun-Falco, O., & Mason, D. Y. (1984). Immunoenzymatic typing of lymphoplasmacytoid skin infiltrates. J Dermatol Surg Oncol, 10(4), 284-290.

Burg, G., Kerl, H., Przybilla, B., & Braun-Falco, O. (1984). Some statistical data, diagnosis, and staging of cutaneous B-cell lymphomas. J Dermatol Surg Oncol, 10(4), 256-262.

Burg, G., Kerl, H., & Schmoeckel, C. (1984). Differentiation between malignant B-cell lymphomas and pseudolymphomas of the skin. J Dermatol Surg Oncol, 10(4), 271-275.

Eberth-Willershausen, W., Steger, O., Barran, W., Burg, G., Ryckmanns, F., & Kaudewitz, P. (1984). [Histiocytosis X. An oligosymptomatic form of Hand-Schuller-Christian disease with a new form and possibilities of diagnosis]. Hautarzt, 35(10), 539-542.

Geerts, M. L., Burg, G., Schmoeckel, C., & Braun-Falco, O. (1984). Alkaline phosphatase activity in non-Hodgkin's lymphomas and pseudolymphomas of the skin. J Dermatol Surg Oncol, 10(4), 306-312.

Geerts, M. L., Burg, G., Schmoeckel, C., & Braun-Falco, O. (1984). Alkaline phosphatase positive lymphoma. Dermatologica, 169(6), 342-347.

Kaudewitz, P., Burg, G., Klepzig, K., Munker, R., Rieber, P., & Braun-Falco, O. (1984). Cells reactive with anti-T-cell monoclonal antibodies in malignant cutaneous B-cell lymphomas and pseudolymphomas. J Dermatol Surg Oncol, 10(4), 313-314.

Kerl, H., & Burg, G. (1984). Histomorphology and cytomorphology of cutaneous B-cell lymphomas. J Dermatol Surg Oncol, 10(4), 266-270.

Burg, G., Kaudewitz, P., Klepzig, K., Przybilla, B., & Braun-Falco, O. (1985). Cutaneous B-cell lymphoma. Dermatol Clin, 3(4), 689-704.

Kaudewitz, P., Burg, G., Stein, H., Klepzig, K., Mason, D. Y., & Braun-Falco, O. (1985). Monoclonal antibody patterns in lymphomatoid papulosis. Dermatol Clin, 3(4), 749-757.

Maier, H., Schmoeckel, C., Burg, G., & Braun-Falco, O. (1985). Primary cutaneous atypical histiocytosis with possible dissemination. Am J Dermatopathol, 7(4), 373-382.

Schanne, R., Burg, G., & Braun-Falco, O. (1985). [Nosologic relation of dyskeratosis follicularis (Darier) and pemphigus benignus chronicus familiaris (Hailey-Hailey). Position based on a case report]. Hautarzt, 36(9), 504-508.

Smolle, J., Kaudewitz, P., Burg, G., Kresbach, H., & Kerl, H. (1985). Significance of non-lymphoid ('accessory') cells in malignant lymphomas and pseudolymphomas of the skin. Br J Dermatol, 113(6), 677-685.

Burg, G. (1986). [Pagetoid skin infiltrates]. Pathologe, 7(4), 199-206.

Burg, G., Klepzig, K., Kaudewitz, P., Wolf, H., & Braun-Falco, O. (1986). Acyclovir in lymphomatoid papulosis and mycosis fungoides. JAMA, 256(2), 214-215.

Burg, G., Klepzig, K., Kaudewitz, P., Wolff, H., & Braun-Falco, O. (1986). [Acyclovir in mycosis fungoides and lymphomatoid papulosis]. Hautarzt, 37(10), 533-536.

Hofmann, C., Burg, G., & Jung, C. (1986). [Cutaneous side effects of gold therapy. Clinical and histologic results]. Z Rheumatol, 45(3), 100-106.

Imai, S., Burg, G., & Braun-Falco, O. (1986). Mycosis fungoides and Sezary's syndrome show distinct histomorphological features. Dermatologica, 173(3), 131-135.

Kaudewitz, P., Burg, G., Smolle, J., & Braun-Falco, O. (1986). [Immunologic phenotyping of cutaneous lymphomas]. Hautarzt, 37(12), 647-655.

Kaudewitz, P., Soldner, R., Burg, G., Bieber, T., Berger, C., Edelson, R., . . . Braun-Falco, O. (1986). Reactivity of monoclonal antibody BE 2 in different stages of mycosis fungoides and in benign dermal infiltrates. Arch Dermatol Res, 279(2), 83-88.

Kaudewitz, P., Stein, H., Burg, G., Mason, D. Y., & Braun-Falco, O. (1986). Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1. J Invest Dermatol, 86(4), 350-354.

Bieber, T., Ruzicka, T., & Burg, G. (1987). [Erosive pustulous dermatitis of the scalp]. Hautarzt, 38(11), 687-689.

Burg, G., Stunkel, K. G., Bieber, T., Opitz, U., & Kaudewitz, P. (1987). Cutaneous infiltrates of histiocytosis X contain plasminogen activator-bearing epidermotropic dendritic cells different from Langerhans cells. Arch Dermatol Res, 279 Suppl, S88-91.

Hofmann, C., Richter, W., Hiller, C., & Burg, G. (1987). [Urticaria vasculitis]. Z Rheumatol, 46(5), 233-236.

Kaudewitz, P., Burg, G., Majiewski, G., Gerdes, J., Schwarting, R., & Braun-Falco, O. (1987). Cell populations in pagetoid reticulosis: an immunological study using cell activation associated monoclonal antibodies. Acta Derm Venereol, 67(1), 24-29.

Ruzicka, T., & Burg, G. (1987). Effects of chronic intracutaneous administration of arachidonic acid and its metabolites. Induction of leukocytoclastic vasculitis by leukotriene B4 and 12-hydroxyeicosatetraenoic acid and its prevention by prostaglandin E2. J Invest Dermatol, 88(2), 120-123.

Smolle, J., Kaudewitz, P., Aberer, E., Torne, R., Burg, G., & Kerl, H. (1987). [Immunohistochemical classification of cutaneous lymphomas and pseudolymphomas]. Hautarzt, 38(8), 461-466.

Burg, G., Bieber, T., & Langecker, P. (1988). [Localized neutrophilic eccrine hydradenitis in mitoxantrone therapy: a typical side-effect of cytostatic drugs]. Hautarzt, 39(4), 233-236.

Burg, G., & Landthaler, M. (1988). [Proliferating tricholemmal tumor]. Hautarzt, 39(2), 117-119.

Burg, G., von der Helm, D., Kaudewitz, P., Klepzig, K., & Braun-Falco, O. (1988). Antihuman T-cell leukemia/lymphoma virus antibodies in three patients with primary cutaneous B-cell lymphoma. J Dermatol Surg Oncol, 14(6), 653-656.

Eckert, F., Burg, G., Braun-Falco, O., Schmid, U., & Gloor, F. (1988). Immunostaining in atypical fibroxanthoma of the skin. Pathol Res Pract, 184(1), 27-34. doi:10.1016/S0344-0338(88)80187-0

Eckert, F., Hein, R., Krieg, T., & Burg, G. (1988). [Local recurrent centroblastic lymphoma of the skin]. Hautarzt, 39(12), 791-794.

Enders, F., Przybilla, B., Ring, J., Burg, G., & Braun-Falco, O. (1988). [Epicutaneous testing with a standard series. Results in 12,026 patients]. Hautarzt, 39(12), 779-786.

Gollhausen, R., Enders, F., Przybilla, B., Burg, G., & Ring, J. (1988). Trends in allergic contact sensitization. Contact Dermatitis, 18(3), 147-154.

Kampgen, E., Burg, G., & Wank, R. (1988). Association of herpes simplex virus-induced erythema multiforme with the human leukocyte antigen DQw3. Arch Dermatol, 124(9), 1372-1375.

Schmoeckel, C., & Burg, G. (1988). Congenital spiradenoma. Am J Dermatopathol, 10(6), 541-545.

Schrallhammer, K., Burg, G., Stolz, W., & Braun-Falco, O. (1988). [Congenital poikiloderma with verrucous hyperkeratosis. An unusual form of Thomson's syndrome?]. Hautarzt, 39(3), 143-148.

von der Helm, D., von der Helm, K., Burg, G., Braun-Falco, O., & Deinhardt, F. (1988). [Antibodies against HTLV I in T-lymphoproliferative diseases of the skin]. Hautarzt, 39(6), 348-350.

Burg, G., & Bergner, T. (1989). Pigmentary disorders associated with nutritional deficiency states. Clin Dermatol, 7(2), 36-43.

Burg, G., Vieluf, D., Stolz, W., Landthaler, M., & Braun-Falco, O. (1989). [Malignant atrophic papulosis (Kohlmeier-Degos disease)]. Hautarzt, 40(8), 480-485.

Eckert, F., Schmid, U., Kaudewitz, P., Burg, G., & Braun-Falco, O. (1989). Follicular lymphoid hyperplasia of the skin with high content of Ki-1 positive lymphocytes. Am J Dermatopathol, 11(4), 345-352.

Hackel, H., Burg, G., Lechner, W., Stolz, W., Ring, J., & Braun-Falco, O. (1989). [Keratoacanthoma centrifugum marginatum]. Hautarzt, 40(12), 763-766.

Hartmann, A. A., & Burg, G. (1989). [Fulminant acne in Klinefelter syndrome treated with testosterone. A side effect of anti-tallness therapy]. Monatsschr Kinderheilkd, 137(8), 466-467.

Kaudewitz, P., Stein, H., Dallenbach, F., Eckert, F., Bieber, K., Burg, G., & Braun-Falco, O. (1989). Primary and secondary cutaneous Ki-1+ (CD30+) anaplastic large cell lymphomas. Morphologic, immunohistologic, and clinical-characteristics. Am J Pathol, 135(2), 359-367.

Kleber, R., Landthaler, M., & Burg, G. (1989). [Post-zoster granuloma anulare]. Hautarzt, 40(2), 110-111.

Pierard-Franchimont, C., Burg, G., Grosshans, E., Kerl, H., & Pierard, G. E. (1989). [Prevalence of skin cancers in the Mosane region and in European countries of the same latitude]. Rev Med Liege, 44(18), 541-545.

Stolz, W., Graubner, U., Gerstmeier, J., Burg, G., & Belohradsky, B. H. (1989). Chediak-Higashi syndrome: approaches in diagnosis and treatment. Curr Probl Dermatol, 18, 93-100.

Braun-Falco, O., Burg, G., & Vieluf, D. (1990). [History of the Munich Dermatology Society]. Hautarzt, 41(5), 290-294.

Burg, G., & Kaudewitz, P. (1990). Where are we today in the diagnosis of cutaneous lymphoma? Curr Probl Dermatol, 19, 90-104.

Burg, G., & Sobetzko, R. (1990). [Florid oral papillomatosis: an indication for etretinate?]. Hautarzt, 41(6), 314-316.

Cavey, D., Bouclier, M., Burg, G., Delamadeleine, F., & Hensby, C. N. (1990). The pharmacological modulation of delayed type hypersensitivity (DTH) reactions to topical oxazolone in mouse skin. Agents Actions, 29(1-2), 65-67.

Dummer, R., Welters, H., Keilholz, U., Tilgen, W., & Burg, G. (1990). [Interleukin 2: immunologic background and clinical use in tumor therapy]. Hautarzt, 41(2), 53-55.

Elsner, P., Hartmann, A. A., & Burg, G. (1990). [Experiences with oxytetracycline treatment of non-gonorrhea urethritis caused by Ureaplasma urealyticum]. Hautarzt, 41(2), 94-97.

Encke, A., Hermanek, P., & Burg, G. (1990). [News on TNM consultation activity of the German Language Committee]. Leber Magen Darm, 20(1), 47.

Hackel, H., Hartmann, A. A., Elsner, P., & Burg, G. (1990). Prevalence of Ureaplasma urealyticum in the urethra of men without urethritis in relation to clinical diagnosis. Dermatologica, 180(2), 76-78.

Hackel, H., Zillikens, D., Lechner, W., & Burg, G. (1990). [Unusual manifestation of scleroderma of the trunk]. Hautarzt, 41(2), 91-93.

Kaudewitz, P., Burg, G., & Stein, H. (1990). Ki-1 (CD30) positive cutaneous anaplastic large cell lymphomas. Curr Probl Dermatol, 19, 150-156.

Kaudewitz, P., Stein, H., Plewig, G., Schwarting, R., Gerdes, J., Burg, G., . . . Braun-Falco, O. (1990). Hodgkin's disease followed by lymphomatoid papulosis. Immunophenotypic evidence for a close relationship between lymphomatoid papulosis and Hodgkin's disease. J Am Acad Dermatol, 22(6 Pt 1), 999-1006.

Sepp, N., Schuler, G., Romani, N., Geissler, D., Gattringer, C., Burg, G., . . . Fritsch, P. (1990). "Intravascular lymphomatosis" (angioendotheliomatosis): evidence for a T-cell origin in two cases. Hum Pathol, 21(10), 1051-1058.

Stolz, W., Vogt, T., Braun-Falco, O., Abmayr, W., Eckert, F., Kaudewitz, P., . . . Burg, G. (1990). Differentiation between lymphomas and pseudolymphomas of the skin by computerized DNA-image cytometry. J Invest Dermatol, 94(2), 254-260.

Weiss, J., Garbe, C., Bertz, J., Biltz, H., Burg, G., Hennes, B., . . . et al. (1990). [Risk factors for the development of malignant melanoma in West Germany. Results of a multicenter-case control study]. Hautarzt, 41(6), 309-313.

Zillikens, D., Miller, K., Hartmann, A. A., & Burg, G. (1990). IgA pemphigus foliaceus: a case report. Dermatologica, 181(4), 304-307.

Bastian, B. C., & Burg, G. (1991). [Computer networks in clinical practice--a histology data bank system]. Hautarzt, 42(6), 376-379.

Bastian, B. C., Romisch, J., Paques, E. P., & Burg, G. (1991). [Lipocortins and phospholipases: new aspects in the physiology of glucocorticosteroid effect]. Hautarzt, 42(7), 417-423.

Becker, J. C., Dummer, R., Hartmann, A. A., Burg, G., & Schmidt, R. E. (1991). Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol, 147(12), 4398-4401.

Burg, G., Dummer, R., Wilhelm, M., Nestle, F., Ott, M. M., Feller, A., . . . Wiede, J. (1991). A subcutaneous delta-positive T-cell lymphoma that produces interferon gamma. N Engl J Med, 325(15), 1078-1081. doi:10.1056/NEJM199110103251506

Burg, G., & Kerl, H. (1991). Seminars in diagnostic pathology. Introduction. Semin Diagn Pathol, 8(2), 53-54.

Dummer, R., Muller, W., Nestle, F., Wiede, J., Dues, J., Lechner, W., . . . Burg, G. (1991). Formation of neutralizing antibodies against natural interferon-beta, but not against recombinant interferon-gamma during adjuvant therapy for high-risk malignant melanoma patients. Cancer, 67(9), 2300-2304.

Dummer, R., Schafer, E., Eilles, C., Borner, W., & Burg, G. (1991). Lymphokine-activated killer-cell traffic in metastatic melanoma. Lancet, 338(8764), 456-457.

Dunkel, F. G., Elsner, P., & Burg, G. (1991). Contact allergies to topical corticosteroids: 10 cases of contact dermatitis. Contact Dermatitis, 25(2), 97-103.

Goldstein, R. K., Bastian, B. C., Elsner, P., & Burg, G. (1991). Giant lichenification of the vulva with marked ulcerations. A case report. J Reprod Med, 36(4), 309-311.

Goldstein, R. K., Zillikens, D., Miller, K., Elsner, P., & Burg, G. (1991). [Local treatment of disseminated granuloma anulare with a vitamin E emulsion]. Hautarzt, 42(3), 176-178.

Hackel, H., Hartmann, A. A., & Burg, G. (1991). Vulvitis granulomatosa and anoperineitis granulomatosa. Dermatologica, 182(2), 128-131.

Hackel, H., Hartmann, A. A., Elsner, P., Martius, J., Engel, C., & Burg, G. (1991). [The value of Gardnerella-vaginalis-culture in bacterial-vaginitis- score-confirmed bacterial vaginosis]. Hautarzt, 42(3), 173-175.

Hackel, H., Miller, K., Elsner, P., & Burg, G. (1991). Unusual combined sensitization to palladium and other metals. Contact Dermatitis, 24(2), 131-132.

Kaudewitz, P., & Burg, G. (1991). Lymphomatoid papulosis and Ki-1 (CD30)-positive cutaneous large cell lymphomas. Semin Diagn Pathol, 8(2), 117-124.

Kerl, H., Cerroni, L., & Burg, G. (1991). The morphologic spectrum of T-cell lymphomas of the skin: a proposal for a new classification. Semin Diagn Pathol, 8(2), 55-61.

Ostmeier, H., Schumann, J., Otto, F., Krieg, V., Fuchs, B., Biess, B., . . . Suter, L. (1991). The relationship between characteristics of the tumor cells and sex of the patients in primary malignant melanomas. J Cancer Res Clin Oncol, 117(4), 364-366.

Schulz, A., Elsner, P., & Burg, G. (1991). Quantification of irritant contact dermatitis in vivo: comparison of the Dermatest system with the evaporimeter. Contact Dermatitis, 24(3), 235-237.

Vogt, T., Stolz, W., Braun-Falco, O., Kaudewitz, P., Eckert, F., Abmayr, W., . . . Burg, G. (1991). Prognostic significance of DNA cytometry in cutaneous malignant lymphomas. Cancer, 68(5), 1095-1100.

Zillikens, D., Bammel, A., Lurz, C., Elsner, P., & Burg, G. (1991). [Eosinophilia-myalgia syndrome after L-tryptophan intake]. Hautarzt, 42(3), 154-157.

Zillikens, D., Mehringer, A., Lechner, W., & Burg, G. (1991). Hypo- and hyperpigmented areas in incontinentia pigmenti. Light and electron microscopic studies. Am J Dermatopathol, 13(1), 57-62.

Ambach, A., Zillikens, D., Klingert, B., Hartmann, A. A., & Burg, G. (1992). [Immune phenotyping of mononuclear infiltrate in bullous pemphigoid]. Hautarzt, 43(2), 81-85.

Baumgartner, R., Trueb, R., Bruckner, L., Schmid, U., Speiser, P., & Burg, G. (1992). [Recurrent eyelid tumor in necrotizing panniculitis]. Klin Monbl Augenheilkd, 200(5), 529-531. doi:10.1055/s-2008-1045816

Becker, J. C., Dummer, R., Schmidt, R. E., Burg, G., & Hartmann, A. A. (1992). [Shedding of soluble intercellular adhesion molecule 1 (ICAM-1) from melanoma cells and the effect on cellular cytotoxicity]. Immun Infekt, 20(2), 62-63.

Becker, J. C., Dummer, R., Schwinn, A., Hartmann, A. A., & Burg, G. (1992). Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy. J Immunother (1991), 12(2), 147-150.

Becker, J. C., Dummer, R., Von Wussow, P., Burg, G., & Schmidt, R. E. (1992). Non-MHC-restricted T-cell interaction with B cells: role of the T-cell receptor. Scand J Immunol, 36(2), 177-181.

Boyera, N., Cavey, D., Bouclier, M., Burg, G., Rossio, P., & Hensby, C. (1992). Repeated application of dinitrochlorobenzene to the ears of sensitized guinea pigs: a preliminary characterization of a potential new animal model for contact eczema in humans. Skin Pharmacol, 5(3), 184-188.

Burg, G. (1992). [The First Bruno Bloch Memorial Lecture]. Hautarzt, 43(6), 390.

Burg, G. (1992). Disseminated granuloma anulare: therapy with vitamin E topically. Dermatology, 184(4), 308-309. doi:10.1159/000247580

Burg, G., & Dummer, R. (1992). [Current treatment methods in skin tumors]. Schweiz Rundsch Med Prax, 81(19), 610-614.

Burg, G., & Schmockel, C. (1992). Syringolymphoid hyperplasia with alopecia--a syringotropic cutaneous T-cell lymphoma? Dermatology, 184(4), 306-307. doi:10.1159/000247579

Cavegn, B., Puppin, D., Jr., & Burg, G. (1992). [Controversial aspects of stage I skin melanomas]. Schweiz Med Wochenschr, 122(49), 1883-1888.

Dummer, R., Becker, J. C., Boser, B., Hartmann, A. A., & Burg, G. (1992). Successful therapy of metastatic eccrine poroma using perilesional interferon alfa and interleukin 2. Arch Dermatol, 128(8), 1127-1128.

Dummer, R., Posseckert, G., Nestle, F., Witzgall, R., Burger, M., Becker, J. C., . . . Burg, G. (1992). Soluble interleukin-2 receptors inhibit interleukin 2-dependent proliferation and cytotoxicity: explanation for diminished natural killer cell activity in cutaneous T-cell lymphomas in vivo? J Invest Dermatol, 98(1), 50-54.

Dummer, R., Roger, J., Vogt, T., Becker, J., Hefner, H., Sindermann, H., & Burg, G. (1992). Topical application of hexadecylphosphocholine in patients with cutaneous lymphomas. Prog Exp Tumor Res, 34, 160-169.

Dunkel, F. G., & Burg, G. (1992). [The pathogenesis of psoriasis--new results]. Fortschr Med, 110(25), 457-460.

Elder, D. E., Freeman, R. G., Bergfeld, W. F., Ackerman, A. B., Azar, H. A., Fechner, R. E., . . . et al. (1992). Do you use the term "dysplasia"? If so, what do you mean by it, and if not, why not? Am J Dermatopathol, 14(5), 462-486.

Goldstein, R. K., Augustin, A., Milz, J., Burg, G., & Lutz, J. (1992). Influence of free radical scavengers on myeloperoxidase activity and lipid peroxidation in acute skin grafts. Adv Exp Med Biol, 316, 253-258.

Haffner, A. C., Garbe, C., Burg, G., Buttner, P., Orfanos, C. E., & Rassner, G. (1992). The prognosis of primary and metastasising melanoma. An evaluation of the TNM classification in 2,495 patients. Br J Cancer, 66(5), 856-861.

Hafner, J., Enderlin, A., Seger, R. A., Wuthrich, B., Bruckner-Tudermann, L., Panizzoni, P., & Burg, G. (1992). Discoid lupus erythematosus-like lesions in carriers of X-linked chronic granulomatous disease. Br J Dermatol, 127(4), 446-447.

Hermanek, P., Encke, A., & Burg, G. (1992). [Histologic study of lymph nodes in tumor resections--results of a survey of the German TNM Committee]. Chirurg, 63(6), Suppl 93-97.

Trueb, R., & Burg, G. (1992). [Drug reaction to amoxicillin simulating toxic pustular dermatosis]. Hautarzt, 43(9), 595-596.

Trueb, R. M., & Burg, G. (1992). [Loose anagen hair]. Hautarzt, 43(8), 505-508.

Wilhelm, M., Meyer, P., Batram, C., Tony, H. P., Dummer, R., Nestle, F., . . . Wilms, K. (1992). Gamma/delta receptor-expressing T-cell clones from a cutaneous T-cell lymphoma suppress hematopoiesis. Ann Hematol, 65(3), 111-115.

Zillikens, D., Ambach, A., Schuessler, M., Dummer, R., Hartmann, A. A., & Burg, G. (1992). The interleukin-2 receptor in lesions and serum of bullous pemphigoid. Arch Dermatol Res, 284(3), 141-145.

Zillikens, D., Blum, C., Dummer, R., Hartmann, A. A., & Burg, G. (1992). Serum levels of soluble interleukin-2 receptor in systemic and circumscribed scleroderma. Dermatology, 184(3), 233-234. doi:10.1159/000247555

Zillikens, D., Mehringer, A., Lechner, W., & Burg, G. (1992). Hypo- and hyperpigmented areas in incontinentia pigmenti. Reply by Zillikens et al. Am J Dermatopathol, 14(3), 288-289.

Ballmer-Weber, B. K., Widmer, M., & Burg, G. (1993). [Acetylsalicylic acid-induced generalized pustulosis]. Schweiz Med Wochenschr, 123(12), 542-546.

Becker, J. C., Schwinn, A., Dummer, R., Burg, G., & Brocker, E. B. (1993). Lesion-specific activation of cloned human tumor-infiltrating lymphocytes by autologous tumor cells: induction of proliferation and cytokine production. J Invest Dermatol, 101(1), 15-21.

Becker, J. C., Schwinn, A., Dummer, R., Burg, G., & Brocker, E. B. (1993). Tumour-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expression. Clin Exp Immunol, 91(1), 121-125.

Blum, C., Zillikens, D., Tony, H. P., Hartmann, A. A., & Burg, G. (1993). [Soluble interleukin 2 receptor as activity parameter in serum of systemic and discoid lupus erythematosus]. Hautarzt, 44(5), 290-295.

Burg, G. (1993). Collision dermatosis: angiolymphoid hyperplasia with eosinophilia developing within a congenital port wine nevus. Dermatology, 187(4), 293-295. doi:10.1159/000247272

Burg, G., Dommann, S., & Dummer, R. (1993). [Malignant lymphoma of the skin]. Ther Umsch, 50(12), 828-834.

Burg, G., Dummer, R., Cavegn, B., & Panizzon, R. (1993). [Malignant melanoma of the skin]. Ther Umsch, 50(12), 822-827.

Dummer, R., Becker, J. C., Eilles, C., Schafer, E., Borner, W., & Burg, G. (1993). T cells migrate to tumour sites after extracorporeal interleukin 2 stimulation and reinfusion in a patient with metastatic melanoma. Br J Dermatol, 128(4), 399-403.

Dummer, R., Burg, G., Nestle, F., & Kohl, O. (1993). Soluble interleukin-2 receptors and cutaneous T-cell lymphoma. Cancer, 71(11), 3793-3795.

Dummer, R., Kohl, O., Gillessen, J., Kagi, M., & Burg, G. (1993). Peripheral blood mononuclear cells in patients with nonleukemic cutaneous T-cell lymphoma. Reduced proliferation and preferential secretion of a T helper-2-like cytokine pattern on stimulation. Arch Dermatol, 129(4), 433-436.

Dummer, R., Krasovec, M., Roger, J., Sindermann, H., & Burg, G. (1993). Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: results of a phase I/II study. J Am Acad Dermatol, 29(6), 963-970.

Dummer, R., Meyer, J. C., Ballmer-Weber, B. K., Muletta, S., Panizzon, R., & Burg, G. (1993). UVA suppresses shedding of ICAM-1 from interferon-gamma (IFN-gamma)-pretreated transformed keratinocytes. Arch Dermatol Res, 285(4), 230-232.

Elsner, P., & Burg, G. (1993). Irritant reactivity is a better risk marker for nickel sensitization than atopy. Acta Derm Venereol, 73(3), 214-216.

Encke, A., Hermanek, P., & Burg, G. (1993). [Report of the German-Speaking TNM Committee]. Zentralbl Chir, 118(5), 310.

Hafner, J., Panizzon, R., Bruckner-Tuderman, L., Wuthrich, B., Seger, R. A., & Burg, G. (1993). [Lupus erythematosus discoid-like dermatosis in a carrier of septic granulomatosis]. Hautarzt, 44(7), 452-456.

Krasovec, M., Elsner, P., & Burg, G. (1993). Generalized eczematous skin rash possibly due to HMG-CoA reductase inhibitors. Dermatology, 186(4), 248-252. doi:10.1159/000247363

Krasovec, M., Widmer, M., Gilliet, F., & Burg, G. (1993). [A case from practice (275). Lupus vulgaris with scar-forming alopecia in florid pulmonary tuberculosis]. Schweiz Rundsch Med Prax, 82(33), 893-895.

Trueb, R. M., Bruckner-Tuderman, L., & Burg, G. (1993). Ectrodactyly-ectodermal dysplasia-clefting syndrome with scalp dermatitis. J Am Acad Dermatol, 29(3), 505-506.

Trueb, R. M., & Burg, G. (1993). [Unilateral "nevoid" spider nevi]. Vasa, 22(1), 82-85.

Trueb, R. M., & Burg, G. (1993). Acute generalized exanthematous pustulosis due to doxycycline. Dermatology, 186(1), 75-78. doi:10.1159/000247308

Trueb, R. M., & Burg, G. (1993). Idiopathic middermal elastolysis. Dermatology, 187(1), 62-66. doi:10.1159/000247201

Trueb, R. M., Elsner, P., & Burg, G. (1993). [Pseudomonas aeruginosa folliculitis after epilation]. Hautarzt, 44(2), 103-105.

Trueb, R. M., Panizzon, R. G., & Burg, G. (1993). Cutaneous ossification in Albright's hereditary osteodystrophy. Dermatology, 186(3), 205-209. doi:10.1159/000247347

Widmer, M., Reverdin, E., Kung, E., Vesti, B., Bollinger, A., Linke, R. P., & Burg, G. (1993). [Amyloidosis cutis nodularis atrophicans (Gottron)]. Hautarzt, 44(5), 319-323.

Wyss, M., Elsner, P., Wuthrich, B., & Burg, G. (1993). Allergic contact dermatitis from natural latex without contact urticaria. Contact Dermatitis, 28(3), 154-156.

Zillikens, D., Ambach, A., Zentner, A., Dummer, R., Schussler, M., Burg, G., & Brocker, E. B. (1993). Evidence for cell-mediated immune mechanisms in the pathology of pemphigus. Br J Dermatol, 128(6), 636-643.

Zillikens, D., Zentner, A., Burger, M., Hartmann, A. A., & Burg, G. (1993). [Pemphigus foliaceus caused by penicillamine]. Hautarzt, 44(3), 167-171.

Burg, G., Dummer, R., & Kerl, H. (1994). Classification of cutaneous lymphomas. Dermatol Clin, 12(2), 213-217.

Burg, G., Dummer, R., & Nestle, F. (1994). Distinct subtypes of subcutaneous T-cell lymphoma. Arch Dermatol, 130(8), 1073.

Burg, G., Schmid, M. H., Kung, E., Dommann, S., & Dummer, R. (1994). Semimalignant ("pseudolymphomatous") cutaneous B-cell lymphomas. Dermatol Clin, 12(2), 399-407.

Burg, G., Wursch, T., Fah, J., & Elsner, P. (1994). Eruptive hamartomatous clear-cell acanthomas. Dermatology, 189(4), 437-439. doi:10.1159/000246904

Burg, G., Zwingers, T., Staegemeir, E., & Santucci, M. (1994). Interrater and intrarater variabilities in the evaluation of cutaneous lymphoproliferative T-cell infiltrates. EORTC-Cutaneous Lymphoma Project Group. Dermatol Clin, 12(2), 311-314.

Dommann, S. N., Widmer, M., Dommann-Scherrer, C., Bernasconi, E., & Burg, G. (1994). [Actinobacillus actinomycetemcomitans isolated from a mycetoma (of the forearm)]. Hautarzt, 45(6), 402-405.

Dummer, R., Sigg-Zemann, S., Kalthof, K., Muletta, S., Meyer, J. C., & Burg, G. (1994). Various cytokines modulate ICAM-1 shedding on melanoma- and CTCL-derived cell lines: inverse regulation of ICAM-1 shedding in a Sezary cell line by interferon-gamma. Dermatology, 189(2), 120-124. doi:10.1159/000246813

Jorg, B., Kerl, H., Thiers, B. H., Brocker, E. B., & Burg, G. (1994). Therapeutic approaches in cutaneous lymphoma. Dermatol Clin, 12(2), 433-441.

Lubbe, J., Kleihues, P., & Burg, G. (1994). [The tumor suppressor gene p53 and its significance for dermatology]. Hautarzt, 45(11), 741-745.

Lubbe, J., Reichel, M., Burg, G., & Kleihues, P. (1994). Absence of p53 gene mutations in cutaneous melanoma. J Invest Dermatol, 102(5), 819-821.

Santucci, M., Burg, G., & Feller, A. C. (1994). Interrater and intrarater reliability of histologic criteria in early cutaneous T-cell lymphoma. An EORTC Cutaneous Lymphoma Project Group study. Dermatol Clin, 12(2), 323-327.

Schneider-Yin, X., Schafer, B. W., Mohr, P., Burg, G., & Minder, E. I. (1994). Molecular defects in erythropoietic protoporphyria with terminal liver failure. Hum Genet, 93(6), 711-713.

Schultz, E. S., Dummer, R., Becker, J. C., Zillikens, D., & Burg, G. (1994). Influence of various cytokines on the interleukin-2-dependent lysis of melanoma cells in vitro. Arch Dermatol Res, 286(2), 73-76.

Trueb, R., Burg, G., Bottani, A., & Schinzel, A. (1994). Ectodermal dysplasia with corkscrew hairs: observation of probable autosomal dominant tricho-odonto-onychodysplasia with syndactyly. J Am Acad Dermatol, 30(2 Pt 1), 289-290.

Trueb, R. M., Spycher, M. A., Schumacher, F., & Burg, G. (1994). [Pili torti et canaliculi in ectodermal dysplasia]. Hautarzt, 45(6), 372-377.

Widmer, J., Elsner, P., & Burg, G. (1994). Skin irritant reactivity following experimental cumulative irritant contact dermatitis. Contact Dermatitis, 30(1), 35-39.

Adams, V., Kempf, W., Schmid, M., Muller, B., Briner, J., & Burg, G. (1995). Absence of herpesvirus-like DNA sequences in skin cancers of non-immunosuppressed patients. Lancet, 346(8991-8992), 1715-1716.

Boni, R., Dummer, R., & Burg, G. (1995). [Are skin tumors on the increase?]. Schweiz Med Wochenschr, 125(35), 1619-1624.

Boni, R., Dummer, R., Dommann-Scherrer, C., Dommann, S., Zimmermann, D. R., Joller-Jemelka, H., & Burg, G. (1995). Necrotizing herpes zoster mimicking relapse of vasculitis in angioimmunoblastic lymphadenopathy with dysproteinaemia. Br J Dermatol, 133(6), 978-982.

Burg, G. (1995). Report from the president (V) 1992-1994. Am J Dermatopathol, 17(5), 534-537.

Burg, G., Dummer, R., Dommann, S., Nestle, F., & Nickoloff, B. (1995). Pathology of cutaneous T-cell lymphoma. Hematol Oncol Clin North Am, 9(5), 961-995.

Buttner, P., Garbe, C., Bertz, J., Burg, G., d'Hoedt, B., Drepper, H., . . . et al. (1995). Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification. Cancer, 75(10), 2499-2506.

Dommann, S. N., Dommann-Scherrer, C. C., Zimmerman, D., Dours-Zimmermann, M. T., Hassam, S., & Burg, G. (1995). Primary cutaneous T-cell-rich B-cell lymphoma. A case report with a 13-year follow-up. Am J Dermatopathol, 17(6), 618-624.

Dommann, S. N., Ziegler, T., Dommann-Schener, C. C., Meyer, J., Panizzon, R., & Burg, G. (1995). CD44v6 is a marker for systemic spread in cutaneous T-cell lymphomas. A comparative study between nodal and cutaneous lymphomas. J Cutan Pathol, 22(5), 407-412.

Dummer, R., Davis-Daneshfar, A., Dohring, C., Dobbeling, U., & Burg, G. (1995). [Strategies for gene therapy of melanoma]. Hautarzt, 46(5), 305-308.

Garbe, C., Buttner, P., Bertz, J., Burg, G., d'Hoedt, B., Drepper, H., . . . et al. (1995). Primary cutaneous melanoma. Prognostic classification of anatomic location. Cancer, 75(10), 2492-2498.

Garbe, C., Buttner, P., Bertz, J., Burg, G., d'Hoedt, B., Drepper, H., . . . et al. (1995). Primary cutaneous melanoma. Identification of prognostic groups and estimation of individual prognosis for 5093 patients. Cancer, 75(10), 2484-2491.

Hafner, J., Haenseler, E., Ossent, P., Burg, G., & Panizzon, R. G. (1995). Benzidine stain for the histochemical detection of hemoglobin in splinter hemorrhage (subungual hematoma) and black heel. Am J Dermatopathol, 17(4), 362-367.

Hinnen, U., Elsner, P., & Burg, G. (1995). Assessment of skin irritancy by 2 short tests compared to acute irritation induced by sodium lauryl sulfate. Contact Dermatitis, 33(4), 236-239.

Krasovec, M., Elsner, P., & Burg, G. (1995). [Cowden's syndrome]. Hautarzt, 46(7), 472-476.

Lubbe, J., Schlupen, E. M., Fierz, W., Panizzon, R. G., & Burg, G. (1995). Identification of Borrelia afzelii in a juxta-articular fibroid nodule from a human immunodeficiency virus-positive patient with acrodermatitis chronica atrophicans. Arch Dermatol, 131(11), 1341-1342.

Steinert, H. C., Huch Boni, R. A., Buck, A., Boni, R., Berthold, T., Marincek, B., . . . von Schulthess, G. K. (1995). Malignant melanoma: staging with whole-body positron emission tomography and 2-[F-18]-fluoro-2-deoxy-D-glucose. Radiology, 195(3), 705-709. doi:10.1148/radiology.195.3.7753998

Trueb, R. M., Becker-Wegerich, P., Hafner, J., Wuthrich, B., & Burg, G. (1995). Relapsing eosinophilic perimyositis. Br J Dermatol, 133(1), 109-114.

Trueb, R. M., Borelli, S., Schmid-Grendelmeier, P., Panizzon, R. G., & Burg, G. (1995). [Overlap of Sjogren-lupus erythematosus syndrome]. Hautarzt, 46(7), 467-471.

Trueb, R. M., Hurlimann, A. F., & Burg, G. (1995). [Periarteritis nodosa cutanea. 20 years follow-up with leg pain, Raynaud syndrome and nail changes]. Hautarzt, 46(8), 568-572.

Allmann, K. H., Leu, H., Burg, G., & Hodler, J. (1996). Hereditary sensory and autonomic neuropathy type I (Thevenard's disease). Skeletal Radiol, 25(5), 501-504.

Boni, R., Davis-Daneshfar, A., Burg, G., Fuchs, D., & Wood, G. S. (1996). No detection of HTLV-I proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T-cell lymphoma. Br J Dermatol, 134(2), 282-284.

Boni, R., Doguoglu, A., Burg, G., Muller, B., & Dummer, R. (1996). MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma. J Am Acad Dermatol, 35(3 Pt 1), 416-418.

Boni, R., Huch-Boni, R. A., Steinert, H., von Schulthess, G. K., & Burg, G. (1996). Early detection of melanoma metastasis using fludeoxyglucose F 18 positron emission tomography. Arch Dermatol, 132(8), 875-876.

Boni, R., Steinert, H., Boni, R. A., Lichtensteiger, W., Dummer, R., Hartman, D. S., . . . Westera, G. (1996). Lack of expression of dopamine D2 receptors in malignant melanoma: evidence for interaction of iodobenzofurans with melanin. Dermatology, 193(3), 198-202. doi:10.1159/000246245

Burg, G., Dummer, R., Nestle, F. O., Doebbeling, U., & Haeffner, A. (1996). Cutaneous lymphomas consist of a spectrum of nosologically different entities including mycosis fungoides and small plaque parapsoriasis. Arch Dermatol, 132(5), 567-572.

Dommann, S. N., Dommann-Scherrer, C. C., Dours-Zimmermann, M. T., Zimmermann, D. R., Kural-Serbes, B., & Burg, G. (1996). Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas. Arch Dermatol Res, 288(4), 163-167.

Dummer, R., Heald, P. W., Nestle, F. O., Ludwig, E., Laine, E., Hemmi, S., & Burg, G. (1996). Sezary syndrome T-cell clones display T-helper 2 cytokines and express the accessory factor-1 (interferon-gamma receptor beta-chain). Blood, 88(4), 1383-1389.

Dummer, R., Nestle, F. O., & Burg, G. (1996). [Modern tumor therapy as seen in melanoma]. Praxis (Bern 1994), 85(50), 1609-1614.

Dummer, R., Posseckert, G., Sugamura, K., Grundmann, H., & Burg, G. (1996). Circulating interleukin-2 receptors are a group of multimeric proteins with immunoreactivity for interleukin-2 receptor alpha, beta, and gamma chains. J Interferon Cytokine Res, 16(4), 315-320. doi:10.1089/jir.1996.16.315

Dummer, R., Potoczna, N., Haffner, A. C., Zimmermann, D. R., Gilardi, S., & Burg, G. (1996). A primary cutaneous non-T, non-B CD4+, CD56+ lymphoma. Arch Dermatol, 132(5), 550-553.

Haffner, A. C., Zepter, K., Elsner, P., & Burg, G. (1996). Isolated delayed-type hypersensitivity to latex rubber. Contact Dermatitis, 35(4), 247-248.

Hafner, J., Bounameaux, H., Burg, G., & Brunner, U. (1996). Management of venous leg ulcers. Vasa, 25(2), 161-167.

Hafner, J., Brunner, U., & Burg, G. (1996). [Treatment guidelines for venous leg ulcers: causal therapy initiation and local wound treatment]. Ther Umsch, 53(4), 304-308.

Hurlimann, A. F., Panizzon, R. G., & Burg, G. (1996). Eruptive vellus hair cyst and steatocystoma multiplex: hybrid cysts. Dermatology, 192(1), 64-66. doi:10.1159/000246319

Kagi, M. K., Trueb, R., Wuthrich, B., & Burg, G. (1996). Confluent and reticulated papillomatosis associated with atopy. Successful treatment with topical urea and tretinoin. Br J Dermatol, 134(2), 381-382.

Kleinhans, M., Schmid-Grendelmeier, P., & Burg, G. (1996). [Levodopa and malignant melanoma--case report and review of the literature. A contribution to causal relationship between levodopa and the development of malignant melanoma]. Hautarzt, 47(6), 432-437.

Lubbe, J., Kormann, A., Adams, V., Hassam, S., Gratz, K. W., Panizzon, R. G., & Burg, G. (1996). HPV-11- and HPV-16-associated oral verrucous carcinoma. Dermatology, 192(3), 217-221. doi:10.1159/000246369

Potoczna, N., Boehncke, W. H., Nestle, F. O., Kuenzlen, C., Sterry, W., Burg, G., & Dummer, R. (1996). T-cell receptor beta variable region (V beta) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin. J Cutan Pathol, 23(4), 298-305.

Rajan, G. P., Seifert, B., Prummer, O., Joller-Jemelka, H. I., Burg, G., & Dummer, R. (1996). Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA. Arch Dermatol Res, 288(9), 543-548.

Wood, G. S., Hardman, D. L., Boni, R., Dummer, R., Kim, Y. H., Smoller, B. R., . . . Burg, G. (1996). Lack of the t(2;5) or other mutations resulting in expression of anaplastic lymphoma kinase catalytic domain in CD30+ primary cutaneous lymphoproliferative disorders and Hodgkin's disease. Blood, 88(5), 1765-1770.

Boni, R., Burg, G., Doguoglu, A., Ilg, E. C., Schafer, B. W., Muller, B., & Heizmann, C. W. (1997). Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions. Br J Dermatol, 137(1), 39-43.

Boni, R., Lichtensteiger, W., Steinert, H. C., Boni, R. A., Fruh, H., Dummer, R., . . . Burg, G. (1997). D1 dopamine receptors are not expressed in human melanoma. Melanoma Res, 7(2), 117-119.

Boni, R., Steinert, H., Huch Boni, R., Von Schulthess, G. K., Meyer, J., Dummer, R., . . . Westera, G. (1997). Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and results in patients. Br J Dermatol, 137(1), 96-100.

Camacho, F. M., Burg, G., Moreno, J. C., Campora, R. G., & Villar, J. L. (1997). Granulomatous slack skin in childhood. Pediatr Dermatol, 14(3), 204-208.

Davis-Daneshfar, A., Boni, R., von Wussow, P., Joller, H., Burg, G., & Dummer, R. (1997). Adjuvant immunotherapy in malignant melanoma: impact of antibody formation against interferon-alpha on immunoparameters in vivo. J Immunother, 20(3), 208-213.

Dobbeling, U., Dummer, R., Hess Schmid, M., & Burg, G. (1997). Lack of expression of the recombination activating genes RAG-1 and RAG-2 in cutaneous T-cell lymphoma: pathogenic implications. Clin Exp Dermatol, 22(5), 230-233.

Dommann, S. N., Dommann-Scherrer, C. C., Ziegler, T., Meyer, J., Trueb, R. M., Kundig, T., . . . Burg, G. (1997). Expression of intercellular adhesion molecule 3 (CDw50) on endothelial cells in cutaneous lymphomas. A comparative study between nodal and cutaneous lymphomas. Am J Dermatopathol, 19(4), 391-395.

Hinnen, U., Elsner, P., Barraud, M., & Burg, G. (1997). Foreign body granuloma of the penis caused by occupational glass fibre exposure. Genitourin Med, 73(6), 577-578.

Lubbe, J., Nakazawa, H., & Burg, G. (1997). [Telomerase]. Hautarzt, 48(9), 615-621.

Mandt, N., Krasovec, M., Ellgehausen, P., & Burg, G. (1997). [Cutaneous artefacts]. Schweiz Med Wochenschr, 127(38), 1579.

Meyer, J. C., Hassam, S., Dummer, R., Muletta, S., Dobbeling, U., Dommann, S. N., & Burg, G. (1997). A realistic approach to the sensitivity of PCR-DGGE and its application as a sensitive tool for the detection of clonality in cutaneous T-cell proliferations. Exp Dermatol, 6(3), 122-127.

Nestle, F. O., Haffner, A. C., Schmid, M. H., Dummer, R., & Burg, G. (1997). [Current therapy concepts in cutaneous T-cell lymphomas]. Schweiz Med Wochenschr, 127(8), 311-320.

Seelentag, W. K., Boni, R., Gunthert, U., Futo, E., Burg, G., Heitz, P. U., & Roth, J. (1997). Expression of CD44 isoforms and beta 1,6-branched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with metastatic potential. J Cutan Pathol, 24(4), 206-211.

Trueb, R. M., Pericin, M., Hafner, J., & Burg, G. (1997). [Tufted hair folliculitis]. Hautarzt, 48(4), 266-269.

Trueb, R. M., Pericin, M., Kohler, E., Barandun, J., & Burg, G. (1997). Necrotizing granulomatosis of the breast. Br J Dermatol, 137(5), 799-803.

Trueb, R. M., Pericin, M., Winzeler, B., Wuthrich, B., & Burg, G. (1997). Eosinophilic myositis/perimyositis: frequency and spectrum of cutaneous manifestations. J Am Acad Dermatol, 37(3 Pt 1), 385-391.

van Vliet, J. J., Vaessen, H. A., van den Burg, G., & Schothorst, R. C. (1997). Twenty-four-hour duplicate diet study 1994; nitrate and nitrite: method development and intake per person per day. Cancer Lett, 114(1-2), 305-307.

Waldmann, V., Kempf, W., Burg, G., & Dummer, R. (1997). [Kaposi sarcoma in cyclosporin A therapy of actinic reticuloid]. Hautarzt, 48(4), 262-265.

Wimmer, I., Meyer, J. C., Seifert, B., Dummer, R., Flace, A., & Burg, G. (1997). Prognostic value of serum 5-S-cysteinyldopa for monitoring human metastatic melanoma during immunochemotherapy. Cancer Res, 57(22), 5073-5076.

Yue, F. Y., Dummer, R., Geertsen, R., Hofbauer, G., Laine, E., Manolio, S., & Burg, G. (1997). Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class-II and ICAM-1 molecules. Int J Cancer, 71(4), 630-637.

Boni, R., Bantschapp, O., Muller, B., & Burg, G. (1998). c-myc is not useful as prognostic immunohistochemical marker in cutaneous melanoma. Dermatology, 196(3), 288-291. doi:10.1159/000017922

Boni, R., Matt, D., Burg, G., Tronnier, M., Vortmeyer, A., & Zhuang, Z. (1998). Ultraviolet-induced acute histological changes in irradiated nevi are not associated with allelic loss. Arch Dermatol, 134(7), 853-856.

Boni, R., Matt, D., Voetmeyer, A., Burg, G., & Zhuang, Z. (1998). Chromosomal allele loss in primary cutaneous melanoma is heterogeneous and correlates with proliferation. J Invest Dermatol, 110(3), 215-217. doi:10.1046/j.1523-1747.1998.00109.x

Boni, R., Vortmeyer, A. O., Burg, G., Hofbauer, G., & Zhuang, Z. (1998). The PTEN tumour suppressor gene and malignant melanoma. Melanoma Res, 8(4), 300-302.

Boni, R., Vortmeyer, A. O., Pack, S., Park, W. S., Burg, G., Hofbauer, G., . . . Zhuang, Z. (1998). Somatic mutations of the MEN1 tumor suppressor gene detected in sporadic angiofibromas. J Invest Dermatol, 111(3), 539-540. doi:10.1046/j.1523-1747.1998.00317.x

Boni, R., Vortmeyer, A. O., Stern, J. B., Burg, G., Hofbauer, G., & Zhuang, Z. (1998). Concordance of genetic changes in basal cell carcinoma and associated clusters of squamous cells. J Invest Dermatol, 111(1), 173-174. doi:10.1046/j.1523-1747.1998.00247.x

Burg, G. (1998). [Dermatology 1997: immune intervention making progress]. Schweiz Med Wochenschr, 128(1-2), 18-20.

Burg, G., Kempf, W., Hochli, M., Huwyler, T., & Panizzon, R. G. (1998). 'Tubular' epithelioid cell nevus: a new variant of Spitz's nevus. J Cutan Pathol, 25(9), 475-478.

Dobbeling, U., Dummer, R., Laine, E., Potoczna, N., Qin, J. Z., & Burg, G. (1998). Interleukin-15 is an autocrine/paracrine viability factor for cutaneous T-cell lymphoma cells. Blood, 92(1), 252-258.

Dummer, R., Geertsen, R., Ludwig, E., Niederer, E., & Burg, G. (1998). Sezary syndrome, T-helper 2 cytokines and accessory factor-1 (AF-1). Leuk Lymphoma, 28(5-6), 515-522. doi:10.3109/10428199809058359

Dummer, R., Graf, P., Greif, C., & Burg, G. (1998). Treatment of vascular lesions using the VersaPulse variable pulse width frequency doubled neodymium:YAG laser. Dermatology, 197(2), 158-161. doi:10.1159/000017989

Dummer, R., Hauschild, A., Henseler, T., & Burg, G. (1998). Combined interferon-alpha and interleukin-2 as adjuvant treatment for melanoma. Lancet, 352(9131), 908-909.

Dummer, R., Kempf, W., & Burg, G. (1998). Pseudo-melanoma after laser therapy. Dermatology, 197(1), 71-73. doi:10.1159/000017962

Dummer, R., Nestle, F. O., Hofbauer, G., Boni, R., & Burg, G. (1998). [Therapy of cutaneous melanoma]. Ther Umsch, 55(8), 509-514.

Dummer, R., Yue, F. Y., Pavlovic, J., Geertsen, R., Dohring, C., Moelling, K., & Burg, G. (1998). Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppression by interleukin 10. Br J Cancer, 77(9), 1413-1419.

Ellgehausen, P., Elsner, P., & Burg, G. (1998). Drug-induced lichen planus. Clin Dermatol, 16(3), 325-332.

Geertsen, R. C., Hofbauer, G. F., Yue, F. Y., Manolio, S., Burg, G., & Dummer, R. (1998). Higher frequency of selective losses of HLA-A and -B allospecificities in metastasis than in primary melanoma lesions. J Invest Dermatol, 111(3), 497-502. doi:10.1046/j.1523-1747.1998.00305.x

Grob, M., Wyss, M., Spycher, M. A., Dommann, S., Schinzel, A., Burg, G., & Trueb, R. M. (1998). Histopathologic and ultrastructural study of lupus-like skin lesions in a patient with Bloom syndrome. J Cutan Pathol, 25(5), 275-278.

Hafner, J., Keusch, G., Wahl, C., & Burg, G. (1998). Calciphylaxis: a syndrome of skin necrosis and acral gangrene in chronic renal failure. Vasa, 27(3), 137-143.

Hofbauer, G. F., Dummer, R., Laine, E., & Burg, G. (1998). Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA. Arch Dermatol Res, 290(8), 458-461.

Kamarashev, J., Burg, G., Kempf, W., Hess Schmid, M., & Dummer, R. (1998). Comparative analysis of histological and immunohistological features in mycosis fungoides and Sezary syndrome. J Cutan Pathol, 25(8), 407-412.

Kempf, W., Dummer, R., Schmid, M. H., Fritz, T., Wuthrich, B., & Burg, G. (1998). Intralesional cisplatin for the treatment of cutaneous B-cell lymphoma. Arch Dermatol, 134(11), 1343-1345.

Kempf, W., Haeffner, A. C., Mueller, B., Panizzon, R. G., & Burg, G. (1998). Experts and gold standards in dermatopathology: qualitative and quantitative analysis of the self-assessment slide seminar at the 17th colloquium of the International Society of Dermatopathology. Am J Dermatopathol, 20(5), 478-482.

Kerl, H., Burg, G., Sterry, W., & Wolff, H. H. (1998). [Problems, responsibility and goals in dermatopathology]. Hautarzt, 49(7), 533-535.

Kleeman, D., Kempf, W., Burg, G., & Hafner, J. (1998). Cutaneous polyarteritis nodosa. Vasa, 27(1), 54-57.

Nestle, F. O., Alijagic, S., Gilliet, M., Sun, Y., Grabbe, S., Dummer, R., . . . Schadendorf, D. (1998). Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells. Nat Med, 4(3), 328-332.

Nestle, F. O., & Burg, G. (1998). [Persistent facial swelling of uncertain origin]. Schweiz Med Wochenschr, 128(51-52), 2056.

Nestle, F. O., Filgueira, L., Nickoloff, B. J., & Burg, G. (1998). Human dermal dendritic cells process and present soluble protein antigens. J Invest Dermatol, 110(5), 762-766. doi:10.1046/j.1523-1747.1998.00189.x

Villeneuve, P., Hafner, J., Prenosil, J. E., Elsner, P., & Burg, G. (1998). A novel culturing and grafting system for the treatment of leg ulcers. Br J Dermatol, 138(5), 849-851.

Boni, R., & Burg, G. (1999). [The atypical nevus: a risk situation?]. Schweiz Med Wochenschr, 129(22), 825-832.

Boni, R., Vortmeyer, A. O., Huang, S., Burg, G., Hofbauer, G., & Zhuang, Z. (1999). Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma. Melanoma Res, 9(3), 249-252.

Burg, G. (1999). [Malignant melanoma]. Ther Umsch, 56(6), 285.

Dummer, R., Nestle, F. O., Hofbauer, G., & Burg, G. (1999). [Systemic therapy of metastatic melanoma]. Ther Umsch, 56(6), 330-333. doi:10.1024/0040-5930.56.6.330

Dummer, R., Nestle, F. O., Niederer, E., Ludwig, E., Laine, E., Grundmann, H., . . . Burg, G. (1999). Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD7- T lymphocyte subsets in Sezary syndrome. Arch Dermatol Res, 291(6), 307-311.

Fritz, T. M., Burg, G., & Hafner, J. (1999). Eyebrow reconstruction with free skin and hair-bearing composite graft. J Am Acad Dermatol, 41(6), 1008-1010.

Fuchs, D., Querings, K., Burg, G., & Boni, R. (1999). [Persistent erythema after total CO2 skin resurfacing]. Schweiz Med Wochenschr, 129(21), 813-817.

Geertsen, R., Zenklusen, R., Kamarashev, J., Burg, G., & Dummer, R. (1999). Inverse regulation of neuronal cellular adhesion molecule (NCAM) by IFN-gamma in melanoma cell cultures established from CNS lesions. Int J Cancer, 83(1), 135-140.

Haffner, A. C., Zepter, K., Fritz, T., Dummer, R., Lejeune, F. J., & Burg, G. (1999). Complete remission of advanced cutaneous leiomyosarcoma following isolated limb perfusion with high-dose tumour necrosis factor-alpha and melphalan. Br J Dermatol, 141(5), 935-936.

Hafner, J., & Burg, G. (1999). [Dermatological aspects in prevention and treatment of the diabetic foot syndrome]. Praxis (Bern 1994), 88(27-28), 1170-1177.

Hess Schmid, M., Dummer, R., Kempf, W., Hilty, N., & Burg, G. (1999). Mycosis fungoides with mucinosis follicularis in childhood. Dermatology, 198(3), 284-287. doi:10.1159/000018131

Kempf, W., Adams, V., Kleinhans, M., Burg, G., Panizzon, R. G., Campadelli-Fiume, G., & Nestle, F. O. (1999). Pityriasis rosea is not associated with human herpesvirus 7. Arch Dermatol, 135(9), 1070-1072.

Krasovec, M., & Burg, G. (1999). Nodular fasciitis (pseudotumor of the skin). Dermatology, 198(4), 431-433.

Nestle, F. O., Hofbauer, G., & Burg, G. (1999). Necrobiotic xanthogranuloma with monoclonal gammopathy of the IgG lambda type. Dermatology, 198(4), 434-435.

Nestle, F. O., Tun Kyi, A., Gilliet, M., Dummer, R., & Burg, G. (1999). [Vaccination therapy of malignant melanoma]. Ther Umsch, 56(6), 334-337. doi:10.1024/0040-5930.56.6.334

Rogalski, C., Dummer, R., & Burg, G. (1999). Immunomodulators in the treatment of cutaneous lymphoma. J Eur Acad Dermatol Venereol, 13(2), 83-90.

Schmid, M. H., Bird, P., Dummer, R., Kempf, W., & Burg, G. (1999). Tumor burden index as a prognostic tool for cutaneous T-cell lymphoma: a new concept. Arch Dermatol, 135(10), 1204-1208.

Shephard, S. E., Zogg, M., Burg, G., & Panizzon, R. G. (1999). Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood. Arch Dermatol Res, 291(9), 491-499.

Trueb, R. M., Scheidegger, E. P., Pericin, M., Singh, A., Hoffmann, U., Sauvant, G., & Burg, G. (1999). Periarteritis nodosa presenting as a breast lesion: report of a case and review of the literature. Br J Dermatol, 141(6), 1117-1121.

Yue, F. Y., Geertsen, R., Hemmi, S., Burg, G., Pavlovic, J., Laine, E., & Dummer, R. (1999). IL-12 directly up-regulates the expression of HLA class I, HLA class II and ICAM-1 on human melanoma cells: a mechanism for its antitumor activity? Eur J Immunol, 29(6), 1762-1773. doi:10.1002/(SICI)1521-4141(199906)29:06<1762::AID-IMMU1762>3.0.CO;2-F

Bader, U., Banyai, M., Boni, R., Burg, G., & Hafner, J. (2000). Leg ulcers in patients with myeloproliferative disorders: disease- or treatment-related? Dermatology, 200(1), 45-48. doi:10.1159/000018315

Bernand, S., Scheidegger, E. P., Dummer, R., & Burg, G. (2000). Multifocal fixed drug eruption to paracetamol, tropisetron and ondansetron induced by interleukin 2. Dermatology, 201(2), 148-150. doi:10.1159/000018459

Boni, R., & Burg, G. (2000). [Aging skin: physiological bases, preventive measures and therapeutic modalities]. Schweiz Med Wochenschr, 130(36), 1272-1278.

Boni, R., Burg, G., & Wirth, H. P. (2000). [Helicobacter pylori and skin diseases--a (still) intact myth?]. Schweiz Med Wochenschr, 130(37), 1305-1308.

Boni, R., Kreyden, O. P., & Burg, G. (2000). Revival of the use of botulinum toxin: application in dermatology. Dermatology, 200(4), 287-291. doi:10.1159/000018389

Boni, R., Xin, H., Kamarashev, J., Utzinger, E., Dummer, R., Kempf, W., . . . Burg, G. (2000). Allelic deletion at 9p21-22 in primary cutaneous CD30(+) large cell lymphoma. J Invest Dermatol, 115(6), 1104-1107. doi:10.1038/jid.2000.4

Burg, G., & Dummer, R. (2000). Historical perspective on the use of retinoids in cutaneous T-cell lymphoma (CTCL). Clin Lymphoma, 1 Suppl 1, S41-44.

Carrozza, P., Hausermann, P., Nestle, F. O., Burg, G., & Boni, R. (2000). Clinical efficacy of narrow-band UVB (311 nm) combined with dithranol in psoriasis. An open pilot study. Dermatology, 200(1), 35-39. doi:10.1159/000018312

Dummer, R., Bergh, J., Karlsson, Y., Horowitz, J. A., Mulder, N. H., Huinink, D. T. B., . . . Osanto, S. (2000). Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors. Cancer Gene Ther, 7(7), 1069-1076. doi:10.1038/sj.cgt.7700214

Dummer, R., & Burg, G. (2000). What's new in the treatment of melanoma? J Eur Acad Dermatol Venereol, 14(5), 337-339.

Dummer, R., Heinzerling, L., Schmid, M. H., & Burg, G. (2000). [Immuno-intervention in cutaneous lymphomas]. Praxis (Bern 1994), 89(37), 1471-1476.

Dummer, R., Hess-Schmid, M., & Burg, G. (2000). Cutaneous T-cell lymphomas: prognosis and quality-of-life issues. Clin Lymphoma, 1 Suppl 1, S21-25.

Dummer, R., Nestle, F. O., & Burg, G. (2000). [Immunotherapy of melanoma]. Dtsch Med Wochenschr, 125(41), 1240-1242. doi:10.1055/s-2000-7722

Dummer, R., Willers, J., Kamarashev, J., Urosevic, M., Dobbeling, U., & Burg, G. (2000). Pathogenesis of cutaneous lymphomas. Semin Cutan Med Surg, 19(2), 78-86.

Fritz, T. M., Burg, G., & Boni, R. (2000). Carpal tunnel syndrome with ulcerous skin lesions. Dermatology, 201(2), 165-167. doi:10.1159/000018464

Hafner, J., Botonakis, I., & Burg, G. (2000). A comparison of multilayer bandage systems during rest, exercise, and over 2 days of wear time. Arch Dermatol, 136(7), 857-863.

Hafner, J., Luthi, W., Hanssle, H., Kammerlander, G., & Burg, G. (2000). Instruction of compression therapy by means of interface pressure measurement. Dermatol Surg, 26(5), 481-486; discussion 487.

Hafner, J., Schaad, I., Schneider, E., Seifert, B., Burg, G., & Cassina, P. C. (2000). Leg ulcers in peripheral arterial disease (arterial leg ulcers): impaired wound healing above the threshold of chronic critical limb ischemia. J Am Acad Dermatol, 43(6), 1001-1008. doi:10.1067/mjd.2000.108375

Hafner, J., Schneider, E., Burg, G., & Cassina, P. C. (2000). Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: the importance of concomitant arterial and venous disease. J Vasc Surg, 32(2), 322-329. doi:10.1067/mva.2000.106942

Heinzerling, L., Dummer, R., Kempf, W., Schmid, M. H., & Burg, G. (2000). Intralesional therapy with anti-CD20 monoclonal antibody rituximab in primary cutaneous B-cell lymphoma. Arch Dermatol, 136(3), 374-378.

Heinzerling, L., Dummer, R., Wildberger, H., & Burg, G. (2000). Cutaneous ulceration after injection of polyethylene-glycol-modified interferon alpha associated with visual disturbances in a melanoma patient. Dermatology, 201(2), 154-157. doi:10.1159/000018461

Heinzerling, L. M., Urbanek, M., Funk, J. O., Peker, S., Bleck, O., Neuber, K., . . . Dummer, R. (2000). Reduction of tumor burden and stabilization of disease by systemic therapy with anti-CD20 antibody (rituximab) in patients with primary cutaneous B-cell lymphoma. Cancer, 89(8), 1835-1844.

Hofbauer, G. F., Burg, G., & Nestle, F. O. (2000). Cocaine-related Stevens-Johnson syndrome. Dermatology, 201(3), 258-260. doi:10.1159/000018500

Hofbauer, G. F., Burg, G., & Nestle, F. O. (2000). [Sporotrichoid infection with Mycobacterium marinum: successful therapy with oral tetracycline administration]. Hautarzt, 51(5), 349-352.

Kamarashev, J., Dummer, R., Schmidt, M. H., Kempf, W., Kurrer, M. O., & Burg, G. (2000). Primary cutaneous T-cell-rich B-cell lymphoma and Hodgkin's disease in a patient with Gardner's syndrome. Dermatology, 201(4), 362-365. doi:10.1159/000051557

Kempf, W., Adams, V. V., Burg, G., Panizzon, R. G., Campadelli-Fiume, G., & Nestle, F. O. (2000). Is pityriasis rosea skin healthier than healthy skin? Arch Dermatol, 136(7), 932-934.

Kempf, W., & Burg, G. (2000). Pityriasis rosea--a virus-induced skin disease? An update. Arch Virol, 145(8), 1509-1520.

Kreyden, O. P., Boni, R., & Burg, G. (2000). [Type A botulinum toxin: a new methods in treating focal hyperhidrosis. A summary of various possibilities in hyperhidrosis therapy with special emphasis type A botulinum toxin injections]. Praxis (Bern 1994), 89(21), 909-915.

Kreyden, O. P., & Burg, G. (2000). [Toxin treatment of sweat pearls. A review of the treatment of hyperhidrosis with a special view of a new therapy option using botulinum toxin A]. Schweiz Med Wochenschr, 130(29-30), 1084-1090.

Kreyden, O. P., Geiges, M. L., Boni, R., & Burg, G. (2000). [Botulinum toxin: from poison to drug. A historical review]. Hautarzt, 51(10), 733-737.

Laetsch, B., Haffner, A. C., Dobbeling, U., Seifert, B., Ludwig, E., Burg, G., & Dummer, R. (2000). CD4 + /CD7- T cell frequency and polymerase chain reaction-based clonality assay correlate with stage in cutaneous T cell lymphomas. J Invest Dermatol, 114(1), 107-111. doi:10.1046/j.1523-1747.2000.00818.x

Matt, D., Xin, H., Vortmeyer, A. O., Zhuang, Z., Burg, G., & Boni, R. (2000). Sporadic trichoepithelioma demonstrates deletions at 9q22.3. Arch Dermatol, 136(5), 657-660.

Santucci, M., Biggeri, A., Feller, A. C., & Burg, G. (2000). Accuracy, concordance, and reproducibility of histologic diagnosis in cutaneous T-cell lymphoma: an EORTC Cutaneous Lymphoma Project Group Study. European Organization for Research and Treatment of Cancer. Arch Dermatol, 136(4), 497-502.

Santucci, M., Biggeri, A., Feller, A. C., Massi, D., & Burg, G. (2000). Efficacy of histologic criteria for diagnosing early mycosis fungoides: an EORTC cutaneous lymphoma study group investigation. European Organization for Research and Treatment of Cancer. Am J Surg Pathol, 24(1), 40-50.

Schaerer, L., Schmid, M. H., Mueller, B., Dummer, R. G., Burg, G., & Kempf, W. (2000). Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas. Am J Dermatopathol, 22(2), 140-143.

Schmid-Grendelmeier, P., Masenga, E. J., Haeffner, A., & Burg, G. (2000). Teledermatology as a new tool in sub-saharan Africa: an experience from Tanzania. J Am Acad Dermatol, 42(5 Pt 1), 833-835.

Yue, F. Y., Cao, L., Hemmi, S., Geertsen, R., Laine, E., Burg, G., & Dummer, R. (2000). Upregulation of interleukin-12 receptor on peripheral blood mononuclear cells and HLA class I, HLA class II or ICAM-1 on melanoma cells by B7.1 and interleukin-12: a mechanism for immunostimulatory impact of melanoma cells adenovirally transfected with B7.1 and IL12? Melanoma Res, 10(4), 313-322.

Bogdan, I., Burg, G., & Boni, R. (2001). Spitz nevi display allelic deletions. Arch Dermatol, 137(11), 1417-1420.

Bogdan, I., Xin, H., Burg, G., & Boni, R. (2001). Heterogeneity of allelic deletions within melanoma metastases. Melanoma Res, 11(4), 349-354.

Boni, R., Kargl, A., Kreyden, O. P., & Burg, G. (2001). [Treatment of hyperfunctional facial lines with botulinum toxin]. Praxis (Bern 1994), 90(34), 1408-1412.

Boni, R., Xin, H., Hohl, D., Panizzon, R., & Burg, G. (2001). Syringocystadenoma papilliferum: a study of potential tumor suppressor genes. Am J Dermatopathol, 23(2), 87-89.

Burg, G., Dummer, R., Haeffner, A., Kempf, W., & Kadin, M. (2001). From inflammation to neoplasia: mycosis fungoides evolves from reactive inflammatory conditions (lymphoid infiltrates) transforming into neoplastic plaques and tumors. Arch Dermatol, 137(7), 949-952.

Burg, G., Kempf, W., & Dummer, R. (2001). Diagnostic signs of cutaneous lymphomas. J Eur Acad Dermatol Venereol, 15(4), 358-360.

Dummer, R., Bosch, U., Panizzon, R., Bloch, P. H., Burg, G., & Task Force 'Skin Cancer'. Swiss National Program against Cancer. Swiss Cancer, L. (2001). Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology, 203(1), 75-80. doi:10.1159/000051710

Dummer, R., Dobbeling, U., Geertsen, R., Willers, J., Burg, G., & Pavlovic, J. (2001). Interferon resistance of cutaneous T-cell lymphoma-derived clonal T-helper 2 cells allows selective viral replication. Blood, 97(2), 523-527.

Dummer, R., Nestle, F. O., & Burg, G. (2001). Report on the Eighth World Congress on Cancers of the Skin 18-21 July 2001, Zurich, Switzerland. Melanoma Res, 11(5), 549-550.

Dummer, R., Willers, J., Dobbeling, U., & Burg, G. (2001). [Current pathogenetic aspects of Sezary syndrome and mycosis fungoides]. Hautarzt, 52(3), 189-192.

Fritz, T. M., Burg, G., & Krasovec, M. (2001). [Allergic contact dermatitis to cosmetics containing Melaleuca alternifolia (tea tree oil)]. Ann Dermatol Venereol, 128(2), 123-126.

Gerlini, G., Hefti, H. P., Kleinhans, M., Nickoloff, B. J., Burg, G., & Nestle, F. O. (2001). Cd1d is expressed on dermal dendritic cells and monocyte-derived dendritic cells. J Invest Dermatol, 117(3), 576-582. doi:10.1046/j.0022-202x.2001.01458.x

Hofbauer, G. F., Dummer, R., Hafner, J., Burg, G., Binswanger, U., & Kempf, W. (2001). Skin cancers in organ transplant recipients: two cases of virus-induced neoplasms. Dermatology, 202(4), 359-361. doi:10.1159/000051683

Hofbauer, G. F., Geertsen, R., Laine, E., Burg, G., & Dummer, R. (2001). Impact of interferons on the expression of melanoma-associated antigens in melanoma short-term cell cultures. Melanoma Res, 11(3), 213-218.

Hofbauer, G. F., Kamarachev, J., Kempf, W., Burg, G., Pestalozzi, B. C., & Dummer, R. (2001). A CD4+ CD56+ natural killer-like T-cell systemic lymphoma with haemorrhagic cutaneous manifestations. Br J Dermatol, 144(2), 432-434.

Hofbauer, G. F., Kessler, B., Kempf, W., Nestle, F. O., Burg, G., & Dummer, R. (2001). Multilesional primary cutaneous diffuse large B-cell lymphoma responsive to antibiotic treatment. Dermatology, 203(2), 168-170. doi:10.1159/000051735

Kamarashev, J., Burg, G., Mingari, M. C., Kempf, W., Hofbauer, G., & Dummer, R. (2001). Differential expression of cytotoxic molecules and killer cell inhibitory receptors in CD8+ and CD56+ cutaneous lymphomas. Am J Pathol, 158(5), 1593-1598. doi:10.1016/S0002-9440(10)64114-4

Kamarashev, J., Ferrone, S., Seifert, B., Boni, R., Nestle, F. O., Burg, G., & Dummer, R. (2001). TAP1 down-regulation in primary melanoma lesions: an independent marker of poor prognosis. Int J Cancer, 95(1), 23-28.

Kamarashev, J., Schaerer, L., Burg, G., Schmid, M. H., Muller, B., & Kempf, W. (2001). Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders. J Cutan Pathol, 28(9), 448-452.

Kempf, W., Kadin, M. E., Kutzner, H., Lord, C. L., Burg, G., Letvin, N. L., & Koralnik, I. J. (2001). Lymphomatoid papulosis and human herpesviruses--A PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 related herpesviruses. J Cutan Pathol, 28(1), 29-33.

Kempf, W., Kazakov, D. V., & Burg, G. (2001). Applications of molecular virology to modern dermatopathology. Curr Top Pathol, 94, 39-47.

Kreyden, O. P., Borradori, L., Trueb, R. M., Burg, G., & Nestle, F. O. (2001). [Successful therapy with tetracycline and nicotinamide in cicatricial pemphigoid]. Hautarzt, 52(3), 247-250.

Kreyden, O. P., Hafner, J., Burg, G., & Nestle, F. O. (2001). [Case report on therapy with granulocyte stimulating factor in diabetic foot]. Hautarzt, 52(4), 327-330.

Kreyden, O. P., Schmid-Grendelmeier, P., & Burg, G. (2001). Idiopathic localized unilateral hyperhidrosis: case report of successful treatment with botulinum toxin type A and review of the literature. Arch Dermatol, 137(12), 1622-1625.

Nestle, F. O., & Burg, G. (2001). Bilateral carpal tunnel syndrome as a clue for the diagnosis of systemic amyloidosis. Dermatology, 202(4), 353-355. doi:10.1159/000051681

Qin, J. Z., Kamarashev, J., Zhang, C. L., Dummer, R., Burg, G., & Dobbeling, U. (2001). Constitutive and interleukin-7- and interleukin-15-stimulated DNA binding of STAT and novel factors in cutaneous T cell lymphoma cells. J Invest Dermatol, 117(3), 583-589. doi:10.1046/j.0022-202x.2001.01436.x

Qin, J. Z., Zhang, C. L., Kamarashev, J., Dummer, R., Burg, G., & Dobbeling, U. (2001). Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells. Blood, 98(9), 2778-2783.

Rogalski, C., Hurlimann, A., Burg, G., Wuthrich, B., & Kempf, W. (2001). [Drug reaction to terbinafine simulating an acute generalized exanthematous pustulosis]. Hautarzt, 52(5), 444-448.

Roos, J., Hennig, I., Schwaller, J., Zbaren, J., Dummer, R., Burg, G., . . . Borisch, B. (2001). Expression of TCL1 in hematologic disorders. Pathobiology, 69(2), 59-66. doi:10.1159/000048758

Schmook, T., Burg, G., & Hafner, J. (2001). Surgical pearl: mini-incisions for the extraction of steatocystoma multiplex. J Am Acad Dermatol, 44(6), 1041-1042. doi:10.1067/mjd.2001.112351

Schmook, T., Hofbauer, G., Kempf, W., Burg, G., & Dummer, R. (2001). [Granulomatous slack skin: partial remission following intralesional administration of interferon-alpha and PUVA]. Hautarzt, 52(10 Pt 2), 985-988.

Schnorf, M., Helfenstein, U., Blum, A., Ellwanger, U., Garbe, C., Burg, G., & Dummer, R. (2001). [Manifestations of the "pretherapeutic phase" of malignant melanoma of the skin in Switzerland 1996-1998]. Praxis (Bern 1994), 90(50), 2193-2198.

Senti, G., Schmid, M. H., & Burg, G. (2001). [Multiple miliary osteomata cutis. Excision with "front lift" approach]. Hautarzt, 52(6), 522-525.

Storz, M., Zepter, K., Kamarashev, J., Dummer, R., Burg, G., & Haffner, A. C. (2001). Coexpression of CD40 and CD40 ligand in cutaneous T-cell lymphoma (mycosis fungoides). Cancer Res, 61(2), 452-454.

Urosevic, M., Kurrer, M. O., Kamarashev, J., Mueller, B., Weder, W., Burg, G., . . . Trojan, A. (2001). Human leukocyte antigen G up-regulation in lung cancer associates with high-grade histology, human leukocyte antigen class I loss and interleukin-10 production. Am J Pathol, 159(3), 817-824. doi:10.1016/S0002-9440(10)61756-7

Willers, J., Haffner, A., Zepter, K., Storz, M., Urosevic, M., Burg, G., & Dummer, R. (2001). The interferon inhibiting cytokine IK is overexpressed in cutaneous T cell lymphoma derived tumor cells that fail to upregulate major histocompatibility complex class II upon interferon-gamma stimulation. J Invest Dermatol, 116(6), 874-879. doi:10.1046/j.1523-1747.2001.01339.x

Willers, J., Urosevic, M., Laine, E., Geertsen, R., Kundig, T., Burg, G., & Dummer, R. (2001). Decreased intraindividual HLA class I expression is due to reduced transcription in advanced melanoma and does not correlate with HLA-G expression. J Invest Dermatol, 117(6), 1498-1504. doi:10.1046/j.0022-202x.2001.01586.x

Boni, R., Schuster, C., Nehrhoff, B., & Burg, G. (2002). Epidemiology of skin cancer. Neuro Endocrinol Lett, 23 Suppl 2, 48-51.

Burg, G. (2002). Public education in skin cancer world-wide. Recent Results Cancer Res, 160, 3-6.

Burg, G., Kempf, W., Haeffner, A., Dobbeling, U., Nestle, F. O., Boni, R., . . . Dummer, R. (2002). From inflammation to neoplasia: new concepts in the pathogenesis of cutaneous lymphomas. Recent Results Cancer Res, 160, 271-280.

Carrozza, P. M., Kempf, W., Kazakov, D. V., Dummer, R., & Burg, G. (2002). A case of Sezary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphoma. Br J Dermatol, 147(3), 582-586.

Carrozza, P. M., Merlani, G. M., Burg, G., & Hafner, J. (2002). CO(2) laser surgery for extensive, cauliflower-like anogenital condylomata acuminata: retrospective long-term study on 19 HIV-positive and 45 HIV-negative men. Dermatology, 205(3), 255-259. doi:10.1159/000065844

Dummer, R., Kamarashev, J., Kempf, W., Haffner, A. C., Hess-Schmid, M., & Burg, G. (2002). Junctional CD8+ cutaneous lymphomas with nonaggressive clinical behavior: a CD8+ variant of mycosis fungoides? Arch Dermatol, 138(2), 199-203.

Erdmann, I., Scheidegger, E. P., Koch, F. K., Heinzerling, L., Odermatt, B., Burg, G., . . . Kundig, T. M. (2002). Fucosyltransferase VII-deficient mice with defective E-, P-, and L-selectin ligands show impaired CD4+ and CD8+ T cell migration into the skin, but normal extravasation into visceral organs. J Immunol, 168(5), 2139-2146.

Farshad, A., Burg, G., Panizzon, R., & Dummer, R. (2002). A retrospective study of 150 patients with lentigo maligna and lentigo maligna melanoma and the efficacy of radiotherapy using Grenz or soft X-rays. Br J Dermatol, 146(6), 1042-1046.

Haffner, A. C., Tassis, A., Zepter, K., Storz, M., Tureci, O., Burg, G., & Nestle, F. O. (2002). Expression of cancer/testis antigens in cutaneous T cell lymphomas. Int J Cancer, 97(5), 668-670.

Heinzerling, L., Dummer, R., Burg, G., & Schmid-Grendelmeier, P. (2002). Panniculitis after subcutaneous injection of interferon beta in a multiple sclerosis patient. Eur J Dermatol, 12(2), 194-197.

Heinzerling, L., Dummer, R., Pavlovic, J., Schultz, J., Burg, G., & Moelling, K. (2002). Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice. Exp Dermatol, 11(3), 232-240.

Heinzerling, L. M., Dummer, R., Panizzon, R. G., Bloch, P. H., Barbezat, R., Burg, G., & Task force 'swiss cancer' of the swiss cancer, l. (2002). Prevention campaign against skin cancer. Dermatology, 205(3), 229-233. doi:10.1159/000065848

Hofbauer, G. F., Boehler, A., Speich, R., Burg, G., & Nestle, F. O. (2002). Painless erythema of the hands associated with non-Hodgkin's lymphoma in a lung transplant recipient. J Am Acad Dermatol, 46(5 Suppl), S159-160.

Hofbauer, G. F., Boni, R., Simmen, D., Mihic, D., Nestle, F. O., Burg, G., & Dummer, R. (2002). Histological, immunological and molecular features of a nasal mucosa primary melanoma associated with nasal melanosis. Melanoma Res, 12(1), 77-82.

Kamarashev, J., Lor, P., Forster, A., Heinzerling, L., Burg, G., & Nestle, F. O. (2002). Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept. Dermatology, 205(2), 213-216. doi:10.1159/000063919

Kazakov, D. V., Belousova, I. E., Muller, B., Palmedo, G., Samtsov, A. V., Burg, G., & Kempf, W. (2002). Primary cutaneous plasmacytoma: a clinicopathological study of two cases with a long-term follow-up and review of the literature. J Cutan Pathol, 29(4), 244-248.

Kazakov, D. V., Burg, G., Dummer, R., & Kempf, W. (2002). Cutaneous lymphomas and pseudolymphomas: newly described entities. Recent Results Cancer Res, 160, 283-293.

Kazakov, D. V., Burg, G., Dummer, R., Palmedo, G., Muller, B., & Kempf, W. (2002). Primary subcutaneous follicular centre cell lymphoma with involvement of the galea: a case report and short review of the literature. Br J Dermatol, 146(4), 663-666.

Kazakov, D. V., Burg, G., & Kempf, W. (2002). Primary cutaneous B-cell lymphomas and pseudolymphomas: review of histopathological features. Cesk Patol, 38(4), 147-154.

Kazakov, D. V., Kempf, W., Michaelis, S., Schmid, U., Cogliatti, S., Dummer, R., & Burg, G. (2002). T-zone lymphoma with cutaneous involvement: a case report and review of the literature. Br J Dermatol, 146(6), 1096-1100.

Kazakov, D. V., Kutzner, H., Rutten, A., Dummer, R., Burg, G., & Kempf, W. (2002). Trichogerminoma: a rare cutaneous adnexal tumor with differentiation toward the hair germ epithelium. Dermatology, 205(4), 405-408. doi:10.1159/000066427

Kazakov, D. V., Mentzel, T., Burg, G., & Kempf, W. (2002). Superficial acral fibromyxoma: report of two cases. Dermatology, 205(3), 285-288. doi:10.1159/000065853

Kazakov, D. V., Prinz, B. M., Michaelis, S., Schmid, M., Muller, B., Adams, V., . . . Kempf, W. (2002). Study of HHV-8 DNA sequences in archival biopsies from lesional skin of Kaposi's sarcoma, various mesenchymal tumors and related reactive conditions. J Cutan Pathol, 29(5), 279-281.

Kempf, W., Haeffner, A. C., Zepter, K., Sander, C. A., Flaig, M. J., Mueller, B., . . . Burg, G. (2002). Angiolymphoid hyperplasia with eosinophilia: evidence for a T-cell lymphoproliferative origin. Hum Pathol, 33(10), 1023-1029.

Kempf, W., Levi, E., Kamarashev, J., Kutzner, H., Pfeifer, W., Petrogiannis-Haliotis, T., . . . Kadin, M. E. (2002). Fascin expression in CD30-positive cutaneous lymphoproliferative disorders. J Cutan Pathol, 29(5), 295-300.

Knobler, R., Burg, G., Whittaker, S., & Baila, L. (2002). EORTC cutaneous lymphoma task force. European Organisation for Research and Treatment of Cancer. Eur J Cancer, 38 Suppl 4, S60-64.

Lor, P., Krueger, U., Kempf, W., Burg, G., & Nestle, F. O. (2002). Monoclonal rearrangement of the T cell receptor gamma-chain in lichenoid pigmented purpuric dermatitis of gougerot-blum responding to topical corticosteroid therapy. Dermatology, 205(2), 191-193. doi:10.1159/000063912

Rubben, A., Bogdan, I., Grussendorf-Conen, E. I., Burg, G., & Boni, R. (2002). Loss of heterozygosity and microsatellite instability in acquired melanocytic nevi: towards a molecular definition of the dysplastic nevus. Recent Results Cancer Res, 160, 100-110.

Schwab, C., Willers, J., Niederer, E., Ludwig, E., Kundig, T., Grob, P., . . . Dummer, R. (2002). The use of anti-T-cell receptor-Vbeta antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas. Br J Haematol, 118(4), 1019-1026.

Urosevic, M., Willers, J., Mueller, B., Kempf, W., Burg, G., & Dummer, R. (2002). HLA-G protein up-regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell T-cell lymphomas and indolent B-cell lymphomas. Blood, 99(2), 609-617.

Vonderheid, E. C., Bernengo, M. G., Burg, G., Duvic, M., Heald, P., Laroche, L., . . . Iscl. (2002). Update on erythrodermic cutaneous T-cell lymphoma: report of the International Society for Cutaneous Lymphomas. J Am Acad Dermatol, 46(1), 95-106.

Bader, U., Cipolat, C., & Burg, G. (2003). Dermatology online with interactive technology (DOIT). Curr Probl Dermatol, 32, 176-181.

Bogdan, I., Smolle, J., Kerl, H., Burg, G., & Boni, R. (2003). Melanoma ex naevo: a study of the associated naevus. Melanoma Res, 13(2), 213-217. doi:10.1097/01.cmr.0000056226.78713.99

Burg, G. (2003). [Herr Professor and Dr. of Medicine Urs Walter Schnyder on his 80th birthday]. J Dtsch Dermatol Ges, 1(2), 157-158.

Burg, G., & Denz, M. (2003). The Telemedical Information Society: doctors' playground or a contribution to the evolution of healthcare? Curr Probl Dermatol, 32, 2-5.

Burg, G., Kempf, W., Kazakov, D. V., Dummer, R., Frosch, P. J., Lange-Ionescu, S., . . . Kadin, M. E. (2003). Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature. Br J Dermatol, 148(3), 580-586.

Cipolat, C., Bader, U., Rufli, T., & Burg, G. (2003). Teledermatology in Switzerland. Curr Probl Dermatol, 32, 257-260.

Dragieva, G., Stahel, H. U., Meyer, M., Kempf, W., Haffner, A., Burg, G., & Hafner, J. (2003). Proteus syndrome. Vasa, 32(3), 159-163. doi:10.1024/0301-1526.32.3.159

Dummer, R., Beyeler, M., Morcinek, J., & Burg, G. (2003). [Cutaneous neoplasms]. Praxis (Bern 1994), 92(36), 1470-1478. doi:10.1024/0369-8394.92.36.1470

Dummer, R., Ivanova, K., Scheidegger, E. P., & Burg, G. (2003). Clinical and therapeutic aspects of polymorphous light eruption. Dermatology, 207(1), 93-95. doi:10.1159/000070956

Dummer, R., Kempf, W., Hess Schmid, M., Haffner, A., & Burg, G. (2003). Therapy of cutaneous lymphoma--current practice and future developments. Onkologie, 26(4), 366-372. doi:10.1159/000072098

Dummer, R., Urosevic, M., Hoek, K., Haffner, A., & Burg, G. (2003). Exploring primary cutaneous B-cell lymphoma by microarray technology. J Invest Dermatol, 120(5), vii-viii. doi:10.1046/j.1523-1747.2003.12151.x

Dummer, R., Urosevic, M., Kempf, W., Hoek, K., Hafner, J., & Burg, G. (2003). Imiquimod in basal cell carcinoma: how does it work? Br J Dermatol, 149 Suppl 66, 57-58.

Dummer, R., Urosevic, M., Kempf, W., Kazakov, D., & Burg, G. (2003). Imiquimod induces complete clearance of a PUVA-resistant plaque in mycosis fungoides. Dermatology, 207(1), 116-118. doi:10.1159/000070962

Gilliet, M., Kleinhans, M., Lantelme, E., Schadendorf, D., Burg, G., & Nestle, F. O. (2003). Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type 1 responses to protein neoantigen. Blood, 102(1), 36-42. doi:10.1182/blood-2002-07-2274

Hauschild, A., Weichenthal, M., Balda, B. R., Becker, J. C., Wolff, H. H., Tilgen, W., . . . Dummer, R. (2003). Prospective randomized trial of interferon alfa-2b and interleukin-2 as adjuvant treatment for resected intermediate- and high-risk primary melanoma without clinically detectable node metastasis. J Clin Oncol, 21(15), 2883-2888. doi:10.1200/JCO.2003.07.116

Kazakov, D. V., Mentzel, T., Burg, G., Dummer, R., & Kempf, W. (2003). Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or myelogenous leukaemia: a coincidence or more? Br J Dermatol, 149(4), 869-876.

Kazakov, D. V., Schmid, M., Adams, V., Cathomas, G., Muller, B., Burg, G., & Kempf, W. (2003). HHV-8 DNA sequences in the peripheral blood and skin lesions of an HIV-negative patient with multiple eruptive dermatofibromas: implications for the detection of HHV-8 as a diagnostic marker for Kaposi's sarcoma. Dermatology, 206(3), 217-221. doi:10.1159/000068896

Kempf, W., Kadin, M. E., Dvorak, A. M., Lord, C. C., Burg, G., Letvin, N. L., & Koralnik, I. J. (2003). Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin. Carcinogenesis, 24(2), 301-306.

Kempf, W., Kettelhack, N., Duvic, M., & Burg, G. (2003). Topical and systemic retinoid therapy for cutaneous T-cell lymphoma. Hematol Oncol Clin North Am, 17(6), 1405-1419.

Kempf, W., Reichlin, S., & Burg, G. (2003). HistoClinC: a Web-based telemedicine application for clinicopathologic correlations in dermatopathology. Curr Probl Dermatol, 32, 213-220.

Kleinhans, M., Tun-Kyi, A., Gilliet, M., Kadin, M. E., Dummer, R., Burg, G., & Nestle, F. O. (2003). Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma. Blood, 101(4), 1487-1493. doi:10.1182/blood-2002-02-0475

Kropf, R., Cipolat, C., & Burg, G. (2003). Telemedicine in Europe. Curr Probl Dermatol, 32, 247-251.

Kropf, R., Cipolat, C., & Burg, G. (2003). Teleteaching tools in dermatology on the Web. Curr Probl Dermatol, 32, 33-38.

Lauchli, S., & Burg, G. (2003). Treatment of hyperhidrosis with botulinum toxin A. Skin Therapy Lett, 8(7), 1-4.

Lauchli, S., Kempf, W., Dragieva, G., Burg, G., & Hafner, J. (2003). CO2 laser treatment of warts in immunosuppressed patients. Dermatology, 206(2), 148-152. doi:10.1159/000068459

Maier, T., Tun-Kyi, A., Tassis, A., Jungius, K. P., Burg, G., Dummer, R., & Nestle, F. O. (2003). Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells. Blood, 102(7), 2338-2344. doi:10.1182/blood-2002-08-2455

Michaelis, S., Kazakov, D. V., Schmid, M., Dummer, R., Burg, G., & Kempf, W. (2003). Hepatitis C and G viruses in B-cell lymphomas of the skin. J Cutan Pathol, 30(6), 369-372.

Papp, K. A., Guenther, L., Boyden, B., Larsen, F. G., Harvima, R. J., Guilhou, J. J., . . . Chu, A. (2003). Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis. J Am Acad Dermatol, 48(1), 48-54. doi:10.1067/mjd.2003.130

Roberts, A. A., Amano, M., Felten, C., Galvan, M., Sulur, G., Pinter-Brown, L., . . . Baum, L. G. (2003). Galectin-1-mediated apoptosis in mycosis fungoides: the roles of CD7 and cell surface glycosylation. Mod Pathol, 16(6), 543-551. doi:10.1097/01.MP.0000071840.84469.06

Urosevic, M., Maier, T., Benninghoff, B., Slade, H., Burg, G., & Dummer, R. (2003). Mechanisms underlying imiquimod-induced regression of basal cell carcinoma in vivo. Arch Dermatol, 139(10), 1325-1332. doi:10.1001/archderm.139.10.1325

Willers, J., Dummer, R., Kempf, W., Kundig, T., Burg, G., & Kadin, M. E. (2003). Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand. Clin Cancer Res, 9(7), 2744-2754.

Zagrodnik, B., Kempf, W., Seifert, B., Muller, B., Burg, G., Urosevic, M., & Dummer, R. (2003). Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2. Cancer, 98(12), 2708-2714. doi:10.1002/cncr.11798

Zhang, C. L., Kamarashev, J., Qin, J. Z., Burg, G., Dummer, R., & Dobbeling, U. (2003). Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells. J Pathol, 200(2), 249-254. doi:10.1002/path.1341

Beyeler, M., Burg, G., & Dummer, R. (2004). [Cutaneous lymphoma]. Hautarzt, 55(10), 1005-1016; quiz 1017. doi:10.1007/s00105-004-0816-2

Beyeler, M., Kempf, W., Hafner, J., Burg, G., & Dummer, R. (2004). The spectrum of mesenchymal skin neoplasms reflected by the new WHO classification. Onkologie, 27(4), 401-406. doi:10.1159/000079097

Cozzio, A., Hafner, J., Kempf, W., Haffner, A., Palmedo, G., Michaelis, S., . . . Burg, G. (2004). Febrile ulceronecrotic Mucha-Habermann disease with clonality: a cutaneous T-cell lymphoma entity? J Am Acad Dermatol, 51(6), 1014-1017. doi:10.1016/j.jaad.2004.06.009

Dragieva, G., Hafner, J., Dummer, R., Schmid-Grendelmeier, P., Roos, M., Prinz, B. M., . . . Kempf, W. (2004). Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients. Transplantation, 77(1), 115-121. doi:10.1097/01.TP.0000107284.04969.5C

Dragieva, G., Prinz, B. M., Hafner, J., Dummer, R., Burg, G., Binswanger, U., & Kempf, W. (2004). A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients. Br J Dermatol, 151(1), 196-200. doi:10.1111/j.1365-2133.2004.06054.x

Dummer, R., Hassel, J. C., Fellenberg, F., Eichmuller, S., Maier, T., Slos, P., . . . Urosevic, M. (2004). Adenovirus-mediated intralesional interferon-gamma gene transfer induces tumor regressions in cutaneous lymphomas. Blood, 104(6), 1631-1638. doi:10.1182/blood-2004-01-0360

Gerlini, G., Tun-Kyi, A., Dudli, C., Burg, G., Pimpinelli, N., & Nestle, F. O. (2004). Metastatic melanoma secreted IL-10 down-regulates CD1 molecules on dendritic cells in metastatic tumor lesions. Am J Pathol, 165(6), 1853-1863. doi:10.1016/S0002-9440(10)63238-5

Gilliet, M., Conrad, C., Geiges, M., Cozzio, A., Thurlimann, W., Burg, G., . . . Dummer, R. (2004). Psoriasis triggered by toll-like receptor 7 agonist imiquimod in the presence of dermal plasmacytoid dendritic cell precursors. Arch Dermatol, 140(12), 1490-1495. doi:10.1001/archderm.140.12.1490

Hafner, J., Schmid, M. H., Kempf, W., Burg, G., Kunzi, W., Meuli-Simmen, C., . . . Steinert, H. (2004). Baseline staging in cutaneous malignant melanoma. Br J Dermatol, 150(4), 677-686. doi:10.1111/j.0007-0963.2004.05870.x

Hasse, U., Kropf, R., & Burg, G. (2004). [Telemedicine in dermatology 2003: a review]. J Dtsch Dermatol Ges, 2(4), 294-300; quiz 301-292.

Hassel, J. C., Meier, R., Joller-Jemelka, H., Burg, G., & Dummer, R. (2004). Serological immunomarkers in cutaneous T cell lymphoma. Dermatology, 209(4), 296-300. doi:10.1159/000080852

Hofbauer, G. F., Burkhart, A., Schuler, G., Dummer, R., Burg, G., & Nestle, F. O. (2004). High frequency of melanoma-associated antigen or HLA class I loss does not correlate with survival in primary melanoma. J Immunother, 27(1), 73-78.

Kazakov, D. V., Burg, G., & Kempf, W. (2004). Clinicopathological spectrum of mycosis fungoides. J Eur Acad Dermatol Venereol, 18(4), 397-415. doi:10.1111/j.1468-3083.2004.00937.x

Kazakov, D. V., Kutzner, H., Rutten, A., Michal, M., Requena, L., Burg, G., . . . Kempf, W. (2004). The anti-MAGE antibody B57 as a diagnostic marker in melanocytic lesions. Am J Dermatopathol, 26(2), 102-107.

Kempf, W., Cathomas, G., Burg, G., & Trueb, R. M. (2004). Micronodular Kaposi's sarcoma - a new variant of classic-sporadic Kaposi's sarcoma. Dermatology, 208(3), 255-258. doi:10.1159/000077313

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., & Smoller, B. R. (2004). International board certification in dermatopathology: paving the way for the future. Am J Dermatopathol, 26(5), 439-440.

Lauchli, S., Zortea-Caflisch, C., Nestle, F. O., Burg, G., & Kempf, W. (2004). Nephrogenic fibrosing dermopathy treated with extracorporeal photopheresis. Dermatology, 208(3), 278-280. doi:10.1159/000077321

Liu, J. Y., Hafner, J., Dragieva, G., & Burg, G. (2004). Bioreactor microcarrier cell culture system (Bio-MCCS) for large-scale production of autologous melanocytes. Cell Transplant, 13(7-8), 809-816.

Liu, J. Y., Hafner, J., Dragieva, G., Seifert, B., & Burg, G. (2004). Autologous cultured keratinocytes on porcine gelatin microbeads effectively heal chronic venous leg ulcers. Wound Repair Regen, 12(2), 148-156. doi:10.1111/j.1067-1927.2004.012205.x

Meier, S., Baumert, B. G., Maier, T., Wellis, G., Burg, G., Seifert, B., & Dummer, R. (2004). Survival and prognostic factors in patients with brain metastases from malignant melanoma. Onkologie, 27(2), 145-149. doi:10.1159/000076903

Michaelis, S., Cozzio, A., Kempf, W., Graf, P., Burg, G., & Dummer, R. (2004). Combination of bexarotene and psoralen-UVA therapy in a patient with Mycosis fungoides. Dermatology, 209(1), 72-74. doi:10.1159/000078595

Murer, K., Urosevic, M., Willers, J., Selvam, P., Laine, E., Burg, G., & Dummer, R. (2004). Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients. Melanoma Res, 14(4), 257-262.

Prinz, B. M., Hafner, J., Dummer, R., Burg, G., Bruswanger, U., & Kempf, W. (2004). Treatment of Bowen's disease with imiquimod 5% cream in transplant recipients. Transplantation, 77(5), 790-791.

Prinz, B. M., Michaelis, S., Kettelhack, N., Mueller, B., Burg, G., & Kempf, W. (2004). Subcutaneous infection with Mycobacterium abscessus in a renal transplant recipient. Dermatology, 208(3), 259-261. doi:10.1159/000077314

Prinz, B. M., Vavricka, S. R., Graf, P., Burg, G., & Dummer, R. (2004). Efficacy of laser treatment of tattoos using lasers emitting wavelengths of 532 nm, 755 nm and 1064 nm. Br J Dermatol, 150(2), 245-251.

Requena, L., Burg, G., Cerroni, L., & Zelger, B. W. (2004). A progressive papular eruption on the chest and back. Am J Dermatopathol, 26(2), 162-165.

Rubben, A., Kempf, W., Kadin, M. E., Zimmermann, D. R., & Burg, G. (2004). Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma. Exp Dermatol, 13(8), 472-483. doi:10.1111/j.0906-6705.2004.00176.x

Schuster, C., & Burg, G. (2004). [The red face]. Praxis (Bern 1994), 93(42), 1727-1732. doi:10.1024/0369-8394.93.42.1727

Urosevic, M., Kamarashev, J., Burg, G., & Dummer, R. (2004). Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2. Blood, 103(5), 1796-1798. doi:10.1182/blood-2003-10-3372

Urosevic, M., Oberholzer, P. A., Maier, T., Hafner, J., Laine, E., Slade, H., . . . Dummer, R. (2004). Imiquimod treatment induces expression of opioid growth factor receptor: a novel tumor antigen induced by interferon-alpha? Clin Cancer Res, 10(15), 4959-4970. doi:10.1158/1078-0432.CCR-04-0193

  • Burg, G., Dummer, R., & Kempf, W. (2005). Dyscrasias with "undetermined significance". Arch Dermatol, 141(3), 382-384.

Burg, G., Hasse, U., Cipolat, C., Kropf, R., Djamei, V., Soyer, H. P., & Chimenti, S. (2005). Teledermatology: just cool or a real tool? Dermatology, 210(2), 169-173. doi:10.1159/000082573

Burg, G., Kempf, W., Cozzio, A., Feit, J., Willemze, R., E, S. J., . . . Whittaker, S. (2005). WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects. J Cutan Pathol, 32(10), 647-674. doi:10.1111/j.0303-6987.2005.00495.x

Dummer, R., Panizzon, R., Bloch, P. H., Burg, G., & Task Force Skin, C. (2005). Updated Swiss guidelines for the treatment and follow-up of cutaneous melanoma. Dermatology, 210(1), 39-44. doi:10.1159/000081482

Feit, J., Kempf, W., Jedlickova, H., & Burg, G. (2005). Hypertext atlas of dermatopathology with expert system for epithelial tumors of the skin. J Cutan Pathol, 32(6), 433-437. doi:10.1111/j.0303-6987.2005.00291.x

Gilliet, M., Cozzio, A., Burg, G., & Nestle, F. O. (2005). Successful treatment of three cases of nephrogenic fibrosing dermopathy with extracorporeal photopheresis. Br J Dermatol, 152(3), 531-536. doi:10.1111/j.1365-2133.2005.06434.x

Greisser, J., Doebbeling, U., Roos, M., Mueller, B., Schmid, M., Burg, G., . . . Kempf, W. (2005). Apoptosis in CD30-positive lymphoproliferative disorders of the skin. Exp Dermatol, 14(5), 380-385. doi:10.1111/j.0906-6705.2005.00293.x

Heinzerling, L., Burg, G., Dummer, R., Maier, T., Oberholzer, P. A., Schultz, J., . . . Moelling, K. (2005). Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. Hum Gene Ther, 16(1), 35-48. doi:10.1089/hum.2005.16.35

Hofbauer, G. F., Hatta, N., Daigle, I., Hemmi, S., Spanaus Schlapbach, K., Willers, J., . . . Dummer, R. (2005). Fas ligand reduces viability in primary melanoma short-term cell cultures more than in metastatic melanoma short-term cell cultures. Dermatology, 211(4), 318-324. doi:10.1159/000088500

Kempf, W., Kutzner, H., Kettelhack, N., Palmedo, G., & Burg, G. (2005). Paraneoplastic pityriasis lichenoides in cutaneous lymphoma: case report and review of the literature on paraneoplastic reactions of the skin in lymphoma and leukaemia. Br J Dermatol, 152(6), 1327-1331. doi:10.1111/j.1365-2133.2005.06457.x

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., Kutzner, H., & Sanguenza, O. (2005). International Board certification dermatopathology: a worldwide effort to rise standards in dermatopathology. J Dtsch Dermatol Ges, 3(4), 309-311.

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., Kutzner, H., & Sangueza, O. (2005). International Board Certification in Dermatopathology: a worldwide effort to raise standards in dermatopathology. Am J Dermatopathol, 27(4), 357-359.

Laetsch, B., Hofbauer, G., Kempf, W., Burg, G., & Dummer, R. (2005). Atypical poorly differentiated cutaneous T-cell lymphoma with an angiocentric growth pattern presenting histologically as vasculitis. Dermatology, 210(4), 341-345. doi:10.1159/000084763

Liu, J. Y., & Burg, G. (2005). An improved organ culture for regeneration of pure autologous keratinocytes from small split-thickness skin specimens. Dermatology, 210(1), 45-48. doi:10.1159/000081483

Nestle, F. O., Conrad, C., Tun-Kyi, A., Homey, B., Gombert, M., Boyman, O., . . . Gilliet, M. (2005). Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production. J Exp Med, 202(1), 135-143. doi:10.1084/jem.20050500

Pimpinelli, N., Olsen, E. A., Santucci, M., Vonderheid, E., Haeffner, A. C., Stevens, S., . . . International Society for Cutaneous, L. (2005). Defining early mycosis fungoides. J Am Acad Dermatol, 53(6), 1053-1063. doi:10.1016/j.jaad.2005.08.057

Schraner, C., Hasse, B., Hasse, U., Baumann, D., Faeh, A., Burg, G., . . . Gunthard, H. F. (2005). Successful treatment with miltefosine of disseminated cutaneous leishmaniasis in a severely immunocompromised patient infected with HIV-1. Clin Infect Dis, 40(12), e120-124. doi:10.1086/430444

Urosevic, M., Braun, B., Willers, J., Burg, G., & Dummer, R. (2005). Expression of melanoma-associated antigens in melanoma cell cultures. Exp Dermatol, 14(7), 491-497. doi:10.1111/j.0906-6705.2005.00305.x

Urosevic, M., Conrad, C., Kamarashev, J., Asagoe, K., Cozzio, A., Burg, G., & Dummer, R. (2005). CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype. Hum Pathol, 36(9), 1020-1024. doi:10.1016/j.humpath.2005.07.002

Urosevic, M., Dummer, R., Conrad, C., Beyeler, M., Laine, E., Burg, G., & Gilliet, M. (2005). Disease-independent skin recruitment and activation of plasmacytoid predendritic cells following imiquimod treatment. J Natl Cancer Inst, 97(15), 1143-1153. doi:10.1093/jnci/dji207

Urosevic, M., Kempf, W., Zagrodnik, B., Panizzon, R., Burg, G., & Dummer, R. (2005). HLA-G expression in basal cell carcinomas of the skin recurring after radiotherapy. Clin Exp Dermatol, 30(4), 422-425. doi:10.1111/j.1365-2230.2005.01790.x

Willemze, R., Jaffe, E. S., Burg, G., Cerroni, L., Berti, E., Swerdlow, S. H., . . . Meijer, C. J. (2005). WHO-EORTC classification for cutaneous lymphomas. Blood, 105(10), 3768-3785. doi:10.1182/blood-2004-09-3502

Beyeler, M., Waldispuhl, S., Strobel, K., Joller-Jemelka, H. I., Burg, G., & Dummer, R. (2006). Detection of melanoma relapse: first comparative analysis on imaging techniques versus S100 protein. Dermatology, 213(3), 187-191. doi:10.1159/000095034

Burg, G., Kempf, W., Cozzio, A., Dobbeling, U., Feit, J., Golling, P., . . . Dummer, R. (2006). Cutaneous malignant lymphomas: update 2006. J Dtsch Dermatol Ges, 4(11), 914-933. doi:10.1111/j.1610-0387.2006.06069.x

Cozzio, A., Kempf, W., Schmid-Meyer, R., Gilliet, M., Michaelis, S., Scharer, L., . . . Dummer, R. (2006). Intra-lesional low-dose interferon alpha2a therapy for primary cutaneous marginal zone B-cell lymphoma. Leuk Lymphoma, 47(5), 865-869. doi:10.1080/10428190500399698

Dummer, R., Hauschild, A., Skalsky, J., Burg, G., & Weichenthal, M. (2006). Bexarotene and systemic disease progression in CTCL? J Am Acad Dermatol, 55(2), 365-366; author reply 366. doi:10.1016/j.jaad.2006.01.022

Dummer, R., Urosevic, M., Cozzio, A., Asagoe, K., Dobbeling, U., & Burg, G. (2006). [Perspective of cutaneous lymphoma reserach]. J Dtsch Dermatol Ges, 4(6), 492-495. doi:10.1111/j.1610-0387.2006.05986.x

Goldinger, S. M., Dummer, R., Schmid, P., Prinz Vavricka, M., Burg, G., & Lauchli, S. (2006). Excimer laser versus narrow-band UVB (311 nm) in the treatment of psoriasis vulgaris. Dermatology, 213(2), 134-139. doi:10.1159/000093852

Greisser, J., Palmedo, G., Sander, C., Kutzner, H., Kazakov, D. V., Roos, M., . . . Kempf, W. (2006). Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30 lymphoproliferative disorders. J Cutan Pathol, 33(11), 711-715. doi:10.1111/j.1600-0560.2006.00560.x

Kazakov, D. V., Kutzner, H., Palmedo, G., Boudova, L., Michaelis, S., Michal, M., . . . Kempf, W. (2006). Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement. Am J Dermatopathol, 28(5), 399-409. doi:10.1097/01.dad.0000211514.98230.ba

Kerl, H., Cerroni, L., Burg, G., Cerio, R., Gollnick, H., Kutzner, H., & Sangueza, O. (2006). International Board Certification in Dermatopathology: a worldwide effort to raise standards in dermatopathology. J Cutan Pathol, 33(2), 156-159. doi:10.1111/j.0303-6987.2006.00390.x

Liu, J. Y., Hafner, J., Dragieva, G., & Burg, G. (2006). High yields of autologous living dermal equivalents using porcine gelatin microbeads as microcarriers for autologous fibroblasts. Cell Transplant, 15(5), 445-451.

Liu, J. Y., Hafner, J., Dragieva, G., & Burg, G. (2006). A novel bioreactor microcarrier cell culture system for high yields of proliferating autologous human keratinocytes. Cell Transplant, 15(5), 435-443.

Michaelis, S., Kazakov, D. V., Burg, G., Dummer, R., & Kempf, W. (2006). Extracutaneous transformation into a high-grade lymphoma: a potential pitfall in the management of patients with Sezary syndrome. Int J Dermatol, 45(3), 277-279. doi:10.1111/j.1365-4632.2006.02378.x

Schadendorf, D., Ugurel, S., Schuler-Thurner, B., Nestle, F. O., Enk, A., Brocker, E. B., . . . DeCOG, D. C. s. g. o. t. (2006). Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol, 17(4), 563-570. doi:10.1093/annonc/mdj138

Dummer, R., Asagoe, K., Cozzio, A., Burg, G., Doebbeling, U., Golling, P., . . . Urosevic, M. (2007). Recent advances in cutaneous lymphomas. J Dermatol Sci, 48(3), 157-167. doi:10.1016/j.jdermsci.2007.09.001

Gachter, T., Muhleisen, B., Scharer, L., Dummer, R., Burg, G., & Hofbauer, G. F. (2007). Weight of decision-making impairs clinical assessment of melanocytic lesions. J Cutan Med Surg, 11(1), 9-18. doi:10.2310/7750.2007.00007

Goldinger, S. M., Dummer, R., Schmid, P., Burg, G., Seifert, B., & Lauchli, S. (2007). Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo. J Eur Acad Dermatol Venereol, 21(4), 504-508. doi:10.1111/j.1468-3083.2006.02016.x

Hafner, J., Fritz, T., Lauchli, S., Bogdan, I., Burg, G., & French, L. E. (2007). [Eyebrow repair after skin cancer surgery: combined naked and hairbearing full thickness graft from the contralateral retroauricular donor site]. J Dtsch Dermatol Ges, 5(11), 1034-1035. doi:10.1111/j.1610-0387.2007.06564.x

Kamarashev, J., Theler, B., Dummer, R., & Burg, G. (2007). Mycosis fungoides--analysis of the duration of disease stages in patients who progress and the time point of high-grade transformation. Int J Dermatol, 46(9), 930-935. doi:10.1111/j.1365-4632.2007.03149.x

Muehleisen, B., Schaerer, L., Dummer, R., Burg, G., & Hofbauer, G. F. (2007). Cancer/testis antigen MAGE-A4 expression pattern differs in epithelial skin tumors of organ-transplant recipients and immunocompetent patients. J Cutan Pathol, 34(1), 1-6. doi:10.1111/j.1600-0560.2006.00576.x

Olsen, E., Vonderheid, E., Pimpinelli, N., Willemze, R., Kim, Y., Knobler, R., . . . Iscl/Eortc. (2007). Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood, 110(6), 1713-1722. doi:10.1182/blood-2007-03-055749

Burg, G. (2008). [E-Learning in medicine: at the top or a flop]. J Dtsch Dermatol Ges, 6(6), 435. doi:10.1111/j.1610-0387.2008.06789.x

Hofbauer, G. F., Baur, T., Bonnet, M. C., Tartour, E., Burg, G., Berinstein, N. L., & Dummer, R. (2008). Clinical phase I intratumoral administration of two recombinant ALVAC canarypox viruses expressing human granulocyte-macrophage colony-stimulating factor or interleukin-2: the transgene determines the composition of the inflammatory infiltrate. Melanoma Res, 18(2), 104-111. doi:10.1097/CMR.0b013e3282f702cf

Kempf, W., Ostheeren-Michaelis, S., Paulli, M., Lucioni, M., Wechsler, J., Audring, H., . . . Treatment of, C. (2008). Granulomatous mycosis fungoides and granulomatous slack skin: a multicenter study of the Cutaneous Lymphoma Histopathology Task Force Group of the European Organization For Research and Treatment of Cancer (EORTC). Arch Dermatol, 144(12), 1609-1617. doi:10.1001/archdermatol.2008.46

Valentini, J., Grotto, D., Paniz, C., Roehrs, M., Burg, G., & Garcia, S. C. (2008). The influence of the hemodialysis treatment time under oxidative stress biomarkers in chronic renal failure patients. Biomed Pharmacother, 62(6), 378-382. doi:10.1016/j.biopha.2007.10.017

Burg, G., Soyer, H. P., & Chimenti, S. (2009). Skin diseases in Europe. Teledermatology. Eur J Dermatol, 19(6), 656-658. doi:10.1684/ejd.2009.0800

Kerl, H., Cerio, R., Burg, G., Anadolu, R. Y., Chimenti, S., & Forsea, D. (2009). Dermatopathology. Eur J Dermatol, 19(5), 536-537. doi:10.1684/ejd.2009.0785

Hafner, J., Nobbe, S., Partsch, H., Lauchli, S., Mayer, D., Amann-Vesti, B., . . . French, L. E. (2010). Martorell hypertensive ischemic leg ulcer: a model of ischemic subcutaneous arteriolosclerosis. Arch Dermatol, 146(9), 961-968. doi:10.1001/archdermatol.2010.224

Olsen, E. A., Whittaker, S., Kim, Y. H., Duvic, M., Prince, H. M., Lessin, S. R., . . . Treatment of, C. (2011). Clinical end points and response criteria in mycosis fungoides and Sezary syndrome: a consensus statement of the International Society for Cutaneous Lymphomas, the United States Cutaneous Lymphoma Consortium, and the Cutaneous Lymphoma Task Force of the European Organisation for Research and Treatment of Cancer. J Clin Oncol, 29(18), 2598-2607. doi:10.1200/JCO.2010.32.0630

Tremp, M., Knafla, I., Burg, G., Wuthrich, B., & Schmid-Grendelmeier, P. (2011). 'EASIdig'--a digital tool to document disease activity in atopic dermatitis. Dermatology, 223(1), 68-73. doi:10.1159/000330333

Burg, G. (2012). History of sexually transmitted infections (STI). G Ital Dermatol Venereol, 147(4), 329-340.

Burg, G., & French, L. E. (2012). [The age of Gutenberg is over: a consideration of medical education--past, present and future]. Hautarzt, 63 Suppl 1, 38-44. doi:10.1007/s00105-011-2301-z

Hafner, J., French, L. E., Burg, G., & Schnyder, U. W. (2012). [To Prof. Dr. Dr. h.c. mult. Otto Braun-Falco: Birthday wishes and expression of appreciation from the Swiss Society for Dermatology and Venereology (SGDV)]. Hautarzt, 63 Suppl 1, 17. doi:10.1007/s00105-011-2308-5

Burg, G., French, L., & Hafner, J. (2013). [In memoriam: Prof. Dr. Dr. h.c. Urs Walter Schnyder: 7 February 1923-21 October 2012]. Hautarzt, 64(1), 65-66. doi:10.1007/s00105-012-2500-2

Pimmer, C., Linxen, S., Grohbiel, U., Jha, A. K., & Burg, G. (2013). Mobile learning in resource-constrained environments: a case study of medical education. Med Teach, 35(5), e1157-1165. doi:10.3109/0142159X.2012.733454

Burg, G. (2015). Systemic involvement in mycosis fungoides. Clin Dermatol, 33(5), 563-571. doi:10.1016/j.clindermatol.2015.05.008

Robson, A., Assaf, C., Bagot, M., Burg, G., Calonje, E., Castillo, C., . . . Berti, E. (2015). Aggressive epidermotropic cutaneous CD8+ lymphoma: a cutaneous lymphoma with distinct clinical and pathological features. Report of an EORTC Cutaneous Lymphoma Task Force Workshop. Histopathology, 67(4), 425-441. doi:10.1111/his.12371

Burg, G., & Finlay, A. Y. (2016). Web-based education. J Eur Acad Dermatol Venereol, 30(12), e226-e227. doi:10.1111/jdv.13560

 

Publikationen, thematisch

Publikationen/ Veröffentlichungen  Günter Burg nach persönlichen Schwerpunkt-Themen

 

1968-2017

 

Inhaltsverzeichnis

 

A Originalarbeiten, Überssichtsarbeiten  und Buchbeiträge                      1

 

Diverse                                                                                                                                        1

 

Allergologie/Immunologie/DRC                                                                                             6

 

Dermatopathologie                                                                                                                   8

 

Drugs/Drug Reaction                                                                                                                9

 

EDV/Telemedizin/E-Learning                                                                                                   9

 

Gefässe, Ulcus                                                                                                                         10

 

Geschichte, Moulagen                                                                                                            11

 

Haare                                                                                                                                        11

 

Histo-Cytochemie/Immuncytochemie                                                                                    12

 

Immundermatosen/Kollagenosen                                                                                          13

 

Kaposi                                                                                                                                        13

 

Lehre (see also EDV/Telemedizin/E-Learning)                                                                    14

 

Licht/Photo/Laser                                                                                                                   14

 

Lymphome/Retikulosen/Histiocytic Disorders                                                                    14

 

Melanom                                                                                                                                   26

 

Malum perforans, neuropathische Erkrankungen                                                             31

 

Mohs Chemosurgery                                                                                                                32

 

Organtransplantierte                                                                                                            33

 

Porphyrien                                                                                                                                33

 

STI/Anogenital                                                                                                                         33

 

Viren, Herpes, HIV                                                                                                                   34

 

B Monographien/Themenhefte/Broschüren/Medienpubli-kationen (Autor/Herausgeber)      34

 

C Auftragspublikation                                                                                                 37

 

 

 

A Originalarbeiten (kursiv), Überssichtsarbeiten (unterstrichen) und Buchbeiträge

 

wichtige Beiträge: gelb;

 

Diverse

 

1.     BURG G (1968) Tierexperimentelle Untersuchungen über den Einfluß von Cyclophosphamid (Endoxan®) auf die akute und chronische Entzündung Inaugural-Dissertation, Marburg

 

2.     BURG G, RASSNER G, BRAUN-FALCO O (1969) ; Tierexperimentelle Untersuchungen über den Einfluß von Cyclophosphamid (Endoxan®) auf die akute und chronische Entzündung; Arch klin exp Derm 236: 61-71

 

3.     BRAUN-FALCO O, BURG G, FARBER EM (1972): Psoriasis. Eine Fragebogenstudie bei 536 Patienten; Münch Med Wschr 114: 1105-1110

 

4.     BRAUN-FALCO O, BURG G, FARBER EM (1973): Psoriasis. Eine Fragebogenstudie bei 536 Patienten ; Münch Med Wschr (ed. esp.) 115: 587-596

 

5.     KERL H, BURG G (1975) : Erworbene (postinflammatorische) Dermatochalasis. "Dermatitis herpetiformis Duhring", Zöliakie-Syndrom, Dermatochalasis; Hautarzt 26: 191-196

 

6.     BODE U, BURG G (1978): Das erworbene digitale Fibrokeratom; Hautarzt 29: 659-660

 

7.     BÖNNIGER F, BURG G (1979) : Multiple Keratoakanthome; Hautarzt 30: 92-94

 

8.     BUTENSCHÖN H, BURG G, LENTZE M (1979) : Das LEOPARD-Syndrom; Z. Hautkr. 54: 613-618

 

9.     SCHMOECKEL C, BRAUN-FALCO O, BURG G (1980): Das atypische Fibroxanthom; Hautarzt 31: 213-215

 

10.   BRAUN-FALCO O, BURG G, SELZLE D, SCHMOECKEL C (1980): Melanosis diffusa congenita; Hautarzt 31: 324-327

 

11.   HOFFMANN R, VAN DE GRAAFF S, BURG G (1983): Verbreitung der Tuberkulose bei Zierfischen; Tierärztl Prax 11: 261-267

 

12.   OEHLSCHLAEGEL G, MARQUART KH, STEUER G, BURG G (1983) : Iatrogener, durch Polyvinylpyrrolidon (PVP) induzierter "Pseudotumor" der Haut.; Hautarzt 34: 555-560:

 

13.   BURG G (1985) : Griseofulvin bei nicht-mykotischen Dermatosen; Schrifttum und Praxis 16:174-175

 

14.   BURG G (1986) : Amcinonid: stark wirksames Glucocorticoid; Arzneimitteltherapie 4:176-177

 

15.   RUZICKA TH, BURG G (1987): Effects of Chronic Intracutaneous Administration of Arachidonic Acid and its Metabolites. Induction of Leucocytoclastic Vasculitis by Leukotriene B4 and 12-Hydroxyeicosatetraenoic Acid and its Prevention by Prostaglandin E2; J Invest Dermatol 88: 120-123

 

16.   BIEBER T, RUZICKA T, BURG G (1987) : Erosive pustulöse Dermatitis des Kapillitiums; Hautarzt 38: 687-689

 

17.   SCHRALLHAMMER K, BURG G, STOLZ W, BRAUN-FALCO O (1988) Kongenitale Poikilodermie mit warzigen Hyperkeratosen. Eine Sonderform des Thomson-Syndroms? Hautarzt 39: 143-148

 

18.   KLEBER R, LANDTHALER M, BURG G (1989) : Postzosterisches Granuloma anulare; Hautarzt 40:110-111

 

19.   HARTMANN AA, BURG G (1989): Acne fulminans bei Klinefelter Syndrom unter Testosteron; Monatsschr Kinderheilkd 137: 466-467

 

20.   PIÉRARD-FRANCHIMONT C, BURG G, GROSSHANS E, KERL H, PIÉRARD GE (1989) : Prévalence des cancers de la peau en région mosane et dans des pays européens de meme latitude ; Revue Médicale de Liège, 44: 541-545

 

21.   HACKEL H, BURG G, LECHNER W, STOLZ W, RING J, BRAUN-FALCO O (1989): Keratoacanthoma centrifugum marginatum; Hautarzt 40: 763-766

 

22.   BURG G, SOBETZKO R (1990): Floride orale Papillomatose: eine Indikation für Etretinat?; Hautarzt 41: 314-316

 

23.   BURGER M, ZILLIKENS D, BURG G (1990 Cutis marmorata teleangiectatica congenita; Akt Dermatol 16: 248-249

 

24.   ZILLIKENS D, GOLDSTEIN RK, ELSNER P, HARTMANN AA, BURG G (1991): Sweet's syndrome associated with salmonella typhimurium infection ; Acta Derm Venereol (Stockh) 71: 77-79

 

25.   GOLDSTEIN RK, ZILLIKENS D, MILLER K, ELSNER P, BURG G (1991): Lokalbehandlung des disseminierten Granuloma anulare mit einer Vitamin-E-Emulsion; Hautarzt 42: 176-178

 

26.   BURGER M, HARTMANN AA, WALLIS S, BURG G (1991): Bullöse kutane Mastozytose; Z Hautkr 66: 889-891

 

27.   BASTIAN BC, RÖMISCH J, PÂQUES E.-P, BURG G (1991): Lipokortine und Phospholipasen. Neue Aspekte in der Physiologie der Glukokortikosteroidwir­kung; Hautarzt 42:417-423

 

28.   BAUMGARTNER R, TRÜEB R, BRUCKNER L, SCHMID U, SPEISER P, BURG G (1992): Rezidivierender Lidtumor bei nekrotisierender Pannikulitis; Klin Mbl Augenheilk 200:529-531

 

29.   DUMMER R, BECKER JC, BOSER B, HARTMANN AA, BURG G (1992): Succesful Therapy of Metastatic Eccrine Poroma Using Perilesional Interferon Alfa and Interleukin 2; Arch Dermatol 128:1127-1128

 

30.   HÜRLIMANN AF, WüTHRICH B, BURG G (1992: Infantile Akropustulose; Z Hautkr 67(12):1073-1079

 

31.   GOLDSTEIN RK, AUGUSTIN A, MILZ J, BURG G, LUTZ J (1992) Influence of free radical scavengers on myeloperoxidase activity and lipid peroxidation in acute skin grafts; Adv Exp Med Biol 316:253-258

 

32.   TRÜEB RM, BURG G (1993): Acute Generalized Exanthematous Pustulosis due to Doxycycline; Dermatology 186:75-78

 

33.   TRÜEB RM, BURG G (1993): Unilaterale “naevoide” Spidernaevi; VASA, Band 22;1:82-85

 

34.   TRÜEB RM, PANIZZON RG, BURG G (1993): Cutaneous Ossification in Albrights Hereditary Osteodystrophy; Dermatology 186:205-209

 

35.   BALLMER BK, WIDMER M, BURG G (1993); Acetylsalicylsäure-induzierte generalisierte Pustulose; Schweiz Med Wschr 123:542-546

 

36.   DUMMER R, ZILLIKENS D, BURGER M, BURG G (1993): Relapsing polychondritis: Presentation of three cases and discussion of therapeutic regimes; acta dermatovenerologica A.P.A. 1:21-24

 

37.   PLÄNITZ V, BURG G (1993): Topische Kortikoid-Therapie bei Ekzemen.. Klinische Studie zur Relation von Wirkstärke und Verträglichkeit in der Therapie von Ekzemen mit Amcinonid Creme und Prednicarbat Creme; Dermatol Monatsschr 179:123-127

 

38.   WIDMER M, REVERDIN E, KÜNG E, VESTI B, BOLLINGER A, LINKE RP, BURG G (1993): Amyloidosis cutis nodularis atrophicans (Gottron); Hautarzt 44:319-323

 

39.   KRASOVEC M, ELSNER P, BURG G (1993): Generalized Eczematous Skin Rash.  Possibly due to HMG-CoA.  Reductase Inhibitors; Dermatology 186:248-252

 

40.   TRÜEB RM, PANIZZON RG, BURG G (1993): Non-recreational Pseudomonas aeruginosa folliculitis.Report of two cases and review of the literature; Eur J Dermatol 3:269-272

 

41.   TRÜEB RM, BURG G (1993): Idiopathic Middermal Elastolysis; Dermatology 187:62-66

 

42.   HÜRLIMANN AF, WüTHRICH B, BURG G (1992); Infantile Akropustulose; Z Hautkr 67(12):1073-1079

 

43.   GOLDSTEIN RK, AUGUSTIN A, MILZ J, BURG G, LUTZ J (1992); Influence of free radical scavengers on myeloperoxidase activity and lipid peroxidation in acute skin grafts; Adv Exp Med Biol 316:253-258

 

44.   TRÜEB RM, ELSNER P, BURG G (1993); Pseudomonas-aeruginosa-Follikulitis nach Epilation; Hautarzt 44:103-105

 

45.   TRÜEB RM, BURG G (1993); Unilaterale “naevoide” Spidernaevi; VASA, Band 22;1:82-85

 

46.   TRÜEB RM, PANIZZON RG, BURG G (1993); Cutaneous Ossification in Albrights Hereditary Osteodystrophy; Dermatology 186:205-209

 

47.   DUMMER R, ZILLIKENS D, BURGER M, BURG G (1993); Relapsing polychondritis: Presentation of three cases and discussion of therapeutic regimes; acta dermatovenerologica A.P.A. 1:21-24

 

48.   PLÄNITZ V, BURG G (1993); Topische Kortikoid-Therapie bei Ekzemen.; Klinische Studie zur Relation von Wirkstärke und Verträglichkeit in der Therapie von Ekzemen mit Amcinonid Creme und Prednicarbat Creme; Dermatol Monatsschr 179:123-127

 

49.   WIDMER M, REVERDIN E, KÜNG E, VESTI B, BOLLINGER A, LINKE RP, BURG G (1993); Amyloidosis cutis nodularis atrophicans (Gottron); Hautarzt 44:319-323

 

50.   TRÜEB RM, PANIZZON RG, BURG G (1993); Non-recreational Pseudomonas aeruginosa folliculitis.Report of two cases and review of the literature; Eur J Dermatol 3:269-272

 

51.   TRÜEB RM, BURG G (1993); Idiopathic Middermal Elastolysis; Dermatology 187:62-66

 

52.   HAFNER J, PANIZZON R, BRUCKNER-TUDERMAN L, WÜTHRICH B, SEGER RA, BURG G (1993); Lupus-erythematodes-discoides-artige Dermatose bei einer Konduktorin der septischen Granulomatose; Hautarzt 44:452-456

 

53.   BURG G (1993): Collision Dermatosis: Angiolymphoid Hyperplasia with Eosinophilia Developing within a Congenital Port Wine Nevus (Case Report); Dermatology, 187:293-295

 

54.   DOMMANN STNW, WIDMER M, DOMMANN-SCHERRER C, BERNASCONI E, BURG G (1994);Actinobacillus actinomycetemcomitans isoliert aus einem Mycetom (des Vorderarms); Hautarzt 45:402-405

 

55.   BALLMER-WEBER BK, DUMMER R, KÜNG E,  BURG G, BALLMER PE (1995); Interleukin 2-induced increase of vascular permeability without decrease of the intravascular albumin pool; Br J Cancer 71: 78-82

 

56.   TRÜEB RM, BECKER-WEGERICH P, HAFNER J, WÜTHRICH, BURG G (1995); Relapsing eosinophilic perimyositis; Br J Dermatol 133: 109 – 114

 

57.   TRÜEB RM, HÜRLIMANN AF, BURG G (1995); Periarteriitis nodosa cutanea; Hautarzt 46: 568 – 572

 

58.   KRASOVEC M, ELSNER P, BURG G (1995); Cowden’s syndrome; Hautarzt 46 (7): 472-476

 

59.   LÜBBE J, KORMANN A, ADAMS V, HASSAM S, GRÄTZ KW, PANIZZON RG, BURG G (1996); HPV-11-and HPV-16-Associated Oral Verrucous Carcinoma; Dermatology 192: 217-221

 

60.   KÄGI M, TRÜEB R, WÜTHRICH B, BURG G (1996); Confluent and reticulated papillomatosis associated with atopy. Successful treatment with topical urea and tretinoin; Br J Dermatol134: 372 – 382

 

61.   TRÜEB RM, TSAMBAOS D, SPYCHER MA, MÜLLER J, BURG G (1997); Scarring Folliculitis in the Ectrodactyly-Ectodermal Dysplasia-Clefting Syndrome; Dermatology 194: 191 – 194

 

62.   TRÜEB RM, LÜBBE J, TORRICELLI R, PANIZZON RG, WÜTHRICH B, BURG G (1997);Eosinophilic Myositis With Eosinophilic Cellulitis like Skin Lesions; Association with increased serum levels of eosinophil cationic protein and interleukin-5; Arch Dermatol 133: 203 – 206

 

63.   BARRAUD-KLENOVSEK MM, LÜBBE J, BURG G (1997); Primary Digital Clubbing Associated with Palmoplantar Keratoderma; Dermatology 194: 302 – 305

 

64.   TRÜEB RM, PERICIN M, KOHLER E, BARANDUN J, BURG G (1997); Necrotizing granulomatosis of the breast; Br J Dermatology 137: 799 – 803

 

65.   DÖBBELING U, BÖNI R, HÄFFNER A, DUMMER R, BURG G (1997); Method for Simultaneous RNA and DNA Isolation from Biopsy Material, Culture Cells, Plants and Bacteria; BioTechniques 22 (1): 88 – 90

 

66.   BADER U, HAFNER J, BURG G (1999); Erythrodermie und Äthylabusus; Schweiz. Med. Wochenschr 129: 508 – 513

 

67.   XIN H, MATT D, QIN J-Z, BURG G, BÖNI R (1999); The Sebaceus Nevus: A Nevus with Deletions of the PTCH Gene; Cancer Research 59: 1834 – 1836

 

68.   FUCHS D, QUERINGS K, BURG G, BÖNI R (1999); Persistierendes Erythem nach CO2-Total-Skinresurfacing; Schweiz Med Wochenschr 129: 813 – 817

 

69.   SHEPHARD SE, ZOGG M, BURG G, PANIZZON RG (1999); Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood; Arch Dermatol Res 291: 491 – 499

 

70.   FRITZ T, BURG G, HAFNER J (1999); Eyebrow reconstruction with free skin abd hair-bearing composite graft. ; J Am Acad Dermatol 41: 1008 – 1010

 

71.   CARROZZA P, HÄUSERMANN P, NESTLE FO, BURG G, BÖNI R (2000); Clinical Efficacy of Narrow-Band UVB (311 nm) Combined with Dithranol in Psoriasis; Dermatology 2000; 200: 35 – 39

 

72.   BÖNI R, XIN H, HOHL D, PANIZZON R, BURG G (2001); Syringocystadenoma Tumor Suppressor Genes; A Study of Potential Tumor Suppressor Genes; Am J of Dermatopath 23(2): 87 – 89

 

73.   SENTI G, HESS SCHMID M, BURG G (2001); Multiple miliäre Osteomata cutis. Exstirpation mittels "front-lift"-Zugang; Hautarzt 52: 522 – 525

 

74.   SCHMOOK T, BURG G, HAFNER J (2001):Surgical Pearl: Mini.incisions for the extraction of steatocystoma multiplex; J Am Acad Dermatol 44: 1041 – 1042

 

75.   KREYDEN O P, SCHMID-GRENDELMEIER P, BURG G (2001); Case Report of successful Treatment with Botulinim Toxin Typ A and review of Literature; Arch Dermatol. 2001; 137: 1622-1625

 

76.   PAPP KA, GUENTHER L, BOYDEN B, LARSEN FG, HARVIMA RJ, GUILHOU JJ, KAUFMANN R, ROGERS S, VAN DE KERKHOF PCM, HANSSEN LI, TEGNER E, BURG G, TALBOT D, CHU A (2003); Early onset of action and efficacy of a combination of calcipotriene and betamethasone dipropionate in the treatment of psoriasis; J Am Acad Dermatol 2003; 48 (1): 48-54

 

77.   LÄEUCHLI S, KEMPF W, DRAGIEVA G, BURG G, HAFNER J (2003); CO-Laser Treatment of Warts in Immunosuppressed Patients; Dermatology 2003; 206:148-152

 

78.   ZAGRODNIK B, KEMPF W, SEIFERT B, MÜLLER B, BURG G, UROSEVIC M, DUMMER R (2003); Superficial Radiotherapy for Patients with Basal Cell Carcinoma; Cancer 2003: 98; 2708-2714

 

79.   PRINZ BM, VAVRICKA SR, GRAF P, BURG G, DUMMER R; Efficacy of laser treatment of tattoos using lasers emitting wavelengths of 532 nm, 755 nm and 1064 nm; British Journal of Dermatology 2004: 150; 245-251

 

80.   UROSEVIC M, KAMARASHEV J, BURG G, DUMMER R (2004); Primary cutaneous CD8+ and CD56+ T-cell lymphomas express HLA-G and killer-cell inhibitory ligand, ILT2; Blood, 2004: 103; 1796-1798

 

81.   ZAGRODNIK, KEMPF W, SEIFERT B, MULLER B, BURG G, UROSEVIC M, DUMMER R (2003; Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2; Cancer 2003: 98; 2708-14

 

82.   PRINZ BM, HAFNER J, DUMMER R, BURG G, BRUSWANGER U, KEMPF W (2004); Treatment of Bowen’s disease with Imiquimod 5% cream in transplant recipients; Transplantation 2004; 77: 790-793

 

83.   LÄUCHLI S, ZORTEA-CAFLISCH C, NESTLE FO, BURG G, KEMPF W (2004); Nephrogenic Fibrosing Dermopathy Treated with Extracorporeal Photopheresis; Dermatology 2004; 208: 278-280

 

84.   BURG G, KAUDEWITZ P (1986) ; Glucocorticoide (G.) und Lymphozyten; Z Hautkr 61 (Suppl.2) 105-115

 

85.   BURG G, NEUBERT U (1987) ; Die Lyme-Krankheit aus dermatologischer Sicht; Colloquia rheumatologica 35: 128-135

 

86.   BURG G, BERGNER T (1989) ; Pigmentary Disorders Associated With Nutritional Deficiency States; Clinics in Dermatology 7: 36-43

 

87.   DUNKEL FG, BURG G (1992) ; Pathogenese der Psoriasis - Neue Ergebnisse; Fortschr Med 25:457-461

 

88.   BURG G, DUMMER R (1992); Neue Behandlungsmethoden bei Hauttumoren; Schweiz Rundschau Med 81:610-614

 

89.   BÖNI R, DUMMER R, BURG G (1995); Nehmen Hauttumoren zu? (Are skin tumors on the increase?); Schweiz Med Wochenschr 125: 1619 – 1624

 

90.   TRÜEB RM, PERICIN M, WINZELER B, WÜTHRICH B, BURG G (1997); Eosinophilic myositis/perimyositis: Frequency and spectrum of cutaneous manifestations; J Am Acad Dermatol; 37: 385 – 391

 

91.   BÖNI R, BURG G (1999); Der atypische Naevus: eine Risikosituation?; Schweiz Med Wochenschr 129: 825 – 832

 

92.   SENTI G, KRASOVEC M, KOMMINOTH P, BURG G (2000); Hautveränderungen bei neuroendokrinen Tumoren; hautnah 2: 8 – 18

 

93.   KREYDEN OPH, BÖNI R, BURG G (2000); Botulintoxin A: Die gifte Lösung in der Behandlung der Hyperhidrose; hautnah 2: 46 – 50

 

94.   KREYDEN O.PH, BÖNI R, BURG G (2000); Botulinumtoxin A: Ein neuer Weg in der Behandlung der fokalen Hyperhidrose; Praxis 2000: 89: 909 – 915

 

95.   BÖNI R, KREYDEN OPH, BURG G (2000); Revival of the Use of Botulinum Toxin: Application in Dermatology; Dermatology 200: 287 – 291

 

96.   KREYDEN OPH, BURG G (2000); Die Giftbehandlung von Schweissperlen; Schweiz Med Wochenschr 130: 1084 – 1090

 

97.   BÖNI R, BURG G (2000); Altershaut: physiologische Grundlagen, prophylaktische Massnahmen und Therapieansätze; Schweiz Med Wochenschr 130: 1272 – 1278

 

98.   BÖNI R, KARGL A, KREYDEN OPH, BURG G (2000); Botulinum A. Gift gegen Falten; Hautnah Schweiz 5:20-22

 

99.   KREYDEN OP, GEIGES ML, BURG G (2000); Botulinumtoxin: Vom Gift zum Medikament; Hautarzt 51: 733 – 737

 

100.DUMMER R, BEYELER M, MORCINEK J, BURG G (2003); Neoplasien der Haut (Cutaneous Neoplasms); Praxis 2003; 92: 1470-1478

 

101.BURG G (2000); The Lancet Reprint Collection; The Lancet 2000

 

102.BURG G (2001) ; The Lancet Reprint Collection; The Lancet 2001

 

103.HAFNER J, KEMPF W, HESS SCHMID M, KURZ M, UROSEVIC M, DUMMER R, BURG G (2002); Epitheliale Hauttumore – Eine interdisziplinäre Aufgabe für Grundversorger und Spezialisten; Schweiz Med Forum Nr. 16, 17. April 2002 (369-375)

 

104.BURG G (2002); Public Education in Skin Cancer World-Wide; (Buch) Cancers of the Skin / Proceedings of the 8th World Congress (S 3 – 6); Springer Verlag, Berlin / Heidelberg / New York

 

105.BURG G, KETTELHACK N (2002); Haut und Alkohol; Dtsch Arztebl 2002; 99:A 2712-2716 (Heft 41)

 

106.PRINZ BM, VAVRICKA SR, GRAF P, BURG G, DUMMER R (2002); Tätowierungen und wie man sie wieder los wird; Hautnah Schweiz 6: 19-27

 

107.LÄUCHLI S, BURG G (2003); Treatment of Hyperhidrosis with Botolinum Toxin A; Skin Therapy Letter 2003; 7: 1-4

 

108.PRINZ B M, VAVRICKA S R, GRAF P, BURG G, DUMMER R (2004); Dermatological Surgery and Lasers; Efficacy of laser treatment of tattoos using lasers emitting wavelengths of 532 nm, 755 nm and 1064 nm; British Journal of Dermatology 2004; 150: 245-251

 

109.BEYELER M, DUMMER R, BURG G, HAFNER J, KEMPF W (2004)¸Mesenchymale Hauttumore: klinische Aspekte¸Schweiz Med Forum 2004; 4: 443-448

 

110.BEYELER M, KEMPF W, HAFNER J, BURG G, DUMMER R (2004); The Spectrum of Mesenchymal Skin Neoplasms Reflected by the New WHO Classification; ONKOLOGIE 2004;27:401-406; SCHUSTER CH, BURG G (2004): Das rote Gesicht. Praxis 2004; 93; 1727 – 1732

 

111.BEYELER M, DUMMER R, BURG G, HAFNER J, KEMPF W (2004): Mesenchymale Hauttumore: klinische Aspekte. Schweiz Med Forum 2004; 4: 443-448

 

112.SCHUSTER CH, BURG G (2004): Das rote Gesicht. Praxis 2004; 93; 1727 – 1732

 

113.GEIGES M.L, BURG G (2005):Bildhaftes in der Dermatologie / Iconography in Dermatology. Aktuelle Dermatologie 2005; 31: 67-78

 

114.KEMPF W, DUMMER R, HOFBAUER G,BINSWANGER U, BURG G (2006): Hautveränderungen bei Transplantatempfängern. Dtsch Artebl 2006; 103(34-35):A 2245-9

 

115.Burg G, Gonseth R (2016): Nepal: ein interessante Destination für Ihre Kongressagenda. Dermatologica Helvetica

 

116.BURG G (1981): Spinozelluläre Karzinome der Haut. In: G.W. Korting (Hrsg.): Dermatologie in Praxis und Klinik. 41. Maligne Hauttumoren, S. 41.1-41.20. Georg Thieme Verlag Stuttgart, New York, Vol. IV

 

117.BÖNNINGER F, BURG G (1981): Multiple Keratoakanthome. In: J. Peters, R. Müller (Hrsg.): Präkanzerosen und Papillomatosen der Haut, S. 139-143. Springer Verlag, Berlin-Heidelberg-New York

 

118.BURG G, BERGNER T (1989): Pigmentary disorders associated with nutritional deficiency states. In: R. Mackie (ed): Disorders of Cutaneous Pigmentation, Clinics in Dermatology, Vol 7, 2: 36-43. J.B. Lippincott Comp., Philadelphia

 

119.STOLZ W, GRAUBNER U, GERSTMEIER J, BURG G, BELOHRADSKY BH (1989): Chédiak-Higashi Syndrome: Approaches in Diagnosis and Treatment. In: Fritsch P, Schuler G, Hintner H (eds): Immunodeficiency and Skin, Vol 18: 93-100. Curr Probl Dermatol, Basel, Karger

 

120.HARTMANN AA, BRUNNER FX, BURG G, HÖHMANN D (1994): Tumoren des äusseren Ohres. In: Hans Heinz Naumann, Jan Helms, Claus Herberhold, Ernst Kastenbauer (eds): Oto-Rhino-Laryngologie in Klinik und Praxis (3 Bände), S. 518. Georg Thieme Verlag Stuttgart, New York

 

121.BURG G (1995): Neutrophilic Eccrine Hidradentitis. In: J. Demis (ed.): Clinical Dermatology. Lippincott - Raven Publishers, Philadelphia, New York

 

122.BURG G, BÖNI R (1995): Neue Verfahren in der dermatoonkologischen Diagnostik. In: W. Tilgen, D. Petzoldt (eds.): Operative und konservative Dermato-Onkologie, S. 13-20. Springer Verlag Berlin-Heidelberg

 

123.BURG G, BORELLI S (1995): Umwelteinflüsse und kutane Neoplasien. In: Tebbe B, Goerdt S, Orfanos CE (Hrsg.): Dermatologie. Heutiger Stand. S. 207 – 211. Ergebnisse und Berichte der 38. Tagung der Deutschen Dermatologischen Gesellschaft in Berlin vom 29. April bis 3. Mai 1995. Georg Thieme Verlag Stuttgart - New York

 

124.HAFNER J, WALDESBÜHL-AMMANN R, STORTO S, GRAF M, HUSZAR A, GROB M, KRAYENBÜHL B, BURG G (1998): Gehört eine kosmetologisdche Sprechstunde an die Dermatologische Universitätsklinik? S. 239 – 245. In: B. Konz, Wörle B, Chr.A. Sander (Hrsg.): Ästhetische und korrektive Dermatologie. Fortschritte der operativen und onkologischen Dermatologie. Band 14

 

125.BURG G, SENTI G (1999): Differentialdiagnose der Lippenschwellungen, S. 580 – 583. In: G. Plewig, H. Wolff (Hrsg.). Fortschritte der praktischen Dermatologie und Venerologie 1998. Springer Verlag Berlin, Heidelberg, New York

 

126.BÖNI R, MATT D, HONG X, BURG G (1999): Die Mikrodissektion: Anwendung in der onkologischen Dermatologie, S. 43 – 45. In: A. Plettenberg, W.N. Meigel, I. Moll (Hrsg.): Dermatologie an der Schwelle zum neuen Jahrtausend . Aktueller Stand von Klinik und Forschung. Springer Verlag Berlin, Heidelberg, New York

 

127.KEMPF W, BURG G (1999): Tumors of the Epidermis. In:  G. Burg (Hrsg): Atlas of Cancer of the Skin, S. 1 - 26 . Churchill Livingstone, New York

 

128.KRASOVEC M, BREITBACH T, BURG G (1999): Connective Tissue Tumors.. In:  G. Burg (Hrsg): Atlas of Cancer of the Skin, S. 157 - 166 . Churchill Livingstone, New York

 

129.BURG G, KEMPF W (2009): Seltene Hauttumore bei alten Menschen.. In: Fortschritte der praktischen Dermatologie und Venerologie 2008.. Hrsg. T. Ruzicka, H. Wolff, P.Thomas, J. Prinz, Vol. 21, 107-113. Springer, Berlin 2008

 

 

 

Allergologie/Immunologie/Dendritic Reticulum Cells (DRC)

 

1.     BRAUN-FALCO O, BURG G (1970): Histochemische und cytochemische Untersuchungen bei der allergischen DNCB-Kontakt­dermatitis des Meerschweinchens ; Arch klin exp Derm 239: 307-322

 

2.     BRAUN-FALCO O, BURG G (1974): Celluläres Infiltrat und Capillaren bei Neurodermitis diffusa; Arch Derm Forsch 249: 113-124

 

3.     KERL H, BURG G, BRAUN-FALCO O (1974) : Quantitative and qualitative dynamics of the epidermal and cellular inflammatory reaction in primary toxic and allergic dinitrochlorobenzene contact dermatitis in guinea pigs; Arch Derm Forsch 249: 207-226

 

4.     v. LIEBE V, KARGE HJ, BURG G (1979): Kontakturtikaria; Hautarzt 30: 544-546

 

5.     KOLZ R, LONSDORF G, BURG G (1980): Unverträglichkeitsreaktionen nach parenteraler Gabe von Vitamin B 1; Hautarzt 31: 657-659

 

6.     LANDTHALER M, BURG G, ZIRBS S (1981): Farbstoff- und Nickelallergie im Friseurgewerbe; Hautarzt 32: 281-284

 

7.     BURG G, ROGL M (1981) : Allergische Kontaktdermatitis auf Methakrylsäureester-haltige Zahnprothesen; Hautarzt 32: 607

 

8.     FÖRG T, BURG G, ZIRBS S (1982) : Häufigkeitsanalytische Untersuchungen allergischer Kontaktekzeme bei Hausfrauen; Dermatosen in Beruf und Umwelt 30: 48-51

 

9.     RING J, LONSDORF G, SCHURY W, BURG G (1982): Bienen- und Wespengiftallergie; Münch med Wschr 124: 587-590

 

10.   PRZYBILLA B, KLÖVEKORN N, BURG G (1982) Dyshidrosiforme Reaktion und Nickelkontaktallergie; Allergologie 5: 252-255

 

11.   LONSDORF G, ROGL M, BURG G (1982): Stomatitis prothetica;Allergologie 5: 256-258

 

12.   LUDERSCHMIDT C, HEILGEMEIR G, RING J, BURG G (1982) : Polyvalente Kontaktallergie versus "Angry-Back": Zur Problematik falsch-positiver Epikutan­testreaktionen; Allergologie 5: 262-264

 

13.   PRZYBILLA B, RING J, BURG G (1983) : Anaphylaxie nach Kaffeegenuß, chronische Urtikaria und Analgetika-Idiosynkrasie; Hautarzt 34: 73-76 RING J, BODE U, KADACH U, STIX E, BURG G (1983) : Gammaglobuline und Allergie; Münch Med Wschr 125: 289-292

 

14.   PRZYBILLA B, BURG G, THIEME CH (1983): Evaluation of the immune status in vivo by the 2,4-dinitro-1-chlorobenzene contact allergy time (DNCB-CAT); Dermatologica 167:1-5

 

15.   BURG G, KRIEG TH (1983): Sind Epikutantestbestecke verschiedener Hersteller miteinander vergleichbar? Anfragen aus der Praxis; Hautarzt 34: 580-583

 

16.   HOFMANN C, RICHTER W, HILLER C, BURG G (1987) : Urtikaria-Vaskulitis; Z Rheumatol 46: 233-236

 

17.   BURG G, PRZYBILLA B (1987) : Aging of cellular immunity; G It Chir Derm Onc 2: 228-231

 

18.   ENDERS F, PRZYBILLA B, RING J, BURG G, BRAUN-FALCO O (1988): Epikutantestung mit einer Standardreihe; Hautarzt 39: 779-786

 

19.   BURG G, FRÖSCHL M, AICHNER L, RING J (1988): DNCB-Sensibilisierung bei HIV-Positiven; Hautarzt 39, S VIII: 166-167

 

20.   GOLDHAUSEN R, ENDERS F, PRZYBILLA B, BURG G, RING J (1988): Trends in allergic contact sensitization; Contact Dermatitis 18:147-154

 

21.   ENDERS F, PRZYBILLA B, RING J, BURG G (1989): Epikutantest-Ergebnisse bei Krankenschwestern; Dermatosen 37: 227-229

 

22.   MEHRINGER A, HARTMANN AA, BURG G (1990): Fünf Fälle einer Kontaktallergie durch Naftifin (Exoderil®); Akt Dermatol 16: 193-195

 

23.   ELSNER P, PEVNY I, BURG G (1990): Anaphylaxis induced by topically applied Bacitracin; Am J Contact Dermatitis 1: 162-164

 

24.   DUNKEL FG, ELSNER P, PEVNY I, BURG G (1990): Olaquindox-Induced Photoallergic Contact Dermatitis and Persistent Light Reaction; Am J Contact Dermatitis 1: 235-239

 

25.   DUNKEL FG, ELSNER P, PEVNY I, RÖGER J, BURG G (1990): Amcinoide-Induced Contact Dermatitis - Possibly Due to the Ketal Structure; Am J Contact Dermatitis 1: 246-249

 

26.   ELSNER P, PEVNY I, BURG G (1990): Occupational contact dermatitis due to glyoxal in health care workers; Am J Contact Dermatitis 1: 250-253

 

27.   HACKEL H, MILLER K, ELSNER P, BURG G (1991): Unusual combined sensitization to palladium and other metals; Contact Dermatitis 24: 131-132

 

28.   HACKEL H, ELSNER P, BURG G (1991): Sensitization to olive oil; Am J Contact Dermatitis 2: 50-51

 

29.   SCHULZ A, ELSNER P, BURG G (1991): Quantification of irritant contact dermatitis in vivo: Comparison of the Dermatest® system with the evaporimeter; Contact Dermatitis 24: 235-237

 

30.   GROTHAUS W, MÜLLER W, ELSNER P, BURG G, HARTMANN AA (1991) : Berufsdermatologische Gutachten und die Folgen. Eine Follow-up-Studie; Z Hautkr 66:951-953

 

31.   DUNKEL FG, ELSNER P, BURG G (1991): Contact allergies to topical corticosteroids: 10 cases of contact dermatitis; Contact Dermatitis 25:97-103

 

32.   DUNKEL FG, ELSNER P, PEVNY I, HARTMANN AA, BURG G, (1991): Kontaktekzem durch lokale Kortikoide - 10 Fälle aus der Würzburger Hautklinik; Z Hautkr 66:946-950

 

33.   DUNKEL FG, ELSNER P, BURG G (1991): Allergic contact dermatitis from prednicarbate; Contact Dermatitis 24:59-60

 

34.   BECKER JC, DUMMER R, VON WUSSOW P, BURG G, SCHMIDT RE (1992) Non-MHC-restricted T-cell interaction with B cells: role of the T-cell receptor; Scand J Immunol 36:177-181

 

35.   BURG G (1993): Die DNCB-Kontaktallergie-Zeit (KAZ) zur Erfassung des Immunstatus bei HIV-positiven Patienten; H + G 68; 1:11-14

 

36.   DUMMER R, MEYER JCH, BALLMER-WEBER BK, MULETTA S, PANIZZON R, BURG G (1993): UVA suppresses shedding of ICAM-1 from interferon- (IFN-)-pretreated transformed keratinocytes; Arch Dermatol Res 285:230-232

 

37.   BECKER JC, DUMMER R, VON WUSSOW P, BURG G, SCHMIDT RE (1992); Non-MHC-restricted T-cell interaction with B cells: role of the T-cell receptor; Scand J Immunol 36:177-181

 

38.   BLUM C, ZILLIKENS D, TONY H-P, HARTMANN AA, BURG G (1993); Der lösliche Interleukin-2-Rezeptor als Aktivitätsparamenter im Serum von systemi­schem und diskoidem Lupus erythematodes; Hautarzt 44:290-295

 

39.   DUMMER R, MEYER JCH, BALLMER-WEBER BK, MULETTA S, PANIZZON R, BURG G (1993); UVA suppresses shedding of ICAM-1 from interferon- (IFN-)-pretreated transformed keratinocytes; Arch Dermatol Res 285:230-232

 

40.   WYSS M, ELSNER P, WÜTHRICH B, BURG G (1993); Allergic contact dermatitis from natural latex without contact urticarial; Contact Dermatitis 28:154-156

 

41.   VON THIESSEN R, ELSNER P, BURG G (1993); Common Ivy (Hedera helix L subspecies helix): Allergic Contact Dermatitis; Am J Contact Dermatitis 3:169-171

 

42.   BECKER JC, SCHWINN A, DUMMER R, BURG G, BRÖCKER EB (1993); Lesion-Specific Activation of Cloned Human Tumor-Infiltrating Lymphocytes by Autologous Tumor Cells: Induction of Proliferation and Cytokine Production; J Invest Dermatol 101:15-21

 

43.   ELSNER P, BURG G (1993); Irritant Reactivity Is a Better Risk Marker for Nickel Sensitization than Atopy; Acta Derm Venereol (Stockh) 73:214-216

 

44.   HINNEN U, ELSNER P, BURG G (1995); Assessment of skin irritancy by 2 short tests compared to acute irritation induced by sodium lauryl sulfate; Contact Dermatitis 33: 236 – 239

 

45.   DUMMER R, POSSECKERT G, SUGAMURA K, GRUNDMANN H, BURG G (1996); Circulating Interleukin-2 Receptors Are a Group of Multimeric Proteins with Immunoreactivity for Interleukin-2 Receptor , ß and Chains; J of Interferon and Cytokine Research 16: 315-320

 

46.   NESTLE F, BURG G, FÄH J, WRONE-SMITH T, NICKOLOFF BJ (1997); Human Sunlight-Induced Basal-Cell-Carcinoma-Associated Dendritic Cells Are Deficient in T Cell Co-Stimulatory Molecules and Are Impaired as Antigen-Presenting Cells; Am J Pathol 150: 641 – 651

 

47.   WYSS M, ELSNER P, HOMBERGER H-P, GRECO P, GLOOR M, BURG G (1997); Follikuläres Kontaktekzem auf eine Tocopherol-linoleat-haltige Körpermilch; Dermatosen 45 (1) 25 – 28

 

48.   NESTLE FO, FILGUEIRA L, NICKOLOFF BJ, BURG G (1998); Human Dermal Dendritic Cells Process and Present Soluble Protein Antigens; J Invest Dermatol 110: 762 – 766

 

49.   WIGGER-ALBERTI W, CADUFF L, BURG G, ELSNER P (1999); Experimentally induced chronic irritant contact dermatitis to evaluate the efficacy of protective creams in vivo; J Am Acad Dermatol 40 (4): 590 – 596

 

50.   FRITZ TM, BURG G, KRASOVEC M (2201); Dermatite de contact allergique aux cosmétiques à base de Melaleuca alternifolia (tea tree oil) ; Ann Dermatol Venereol 128: 123 – 126

 

51.   Mathias Tremp,  Imke Knafla, Günter Burg, Brunello Wüthrich, Peter Schmid-Grendelmeier  (2011); ‘EASIdig’ – A Digital Tool to Document Disease Activity in Atopic Dermatitis ; Dermatology 2011

 

52.   NESTLE FO, BURG G (1999); Dendritic cells: role in skin diseases and therapeutic application; Clinical and Experimental Dermatology 24: 204 – 207

 

53.   BURG G, PRZYBILLA B, BOGNER J (1986): Contact-Allergy Time. In: J. Ring and G. Burg (eds): New Trends in Allergy II, S. 230-238. Springer Verlag, Berlin-Heidelberg-New York

 

54.   HOFMANN C, BURG G, JUNG C (1988): Nebenwirkungen der Goldtherapie an der Haut. Klinische und histologische Ergebnisse. In: H. Holzmann, P. Altmeyer, H.G. Vogel (Hrsg.): Dermatologie und Rheuma. Springer, Berlin-Heidelberg-New York

 

55.   DUMMER R, BECKER JC, HARTMANN AA, EILLES C, BURG G (1992): Immunmodulation: Neue Wege in der Tumortherapie. In: G Burg, AA Hartmann, B Konz (Hrsg.): Onkologische Dermatologie. S 143-152. Springer Verlag, Berlin-Heidelberg-New York

 

56.   NESTLE FO, MÜLLER B, NICKOLOFF BJ, BÜCHNER ST, BURG G (1996): Umgehung des menschlichen Immunüberwachungssystems bei Hauttumoren: Bedeutung von tumorassoziierten antigenpräsentierenden Zellen und kostimulatorischen Molekülen. . In: R. Dummer, R. Panizzon, G. Burg (Hrsg.): Fortschritte der operativen und onkologischen Dermatologie, Band 11, S. 226 – 231. Operative und konservative Dermatoonkologie im interdisziplinären Grenzbereich. Blackwell Wissenschaftsverlag Berlin-Wien 1996

 

57.   BURG G, ASCHOFF A, DUMMER R (1997): Zytokine in der Dermatotherapie, . In: G. Plewig, B. Przybilla (Hrsg.): Fortschritte der praktischen Dermatologie und Venerologie 1996, S. 371 – 376. Springer Verlag Berlin Heidelberg New York 1997

 

58.   DUMMER R, HOFBAUER G, BURG G, BARTLETT RR (1997): Leflunomide.. In: Burg G, Dummer R (Hrsg.): Strategies for immunointerventions in Dermatology, S. 72 – 77. Springer Verlag Berlin Heidelberg New York 1997

 

59.   KLEINHANS M, BURG G, NESTLE F (1999): Chemokine und Chemokinerezeptoren als wichtigstes Kontrollinstrument für die Migration von Leukozyten in die Haut, S. 456 – 459. In: A. Plettenberg, W.N. Meigel, I. Moll (Hrsg.): Dermatologie an der Schwelle zum neuen Jahrtausend . Aktueller Stand von Klinik und Forschung. Springer Verlag Berlin, Heidelberg, New York

 

60.   NESTLE FO, DUMMER R, BURG G, Schadendorf D (1999):Innovative Konzepte zur Immunointervention bei Hauttumoren: Vakzinierung mit Tumorantigen beladenen dendritischen Zellen.. In: A. Plettenberg, W.N. Meigel, I. Moll (Hrsg.): Vakzinierung mit Tumorantigen beladenen dendritischen Zellen.. Springer Verlag Heidelberg

 

 

 

Dermatopathologie

 

1.     KERL H, BURG G, HASHIMOTO K (1983) : Fatal penicillin-induced, generalized, postinflammatory elastolysis (cutis laxa); Am J Dermatopathol 3:267-276

 

2.     SCHANNE R, BURG G, BRAUN-FALCO O (1985): Zur nosologischen Beziehung der Dyskeratosis follicularis (Darier) und des Pemphigus benignus chronicus familiaris (Hailey-Hailey); Hautarzt 36:504-508

 

3.     HOFMANN C, BURG G, JUNG C (1986): Kutane Nebenwirkungen der Goldtherapie. Klinische und histologische Ergebnisse; Z Rheumatol 45:100-106

 

4.     BURG G, LANDTHALER M (1988) : Proliferierender Tricholemmaltumor; Hautarzt 39: 117-119

 

5.     BURG G, BIEBER T, LANGECKER P (1988): Lokalisierte neutrophile ekkrine Hidradenitis unter Mitoxantron: eine typische Zytostatikane­benwirkung; Hautarzt 39: 233-236

 

6.     SCHMOECKEL C, BURG G (1988): Congenital spiradenoma; Am J Dermatopathol 10:541-545

 

7.     ECKERT F, BURG G, BRAUN-FALCO O, SCHMID U, GLOOR F (1989) : Immunostaining in atypical fibroxanthoma of the skin; Path Res Prakt 184: 27-34

 

8.     ZILLIKENS D, MEHRINGER A, LECHNER W, BURG G (1991): Hypo- and hyperpigmented areas in incontinentia pigmenti; Am J Dermatopathol 13: 57-62

 

9.     HERMANEK P, ENCKE A, BURG G (1992): Histologische Untersuchung von Lymphknoten bei Tumorresektionen - Ergebnisse einer Umfrage des Deutschsprachigen TNM-Komitees (DSK); Der Chirurg 31:93-97

 

10.   HAFNER J, HAENSELER E, OSSENT P, BURG G, PANIZZON RG (1995); Benzidine stain for the histochemical detection of hemoglobin in spinter hemorrhage (subungual hematoma) and black heel.; Am J Dermatopathol 17; 4: 362 – 367

 

11.   HÜRLIMANN AF, PANIZZON RG, BURG G (1996); Eruptive Vellus Hair Cyst and Steatocystoma multiplex: Hybride Cysts; Dermatology 1996: 192: 64 – 66

 

12.   GROB M, WYSS M, SPYCHER MA, DOMMANN ST, SCHINZEL A, BURG G TRÜEB RM (1998); Histopathologic and ultrastructural study of lupus-like skin lesions in a patient with Bloom syndrome; J Cutan Pathol 25: 275 – 279

 

13.   BURG G, KEMPF W, HÖCHLI M, HUWYLER T, PANIZZON RG (1998); "Tubular" epitheliod cell nevus: a new variant of Spitz's nevus; J Cutan Pathol 25: 475-478

 

14.   KEMPF W, HÄFFNER AC, MÜLLER B, PANIZZON RG, BURG G (1998); Experts and Gold Standards in Dermatopathology; J Am Dermatopathol 20 (5): 478 – 482

 

15.   FEIT J., KEMPF W., JEDLICKOVA H., BURG G. (2005); Hypertext atlas of dermatopathology with expert system for epithelial tumors of the skin; Journal of Cutaneous Pathology 2005:32:433-437

 

16.   BURG G (1986) ; Pagetoide Hautinfiltrate ; Pathologe 7:199-206BURG G (1986)

 

17.   BURG G, VIELUF D, STOLZ W, LANDTHALER M, BRAUN-FALCO O (1989); Maligne atrophische Papulose (Morbus Köhlmeier-Degos); Hautarzt 40: 480-485

 

18.   ELDER DE, FREEMAN RG, BERGFELD WF, ACKERMANN AB, AZAR HA, FECHNER RE, CAPUTO R, METCALF JS, BORRONI G, BURG G, et al (1992?); Do you use the term “dysplasia”? If so, what do you mean by it, and if not, why not?; Am J Dermatopathol 14:462-486

 

19.   KEMPF W, DUMMER R, BURG G (1999); Approach to Lymphoproliferative Infiltrates of the Skin; Am J Clin Pathol 111 (Suppl. 1): 84 – 93

 

20.   BÖNI R; ZHUANG Z, BURG G, VORTMEYER A (1999); Die Mikrodissektion. Anwendung in der molekularen onkologischen Dermatologie; Hautarzt 50: 98 – 102

 

21.   KAZAKOV DV, BURG G, KEMPF W (2003); Primary cutaneous B-cell lymphomas and pseudolymphomas: review of histopathological features; Cesk Pathol 2003; 38: 147-54

 

22.   KERL H, CERRONI L, BURG G, CERIO R, GOLLNICK H, KUTZNER H, SANGUEZA O (2005); International Board Certifiaction in Dermatopathology. A Worldwide Effort to Raise Standards in Dermatopathology; Am J Dermatopathol, Vol. 27, No. 4, August 2005: P357

 

23.   BEYELER M, KEMPF W, HAFNER J, BURG G, DUMMER R (2004): The Spectrum of Mesenchymal Skin Neoplasms Reflected by the New WHO Classification. ONKOLOGIE 2004;27:401-406

 

24.   KERL H, CERRONI L, BURG G, CERIO R, GOLLNICK H, KUTZNER H, SANGUEZA O (2005): Board Certifiaction in Dermatopathology. A Worldwide Effort to Raise Standards in Dermatopathology. Am J Dermatopathol, Vol. 27, No. 4, August 2005: P357

 

25.   BURG G, GEIGES M, KEMPF W, DUMMER R (2005): Haut und lymphatisches System. In: G. Plewig, P. Kaudewitz, C.A. Sander: Fortschritte der praktischen Dermatologie und Venerologie vol. 19. Springer-Verlag Berlin Heidelberg 2005

 

26.   KERL H, CERIO R, BURG G, YAVUZER ANADOLU R, CHIMENTI S, FORSEA D (2005): Dermatopathology (Chapter 4.10). EDF White Book, Skin Diseases in Europe, 2nd Edition, ABW Wissenschaftsverlag, Editors: Peter Frisch/Walter Burgdorf, ISBN 3-936072-41-8

 

Drugs/Drug Reactions

 

1.     TRÜEB RM, BURG G (1993); Acute Generalized Exanthematous Pustulosis due to Doxycycline; Dermatology 186:75-78

 

2.     TRÜEB R, BURG G(1992); Arzneimittelreaktion auf Amoxicillin unter dem Bild eines toxischen Pustuloderms; Hautarzt 42:713-716

 

3.     ZILLIKENS D, ZENTNER A, BURGER M, HARTMANN AA, BURG G (1993); Pemphigus foliaceus durch Penicillamin; Hautarzt 44:167-171

 

4.     BALLMER BK, WIDMER M, BURG G (1993); Acetylsalicylsäure-induzierte generalisierte Pustulose; Schweiz Med Wschr 123:542-546

 

5.     KRASOVEC M, ELSNER P, BURG G (1993); Generalized Eczematous Skin Rash.  Possibly due to HMG-CoA.  Reductase Inhibitors; Dermatology 186:248-252

 

6.     HEINZERLING L, DUMMER R, WILDBERGER H, BURG G (2000); Cutaneous Ulceration after Injection of Polyethylene-Glycol-Modified Interferon Alpha Associated with Visual Disturbances in a Melanoma Patient (Case Report); Dermatology 201: 154 – 157

 

7.     BERNAND S, SCHEIDEGGER EP, DUMMER R, BURG G (2000); Multifocal Fixed Drug Eruption to Paracetamol, Tropisetron and Ondansetron Induced by Interleukin 2; Dermatology 201: 148 – 150

 

8.     BRAUN-FALCO O, BURG G (1970) ; Cytostatica und Immunsuppressiva in der Dermatologie; Hautarzt 21: 391-397

 

9.     BRAUN-FALCO O, BURG G (1971); Zytostatische und immunsuppressive Behandlung dermatologischer Erkrankungen; Therap Gegenw 110: 488-500

 

10.   DUMMER R, WELTERS H, KEILHOLZ U, TILGEN W, BURG G (1990); Interleukin 2: immunologischer Hintergrund und klinische Anwendung in der Tumortherapie; Hautarzt 41: 53-55

 

11.   BASTIAN BC, RÖMISCH J, PAQUES E.-P, BURG G (1991; Lipokortine und Phospholipasen: neue Aspekte in der Physiologie der Glukokortikosteroidwir­kung; Hautarzt 42: 417-423

 

12.   BURG G, FRITZ H (1994); Unerwünschte Arzneimittelwirkungen im Bereich der Mundhöhle; ZWR 103, 2:103-106

 

13.   DUMMER R, DAVID M, BURG G (1994); Topical Use Of Miltefosine (Hexadecylphosphocholine) In Patients With Cutaneous Neoplasms; Present Status And Perspectives; Drugs of Today (Suppl. B) 30:73-81

 

14.   ELLGEHAUSEN P, ELSNER P, BURG G (1998); Drug-Induced Lichen Planus; Clinics in Dermatology 16 (3): 325 – 332

 

15.   BURG G, DUMMER R (2000); Historical Perspective on the Use of Retinoids in Cutaneous T-Cell Lymphoma (CTCL); Clinical Lymphoma suppl. Vol. 1: 41 – 44

 

EDV/Telemedizin/E-Learning

 

1.     BASTIAN BC, BURG G (1991): Computernetzwerke im Klinikbereich - ein Histologie-Datenbanksystem; Hautarzt 42:376-379

 

2.     SCHMID-GRENDELMEIER P, MASENGA EJ, HAEFFNER A, BURG G (2000); Teledermatology as a new tool in sub-Saharan Africa: An experience from Tanzania; J Am Acad Dermatol 42: 833 – 835

 

3.     BURG G, CIPOLAT C, HAEFFNER A, RUFLI T (2002); Telemedizin – aus der Zukunft nicht wegzudenken; Competence 05/2002

 

4.     HASSE U, KROPF R, BURG G (2004); Telemedizin in der Dermatologie 2003: Eine Übersicht; JDDG 2004; 2, 294-300

 

5.     BURG G, HASSE U, CIPOLAT C, KROPF R, DJAMEI R, SOYER H.P, CHIMENTI S (2005); Teledermatology: Just Cool or Real Tool?; DERMATOLOGY 2005;210:169-173

 

6.     BURG G, HASSE U, CIPOLAT C, KROPF R, DJAMEI R, SOYER H.P, CHIMENTI S (2005) Teledermatology: Just Cool or Real Tool?. DERMATOLOGY 2005;210:169-173

 

7.     BURG G (2009): Blended Learning in der Medizin. DFN Mitteilungen 77 (11),20-21, 2009

 

8.     BURG G, GOLLNICK H, LUGER T, GRILLET JP, VOLC-PLATZER B (2010) : Dermokrates (DMK). Tagesnotizen, JDDG 9, 2010 (8): 731-732

 

9.     Burg G, French L (2012): Gutenberg war gestern. Ein Beitrag zur Ausbildung in der Medizin gestern, heute und morgen. Hautarzt 2012

 

10.  Burg G (2015): Webbasiertes lebenslanges Lernen. Jatros 18 (3), 34-36

 

11.   KEMPF W, REICHLIN S, BURG G (2003): HistoClinC: A Web-Based Telemedicine Application for Clinicopathologic Correlations in Dermatopathology pp213-220. In: G. Burg (ed): Telemedicine and Teledermatology. Curr Probl Dermatol.  vol. 32. Karger-Verlag Basel, 2003

 

12.   CIPOLAT C, BADER U, RUFLI T, BURG G (2003): Teledermatology in Switzerland, pp257-60. In: G. Burg (ed): Telemedicine and Teledermatology. Curr Probl Dermatol.  vol. 32. Karger-Verlag Basel, 2003

 

13.   KROPF R, CIPOLAT C, BURG G (2003): Telemedicine in Europe, pp 247-51. In: G. Burg (ed): Telemedicine and Teledermatology. Curr Probl Dermatol.  vol. 32. Karger-Verlag Basel, 2003

 

14.   BADER U, CIPOLAT C, BURG G (2003): Dermatology online with interactive technology (DOIT), pp 176-81.In: G. Burg (ed): Telemedicine and Teledermatology.Curr Probl Dermatol.  vol. 32. Karger-Verlag Basel, 2003

 

15.   KROPF R, CIPOLAT C, BURG G (2003): Teleteaching tool in dermatology on the web, pp 33-8. In: G. Burg (ed): Telemedicine and Teledermatology. Curr Probl Dermatol.  vol. 32. Karger-Verlag Basel, 2003

 

16.   BURG G, DENZ M (2003): The Telemedical Information Society: doctor’s playground or a contribution to the evolution of healthcare? Pp 2-5. In: G. Burg (ed): Telemedicine and Teledermatology. Curr Probl Dermatol.  vol. 32. Karger-Verlag Basel, 2003

 

17.   BURG G, SOYER H.P., CHIMENTI S (2005): Teledermatology (Chapter 4.11). EDF White Book, Skin Diseases in Europe, 2nd Edition, ABW Wissenschaftsverlag, Editors: Peter Frisch/Walter Burgdorf, ISBN 3-936072-41-8

 

Gefässe, Ulcus

 

1.     HAFNER J, KEUSCH G, WAHL CH, SAUTER B, HÜRLIMANN A, VON WEIZSÄCKER, KRAYENBÜHL M, BIEDERMANN K, BRUNNER U, HELFENSTEIN U, BURG G (1995); Uremic small-artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): A complication of chronic renal failure and benefit from parathyroidectomy; J Am Acad Dermatol: 33: 954 – 962

 

2.     BALLMER-WEBER BK, DUMMER R, KÜNG E,  BURG G, BALLMER PE (1995); Interleukin 2-induced increase of vascular permeability without decrease of the intravascular albumin pool; Br J Cancer 71: 78-82

 

3.     HAFNER J, BRUNNER U, BURG G (1996); Behandlungs-Richtlinien für venöse Beinulzera: Kausaler Therapieansatz und lokale Wundbe­handlung; Treatment guidelines for venous leg ulcers: causal therapy initiation and local wound treatment; Ther Umschau 53; 4: 304 – 308

 

4.     HAFNER J, BOUNAMEAUX H, BURG G, BRUNNER U (1996); Management of venous leg ulcera; VASA 25; 2: 161 – 167

 

5.     KLEEMAN D, KEMPF W, BURG G, HAFNER J (1998); Cutaneous polyarteritis nodosa; VASA 27: 54 – 57

 

6.     VILLENEUVE P, HAFNER J, PRENOSIL JE, ELSNER P, BURG G (1998); A novel culturing and grafting system for the treatment of leg ulcers; Br J Dermatol 138: 849 – 851

 

7.     DUMMER R, GRAF P, GREIF C, BURG G (1998); Treatment of Vascular Lesions Using the VersaPulse® Variable Pulse With Frequency Doubled Neodymium: YAG Laser; Dermatology 197: 158 – 161

 

8.     SLONKOVA V, KINO-oka M, MAZZA S, NIEVERGELT C, PRENOSIL JE, BURG G, HAFNER J (1999): Cultured Epithelial Autografts for the Management of a Chronic Pretibial Leg Ulcer due to Congenital Valvular Aplasia; Dermatology 198: 101 – 103

 

9.     TRÜEB RM, SCHEIDEGGER EP, PERICIN M, SINGH A, HOFFMANN U, SAUVANT G, BURG G (1999); Periarteritis nodosa presenting as a breast lesion: Report of a case and review of the literature.; Br J Dermatol 141: 1117 – 1121

 

10.   HAFNER J, BOTONAKIS I, BURG G (2000): A Comparison of Multilayer Bandage Systems During Rest, Exercise, and Over 2 Days of Wear Time; Arch Dermatol 136: 857 – 863

 

11.   HAFNER J, SCHNEIDER E, BURG G, CASSINA PC (2000); Management of leg ulcers in patients with rheumatoid arthritis or systemic sclerosis: The importance of concomitant arterial and venous disease; J Vasc Surg 32: 322 – 329

 

12.   HAFNER J, SCHADD I, SCHNEIDER E, SEIFERT B, BURG G, CASSINA PC (2000); Leg ulcers in peripheral arterial disease (arterial leg ulcers): Impaired wound healing above the threshold of chronic critical limb ischemia; J Am Acad Dermatol 43: 1001 – 1008

 

13.   LIU JY, HAFNER J, DRAGIEVA G, SEIFERT B, BURG G (2004); Autologous cultured keratinocytes on porcine gelatin microbeads effectively heal chronic leg ulcers; Wound repair and regeneration 2004; 12: 148-156

 

14.   LIU J.Y., BURG G. (2005); An Improved Organ Culture for Regeneration of Pure Autologous Keratinocytes from Small Split-Thickness Skin Specimens; Dermatology 2005: 210:45-48

 

15.   LIU J.Y., HAFNER J., DRAGIEVA G., BURG G. (2004); Bioreactor Microcarrier Cell Culture System (Bio-MCCS) for Large-Scale Production of Autologous Melanocytes; Cell Transplantation 2004:13:809-816

 

16.   HAFNER J, CASSINA P, BRUNNER U, BURG G (1997); Ulcus cruris: Behandlung der schwierigen Fälle; Geriatrie Praxis 8: 29 – 34

 

17.   HAFNER J, KEUSCH G, WAHL C, BURG G (1998); Calciphylaxis: A syndrome of skin necrosis and acral gangrene in chronic renal failure; VASA 27: 137 – 143

 

 

 

Geschichte, Moulagen

 

1.     BRAUN-FALCO O, BURG G, VIELUF D (1990); Geschichte der Münchener Dermatologischen Gesellschaft; Hautarzt 41: 290-294

 

2.     BURG G (1992); Die Dermatologische Klinik des Universitätsspitals; Puls 1993, 1:4-9 (Personalzeitung des Unispitals Zürich)

 

3.     BURG G, GLOOR M (1994);Dermatologische “Evergreens made in Switzerland”. 76. Jahresversammlung der Schweizerischen Gesellschaft für Dermatologie und Venerologie gemeinsam mit der Arbeitsgemeinschaft Dermatologische Onkologie der Deutschen Dermatolo­gischen Gesellschaft; Zürich, 22.-25. September 1994; Dermatologica Helvetica 7:6 – 9

 

4.     GEIGES M.L, BURG G (2005); Bildhaftes in der Dermatologie / Iconography in Dermatology;Aktuelle Dermatologie 2005; 31: 67-78

 

5.     Hafner J, Geiges M, Burg G, French L (2013): Zürich stellt sich vor. Eine beachtliche Geschichte-ein beachtlicher Leistungsausweis. Dermatologie Praxis 2013 (3), 20-22

 

6.     Burg G, Geiges M (2014): Lepra vulgaris:History of Psoriasis. J Turk Acad Dermatol 2014; 8 (3): 1483r1.

 

7.     BURG G, VIELUF D (1988): Geschichte der Münchener Dermatologischen Gesellschaft. In: S. Borelli, O. Braun-Falco et al. (Hrsg.): Geschichte der Dermatologie und Venerologie in München, S. 69-78. Grosse Verlag, Berlin

 

8.     STOIBER E, SCHOLZ A, BURG G (1996): Wachsmoulagen von Hauttumoren. In: R. Dummer, R. Panizzon, G. Burg (Hrsg.): Operative und konservative Dermatoonkologie im interdisziplinären Grenzbereich. S 285 - 287 (Sonderdruck). Fortschritte der operativen und onkologischen Dermatologie Bamd 11. Blackwell Wissenschafts-Verlag Berlin-Wien

 

Haare

 

1.     ZAUN H, BURG G (1969): Pili torti verti (Galewsky-Ronchese) mit Beteiligung von Augenbrauen und Lanugines; Aesthet Med 18: 95-100

 

2.     TRÜEB RM, BURG G (1992): Alopecia triangularis congenital; Dermatol Monatsschr 178:367-370

 

3.     TRÜEB RM, BURG G (1992) Loses Anagen-Haar*¸Hautarzt 43:505-508

 

4.     TRÜEB RM, ELSNER P, BURG G (1993): Pseudomonas-aeruginosa-Follikulitis nach Epilation; Hautarzt 44:103-105

 

5.     AXT M, RÖEGER J, BURG G: Untersuchungen zum Zink- und Kupferspiegel und der Aktivität der Alkalischen Phosphatase im Serum von Patienten mit Alopecia areata; Dermatol Monatsschr 1993, 179:151-155

 

6.     TRÜEB RM, BURG G (1992); Loses Anagen-Haar; Hautarzt 43:505-508

 

7.     AXT M, RÖEGER J, BURG G; Untersuchungen zum Zink- und Kupferspiegel und der Aktivität der Alkalischen Phosphatase im Serum von Patienten mit Alopecia areata; Dermatol Monatsschr 1993, 179:151-155

 

8.     TRÜEB RM, SPYCHER MA, SCHUMACHER F, BURG G (1994); Pili torti et canaliculi bei ektodermaler Dysplasie; Hautarzt 45:372-377

 

9.     TRÜEB RM, BRUCKNER-TUDERMAN L, WYSS M, WIDMER M, WÜTHRICH B, BURG G (1995); Scalp dermatitis, distinctive hair abnormalities and atopic disease in the ectrodactyliy-ectoder­mal dysplasia-clefting syndrome; Br J Dermatol 132: 621-625

 

10.   TRÜEB RM, PERICIN M, HAFNER J, BURG G (1997); Bündelhaar-Follikulitis; Hautarzt 48: 266 – 269

 

11.   GILLIET M, KLEINHANS M, LANTELME E, SCHADENDORF D, BURG G, NESTLE FO (2003); Intranodal injection of semimature monocyte-derived dendritic cells induces T helper type  1 responses to protein neoantigen; Blood 2003: 102; 36-42

 

12.   HAFNER J,NOBBE S, PARTSCH H, LÄUCHLI S,MAYER D,AMANN-VESTI B, SPEICH R, SCHMID C, BURG G, FRENCH L (2010); Martorell hypersensitive ischemic leg ulcer. A model of ischemic subcutaneous arteriolosclerosis.; Arch Dermatol 146: 961-968, 2010

 

Histo-und Cytochemie/Immuncytochemie

 

1.     BRAUN-FALCO O, BURG G (1970): Das entzündliche Infiltrat bei Psoriasis vulgaris; Arch klin exp Derm 236: 297-314

 

2.     BRAUN-FALCO O, BURG G (1970): Zur Histochemie der Capillaren bei Psoriasis vulgaris; Arch klin exp Derm 236: 173-189

 

3.     BRAUN-FALCO O, BURG G (1971): Zur Dynamik der Hautreaktion nach Hornschichtabriß. Histochemische und cytochemische Untersuchungen am Meerschweinchenohr; Arch klin exp Derm 241: 1-14

 

4.     BRAUN-FALCO O, BURG G, SCHOEFINIUS HH (1971): Über die Wirkung von Dithranol (Cignolin®) bei Psoriasis vulgaris. Cyto- und histochemische Untersuchungen; Arch Derm Forsch 241: 217-236

 

5.     BURG G (1976): Fermentcytochemische Befunde proliferationsfähiger Bindegewebszellen in der Haut unter besonderer Berücksichtigung von Lymphocyten, Monocyten, Makrophagen und Histiocyten; Hautarzt, Suppl. I: 310-311

 

6.     BURG G (1976): Fermentcytochemische Befunde proliferationsfähiger Bindegewebszellen in der Haut unter besonderer Berücksichtigung von Lymphocyten, Monocyten, Makrophagen und Histiocyten; Hautarzt, Suppl. I: 310-311

 

7.     LONSDORF G, RING J, BURG G (1981) : Anaphylaktische Reaktionen nach Insektenstichen; Notfallmedizin 7: 409-415

 

8.     BURG G, KERL H, KAUDEWITZ P, BRAUN-FALCO O, MASON DY (1984):Immunoenzymatic  typing of lymphoplasmacytoid skin infiltrates; J Dermatol Surg Oncol 10:284-290

 

9.     GEERTS ML, BURG G, SCHMOECKEL CH, BRAUN-FALCO O (1984) : Alkaline phosphatase activity in non-Hodgkin's lymphomas and pseudolymphomas of the skin; J Dermatol Surg Oncol 10:306-312

 

10.   KAUDEWITZ P, BURG G, KLEPZIG K, MUNKER R, RIEBER P, BRAUN-FALCO O (1984) :Cells reactive with anti-T-cell monoclonal antibodies in malignant cutaneous B-cell lymphomas and pseudolymphomas; J Dermatol Surg Oncol 10:303-314

 

11.   FÄH J, PAVLOVIC J, BURG G (1995);Expression of MxA Protein in Inflammatory Dermatoses; J Histochem Cytochem 43: 47-52

 

12.   NESTLE FO, NICKOLOFF BJ, BURG G (1995); Dermatofibroma. An Abortive Immunoreactive Process Mediated by Dermal Dendritic Cells?; Dermatology 190: 265 – 268

 

13.   Ojnino

 

14.   BÖNI R, BURG G, DOGUOGLU A, ILG EC, SCHÄFER BW, MÜLLER B, HEIZMANN CW (1997); Immunohistochemical localization of the Ca2+ binding S100 proteins in normal human skin and melanocytic lesions; Br J Dermatol 137: 39 – 43

 

15.   GERLINI G, HEFTI HP, KLEINHANS M, NICKOLOFF BJ, BURG G, NESTLE FO (2001); CD1d Expressed on Dermal Dendritic Cells and Monocyte-Derived Dendritic Cells; J Invest Dermatol 117: 576 – 582

 

16.   UROSEVIC M, KURRER MO, KAMARASHEV J, MUELLER B, WEDER W, BURG G, STAHEL RA, DUMMR R, TROJAN A (2001); Short Communication; Human Leukocyte Antigen G Up-Regulation in Lung Cancer Associates with High-Grade Histology, Human Leukocyte Antigen Class I Loss and Interleukin-10 Production; Am J Pathol 159 (3): 817 – 824

 

17.   Gerlini G., Hefti HP, Kleinhans M., Nickolof Brian J., Burg G., Nestle F.O. (2001); CD1d ist expressed on dermal dendritic cells and monocyte-derived dentritic cells; J Invest Dermatol 117:576-582, 2001

 

18.   ERDMANN I, SCHEIDEGGER E P, KOCH F K, HEINZERLING L, ODERMATT B,
BURG G, LOWE J B, KUENDIG T M (2002); Fucosyltransferase VII-Deficient Mice with Defective E-, P-, and L-Selectin Ligands Show Impaired CD4+ and CD8+ T Cell Migration into the Skin, but Normal Extravasation into Visceral Organs
; The Journal of Immunology, 2002, 168: 0000-0000

 

19.   UROSEVIC M, MAIER T, BENNINGHOFF B, SLADE H, BURG G, DUMMER R (2003); Mechanisms Underlying Imiquimod-Induced Regression of Basal Cell Carcinoma in Vivo; Arch Dermatol 2003: 139; 1325-1332

 

20.   DUMMER R, UROSEVIC M, KEMPF W, HOEK K, HAFNER J, BURG G (2003); Imiquimod in basal cell carcinoma: how does it work?; British Journal of Dermatology 2003: 149 (Suppl 66); 57-58

 

21.   UROSEVIC M, OBERHOLZER P.A., MAIER T, HAFNER J, LAINE E, SLADE H, BENNINGHOFF B, BURG G, DUMMER R (2004); Imiquimod Treatment Induces Expression of Opioid Growth Factor Receptor: A Novel Tumor Antigen Induced by Interferon-a?; Clinical Cancer Research 2004; 10: 4959 – 4970

 

22.   GILLIET M., CONRAD C., GEIGES M., COZZIO A., THÜRLIMANN W., BURG G., NESTLE F., DUMMER R. (2004); Psoriasis Triggered by Toll-like Receptor 7 Agonist Imiquimod in the Presence of Dermal Plasmacytoid Dendritic Cell Precursors; Archives of Dermatology 2004:140:1490-1495

 

23.   UROSEVIC M, DUMMER R, CONRAD C, BEYELER M, LAINE E, BURG G, GILLIET M (2005); Disease-Independent Skin Recruitment and Activation of Plasmacytoid Predendritic Cells Following Imiquimod Treatment; Journal of the National Cancer Institute, Vol. 97, No. 15, August 3, 2005; 1143-1153

 

24.   NESTLE FO,CONRAD C, TUN-KYI A, HOMEY B, GOMBERT M,BOYMAN O, BURG G, LIU YJ, GILLIET M (2005); Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha production; J Exp Med 202; 135-143

 

25.   BURG G, BRAUN-FALCO O (1974) ; Fortschritte in der cytochemischen Differenzierung von Infiltratzellen in der Haut; Hautarzt 25: 1-8

 

26.   BURG G (1980) ; Enzymzytochemische und immunologische Methoden bei Pseudolymphomen und kutanen Lymphomen; Z Hautkr 55: 1351-1366

 

27.   BURG G (1980); Enzymcytochemistry of histiocytes; Giorn I Derm Vener 115: 21-30

 

28.   KERL H, BURG G (1984) ;Histomorphology and cytomorphology of cutaneous B-cell lymphomas; J

 

29.   BURG G, KAUDEWITZ P, ECKERT F (1987) ; Immunhistochemische Diagnostik in der Dermatologie.; Hautarzt 38: 69-75Dermatol Surg Oncol 10:266-270

 

30.   Burg G (1988) ; Die diagnostische Bedeutung von monoklonalen Antikörpern; Hautarzt 39, S VIII:20-24

 

31.   BURG G, KAUDEWITZ P, ECKERT F (1989) ; Moderne Methoden zur Lymphozyten-Differenzierung am paraffineingebetteten Material.; Hautarzt 39, S VIII: 200

 

32.   LÜBBE J, KLEIHUES P, BURG G (1994); Das Tumorsuppressor-Gen p53 und seine Bedeutung für die Dermatologie; Hautarzt 45:741-745

 

33.   LÜBBE J, NAKAZAWA H, BURG G (1997); Telomerase; Hautarzt 48: 615 – 621

 

34.   BURG G (1998); Dermatologie 1997: Immunintervention auf dem Vormarsch; Schweiz Med Wochenschr 128: 18 – 20

 

35.   BURG G (1979): Histochemistry and cytochemistry of striae distensae. In: G. Moretti, A. Rebora (eds.): Striae Distensae, S.23-30. Brocades spa Cologno Monzese (Milan) Italy

 

36.   BURG G, VAN VLOTEN W (1983): Identification of cells in dermal infiltrates.. Proceedings of the XVIth International Congress of Dermatology, S 559-602. University of Tokyo Press

 

37.   BURG G, KOHDA M, KAUDEWITZ P, DETMAR U, MASON DY (1984): Plasma cells accumulating around epidermal neoplasias.. Immunoenzymatic staining of paraffin sections. In: DM MacDonald (Hrg.): Immunodermatology DM MacDonald, S. 167-171. Butterworth London-Boston-Durban-Sydney-Toronto-Washington

 

 

 

Immundermatosen/Kollagenosen

 

1.     ZILLIKENS D, MILLER K, HARTMANN AA, BURG G (1990): IgA Pemphigus foliaceus: A case report; Dermatologica 181: 304-307

 

2.     HACKEL H, ZILLIKENS D, LECHNER W, BURG G (1990): Ungewöhnliche Ausprägung einer Stammsklerodermie; Hautarzt 41: 91-93

 

3.     RÖGER J, ZILLIKENS D, HARTMANN AA, BURG G, GLEICHMANN E (1992): Systemic autoimmune disease in a patient with long-standing exposure to mercury; EJD 2:168-170

 

4.     AMBACH A, ZILLIKENS D, KLINGERT B, HARTMANN A.A, BURG G (1992): Immunphänotypisierung des mononukleären Infiltrats beim bullösen Pemphigoid; Hautarzt 43:81-85

 

5.     ZILLIKENS D, AMBACH A, SCHUESSLER M, DUMMER R, HARTMANN AA, BURG G (1992): The interleukin-2 receptor in lesions and serum of bullous pemphigoid; Arch Dermatol Res 284:141-145

 

6.     ZILLIKENS D, ZENTNER A, BURGER M, HARTMANN AA, BURG G (1993): Pemphigus foliaceus durch Penicillamin; Hautarzt 44:167-171

 

7.     BLUM C, ZILLIKENS D, TONY H-P, HARTMANN AA, BURG G (1993): Der lösliche Interleukin-2-Rezeptor als Aktivitätsparamenter im Serum von systemi­schem und diskoidem Lupus erythematodes; Hautarzt 44:290-295

 

8.     HAFNER J, PANIZZON R, BRUCKNER-TUDERMAN L, WÜTHRICH B, SEGER RA, BURG G (1993): Lupus-erythematodes-discoides-artige Dermatose bei einer Konduktorin der septischen Granulomatose;

 

9.     Hautarzt 44:452-456

 

10.   ZILLIKENS D, AMBACH A, ZENTNER A, DUMMER R, SCHÜSSLER  M, BURG G, BRÖCKER EB (1993); Evidence for cell-mediated immune mechanisms in the pathology of pemphigus; Br J Dermatology 128:636-643

 

11.   TRÜEB RM, BORELLI S, SCHMID-GRENDELMEIER P, PANIZZON R, BURG G (1995); Sjögren-Lupus erythematodes-Ueberlappungssyndrom; Hautarzt 46: 467 – 471

 

12.   KREYDEN OPH, BORRADORI L, TRÜEB RM, BURG G, NESTLE FO (2001); Erfolgreiche Therapie mit Tetracyclin und Nikotinaminsäure beim vernarbenden Pemphigoid; Hautarzt 52: 247 – 250

 

13.   BURG G (1994); Autoimmunkrankheiten in der Dermatologie;SSMG/SGAM mit Kongressheft “Immunoendokrinologie”: Seiten 432-436

 

Kaposi

 

1.     KAZAKOV DV, PRINZ BM, MICHAELIS S, SCHMID M, MUELLER B, ADAMS V, BURG G, KEMPF W (2002); Study of HHV-8 DNA sequences in archival biopsies from lesional skin of Kaposi’s sarcoma, various mesenchymal tumors and related reactive conditions; Journal of Cutaneous Pathology 2002: 29: 279-281

 

2.     KAZAKOV DV, SCHMID M, ADAMS V, CATHOMAS G, MÜLLER B, BURG G, KEMPF W (2003); HHV-8 DNA sequences in the peripheral blood and skin lesions of an HIV-negative patient with multiple eruptive dermatofibromas: implications for the detection of HHV-8 as a diagnostic marker for Kaposi’s sarcoma; Dermatology 2003: 206; 217-21

 

3.     KEMPF W, CATHOMAS G, BURG G, TRÜEB RM (2004); Micronodular Kaposi’s Sarcoma – A New Variant of Classic-Sporadic Kaposi’s Sarcoma; Dermatology 2004; 208: 255-258

 

4.     WALDMANN V, KEMPF W, BURG R, DUMMER R (1997); Kaposi-Sarkom unter Cyclosporin-A-Therapie bei aktinischem Retikuloid; Hautarzt 48: 262 – 265

 

5.     BURG G (1989) ; Kaposi-Sarkom: Diagnose und Therapie; Ärztl Lab 35: 19-2143.

 

6.     BURG G, LANZ U, MESSLINGER K (1990): Kaposi-Sarkom.. In: Gall FP, Göhl J, Hohenberger W (Hrsg): Weichteilsarkome. Serie: Fortschritte in der Chirur­gie 7, S. 168-173. . W. Zuckschwerdt Verlag München, Bern, Wien, San Francisco

 

7.     BURG G, DUMMER R (1994): Kaposi-Sarkom. In: W. Wilmanns, D. Huhn, K. Wilms (eds.): Internistische Onkologie, S. 651 – 656. Georg Thieme Verlag Stuttgart, New York 1994

 

8.     KEMPF W, ADAMS V, PFALTZ M, HASSAM S, SCHMID M, MOOS R, BRINER J, BURG G (1996): Nachweis von Zytomegalievirus, humanem Herpesvirus Typ 6 und humanem Herpesvirus Typ 7 in AIDS-assoziierten Kaposi-Sarkomender Haut. . In: R. Dummer, R. Panizzon, G. Burg (Hrsg.): Fortschritte der operativen und onkologischen Dermatologie, Band 11, S. 218 – 220. Operative und konservative Dermatoonkologie im interdisziplinären Grenzbereich. Blackwell Wissenschaftsverlag Berlin-Wien 1996

 

Lehre (see also EDV/Telemedizin/E-Learning)

 

1.     BRAUN-FALCO O, BURG G (1971): Freiwilliger Leistungstest in Dermatologie und Venerologie; Rezente 3: 16-17

 

2.     PIMMER, C., LINXEN, S., GRÖHBIEL, U., JHA, A., & BURG, G. (2013). Mobile learning in resource-constrained environments: a case study of medical education. Med Teach. 2013 May;35(5):e1157-65

 

Licht/Photo/Laser

 

1.     PANIZZON R, BRUCKNER-TUDERMAN L, MINDEK G, BURG G (1992) : Tretinoin bei lichtgeschädigter Haut: Erste experimentelle Untersuchungsergebnisse; hautnah derm-ch 2/1992,79-85

 

2.     SHEPHARD SE, ZOGG M, BURG G, PANIZZON RG (1999); Measurement of 5-methoxypsoralen and 8-methoxypsoralen in saliva of PUVA patients as a noninvasive, clinically relevant alternative to monitoring in blood; Arch Dermatol Res 291: 491 – 499

 

3.     DRAGIEVA G, PRINZ BM, HAFNER J, DUMMER R, BURG G, BINSWANGER U, KEMPF W (2004); A randomized controlled clinical trial of topical photodynamic therapy with methyl aminolaevulinate in the treatment of actinic keratoses in transplant recipients; British Journal of Dermatology 2004; 151: 196-200

 

4.     DRAGIEVA G, HAFNER J, DUMMER R, SCHMID-GRENDELMEIER P, ROOS M, PRINZ B, BURG G, BINSWANGER U, KEMPF W (2004); Topical photodynamic therapy in the treatment of actinic keratoses and Bowen's disease in transplant recipients; Transplantation 2004: 77; 115-121

 

5.     DUMMER R, MAIER T, BLOCH PH, BURG G (2001); Photoprotektion. Lichtschutzmassnahmen zum Schutz vor akuten und chronischen UV-induzierten Hautschäden; Schweiz Med Forum 14: 364-368

 

6.     DUMMER R, MAIER T, BLOCH PH, BURG G (2001); Lichtschutzmassnahmen zum Schutz vor akuten und chronischen UV-induzierten Hautschäden; Swiss Medical Forum / Schweizerisches Medizin-Forum 14: 364 - 368 (Sonderdruck)

 

7.     DUMMER R, IVANOVA K, SCHEIDEGGER EP, BURG G (2003);Clinical and Therapeutic Aspects of Polymorphous Light Eruption; Dermatology 2003; 207:93-95

 

8.     PRINZ B M, VAVRICKA S R, GRAF P, BURG G, DUMMER R (2004): Dermatological Surgery and Lasers; Efficacy of laser treatment of tattoos using lasers emitting wavelengths of 532 nm, 755 nm and 1064 nm. British Journal of Dermatology 2004; 150: 245-251

 

9.     BURG G (1974): Polymorphe Lichtdermatose. In: H. Ippen, G. Goerz (Hrsg.): Photodermatosen und Porphyrien. Beiträge zur Tagung der Rheinisch-Westfälischen Dermatologen-Vereinigung. Bochum, 26.8.72

 

10.   BURG G (1974): Erythropoetische Protoporphyrie. In: H. Ippen, G. Goerz (Hrsg.): Photodermatosen und Porphyrien. Beiträge zur Tagung der Rheinisch-Westfälischen Dermatologen-Vereinigung. Bochum, 26.8.72

 

11.   BRAUN-FALCO O, HOFMANN C, PLEWIG G, BURG G (1977): Photochemotherapie of psoriasis vulgaris and mycosis fungoides. In: W. Weidelich (Hrsg.): Laser 77, Opto-Electronics, S. 508-515. Ips science and technology press, Kingprint Ltd. Richmond, Surrey

 

Lymphome/Retikulosen/Histiocytic Disorders

 

1.     BURG G   (1975): Erkrankungen des Retikulohistiocytären Systems (RHS) der Haut. Enzymcytochemische und immuncytologische Untersuchungen mit besonderer Berücksichtigung der Zelldifferenzierung; Habilitationsschrift, München

 

2.     HUHN D, BURG G, MEMPEL W (1973): Spezifische Hautveränderungen bei Morbus Hodgkin; Dtsch med Wschr 52: 2469-2472

 

3.     BURG G, BRAUN-FALCO O (1974) :Qualitative und quantitative Aspekte der cellulären Reaktion in Haut und Blut bei Mycosis fungoides; Hautarzt 25: 178-187

 

4.     BURG G, BRAUN-FALCO O (1975) : T- und B- Lymphocyten in Hautveränderungen kutaner Lymphome. Ein Beitrag zur Klassifikation lymphoretikulärer Proliferationen in der Haut; Dtsch med Wschr 100: 2562-2564

 

5.     BURG G, BRAUN-FALCO O (1975): Classification and Differentiation of Cutaneous Lymphomas.  Enzyme-cytochemical and immunocytological studies; Br J Dermatol 93: 597-599

 

6.     BRAUN-FALCO O, BURG G (1975) : Lymphoretikuläre Proliferationen in der Haut. Cytochemische und immunocytologische Unter­suchungen bei Lymphadenosis benigna cutis; Hautarzt 26: 124-132

 

7.     WEBER K, BURG G, WOLFF HH, BRAUN-FALCO O, EHLERS G (1975): Sézary-Syndrom. Ein Bericht anhand eines Falles; Hautarzt 26: 255-259

 

8.     BURG G, BRAUN-FALCO O (1977) : Enzymzytochemische und immunzytologische Untersuchungen bei Mycosis fungoides; Acta histochemica Suppl. Bd. XVIII: 209-214

 

9.     HOFMANN C, BURG G, PLEWIG G, BRAUN-FALCO O (1977): Photochemotherapie kutaner Lymphome. Orale und lokale 8-MOP-UVA-Therapie; Dtsch med Wschr 102: 675-679

 

10.   v.LIEBE V, BURG G (1977) : Lymphozytentransformationstest bei kutanen Lymphomen; Hautarzt 28, Suppl. II: 200-203

 

11.   SCHMOECKEL CH, BRAUN-FALCO O, BURG G (1977) : Zur Ultrastruktur der Mycosis fungoides und des Sézary Syndroms; Hautarzt 28, Suppl. II: 197-198

 

12.   SCHMOECKEL C, BURG G, WOLFF HH, BRAUN-FALCO O (1977): The ultrastructure of lymphadenosis benigna cutis (pseudolymphoma cutis); Arch Derm-Res 258: 161-167

 

13.   BURG G, BRAUN-FALCO O, HOFFMANN-FEZER G, RODT H, SCHMOECKEL C (1978) : Patterns of cutaneous lymphomas. Histological, Enzyme Cytochemical, and Immunological Typing of Lymphorecticular Proliferations in the Skin; Dermatologica 157: 282-291

 

14.   BURG G, BRAUN-FALCO O, SCHMOECKEL C, HOFFMANN-FEZER G,FATEH-MOGHADAM A, HERTERICH J (1978): Preferential microenvironments for B- and T- lymphocytes in the skin; Inserm 80: 221-238

 

15.   BURG G, RODT H, GROSSE-WILDE H, BRAUN-FALCO O (1978): Surface markers and mitogen response of cells harvested from cutaneous infiltrates in mycosis fungoides and Sézary's syndrome; J Invest Derm 70: 257-259

 

16.   BURG G, SCHMOECKEL C, BRAUN-FALCO O, WOLFF HH (1978): Monocytic Leukemia. Clinically Appearing as "Malignant Reticulosis of the Skin"; Arch Derm 114: 418-420

 

17.   BRAUN-FALCO O, GUGGENBERGER K, BURG G, FATEH-MOGHADAM A (1978): Immunozytom unter dem Bild einer Acrodermatitis chronica atrophicans; Hautarzt 29: 644-647

 

18.   SCHMOECKEL C, BRAUN-FALCO O, BURG G (1978): Die pagetoide Retikulose - ein T-Zell Lymphom?; Hautarzt 29, Suppl. III: 57-60

 

19.   KERL H, BURG G (1979) : Immunozytome und immunoblastische Lymphome der Haut; Hautarzt 30: 666-672

 

20.   KIENITZ T, BURG G, SCHMOECKEL C, WEITZ H, BRAUN-FALCO O (1979): High-grade malignant lymphoma arising from Sézary's syndrome; Dermatologica 158: 126-136

 

21.   SCHMOECKEL C, BURG G, BRAUN-FALCO O (1979): Quantitative analysis of lymphoid cells in mycosis fungoides, Sézary's syndrome and para­psoriasis en plaques; Arch Dermatol Res 264: 17-28

 

22.   SCHMOECKEL C, BURG G, BRAUN-FALCO O (1979): Quantitiative analysis of lymphoid cells in cutaneous low-grade malignant B-cell lymphomas; Arch Dermatol Res 266: 239-251

 

23.   BURG G, GUGGENBERGER K, SCHMOECKEL C, BRAUN-FALCO O (1980): Therapie der Mycosis fungoides; Therapie der Gegenwart 119: 773-790

 

24.   SCHMOECKEL C, BURG G, BRAUN-FALCO O, KLINGMÜLLER G (1981): Mycosis fongoide à forte malignité avec transformation cytologique ; Ann Dermatol Venereol (Paris) 108: 231-241

 

25.   BURG G, HOFFMANN-FEZER G, NIKOLOWSKI J, SCHMOECKEL C, BRAUN-FALCO O, STÜNKEL L (1981): Lymphomatoid papulosis: A cutaneous T-cell pseudolymphoma; Acta Dermatovener (Stockholm) 61: 491-496

 

26.   SCHMOECKEL C, BURG G, HOFFMANN-FEZER G, STOLZ W, WEITZ H, LÖHRS U, BRAUN-FALCO O (1982) : Cutaneous Immunoblastic T-cell lymphoma; SArch Dermatol Res 274: 141-154

 

27.   STOLZ W, SCHMOECKEL CH, BURG G, BRAUN-FALCO O (1983): Circulating Sézary cells in the diagnosis of Sézary Syndrome (quantitative and morphometric analysis);  J Invest Derm 81:314-319

 

28.   PRZYBILLA B, BURG G, SCHMOECKEL CH, BRAUN-FALCO O (1983): Treatment of cutaneous T-cell lymphomas with TP-5; Acta Derm Venereol 63:524-529

 

29.   EBERTH-WILLERSHAUSEN W, STEGER O, BARRAN W, BURG G, RYCKMANNS F, KAUDEWITZ P (1984): Histiozytosis X. Eine oligosymptomatische Form des M. Hand-Schüller-Christian mit einer neuen Form und Möglichkeit der Diagnostik; Hautarzt 35:539-542

 

30.   GEERTS ML, BURG G, SCHMOECKEL CH, BRAUN-FALCO O (1984): Alkaline phosphatase positive lymphoma; Dermatologica 169:342-347

 

31.   KAUDEWITZ P, BURG G, STEIN H, KLEPZIG K, MASON DY, BRAUN-FALCO O (1985) : Monoclonal antibody patterns in lymphomatoid papulosis; Dermatologic Clinics 3:749-757

 

32.   MAIER H, SCHMOECKEL CH, BURG G, BRAUN-FALCO O (1985) : Primary cutaneous atypical histiocytosis with possible dissemination; Am J Dermatopathol 7:373-382

 

33.   SMOLLE J, KAUDEWITZ P, BURG G, KRESBACH H, KERL H (1985): Significance of non-lymphoid ("accessory") cells in malignant lymphomas and pseudo-lymphomas of the skin; Br J Dermatol 111:677-685

 

34.   IMAI S, BURG G, BRAUN-FALCO O (1986): Mycosis fungoides and Sézary syndrome show distinct histomorphological features; Dermatologica 173:131-135

 

35.   KAUDEWITZ P, STEIN H, BURG G, MASON DY, BRAUN-FALCO O (1986):Atypical cells in lymphomatoid papulosis express the Hodgkin cell-associated antigen Ki-1; J Invest Dermatol 86:350-354

 

36.   BURG G, KLEPZIG K, KAUDEWITZ K, WOLF H, BRAUN-FALCO O (1986): Acyclovir in lymphomatoid papulosis and mycosis fungoides; JAMA 256:214-215

 

37.   BURG G, KLEPZIG K, KAUDEWITZ P, WOLF H, BRAUN-FALCO O (1986) Acyclovir bei Mycosis fungoides und lymphomatoider Papulose; Hautarzt 37:533-536

 

38.   KAUDEWITZ P, SOLDNER R, BURG G, BIEBER T, BERGER C, EDELSON R, RIEBER P, BRAUN-FALCO O (1986) : Reactivity of monoclonal antibody BE2 in different stages of mycosis fungoides and in benign dermal infiltrates; Arch Dermatol Res 279:83-88

 

39.   KAUDEWITZ P, BURG G, MACIEJEWSKI G, GERDES J, SCHWARTING R, BRAUN-FALCO O (1987): Cell Populations in Pagetoid Reticulosis: An Immunological Study Using Cell Activation Associated Monoclonal Antibodies; Acta Derm Venereol 67: 24-29

 

40.   BURG G, STÜNKEL GK, BIEBER T, OPIZ U, KAUDEWITZ P (1987): Cutaneous infiltrates of histiocytosis X contains plasminogen activator-bearing epidermtropic dentritic cells different from Langerhans cells ; Arch Dermatol Res 279: 88- 91

 

41.   FEIST H, ROHLOFF R, WIESMETH A, WIELLICH N, WENDT TH, BURG G (1987) : Dosimetry and first clinical results of total skin electron beam therapy of cutaneous T cell lymphoma; Strahlentherapie und Onkologie 163: 273-274

 

42.   VON DER HELM D, VON DER HELM K, BURG G, BRAUN-FALCO O, DEINHARDT F (1988) : Antikörper gegen HTLV I bei T-lymphoproliferativen Erkrankungen der Haut; Hautarzt 39: 348-350

 

43.   ECKERT F, HEIN R, KRIEG TH, BURG G (1988) : Lokal rezidivierendes zentroblastisches Lymphom der Haut; Hautarzt 39: 791-794

 

44.   ECKERT F, SCHMID U, KAUDEWITZ P, BURG G, BRAUN-FALCO O (1989): Follicular lymphoid hyperplasia of the skin with high content of Ki-1 positive lymphocytes; Am J Dermatopathol 11: 345-352

 

45.   KAUDEWITZ P, STEIN H, DALLENBACH F, ECKERT F, BIEBER K, BURG G, BRAUN-FALCO O (1989): Primary and Secondary Cutaneous Ki-1+ (CD30+) Anaplastic Large Cell Lymphomas; Am J Pathol 135: 359-367

 

46.   STOLZ W, VOGT T, BRAUN-FALCO O, ABMAYR W, ECKERT F, KAUDEWITZ P, VIELUF D, BIEBER K, BURG G (1990): Differentiation Between Lymphomas and Pseudolymphomas of the Skin by Computerized DNA-Image Cytometry; J Invest Dermatol 94: 254-260

 

47.   KAUDEWITZ P, STEIN H, PLEWIG G, SCHWARTING R, GERDES J, BURG G, KIND P, ECKERT F, BRAUN-FALCO O (1990): Hodgkin's disease followed by lymphomatoid papulosis; J Am Acad Dermatol 22: 999-1006

 

48.   SEPP N, SCHULER G, ROMANI N, GEISSLER D, GATTRINGER C, BURG G, BARTRAM CR, FRITSCH P (1990): "Intravascular Lymphomatosis" (Angioendotheliosis): Evidence for a T-cell origin in two cases; Hum Pathol 21: 1051-1058

 

49.   DUMMER R, NESTLE F, WIEDE J, SCHÄFER E, RÖGER J, BECKER J.C, VOGT TH, BURG G (1991): Coincidence of increased soluble interleukin-2 receptors, diminished natural killer cell activity and progressive disease in cutaneous T-cell lymphomas; Eur J Dermatol 1:135-138

 

50.   VOGT TH, STOLZ W, BRAUN-FALCO O, KAUDEWITZ P, ECKERT F, ABMAYR W, DUMMER R, BURG G (1991): Prognostic Significance of DNA Cytometry in Cutaneous Malignant Lymphomas; Cancer 68:1095-1100

 

51.   RÖGER J, BURG G, MILLER K, LANZ U (1991): Pityriasis rubra pilaris-artiges Vorstadium eines Sézary-Syndroms; Z Hautkr 66:1046-1050

 

52.   BURG G, DUMMER R, WILHELM M, NESTLE F, OTT MM, FELLER A, HEFNER H, LANZ U, SCHWINN A, WIEDE J (1991): A Subcutaneous Delta-Positive T-Cell Lymphoma That Produces Interferon Gamma; New Engl J Med 325:1078-1081

 

53.   DUMMER R, POSSECKERT G, NESTLE F, WITZGALL R, BURGER M, BECKER JC, SCHÄFER E, WIEDE J, SEBALD W, BURG G (1991); Soluble Interleukin-2 Receptors Inhibit Interleukin 2-Dependent Proliferation and Cyto-toxicity: Explanation for Diminished Natural Killer Cell Activity in Cutaneous T-Cell Lymphomas In Vivo?; J Invest Dermatol 98:50-54

 

54.   WILHELM M, MEYER P, BATRAM C, TONY HP, DUMMER R, NESTLE F, BURG G, WILMS K (1992) : Receptor-expressing T-cell clones from a cutaneous T-cell lymphoma suppress hemato­poiesis*; Ann Hematol 65:111-115

 

55.   DUMMER R, RÖGER J, VOGT TH, BECKER J, HEFNER H, SINDERMANN H, BURG G (1992): Topical Application of Hexadecylphosphocholine in Patients with Cutaneous Lymphomas ; Prog Exp Tumor Res. Basel, Karger, 34:160-169

 

56.   DUMMER R, KOHL O, GILLESSEN J, KÄGI M, BURG G (1993): Peripheral Blood Mononuclear Cells in Patients With Nonleukemic Cutaneous T-Cell Lymphoma; Arch Dermatol 129:433-436

 

57.   DUMMER R, BURG G, NESTLE F, KOHL O (1993): Soluble interleukin-2 receptors and cutaneous T-cell lymphoma (letter); Cancer 71:3793-3795

 

58.   WILHELM M, MEYER P, BATRAM C, TONY HP, DUMMER R, NESTLE F, BURG G, WILMS K (1992); Receptor-expressing T-cell clones from a cutaneous T-cell lymphoma suppress hemato­poiesis; Ann Hematol 65:111-115

 

59.   DUMMER R, RÖGER J, VOGT TH, BECKER J, HEFNER H, SINDERMANN H, BURG G (1992); Topical Application of Hexadecylphosphocholine in Patients with Cutaneous Lymphomas ; Prog Exp Tumor Res. Basel, Karger, 34:160-169

 

60.   DUMMER R, KOHL O, GILLESSEN J, KÄGI M, BURG G (1993); Peripheral Blood Mononuclear; Cells in Patients With Nonleukemic Cutaneous T-Cell Lymphoma; Arch Dermatol 129:433-436

 

61.   DUMMER R, BURG G, NESTLE F, KOHL O (1993);Soluble interleukin-2 receptors and cutaneous T-cell lymphoma (letter); Cancer 71:3793-3795

 

62.   DUMMER R, KRASOVEC M, RÖGER J, SINDERMANN H, BURG G (1993); Topical administration of hexadecylphosphocholine in patients with cutaneous lymphomas: Results of a phase I/II study; J Am Acad Dermatol 29:963-970

 

63.   DUMMER R, HAEFFNER AC, BURG G (1994); Cutaneous T-cell lymphomas (CTCL): new aspects in PCR-based diagnostic tools, immunology and treatment; Eur J Dermatol 4: 281-286

 

64.   BURG G, HESS SCHMID M, KÜNG E, DOMMANN ST, DUMMER R (1994); Semimalignant (“pseudolymphomatous”) cutaneous B-cell lymphomas; Dermatologic Clinics 12; 2: 399-407

 

65.   BURG G, ZWINGERS TH, STAEGEMEIR E, SANTUCCI M (1994); EORTC-Cutaneous Lymphoma Project Group; Interrater and intrarater variabilities in the evaluation of cutaneous lymphoproliferative T-cell infiltrates; Dermatologic Clinics 12:2:311-314

 

66.   SANTUCCI M, BURG G, FELLER AC (1994); Interrater And Intrarater Reliability Of Histologic Criteria In Early Cutaneous T-Cell Lymphoma; Dermatologic Clinics 12;2:323-327

 

67.   BURG G, DUMMER R, BECKER JC (1995); The skin as a target organ during IL-2 administration; Basic Mechanisms of Physiologic and Aberrant Lymphoproliferation in the Skin; Edited by W.C. Lambert et al., Plenum Press New York, 1994; S. 451-458

 

68.   BAUCH B, BARRAUD-KLENOVSEK M, BURG G, DUMMER R (1995); Eindrucksvolle Remission einer Mycosis fungoides im Tumorstadium unter low-dose Interferon- und Acitretin nach erfolgloser Chemotherapie; H+G 70; 3: 200-202

 

69.   WYSS M, DUMMER R, DOMMANN SN, JOLLER-JEMELKA HI, DOURS-ZIMMERMANN MT, GILLIET F, BURG G (1995); Lymphomatoid Papulosis - Treatment with recombinant Interferon Alfa-2a and Etretinate; Dermatology 190: 288 – 291

 

70.   PAULLI M, BERTI E, ROSSO R, BURG G  ET AL (1995); CD30/Ki-1-Positive Lymphoproliferative Disorders of the Skin - Clinicopathologic Correlation and Statistical Analysis of 86 Cases: A Multicentric Study From the European Organization for Research and Treatment of Cancer Cutaneous Lymphoma Project Group; J Clin Oncol 13: 1343 – 1354

 

71.   BÖNI R, DUMMER R, DOMMANN-SCHERRER C, DOMMANN S, ZIMMERMANN DR, JOLLER-JEMELKA H, BURG G (1995): Necrotizing herpes zoster mimicking relapse of vasculitis in angioimmunoblastic lymphadeno­pathy with dysproteinaemie; Br J Dermatology 133: 978 – 982

 

72.   DOMMANN SN, DOMMANN-SCHERRER CC, ZIMMERMANN D, DOURS-ZIMMER­MANN MT, HASSAM S, BURG G (1995); Primary cutaneous T-cell-rich B-cell lymphoma. A case report with a 13-year follow-up. ; Am J Dermatopathol. 17; 6: 618 – 624

 

73.   BÖNI R, DAVIS-DANESHFAR A, BURG G, FUCHS D, WOOD GS (1996); No detection of HTLV-I proviral DNA in lesional skin biopsies from Swiss and German patients with cutaneous T-cell lymphoma; Br J Dermatol 134: 282 – 284

 

74.   DUMMER R, POTOCZNA N, HÄFFNER AC, ZIMMERMANN DR, GILARDI ST, BURG G (1996); A Primary Cutaneous Non-T, Non-B CD4+, CD56+ Lymphoma; Arch Dermatol, 1996; 132: 550-553

 

75.   BURG G, DUMMER R, NESTLE FO, DOEBBELING U, HÄFFNER A (1996); Cutaneous Lymphomas Consist of a Spectrum of Nosologically Different Entities Including Mycosis Fungoides and Small Plaque Parapsoriasis; Arch Dermatol 132: 567 – 572

 

76.   KALINKE U, DUMMER R, BURG G (1996); Management of cutaneous T-cell lymphoma; Current Opinion in Dermatology 3: 71 – 76

 

77.   POTOCZNA N, BOEHNCKE W.-H. , NESTLE FO, KÜENZLEN CH, STERRY W, BURG G, DUMMER R (1996); T-cell receptor ß variable region (Vß) usage in cutaneous T-cell lymphomas (CTCL) in comparison to normal and eczematous skin; J Cutan Pathol 23: 298 – 305

 

78.   DOMMANN STNW, DOMMANN-SCHERRER CC, DOURS-ZIMMERMANN M-T, ZIMMERMANN DR, KURAL-SERBES B, BURG G (1996); Clonal disease in extracutaneous compartments in cutaneous T-cell lymphomas. A comparative study between cutaneous T-cell lymphomas and pseudo lymphomas; Arch Dermatol Res 288: 163-167

 

79.   RAJAN GP, SEIFERT B, PRÜMMER O, JOLLER-LEMELKA HI, BURG G, DUM­MER R (1996); Incidence and in-vivo relevance of anti-interferon antibodies during treatment of low-grade cutaneous T-cell lymphomas with interferon alpha-2a combined with acitretin or PUVA; Arch Dermatol Res 288: 543-548

 

80.   DUMMER R, HEALD PW, NESTLE FO, LUDWIG E, LAINE E, HEMMI S, BURG G (1996); Sézary Syndrome T-Cell Clones Display T-Helper 2 Cytokines and Express the Accessory Factor-1 (Interferon- Receptor ß-Chain); Blood 88 (4): 1383 – 1389

 

81.   WOOD GS, HARDMAN DL, BÖNI R, DUMMER R, KIM Y-H, SMOLLER BR, TAKESHI­TA M, KIKUCHI M, BURG G (1996); Lack of the t (2;5) or Other Mutations Resulting in Expression of Anaplastic Lymphoma Kinase Catalytic Domain in CD30+ Primary Cutaneous Lymphoproliferative Disorders and Hodgkin’s Disease; Blood (88) 5; 1765 – 1770

 

82.   DOMMANN SNW, DOMMANN-SCHERRER CC, DOURS-ZIMMERMANN MT, ZIMMERMANN DR, KURAL-SERBES B, BURG G (1996); Cutaneous pleomorphic T-cell lymphoma showing lineage cross-over of antigen receptor gene rearrangement ; Eur J Dermatol 6: 196 – 199

 

83.   CAMACHO FM, BURG G, MORENO JC, CAMPORA RG, VILLAR JL (1997); Granulomatous Slack Skin in Childhood; Pediatric Dermatology 14 (3): 204 – 208

 

84.   MEYER JC, HASSAM S, DUMMER R, MULETTA S, DÖBBELING U, DOMMANN SNW, BURG G (1997); A realistic approach to the sensitivity of PCR-DGGE and its application as a sensitive tool for the detection of clonality in cutaneous T-cell proliferations; Exp Dermatol 6: 122 – 127

 

85.   DOMMANN SNW, DOMMANN-SCHERER CC, ZIEGLER TH, MEYER J, TRÜEB RM, KÜNDIG TH, PANIZZON R, BURG G (1997); Expression of Intercellular Adhesion Molecule 3 (CDw50) on Endithelial Cells in Cutaneous Lymphomas;Am J Dermatopathol 19 (4): 391 – 395

 

86.   DÖBBELING U, DUMMER R, HESS SCHMID M, BURG G (1997);Lack of expression of the recombination activating genes RAG-1 and RAG-2 in cutaneous T-cell lymphoma: pathogenic implications; Clinical and Experimental Dermatology 22: 230 – 233

 

87.   DUMMER R, GEERTSEN R, LUDWIG E, NIEDERER E, BURG G (1998); Sézary Syndrome, T-Helper 2 Cytokines and Accessory Factor-1 (AF-1); Leukemia and Lymphoma, 28: 515 – 522

 

88.   DÖBBELING U, DUMMER R, LAINE E, POTOCZNA N, QIN JZ, BURG G (1998); Interleukin-15 Is an Autocrine/Paracrine Viability Factor for Cutaneous T-cell Lymphoma Cells; Blood 92 (1): 252 – 258

 

89.   KEMPF W, DUMMER R, MÜLLER B, DÖBBELING U, HÄFFNER A, NESTLE FO, BURG G (1998); Cutaneous Lymphoproliferative Infiltrates-  Entities, Concepts and a New Clinically-Oriented Approach Beyond the Classifications; Korean Journal of Investigative Dermatology; 5 (2): 103 – 120

 

90.   KAMARASHEV J, BURG G, KEMPF W, HESS SCHMID M, DUMMER R (1998); Comparative analysis of histological and immunohistologal features in mycosis fungoides and Sézary syndrome; J Cutan Pathol 25: 407 – 412

 

91.   BRÄUNINGER A, HANSMANN M-L, STRICKLER JG, DUMMER R, BURG G, RAJEWS­KY K, KÜPPERS R (1999); Identification of common germinal-center B-cell precursors in two patients with both Hodgkin's disease and non-Hodgkin's lymphoma; The New England Journal of Medicine 340: 1239 – 1247

 

92.   DUMMER R, NESTLE FO, NIEDERER E, LUDWIG E, LAINE E, GRUNDMANN HP, GROB P, BURG G (1999); Genotypic, phenotypic and functional analysis of CD4+CD7+ and CD4+CD71 T lymphocyte subsets in Sézary syndrome; Arch Dermatol Res 291: 307 – 311

 

93.   HESS SCHMID M, DUMMER R, KEMPF W, HILTY N, BURG G (1999): Mycosis fungoides with Mucinosis follicularis in Childhood; Dermatology 198: 284 – 287

 

94.   FRITZ TM, KLEINHANS M, NESTLE FO, BURG G, DUMMER R (1999); Combination treatment with extracorporeal photopheresis, interferon alfa and interleukin-2 in a patient with the Sézary syndrome; Br J Dermatol 140: 1144 – 1147

 

95.   QIN J-Z, DUMMER R, BURG G, DÖBBELING U (1999); Constitutive and Interleukin-7/Interleukin-15 Stimulated DNA Binding of Myc, Jun, and Novel Myc-Like Proteins in Cutaneous T-Cell Lymphoma Cells; Blood 93 (1): 260 – 267

 

96.   HESS SCHMID M, BIRD P, DUMMER R, KEMPF W, BURG G (1999); Tumor Burden Index as a Prognostic Tool for Cutaneous T-Cell Lymphoma; Arch Dermatol 135: 1204 – 1208

 

97.   LAETSCH B, HÄFFNER AC, DÖBBELING U, SEIFERT B, LUDWIG E, BURG G (1999); CD4+/CD7- T Cell Frequency and Polymerase Chain Reaction-Based Clonality Assay Correlate with Stage in Cutaneous T Cell Lymphomas; J Invest Dermatol 114: 107-111, 2000

 

98.   SCHÄRER L, SCHMID MH, MÜLLER B, DUMMER RG, BURG G, KEMPF W (2000); Angiogenesis in cutaneous lymphoproliferative disorders: microvessel density discriminates between cutaneous B-cell lymphomas and B-cell pseudolymphomas; Am J Dermatopathol 2000 22 (2): 140 – 143

 

99.   HEINZERLING L, DUMMER R, KEMPF W, HESS SCHMID M, BURG G (2000);Intralesional Therapy With Anti-CD20 Monoclonal Antibody Rituximab in Primary Cutaneous B-Cell Lymphoma; Arch Dermatol 136: 374 – 378

 

100.KAMARASHEV J,DUMMER R, HESS SCHMIDT M, KEMPF W, KURRER M.O, BURG G  (2000); Primary Cutaneous T-Cell-Rich B-Cell Lymphoma and Hodgkin’s Disease in a Patient with Gardner’s Syndrome; Dermatology 201: 362 – 365

 

101.BÖNI R, XIN H, KAMARASHEV J, UTZINGER E, DUMMER R, KEMPF W, KUTZNER H, BURG G  (2000); Allelic Deletion at 9p21-22 in Primary Cutaneous CD30+ Large Cell Lymphoma; The Journal of Investigative Dermatology 115 / Number 6: 1104 – 1107

 

102.DUMMER R, DÖBBELING U, GEERTSEN R, WILLERS J, BURG G, PAVLOVIC J  (2001); Interferon resistance of cutaneous T-cell lymphoma-derived clonal Thhelper 2 cells allows selective viral replication; Blood 97 / Number 2: 523 – 527

 

103.DUMMER R, WILLERS J, DÖBBELING U, BURG G (2001); Aktuelle Aspekte zur Pathogenese von Sézary-Syndrom und Mycosis fungoides; Hautarzt; 52: 189 – 192

 

104.KAMARASHEV J, BURG G, MINGARI MC, KEMPF W, HOFBAUER G, DUMMER R (2001); Short Communication. Differential Expression of Cytotoxic Molecules and Killer Cell Inhibitory Receptors in CD8+ and CD56+ Cutaneous Lymphomas; Am J Pathol 158 (5): 1593 – 1598

 

105.WILLERS J, HAEFFNER A, ZEPTER K, STORZ M, UROSEVIC M, BURG G, DUMMER R (2001); The Interferon Inhibiting Cytokine IK is Overexpressed in Cutaneous T Cell Lymphomas Derived Tumor Cells That Fail to Upregulate Major Histocompatibility Complex Class II Upon Interferon-gamma Stimulation; J Invest Dermatol 116: 874 – 879

 

106.KAMARACHEV J, SCHAERER L, BURG G, HESS SCHMID M, MUELLER B, KEMPF W (2001); Tumor-infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders; J Cutan Pathol 28: 448 – 452

 

107.SCHMOOK T, HOFBAUER G, KEMPF W, BURG G, DUMMER R (2001); Granulomatous slack skin. Partielle Remission unter intraläsionärer Gabe von Interferon-alpha und PUVA; Hautarzt 52: 985 – 988

 

108.BURG G, DUMMER R, HÄFFNER A, KEMPF W, KADIN M (2001); From Inflammation to Neoplasia; Mycosis fngoides evolves from reactive onflammatroy conditions (Lymphoid Infiltrates) transforming into neoplastic plaques and tumors; Arch Dermatol 137: 949 – 952

 

109.QIN JZ, ZHANG CL, KAMARASHEV J, DUMMER R, BURG G, DÖBBELING Ü (2001); Interleukin-7 and interleukin-15 regulate the expression of the bcl-2 and c-myb genes in cutaneous T-cell lymphoma cells; Blood 98(9): 2778 - 2783

 

110.UROSEVIC M, WILLERS J, MÜELLER B, KEMPF W, BURG G DUMMER R (2002); HLA-G protein up regulation in primary cutaneous lymphomas is associated with interleukin-10 expression in large cell-T-cell lymphomas and indolent B-cell lymphomas.; Blood. 2002; 99:609-617 by American Society of Hematology

 

111.ROOS J, HENNIG I, SCHWALLER J, ZBAEREN J, DUMMER R, BURG G, TOBLER A, VIRIGLIO L, CROCE C.M., FREY J.F., BORISCH B (2001); Expression of TCL1 in Hematologic disorders; Pathobiology 2001; 69:59-66

 

112.HAEFFNER A, TASSIS A, ZEPTER C, STORZ M, TURECI O, BURG G, NESTLE F O (2002); Expression of cancer/testis antigens in cutaneous T-cell lymphomas; Int. J. Cancer 97, 668-670 (2002)

 

113.KAMARASHEV J, SCHAERER L, BURG G, HESS SCHMID M, MÜELLER B, KEMPF W (2001); Tumor-Infiltrating T cells in primary cutaneous B-cell lympho-proliferative disorders ; J Cutan Pathol 2001, 28: 448-452

 

114.VONDERHEID E C, BERNENGO M G, BURG G, DUVIC M, HEALD P, LAROCHE L, OLSEN E, PITTELKOW M, RUSSEL-JONES R, TAKIGAWA, M (2002); Update on erythrodermic cutaneous T-cell lymphoma: Report of the International Society for Cutaneous Lymphomas; J Am Acad Dermatol 2002; 46: 95 – 106

 

115.DUMMER R, KAMARASHEV J, KEMPF W, HAEFFNER A, HESS SCHMID M, BURG G (2002); Junctional CD8+ Cutaneous Lymphomas With Nonaggressive Clinical Behavior; Arch Dermatol. 2002; 138: 199-203

 

116.KAZAKOV DV, BURG G, DUMMER R, PALMEDO G, MUELLER B, KEMPF W (2002); Primary subcutaneous follicular centre cell lymphoma with involvement of the galea: a case report and short review of the literature; British Journal of Dermatology 2002: 146: 663-666

 

117.KEMPF W, LEVI E, KAMARASHEV J, KUTZNER H, PFEIFER W, PETROGIANNIS-HALIOTIS T, BURG G, KADIN ME (2002); Fascin expression in CD30-positive cutaneous lymphoproliferative disorders; Journal of Cutaneous Pathology 2002: 29: 295-300

 

118.KAMARASHEV J, BURG G, KEMPF W, DUMMER R (2002); Prognoseevaluation mittels Immunhistologie; Akt Dermatol 2002; 28: 314-318 ã Georg Thieme Verlag Stuttgart × New York × ISSN 0340-2541

 

119.CARROZZA P M, KEMPF W, KAZAKOV D V, DUMMER R, BURG G (2002); A case of Sézary's syndrome associated with granulomatous lesions, myelodysplastic syndrome and transformation into CD30-positive large-cell pleomorphic lymphoma; British Journal of Dermatology 2002; 147: 582-586

 

120.SCHWAB C, WILLERS J, NIEDERER E, LUDWIG E, KUENDIG TH, GROB P, BURG G, DUMMER R (2002); The use of anti-T-cell receptor-Vß antibodies for the estimation of treatment success and phenotypic characterization of clonal T-cell populations in cutaneous T-cell lymphomas; British Journal of Haematology, 2002, 118; 1019-1026

 

121.KEMPF W, HAEFFNER A, ZEPTER K, SANDER  C A, FLAIG M J, MUELLER B, PANIZZON R G, HARDMEIER T, ADAMS V, BURG G (2002); Angiolymphoid Hyperplasia With Eosinophilia: Evidence for a T-Cell Lymphoproliferative Origin; Human Pathol 2002; 33: 1023-1030

 

122.BURG G, KEMPF W, KAZAKOV DV, DUMMER R, FROSCH PJ, LANGE-IONESCU S, NISHIKAWA T, KADIN ME (2003); Pyogenic lymphoma of the skin: a peculiar variant of primary cutaneous neutrophil-rich CD30+ anaplastic large-cell lymphoma. Clinicopathological study of four cases and review of the literature; British Journal of Dermatology 2003; 148: 580-586

 

123.KLEINHANS M, TUN-KYI A, GILLIET M, KADIN M, DUMMER R, BURG G, NESTLE FO (2003); Functional expression of the eotaxin receptor CCR3 in CD30+ cutaneous T-cell lymphoma; Blood 2003; 101: 1487-1493

 

124.ROBERTS AA, AMANO M, FELTEN CH, GALVAN M, SULUR G, PINTER-BROWN L, DOEBBELING U, BURG G, SAID J, BAUM L (2003); Galectin-1-Mediated Apoptosis in Mycosis fungoides: The Roles of CD7 and Cell Surface Glycosylation; Mod Pathol 2003; 16(6): 543-551

 

125.DUMMER R, UROSEVIC M, KEMPF W, KAZAKOV D, BURG G (2003); Imiquimod Induces Complete Clearance of a PUVA-Resistant Plaque in Mycosis fungoides; Dermatology 2003; 207:116-118

 

 

126.MAIER T, TUN-KYI A, TASSIS A, JUNGIUS KP, BURG G, DUMMER R, NESTLE FO (2003); Vaccination of patients with cutaneous T-cell lymphoma using intranodal injection of autologous tumor-lysate-pulsed dendritic cells; Blood 2003; 102: 2338-2344

 

 

127.KAZAKOV D V, MENTZEL T, BURG G, DUMMER R, KEMPF W; Blastic natural killer-cell lymphoma of the skin associated with myelodysplastic syndrome or meylogenous leukaemia: a coincidence or more?; British Journal of Dermatology 2003: 149; 869-876

 

128.WILLERS J, DUMMER R, KEMPF W, KÜNDIG T, BURG G, KADIN ME (2003); Proliferation of CD30+ T-helper 2 lymphoma cells can be inhibited by CD30 receptor cross-linking with recombinant CD30 ligand; Clin Cancer Res 2003: 7; 2744-54

 

129.ZHANG CL, KAMARASHEV J, QIN JZ, BURG G, DUMMER R, DÖBBELING U (2003); Expression of apoptosis regulators in cutaneous T-cell lymphoma (CTCL) cells ; J Pathol 2003: 200; 249-54

 

130.RUEBBEN A, KEMPF W, KADIN ME, ZIMMERMANN DR, BURG G (2004); Multilineage progression of genetically unstable tumor subclones in cutaneous T-cell lymphoma; Experimental Dermatology 2004: 13: 472-482

 

131.HASSEL J., MEIER R., JOLLER-JEMELKA H., BURG G., DUMMER R. (2004); Serological Immunomarkers in Cutaneous T Cell Lymphoma; Dermatology 2004; 209: 296-300

 

132.GREISSER J., DOEBBELING U., ROOS M., MUELLER B., SCHMID M., BURG G., KADIN ME., KEMPF W. (2005); Apoptosis in CD30-positive lymphoproliferative disorders of the skin; Experimental Dermatology 2005: 14: 380-385

 

133.WILLEMZE R, JAFFE E. S, BURG G, CERRONI L, BERTI E, SWERDLOW S H, RALFKIAER E, CHIMENTI S, DIAZ-PEREZ J,  L, DUNCAN L M, GRANGE F, HARRIS N L, KEMPF W, KERL H, KURRER M, KNOBLER R, PIMPINELLI N, SANDER C, SANTUCCI M, STERRY W, VERMEER; M H, WECHSLER J, WHITTAKER S, MEIJER C J  (2005).;"WHO-EORTC classification for cutaneous lymphomas." ; Blood 105(10): 3768-85

 

134.UROSEVIC M, CONRAD C, KAMARACHEV J, ASAGOE K, COZZIO A, BURG G, DUMMER R (2005); CD4+CD56+ hematodermic neoplasms bear a plasmacytoid dendritic cell phenotype; Journal of Human Pathology (2005) 36, 1020 – 1024

 

135.BURG G, KEMPF W, COZZIO A, FEIT J, WILLEMZE R, JAFFE E.S, DUMMER R, BERTI E, CERRONI L, CHIMENTI S, DIAZ-PEREZ J.L, GRANGE F, HARRIS N.L,KAZAKOV D.V, KERL H, KURER M, KNOBLER R, MEIJER CH. J.L.M, PIMPINELLI N, RALFKIAER E, RUSSEL-JONES R, SANDER CH, SANTUCCI M, STERRY W, SWERDLOW ST.H, VERMEER M.H., WECHSLER J, WHITTAKER S (2005); WHO/EORTC classification of cutaneous lymphomas 2005: histological and molecular aspects; Journal of Cutaneous Pathology 2005;32:647-674

 

136.DUMMER R, UROSEVIC M,COZZIO A, ASAGOE K, DÖBBELING U, BURG G (2006); Perspektiven der Forschung bei kutanen Lymphomen; Perspectives concerning research in cutaneous lymphomas; Journal German Dermatologic Society (JDDG) 2006; 4; 492-495

 

137.COZZIO A, KEMPF W, SCHMID-MEYER R, GILLIET M, MICHAELIS S, SCHA¨ RER L, BURG G,  DUMMER R; Intra-lesional low-dose interferon a 2a therapy for primary cutaneous marginal zone B-cell lymphoma

 

138.GREISSER J, PALMEDO G, SANDER C, KUTZNER H, KAZAKOV D, ROOS M, BURG G, KEMPF W (2006); Detection of clonal rearrangement of T-cell receptor genes in the diagnosis of primary cutaneous CD30+ lymphoproliferative disorders; J Cutan Pathol

 

 

139.BURG G (1976) ; Fortschritte in der Diagnostik kutaner Lymphome. Enzymzytochemische und immunzytologische Untersuchungen; Fortschr Med 94: 1089-1098;

 

140. BRAUN-FALCO O, BURG G, WOLFF HH (1976) ; Kutane Lymphome und Pseudolymphome. Immunzytologische, enzymzytochemische und elektronenmikroskopische Untersuchungen; Therap Umschau 33: 543-550

 

141.BRAUN-FALCO O, BURG G (1976) ; Adelantos en la Diferenciacion y Clasificacion del Linfoma cutaneo ; Dermatologia Revista Mexicana, XX, 3: 265-272

 

142.BURG G (1977) ; Moderne Aspekte in der Diagnostik und Klassifikation kutaner Lymphome; Hautarzt 28, Suppl. II: 280-282

 

143.BURG G, BRAUN-FALCO O (1977) ; Morphological and functional differentiation and classification of cutaneous lymphomas; Bull du Cancer 64: 225-240

 

144. BURG G, BRAUN-FALCO O, SCHMOECKEL CH, WOLFF HH (1977) ;Fortschritte in der Diagnostik kutaner Lymphome;Hautarzt 8, Suppl. II: 346-348;

 

145.BURG G, BRAUN-FALCO O (1978) ; Cutaneous Non-Hodgkin Lymphoma: Re-evaluation of histology using enzymecytochemical and immunologic studies; Int J Dermatol 17: 496-505

 

146.BURG G, BRAUN-FALCO O (1978); Methoden zur Klassifikation der Hautlymphome; Hautarzt 29, Suppl. III: 5-13

 

147.BURG G, BRAUN-FALCO O, SCHMOECKEL C (1988); Kutane T-Zell-Lymphome; Fortschr Med 96: 199-205

 

148.BRAUN-FALCO O, BURG G, SCHMOECKEL C (1978) ; Klassifikation von malignen Hautlymphomen; Hautarzt 29, Suppl. 111: 37-45

 

149.BURG G (1979) ; Retikulosen und Lymphome der Haut aus heutiger Sicht; Hautarzt 30: 167-168

 

150.BRAUN-FALCO O, SCHMOECKEL C, BURG G, RYCKMANNS F(1979); Pagetoid reticulosis; Acta Dermatovener 59, Suppl 85: 1-21

 

151.BRAUN-FALCO O, BURG G, HOFFMANN-FEZER G, FATEH-MOGHADAM A,HERTERICH J (1980); Die "Retikulosen" der Haut - eine heterogene Gruppe von Erkrankungen; Acta Histochem Suppl XXI: 57-69 

 

152.BRAUN-FALCO O, BURG G, SCHMOECKEL C (1981) ; Recent advances in the understanding of cutaneous lymphoma; Clin Exp Dermatol 6: 89-109

 

153.BURG G, SCHMOECKEL C, BRAUN-FALCO O (1981) ; Möglichkeiten zur Abgrenzung von Pseudolymphomen und malignen B-Zell-Lymphomen der Haut; Hautarzt Suppl. V: 210-217

 

154.BRAUN-FALCO O, NIKOLOWSKI J, BURG G, SCHMOECKEL C (1983) ; Lymphomatoide Papulose; Hautarzt 34: 59-65

 

155.BRAUN-FALCO O, BURG G (1983) ; Maligne Lymphome der Haut; Internist 24: 306-320

 

156.BURG G, KERL H, SCHMOECKEL CH (1984) ; Differentiation between malignant B-cell lymphomas and pseudolymphomas of the skin; J Dermatol Surg Oncol 10:271-275

 

157.BURG G, KERL H, PRZYBILLA B, BRAUN-FALCO O (1984) ; Some statistical data, diagnosis, and staging of cutaneous B-cell lymphomas;J Dermatol Surg Oncol 10:256-262

 

158.BURG G, KAUDEWITZ P, KLEPZIG K, PRZYBILLA B, BRAUN-FALCO O (1985); Cutaneous B-cell lymphoma; Dermatologic Clinics 3:689-704

 

159.KAUDEWITZ P, BURG G, SMOLLE J (1986) ; Immunologische Phänotypisierung kutaner Lymphome; Hautarzt 37:647-655

 

160.SMOLLE J, KAUDEWITZ P, ABERER E, TORNE R, BURG G, KERL H (1987); Immunhistochemische Klassifikation von kutanen Lymphomen und Pseudolymphomen; Hautarzt 38: 461-466

 

161.BURG G (1988) ; Häufigkeit und Klassifikation der Hautlymphome; Hautarzt 39, S VIII: 276-277

 

162.BURG G, KERL H (1991) ; Cutaneous Lymphomas and Pseudolymphomas – Introduction; Sem Diagn Pathol 8:53-54

 

163.KAUDEWITZ P, BURG G (1991) : Lymphomatoid Papulosis and Ki-1 (CD30)-Positive Cutaneous Large Cell Lymphomas; Sem Diagn pathol 8:117-124

 

164.KERL H, CERRONI L, BURG G (1992) ; The Morphologic Spectrum of T-Cell Lymphomas of the Skin: A Proposal for a New Classifica­tion; Sem Diagn Pathol 8:55-61

 

165.BURG G, DOMMANN S, DUMMER R (1993); Maligne Lymphome der Haut; Therapeutische Umschau 50, 12:828-834

 

166.BURG G, DUMMER R, KERL H (1994); Classification of cutaneous lymphomas; Dermatologic Clinics 12;2:213-217

 

167. BURG G, DUMMER R, DOMMANN ST, NESTLE F, NICKOLOFF B (1995); Pathology of cutaneous T-cell lymphoma; Hematology/Oncology Clinics of North America 9(5): 961 – 995

 

168. DUMMER R, HÄFFNER AC, HESS M, BURG G (1996); Rational Approach to the Therapy of Cutaneous T-Cell Lymphomas; Onkologie 1996; 19: 226 – 230

 

169.NESTLE FO, HÄFFNER AC, HESS SCHMID M, DUMMER R, BURG G (1997); Moderne Therapiekonzepte bei kutanen T-Zell-Lymphomen; Schweiz Med Wochenschr 1997; 127: 311 – 320

 

170.BURG G (1997); Ungewöhnliche Varianten kutaner Lymphome; Unusual variants of cutaneous lymphomas; H+G 4 (72); 253 – 256

 

171.JAFFE ES, BURG G (1997); Report of the Symposium on Cutaneous Lymphomas: Sixth International Conference on Malignant Lymphoma; Annals of Oncology 8 (Suppl. 1): 83 – 84

 

172.BURG G (1999); Challenges in Cutaneous Lymphomas: A Morphologist's Perspective (Review articlein "Cutaneous Lymphomas XVIII; Masahiro Takigawa (editor); Japanese Society for Cutaneous Lymphomas, Abstraktband 1999.5; p 2 – 20

 

173.ROGALSKI C, DUMMER R, BURG G (1999); Immunomodulators in the treatment of cutaneous lymphoma; Journal of the European Academy of Dermatology and Venerology 13: 83 – 90

 

174.KAMARASHEV J, KEMPF W, DUMMER R, MÜLLER B, BURG G (2000); Cutaneous lymphomas; G Ital Dermatol Venereol 135: 29 – 48

 

175.BURG G (2000); Cutaneous Lymphomas; Medical Dermatology Part I; Current Problems in Dermatology; 12 (1): 25 – 29

 

176.DUMMER R, WILLERS J, KAMARASHEV J, UROSEVIC M, DÖBBELING Ü, BURG G; Pathogenesis of Cutaneous Lymphomas; Seminars in Cutaneous Medicine and Surgery 109 (2): 78 – 86

 

177.BURG G (2000); Cutaneous Lymphomas: Classification and Staging; AIDA (Sonderheft) VIII; 1: 39-44

 

178.DUMMER R, HESS-SCHMID M, BURG G (2000); Cutaneous T-Cell Lymphomas: Prognosis and Quality-of-Life Issues; Clinical Lymphoma suppl. Vol. 1: 21 – 25

 

179.KEMPF W, DUMMER R, BURG G (2001); Klinische und therapeutische Besonderheiten kutaner Lymphome; Deutsches Ärzteblatt 98; 11: 697 – 703

 

180.KNOBLER R, BURG G, WHITTAKER S, BAILA L (2002); EORTC Cutaneous Lymphoma Task Force; European Journal of Cancer 38 (2002) S60-S64

 

181.DUMMER R, UROSEVIC M, DÖBBELING U, BURG G (2003); Immunobiology of cutaneous T-cell lymphomas; haematologica 2003, Volume 88; supplement No. 5 – April 2003

 

182DUMMER R, KEMPF W, HESS SCHMID M, HAEFFNER A, BURG G (2003); Therapy of Cutaneous DRAGIEVA G, KEMPF W, BURG G, HESS M, SCHÄRER L, KETTELHACK N, PRINZ BM, DUMMER R, HAFNER J (2003): Hautveränderungen bei organtransplantierten, immunsupprimierten Patienten. Haut 2003; XIV: 172Lymphoma – Current Practice and Future Developments; Onkologie 2003; 26:366-372

 

183DUMMER R, BEYELER M, HESS SCHMID M, KEMPF W, BURG G (2003); Diagnostik und Therapie kutaner Lymphome; Schweiz Med Forum 2003; 47: 1136-1143

 

184KEMPF W, KETTELHACK N, DUVIC M, BURG G (2003); Topical and systemic retinoid therapy for cutaneous T-cell lymphoma; Hematol Oncol Clin N Am 17 (2003): 1405-1419

 

185.KAZAKOV DV, BURG G, KEMPF W (2004)¸Clinicopathological spectrum of mycosis fungoides; JEADV 2004; 18, 397-415

 

186.BEYELER M, BURG G, DUMMER R (2004); Kutane Lymphome; Der Hautarzt 2004; 55:1005-1017

 

187.BURG G, KEMPF W, COZZIO A, DÖBBELING U,FEIT J, GOLLING P,MICHAELIS S, SCHÄRER L, NESTLE F, DUMMER R (2006); Kutane maligne Lymphome: Update 2006 zu ausgewählten Aspekten; JDDG 2006; 4: 914-934

 

188.BURG G, KEMPF W, DUMMER R (2007); Cutaneous Lymphomas : Current and future concepts; J Egypt wom Derm Soc 4(1), 1-23

 

189.KAZAKOV DV, BURG G, KEMPF W (2004): Clinicopathological spectrum of mycosis fungoides. JEADV 2004; 18, 397-415

 

190.BEYELER M, BURG G, DUMMER R (2004): Kutane Lymphome. Der Hautarzt 2004; 55:1005-1017

 

191.BURG G, KEMPF W, COZZIO A, DÖBBELING U,FEIT J, GOLLING P,MICHAELIS S, SCHÄRER L, NESTLE F, DUMMER R (2006): Kutane maligne Lymphome: Update 2006 zu ausgewählten Aspekten. JDDG 2006; 4: 914-934

 

192.BURG G, KEMPF W, DUMMER R (2007): Cutaneous Lymphomas : Current and future concepts. J Egypt wom Derm Soc 4(1), 1-23

 

193.BURG G, RODT H, GROSSE-WILDE H, NETZEL B, FATEH-MOGHADAM A, BRAUN-FALCO O (1977): Enzymzytochemical and immuncytological studies as a basis for the reevaluation of the histolo­gy of cutaneous B-cell and T-cell lymphomas. In: S.S. Thierfelder, H. Rodt, E. Thiel (Hrsg.): Haematology and Blood Transfusion, Vol. 20:Immunological Diagnosis of Leukemias and Lymphomas, S. 179-187. Springer, Berlin-Heidelberg-New York

 

194.BURG G (1979): Moderne Diagnostik and stadiengerechte Therapie kutaner Lymphome. In: O. Braun-Falco und H.H. Wolff (Hrsg.): Fortschritte der praktischen Dermatologie und Venerologie, Vol. 9, S. 215-227. Springer, Berlin-Heidelberg-New York

 

195.BURG G (1981): Malignant histiocytic disorders of the skin. In: F. Schmalzl, D. Huhn, H.E. Schaefer (Hrsg.): Haematology and Blood Transfusion Vol 27: 221-224. Disorders of the Monocyte Macrophage System. Springer-Verlag, Berlin-Heidelberg-New York

 

196.KUMMERMEHR J, BURG G (1982): Autoradiographic pattern of cell proliferation in cutaneous malignant lymphoma. In: M. Goos, E. Christophers (Hrsg.): Lymphoproliferative Diseases of the skin, S. 71-78. Springer Verlag, Berlin-Heidelberg-New York

 

197.BURG G, BRAUN-FALCO O, HOFFMANN-FEZER G, SCHMOECKEL C (1982): Differentiation between pseudolymphomas and malignant B cell lymphomas of the skin. In: M. Goos and E. Christophers (Hrsg.): Lymphoproliferative Diseases of the skin, S. 101-107. Springer Verlag, Berlin-Heidelberg-New York

 

198.NIKOLOWSKI J, BURG G, SCHMOECKEL C, BRAUN-FALCO O, HOFFMANN-FEZER G (1982): Lymphomatoid papulosis: A cutaneous T cell pseudo-lymphoma?. In: M. Goos, E. Christophers (Hrsg.): Lymphoproliferative Diseases of the Skin, S. 163-167. Springer Verlag, Berlin-Heidelberg-New York

 

199.GUGGENBERGER K, BURG G, SCHMOECKEL C, DETMAR U (1982) : Follow-ups in cutaneous immunocytomas. In: M. Goos, E. Christophers (Hrsg.): Lymphoproliferative Diseases of the Skin, S. 192-196. Springer Verlag, Berlin-Heidelberg-New York

 

200.SCHMOECKEL C, BURG G, HOFFMANN-FEZER G, WOLFF HH, BRAUN-FALCO O (1982): Pagetoid reticulosis - a rare entity?. In: M. Goos, E. Christophers (Hrsg.): Lymphoproliferative Diseases of the Skin,S. 217-221. Springer Verlag, Berlin-Heidelberg-New York

 

201.BRAUN-FALCO O, KRESBACH H, BURG G, KERL H (1982): German-Austrian cutaneous lymphoma cooperative study group. In: M. Goos, E. Christophers (Hrsg.): Lymphoproliferative Diseases of the Skin, S. 256-259. Springer Verlag, Berlin-Heidelberg-New York

 

202.SCHMOECKEL C, BURG G, HOFFMANN-FEZER G, WEITZ H, BRAUN-FALCO O (1982): Cutaneous immunoblastic T-cell lymphoma. In: XVI Congressus Internationalis Dermatologiea1982 Tokyo, Case Presenta­tions S. 71-72. University Press of Tokyo

 

203.KAUDEWITZ P, KIND P, BURG G, RIEBER P, BERGER C, EDELSON R, BRAUN-FALCO O (1984): Longitudinal study of surface antigen pattern in cutaneous T-cell lymphomas. In: DM MacDonald (Hrg.): Immunodermatology, S. 123-124. Butterworth London-Boston-Durban-Sydney-Toronto-Washington

 

204.BURG G (1984): Lymphome: Diagnostik und Klassifikation. In: J. Petres, J. Kunze, RPA Müller (Hrsg.): Onkologie der Haut, S. 179-189. Grosse Verlag, Berlin

 

205.BURG G (1984): Kooperative Studiengruppe "Kutane Lymphome".  Geplante Therapie-Konzepte. In: J. Petres, J. Kunze, RPA Müller (Hrsg.): Onkologie der Haut, S. 240-243. Grosse Verlag, Berlin

 

206.BURG G (1987): Cutaneous Lymphomas. In: C.E.Orfanos, R. Stadler, H. Gollnick (Hrgs.): Dermatology in Five Continents, S. 188-193. Springer, Berlin-Heidelberg-New York

 

207.BURG G, KAUDEWITZ P (1990): Where we are today in the Diagnosis of Cutaneous Lymphoma?. In: van Vloten WA et al. (eds): Curr Probl Dermatol. Cutaneous Lymphoma, Vol 19: 90-104. Karger, Basel

 

208.KAUDEWITZ P, BURG G, STEIN N (1990): Ki-1 (CD30) positive cutaneous anaplastic large cell lymphomas. In: van Vloten WA et al (eds): Curr Probl Dermatol. Cutaneous Lymphomas, Vol 19: 150-156. Curr Probl Dermatol, Karger, Basel

 

209.BURG G, ZIFFER S, LANZ U (1990): Light and electron microscopy findings in lymphomatoid papulosis.. In: Muller SA (ed): Parapsoriasis. S. 78-81. Mayo Foundation Rochester

 

210.WEIDENHILLER M, ACKERMANN S, DUMMER R, BURG G (1992) Zytokin- und Zytokin-rezeptor-Expression in kutanen Lymphomen. In: G Burg, AA Hartmann, B Konz (Hrsg.): Onkologische Dermatologie. S 41-48. Springer Verlag, Berlin-Heidelberg-New York

 

211.BURG G, ZIFFER S, LANZ U (1990): Light and electron microscopy findings in lymphomatoid papulosis.. In: Muller SA (ed): Parapsoriasis. S. 78-81,. Mayo Foundation Rochester

 

212.KOHL O, DUMMER R, GILLESSEN J, BURG G (1992): Interleukin-4 (IL-4) und kutane T-Zell-Lymphome (CTCL). In: G Burg, AA Hartmann, B Konz (Hrsg.): Onkologische Dermatologie. S 75-81. Springer Verlag, Berlin-Heidelberg-New York

 

213.BURG G, HEFNER H, RÖGER J, VOGT T, DUMMER R (1992). Topische Behandlung kutaner T-Zell-Lymphome mit Carmustin (BCNU). In: G Burg, AA Hartmann, B Konz (Hrsg.): Onkologische Dermatologie. S 171-173. Springer Verlag, Berlin-Heidelberg-New York

 

214.BURG G, DUMMER R, SCHMID MH, FELLER A (1993): B-cell lymphomas and B-cell pseudolymphomas. In: W.H.C. Burgdorf, S.I. Katz (eds.): Dermatology, Progress & Perspectives. The Proceedings of the 18th World Congress of Dermatology. The Parthenon Publisher Group, New York, Casterton, London 1993, p 618-621

 

215.BURG G (1992): Cutaneous B Cell Lymphoma, Multiple Myeloma, And Myelomonocytic Leukemia. In: Moschella and Hurley (eds.), 3rd ed. Dermatology, Chapter 69: 1829-1844. W. B. Saunders Company, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo

 

216.BURG G, BERTI E, EVERETT MA (1993): Chair’s summary: Immunophenotyping of cutaneous lymphomas. In: W.H.C. Burgdorf, S.I. Katz (eds.): Dermatology, Progress & Perspectives, S. 1142-1145. The Proceedings of the 18th World Congress of Dermatology. The Parthenon Publisher Group, New York, Casterton, London

 

217.BURG G (1993): Histiozytosen. In: O. Braun-Falco, G. Plewig, M. Meurer (Hrsg.): Fortschritte der praktischen Dermatologie und Venerologie, S. 3-9. Springer-Verlag Berlin, Heidelberg, New York, London,

 

218.DUMMER R, DOMMANN SNW, HASSAM SH, BÖNI R, DÖBBELING U, NESTLE FO, BURG G (1994). : Diagnostik und Pathogenesen kutaner Lymphome. . In: E Macher, G. Kolde, E.B. Bröcker (Hrsg.): Jahrbuch (1994/95) der Dermatologie - Tumoren und Haut - . Biermann Verlag FRG, p 151-164Paris

 

219.BURG G (1994): Dermatologia ed Ematologia / Dermatologia e i suoi Limitrofi. 31° Congresso Nazionale Associazione Dermatologi Ospedalieri Italiani. Merano, 28.-31. Ottobre 1992(Kongressbuch: Erschienen VII n. 2 Maggio 1994, S. 73-77)

 

220.BURG G, HÄFFNER A, BÖNI R, DOMMANN S, DUMMER R (1995): New Perspectives in Experimental and Clinical Research for Cutaneous T Cell Lymphomas. III. Cutaneous Lymphoma. In: Recent Results in Cancer Research, Vol. 139: 225-237. Springer-Verlag Berlin-Heidelberg

 

221.BURG G, DUMMER R, DOMMANN ST, BÖNI R, DÖBBELING U, NESTLE F (1995): Maligne Lymphome der Haut. Klinische Besonderheiten und aktuelle Therapiekonzepte. In: Diehl V, Schlag R, Thoel E (Hrsg.): Morbus Hodgkin und Non-Hodgkin-Lymphome, S. 126 – 150. Karger Verlag Basel

 

222.DUMMER R, BURG G (1995): Pathogenetisch orientierte Perspektiven einer zukünftigen Behandlung kutaner Lymphome. In: Tebbe B, Goerdt S, Orfanos CE (Hrsg.): Dermatologie. Heutiger Stand. S. 235 – 237. Ergebnisse und Berichte der 38. Tagung der Deutschen Dermatologischen Gesellschaft in Berlin vom 29. April bis 3. Mai 1995. Georg Thieme Verlag Stuttgart - New York

 

223.BURG G, DUMMER R, DOMMANN ST (1996): Other Cutaneous Lymphomas: B-Cell Lymphoma, Non-Mycosis Fungoides T-Cell Lymphoma, and Adult T-Cell Lymphoma/Leukemia. In: Kenneth A. Arndt  et al. (eds.): Cutaneous Medicine And Surgery: An Integrated Program in Dermatology. Vol. 2, Chapter 159: 1660-1669. W.B. Saunders Company, Philadelphia, London, Toronto, Montreal, Sydney, Tokyo

 

224.KALINKE D.U., DUMMER R, BURG G (1996): Management of cutaneous T-cell lymphoma. In: Mark V. Dahl (editor): Current Opinion in Dermatology, Vol. 3: S.71-76. Pearon G. Lang (editor): Neoplasms. . Rapid Science Publishers, Philadelphia, PA

 

225.BURG G, DOMMANN S, PÖTTER R, SCHLAPPACK O, DUMMER R (1997): Kutane Non-Hodgkin-Lymphome. In: H.-J. Schmoll, K. Höffken, K. Possinger (Hrsg.): Kompendium Internistische Onkologie. 2. Auflage, Teil 2. S 293 - 308 . Springer-Verlag Berlin, Heidelberg, New York

 

226.POTOCZNA N, MÜLLER B, BURG G, DUMMER R (1996): Immunhistochemischer Klonalitätsnachweis in kutanen T-Zell-Lymphomen mittels monoklonaler Antikörper gegen die variable Region des T-Zell-Rezeptors. . In: R. Dummer, R. Panizzon, G. Burg (Hrsg.): Fortschritte der operativen und onkologischen Dermatologie, Band 11, S. 203 – 207. Operative und konservative Dermatoonkologie im interdisziplinären Grenzbereich. Blackwell Wissenschaftsverlag Berlin-Wien 1996

 

227.MEYER JCH, HASSAM S, DUMMER R, MULETTA S, DÖBBELING U, DOMMANN SNW (1996): Konalitätsnachweis bei Verdacht auf kutanes T-Zell-Lymphom: Vertgleich von PCR-DGGE des T-Zell-Rezeptor-Gamma-Gens mit der Southern-Blot-Analyse (SBA) des T-Zell-Rezeptor-Beta-Gens. . In: R. Dummer, R. Panizzon, G. Burg (Hrsg.): Fortschritte der operativen und onkologischen Dermatologie, Band 11, S. 208-211. Operative und konservative Dermatoonkologie im interdisziplinären Grenzbereich. Blackwell Wissenschaftsverlag Berlin-Wien 1996

 

228.BURG G, DUMMER R (1998): Leitlinien: kutane Lymphome. In: C. Garbe, G. Rassner (Hrsg.): Dermatologie. Leitlinien und Qualitätssicherung für Diagnostik und Therapie. Berichte von der 39. Tagung der Deutschen Dermatologischen Gesellschaft, S. 363 – 368. Springer Verlag Berlin Heidelberg New York 1998

 

229.DUMMER R, DÖBBELING U, GEERTSEN R, WILLERS J, BURG G (1999): Pathogenese kutaner T-Zell-Lymphome, S. 455 – 456. In: A. Plettenberg, W.N. Meigel, I. Moll (Hrsg.): Dermatologie an der Schwelle zum neuen Jahrtausend . Aktueller Stand von Klinik und Forschung. Springer Verlag Berlin, Heidelberg, New York

 

230.BURG G (1999) : Pseudolymphomas: B-cell pseudolymphoma, T-cell pseudolymphoma. . In:  G. Burg (Hrsg): Atlas of Cancer of the Skin, S. 109 - 112. . Churchill Livingstone, New York

 

231.BURG G (1999): Histiocytic Disorders.. In:  G. Burg (Hrsg): Atlas of Cancer of the Skin, S. 130 – 145. Churchill Livingstone, New York

 

232.BURG G, KEMPF W, DUMMER R (2002): Kutane Lymphome, P 33 –51. In: B. Konz, G. Plewig (Hrsg): Fortschritte der Dermatologie. Ein Rückblick auf 50 Jahre anlässlich des 80. Geburtstages von Herrn Professor Dr. Dr. h.c. mult. Otto Braun-Falco. Steinkopff Verlag Darmstadt

 

233.KAZAKOV DV, BURG G, DUMMER R, KEMPF W (2002): Cutaneous Lymphomas and Pseudolymphomas: Newly Described Entities. Recent Results in Cancer Research, Vol. 160. Springer-Verlag Berlin Heidelberg 2002

 

234.BURG G, KEMPF W, HAEFFNER A, DOEBBELING U, NESTLE F O, BOENI R, KADIN M, DUMMER R (2002) : From Inflammation to Neoplasia: New Concepts in the Pathogenesis of Cutaneous Lymphomas. (Buch) Cancers of the Skin / Proceedings of the 8th World Congress (S 271 - 280)

 

235.BURG G, KEMPF W, MICHAELIS S, SCHÄRER L, DUMMER R (2005): T- und B-Zell-Neoplasien der Haut. In: G. Plewig, P. Kaudewitz, C.A. Sander: Fortschritte der praktischen Dermatologie und Venerologie vol. 19. Springer-Verlag Berlin Heidelberg 2005

 

236.KEMPF W, BURG G (2005): Maligne Lymphome der Haut. In: O. Braun-Falco, G. Plewig, H. Wolff, W. Burgdorf, M. Landthaler: Dermatologie und Venerologie 5. Auflage. Springer Medizin Verlag Heidelberg 2005

 

237.DUMMER R, UROSEVIC M, COZZIO A, BURG G (2005): Targeting the cytokine dysbalance for the immunotherapy of cutaneous T-cell lymphomas . Eurocancer 2005. John Libbey Eurotext, Paris 2005, pp. 159-160

 

238.BURG G, KEMPF W, SMOLLER B, RALFKIAER E, KAZAKOV D.V, SANDER C, FEIT J, LEBOIT PH (2006): Mycosis fungoides. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 169-174; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

 

239.RUSSEL-JONES R, BERNENGO M, BURG G, LAROCHE L, MICHAELIS S, RALFKIAER E, VONDERHEID E, WHITTAKER S (2006): Sézary syndrome. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 175-177; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

 

240.KEMPF W, KAZAKOV D.V, MICHAELIS S, BURG G, LEBOIT P (2006): Granulomatous slack skin . World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 178; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

 

241.KEMPF W, WILLEMZE R, JAFFE E.S, BURG G, KADIN M.E (2006): CD30+ T-cell lymphoproliferative disorders . World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 179-181; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

 

242.JAFFE E.S, BURG G (2005): Subcutaneous panniculitis-like T-cell lymphoma. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 182-183; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

 

243.RALFKIAER E, WILLEMZE, MEIJER C.J.L.M, DUMMER R, JAFFE E.S, SWERDLOW S.H, BERTI E, KEMPF W, BURG G, CERRONI L, TORO J.R (2006): Primary cutaneous peripheral T-cell lymphoma, unspecified . World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 184-188; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

 

244.KEMPF W, RALFKIAER E, DUNCAN L, BURG G, WILLEMZE R, SWERDLOW S.H, JAFFE E.S (2006): Cutaneous marginal zone B-cell lymphoma . World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 194-195; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

 

245.PIMPINELLI N, BERTI E, BURG G, DUNCAN L, HARRIS N.L, JAFFE E.S, KERL H, KURRER M, KEMPF W, MEIJER C.J.L.M, SANTUCCI M, SWERDLOW S.H, WILLEMZE R (2006): Cutaneous follicle centre lymphoma. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 196-197; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

 

246.BURG G, JAFFE E.S, WILLEMZE R, DOMMANN-SCHERRER C, SWERDLOW S.H, KEMPF W, KURRER M, KUTZNER H, WECHSLER J, HARRIS N.L (2005): Cutaneous diffuse large B-cell lymphoma. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 198-199; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

 

247.SANDER C.A, JAFFE E.S, FLAIG M.J, DUMMER R, KAZAKOV D.V, KEMPF W, BURG G (2006): Blastic NK-cell lymphoma. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 208-209; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

 

248.SANDER C.A, JAFFE E.S, BURG G (2006): Precursor T-lymphoblastic leukaemia / lymphoma and precursor B-lymphoblastic leukaemia / lymphoma. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 210; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

 

249.BURG G, KEMPF W, SANDER C.A, WOOD G, SCHMID U, COGLIATTI S (2006): Lymphoid infiltrates of the skin mimicking lymphoma (cutaneous pseudolymphoma) . World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 212-214; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

 

250.BURG G, SANTUCCI M, SMOLLER B, GUITART J, EVERETT M, KEMPF W (2006): Parapsoriasis. World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 215-216; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

 

251.ZELGER B, RAPINI R.P, BURGDORF W, BURG G (2006): Langerhans cell histiocytosis . World Health Organization Classification of Tumors;  Pathology & Genetics Skin Tumours, pp. 217-219; Editors: Philip E. LeBoit, Günter Burg, David Weedon, Alain Sarasin, ISBN 92 832 2414 0

 

252.KEMPF W, BURG G (2008): Kutane lympoproliferative und hämatopoetische Erkrankungen. In: A. Cardesa, Th Mentzel, P. Rudolph, P.J. Slootweg (Hrsg.). Pathologie. Springer Berlin, Heidelberg, 2009 . Seite 979-1002

 

Melanom

 

1.     BURG G, BRAUN-FALCO O (1972): The cellular stromal reaction in malignant melanoma. A cytochemical investigation; Arch Derm Forsch 245: 318-333

 

2.     BURG G, BRAUN-FALCO O (1972): Cytochemische Untersuchungen zur cellulären Stromareaktion beim Melanom; Arch Derm Forsch 244: 261-264

 

3.     BRAUN-FALCO O, BURG G (1973) : Zur Enzym-Histochemie des malignen Melanoms. Untersuchungen an Primärtumoren und Metastasen; Arch Derm Forsch 246: 303-316

 

4.     BURG G, BRAUN-FALCO O (1977): 1-Chlor-2,4-dinitrobenzol (DNCB)-Salbe zur Sensibilisierung, Testung und Behandlung von Patienten mit malignem Melanom; Dtsch med Wschr 102: 210-211

 

5.     WEIß J, GARBE C, BERTZ J, BILTZ H, BURG G, HENNES B, JUNG EG, KREY­SEL HW, ORFANOS CE, PETZOLDT D, SCHWERMANN M, STADLER R, TILGEN W, TRONNIER H, VÖLKERS W (1990): Risikofaktoren für die Entwicklung maligner Melanome in der Bundesrepublik Deutschland; Hautarzt 41: 309-313

 

6.     SCHÄFER E, DUMMER R, EILLES CH, BÖRNER W, MARTIN R, RENDL J, BURG G (1991): Imaging pattern of radiolabelled lymphokine-activated killer cells in patients with metastatic malignant melanoma; Eur J Nucl Med 18: 106-110

 

7.     DUMMER R, BECKER J.C, KALHAMMER U, MICHAELIS A, OSTMEIER H, TSCHAMMLER A, HARTMANN AA, BURG G (1991): Combined chemo- and immuno-therapy using dacarbazine and continuous infusion of interleukin 2 in metastatic malignant melanoma.  Results of a phase II clinical trial; Eur J Dermatol 1:201-205

 

8.     DUMMER R, MILLER K, EILLES CH, BURG G (1991): The Skin: An Immunoreactive Target Organ during Interleukin-2 Administration?; Dermatologica 183:95-99

 

9.     DUMMER R, SCHÄFER E, EILLES C, BÖRNER W, BURG G (1991): Lymphokine-activated killer-cell traffic in metastatic melanoma; Lancet 338:456-457

 

10.   OSTMEIER H, SCHUMANN J, OTTO F, KRIEG V, FUCHS B, BIESS B, BURG G, SUTER L (1991): The relationship between characteristics of the tumor cells and sex of the patients in primary malignant melanomas; J Cancer Res Clin Oncol 117:364-366

 

11.   DUMMER R, MÜLLER W, NESTLE F, WIEDE J, DUES J, LECHNER W, HAUBITZ I, WOLF W, BILL E, BURG G (1991): Formation of neutralizing antibodies against natural Interferon-, but not against recombinant Interferon- during adjuvant therapy for high-risk malignant melanoma patients ; Cancer 67:2300-2304

 

12.   BECKER JC, DUMMER R, HARTMANN AA, BURG G, SCHMIDT RE (1991): Shedding of ICAM-1 from human melanoma cell lines induced by IFN-and tumor necrosis factor-. Functional consequences on cell-mediated cytotoxicity; J Immunol 147:4398-4401

 

13.   HÄFFNER AC, GARBE C, BURG G, BÜTTNER P, ORFANOS CE, RASSNER G (1992) The prognosis of primary and metastasising melanoma. An avaluation of the TNM classification in 2,495 patients; Br J Cancer 66:856-861

 

14.   BECKER J, DUMMER R, SCHWINN A, HARTMANN AA, BURG G (1992): Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy; J Immunother 12:147-150

 

15.   BECKER JC, DUMMER R, SCHMIDT RE, BURG G, HARTMANN AA (1992): Shedding of soluble intercellular adhesion molecule 1 (ICAM-1) from melanoma cells and the effect on cellular cytotoxicity; Immun Infekt 20:62-63

 

16.   BECKER JC, DUMMER R, SCHMIDT RE, BURG G, HARTMANN AA (1992)Freigabe von löslichem interzellulärem Adhäsionsmolekül 1 (ICAM-1) von Melanomzellen und dessen Einfluss auf die zelluläre Zytotoxizität; Immun Infekt 20:62-63

 

17.   BECKER JC, SCHWINN A, DUMMER R, BURG G, BROCKER EB :
Tumor-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expression; Clin Exp Immun 91:121-125

 

18.   HÄFFNER AC, GARBE C, BURG G, BÜTTNER P, ORFANOS CE, RASSNER G (1992); The prognosis of primary and metastasising melanoma. An avaluation of the TNM classification in 2,495 patients; Br J Cancer 66:856-861

 

19.   BECKER J, DUMMER R, SCHWINN A, HARTMANN AA, BURG G (1992); Circulating intercellular adhesion molecule-1 in melanoma patients: induction by interleukin-2 therapy; J Immunother 12:147-150

 

20.   BECKER JC, DUMMER R, SCHMIDT RE, BURG G, HARTMANN AA (1992); Shedding of soluble intercellular adhesion molecule 1 (ICAM-1) from melanoma cells and the effect on cellular cytotoxicity; Immun Infekt 20:62-63

 

21.   BECKER JC, DUMMER R, SCHMIDT RE, BURG G, HARTMANN AA (1992); Freigabe von löslichem interzellulärem Adhäsionsmolekül 1 (ICAM-1) von Melanomzellen und dessen Einfluss auf die zelluläre Zytotoxizität; Immun Infekt 20:62-63

 

22.   DUMMER R, BECKER JC, EILLES C, SCHÄFER E, BÖRNER W, BURG G (1993): T cells migrate to tumour sites after extracorporeal interleukin 2 stimulation and reinfusion in a patient with metastatic melanoma; Br J Dermatol 128:399-403

 

23.   DUMMER R, BECKER JC, EILLES C, SCHÄFER E, BÖRNER W, BURG G (1993);T cells migrate to tumour sites after extracorporeal interleukin 2 stimulation and reinfusion in a patient with metastatic melanoma; Br J Dermatol 128:399-403

 

24.   BECKER JC, SCHWINN A, DUMMER R, BURG G, BROCKER EB (1993); Tumor-infiltrating lymphocytes in primary melanoma: functional consequences of differential IL-2 receptor expression; Clin Exp Immun 91:121-125

 

25.   SCHULTZ ES, DUMMER R, BECKER JC, ZILLIKENS D, BURG G (1994); Influence of various cytokines on the interleukin-2-dependent lysis of melanoma cells in vitro; Arch Dermatol Res 286:73-76

 

26.   LÜBBE J, REICHEL M, BURG G, KLEIHUES P (1994); Absence of p53 Gene Mutations in Cutaneous Melanoma;J Invest Dermatol 102:819-821

 

27.   DUMMER R, SIGG-ZEMANN S, KALTHOF K, MULETTA S, MEYER JCH, BURG G (1994); Various Cytokines Modulate ICAM-1 Shedding on Melanoma- and CTCL-Derived Cell Lines: Inverse Regulation of ICAM-1 Shedding in a Sézary Cell Line by Interferon-; Dermatology 189:120-124

 

28.   DOMMANN SNW, PANIZZON R, BURG G (1995); Melanom-Präventivuntersuchung. Aufklärungskampagne in einer Zürcher Grossbank; Schweizerische Ärztezeitung 76(41): 1666 – 1668

 

29.   BECKER JC, BORMANN C, DUMMER R, SCHWINN A, BURG G (1994);Specific Immune Response Against Melanoma: Analysis At A Clonal Level. Basic Mechanisms of Physiologic and Aberrant Lymphoproliferation in the Skin; Edited by W.C. Lambert et al., Plenum Press New York, 1994; S. 459-467

 

30.   DUMMER R, GORE ME, HANCOCK BW, GUILLOU PJ, GROBBEN HC, BECKER JC, OSKAM R, DIELEMAN JP, BURG G (1995); A Multicenter Phase II Clinical Trial Using Dacarbazine and Continous Infusion Interleukin-2 for Metastatic Melanoma. ; Cancer 75: 1038-1044

 

31.   BÖNI R, HUCH BÖNI RA, STEINERT H, BURG G, BUCK A, MARINCEK B, BERTHOLD T, DUMMER R, VIELLMY D, BALLMER B, VON SCHULTHESS GK (1995); Staging of metastatic melanoma by whole-body positron emission tomography using 2-fluorine-18-fluoro-2-deoxy-d-glucose; Br J Dermatol 132: 556 – 562

 

32.   GARBE C, BÜTTNER P, BERTZ J, BURG G, d’HOEDT B, DREPPER H, GUGGENMOOS-HOLZMANN I, LECHNER W, LIPPOLD A, ORFANOS CE, PETERS A, RASSNER G, STADLER R, STROEBEL W (1995); Primary Cutaneous Melanoma: Identification of Prognostic Groups and Estimation of Indivudual Prognosis for 5093 Patients; Cancer 75: 2484 – 2491

 

33.   GARBE C, BÜTTNER P, BERTZ J, BURG G, d’HOEDT B, DREPPER H, GUGGENMOOS-HOLZMANN I, LECHNER W, LIPPOLD A, ORFANOS CE, PETERS A, RASSNER G, STADLER R, STROEBEL W (1995); Primary Cutaneous Melanoma: Prognostic Classification of Anatomic Location; Cancer 75: 2492 – 2498

 

34.   GARBE C, BÜTTNER P, BERTZ J, BURG G, d’HOEDT B, DREPPER H, GUGGENMOOS-HOLZMANN I, LECHNER W, LIPPOLD A, ORFANOS CE, PETERS A, RASSNER G, STADLER R, STROEBEL W (1995); Primary Cutaneous Melanoma: Optimized Cutoff Points of Tumor Thickness and Importance of Clark’s Level for Prognostic Classification; Cancer 75: 2499 – 2506

 

35.   STEINERT HC, HUCH BÖNI RA, BUCK A, BÖNI R, BERTHOLD T, MARINCEK B, BURG G (1995);Malignant Melanoma: Staging with Whole-Body Positron Emission Tomography and 2-(F-18)-Fluoro-2-deoxy-D-glucose; Radiology 195: 705 - 709

 

36.   BÖNI R, DUMMER R, BURG G (1995); Acral sclerosis and leukoderma in a melanoma patient treated with inteferon alpha und interleukin-2 (Case report); Eur J Dermatol 5: 383 - 385

 

37.   BÖNI R, HUCH BÖNI R, STEINERT H, DUMMER R, BURG G, VON SCHULTHESS GK (1995); Anti-Melanoma Monoclonal Antibody 225.28S; Immunoscintigraphy in Metastatic Melanoma; Dermatology 191: 119 – 123

 

38.   JAFARI M, PAPP T, KIRCHNER S, DIENER U, HENSCHLER D; BURG G, SCHIFFMANN D; Analysis of ras mutations in human melanocytic lesions: activation of the ras gene seems to be associated with the nodular type of human malignant melanoma.; J Cancer Res Clin Oncol 121(1): 23-30

 

39.   KLEINHANS M, SCHMID-GRENDELMEIER P, BURG G (1996); Levodopa und malignes Melanom: Fallbericht und Literaturübersicht; Hautarzt 47: 432 – 437

 

40.   BÖNI R, HUCH -BÖNI RA, STEINERT H, VON SCHULTHESS GK, BURG G (1996); Early Detection of Melanoma Metastasis Using Fludeoxyglucose F 18 Positron Emission Tomo­graphy; Arch Dermatol 132: 875 – 876

 

41.   BÖNI R, DOGUOGLU A, BURG G, MÜLLER B, DUMMER R (1996); MIB-1 immunoreactivity correlates with metastatic dissemination in primary thick cutaneous melanoma; J American Acad Dermatol 35: 416 – 418

 

42.   BÖNI R, STEINERT H, HUCH BÖNI RA, LICHTENSTEIGER W, DUMMER R, HART­MANN DS, VON SCHULTHESS GK, BURG G, WESTERA G (1996); Lack of Expression of Dopamine D2 Receptors in Malignant Melanoma: Evidence for Interaction of Iodobenzofurans with Melanin; Dermatology 193: 198 – 202

 

43.   DUMMER R, NESTLE FO, BURG G (1996); Moderne Tumortherapie am Beispiel des Melanoms. ; Modern Oncologic Treatment: for Example Melanoma; Praxis 85; 50: 1609 – 1614

 

44.   BÖNI R, HEIZMANN CW, DOGUOGLU A, ILG EC, SCHÄFER BW, DUMMER R, BURG G (1997); Ca2+-binding proteins S100A6* and S100B in primary cutaneous melanoma; J Cutan Pathol 24: 76 – 80

 

45.   YUE FY, DUMMER R, GEERTSEN R, HOFBAUER G, LAINE E, MANOLIO S, BURG G (1997); Interleukin-10 is a growth factor for human melanoma cells and down-regulates HLA class-I, HLA class II and ICAM-1 molecules; Int J Cancer 71: 630 – 637

 

46.   BURG G, NESTLE F, DUMMER R (1997); Neue Erkenntnisse zum malignen Melanom; Dt Aerzteblatt 94: A 1191 – 1196

 

47.   HENZE G, DUMMER R, JOLLER-JEMELKA HI, BÖNI R, BURG G (1997); Serum S100- A Marker for Disease Monitoring in Metastatic Melanoma; Dermatology 194: 208 – 212

 

48.   SEELENTAG WKF, BÖNI R, GÜNTHERT U, FUTO E, BURG G, HEITZ PU, ROTH J (1997); Expression of CD44 isoforms and ß1, 6-branched oligosaccharides in human malignant melanoma is correlated with tumor progression but not with metastatic potential; J Cutan Pathol 24: 206 – 211

 

49.   DAVIS-DANESHFAR A, BÖNI R, VON WUSSOW P, JOLLER H, BURG G, DUMMER R (1997); Adjuvant Immuntherapy in Malignant Melanoma: Impact of Antibody Formation Against Interferon-on Immunoparameters in Vivo; J of Immunotherapy 20 (3): 208 – 213

 

50.   BÖNI R, LICHTENSTEIGER W, STEINERT HC, HUCH BÖNI RA, FRÜH H, DUMMER R, HARTMANN DG, LAINE E, BURG G (1997); D1 dopamine receptors are not expressed in human melanoma; Melanoma Research 7: 117 – 119

 

51.   BÖNI R, STEINERT H, HUCH BÖNI R, VON SCHULTHESS G.K., MEYER J, DUMMER R, BURG G, WESTERA G (1997); Radioiodine-labelled alpha-methyl-tyrosine in malignant melanoma: cell culture studies and results in patients; Br J Dermatol 137: 96 – 100

 

52.   WIMMER I, MEYER JC, SEIFERT B, DUMMER R, FLACE A, BURG G (1997); Prognostic Value of Serum 5-S-Cysteinyldopa for Monitoring Human Metastatic Melanoma during Immunchemotherapy; Cancer Res 57 (15): 5073 – 5076

 

53.   BÖNI R, MATT D, VOETMEYER A, BURG G, ZHUANG Z (1998); Chromosomal Allele Loss in Primary Cutaneous Melanoma is Heterogeneous and Correlates with Proliferation; J Invest Dermatol 110: 215 – 217

 

54.   DUMMER R, YUE F-Y, PAVLOVIC J, GEERTSEN R, DÖHRING, MOELLING K, BURG G (1998); Immune stimulatory potential of B7.1 and B7.2 retrovirally transduced melanoma cells: suppres­sion by interleukin 10; Br J Cancer 77 (9): 1413 – 1419

 

55.   GEERTSEN RC, HOFBAUER GFL, YUE F-Y, MANOLIO S, BURG G, DUMMER R (1998); Higher Frequency of Selective Losses of HLA-A and -B Allospecificities in Metastasis Than in Primary Melanoma Lesions; J Invest Dermatol 111: 497 – 502

 

56.   NESTLE FO, ALIJAGIC S, GILLIET M, SUN Y, GRABBE ST, DUMMER R, BURG G, SCHADENDORF D (1998); Vaccination of melanoma patients with peptide- or tumor lysate-pulsed dendritic cells; Nature Medicine 4 (3): 328 – 332

 

57.   DUMMER R, KEMPF W, BURG G (1998); Pseudo-Melanoma after Laser Therapy; Dermatology 197: 71 – 73

 

58.   HOFBAUER GFL, DUMMER R, LAINE E, BURG G (1998); Expression of melanoma-associated antigens in short-term melanoma cultures detected by RT-PCR and subsequent ELISA; Arch Dermatol Res 290: 458 – 461

 

59.   DUMMER R, HAUSCHILD A, HENSELER T, BURG G (1998); Combined interferon-a and interleukin-2 as adjuvant treatment for melanoma; The Lancet, 352: 908-909

 

60.   YUE YF, GEERTSEN R, HEMMI S, BURG G, PAVLOVIC J, LAINE E, DUMMER R (1999); IL-12 directly up-regulates the expression of HLA class I, HLA class II and ICAM-1 on human melanoma cells: a mechanism for its antitumor activity?; Eur J Immunol 29: 1762 – 1773

 

61.   DUMMER R, NESTLE FO, HOFBAUER G, BURG G (1999); Systemische Therapie des metastasierenden Melanoms; Therapeutische Umschau 56 (6): 330 – 333

 

62.   DUMMER R, NESTLE FO, BURG G (1999); Aktueller Stand der adjuvanten Therapie des kutanen Melanoms; Therapie Woche, Autoren-Sonderdruck: 271 – 273

 

63.   GEERTSEN R, ZENKLUSEN R, KAMARASHEV J, BURG G, DUMMER R (1999); Inverse Regulation of Neuronal Cellular Adhesion Molecule (NCAM) By IFN-c in Melanoma Cell Cultures Established from CNS Lesions; Int J Cancer 83: 135 – 140

 

64.   BÖNI R, VORTMEIER AO, HUANG S, BURG G, HOFBAUER G, ZHUANG Z (1999); Mutation analysis of the MEN1 tumour suppressor gene in malignant melanoma.; Melanoma Research 9: 1- 4

 

65.   KELLER B, SCHMID-GRENDELMEIER P, DUMMER R, BURG G (2000);Zur Prävention des malignen Melanoms; Schweizerische Aerztezietung 2000; 82 (6): 298 – 304

 

66.   DUMMER R, BERGH J, KARLSSON Y, HOROWITZ JA, MULDER NH, TEN BOKKEL HUININK D, BURG G, HOFBAUER G, OSANTO S (2000); Biological activity and safety of adenoviral vector-expressed wild-type p53 after intratumoral injection in melanoma and breast cancer patients with p53-overexpressing tumors; Cancer Gene Therapy 7: 1069 – 1076

 

67.   YUENG FY, CAO L, HEMMI S, GEERTSEN R, LAINE E, BURG G, DUMMER R (2000); Upregulation of interleukin-12 receptor on peripheral blood mononuclear cells and HLA class I, HLA class II or ICAM-1 on melanoma cells by B7.1 and interleukin-12:a mechanism for immunostimulatory impact of melanoma cells adenovirally transfected with B7.1 and Il 12?; Melanoma Research 10: 313 – 322

 

68.   KAMARASHEV J, FERRONE S, SEIFERT B, BÖNI R, NESTLE FO, BURG G, DUMMER R (2001); TAP1 Down-regulation in primary melanoma lesions: an independent marker of poor prognosis; Int J Cancer (Pred. Oncol.): 95: 23-28

 

69.   DUMMER R, BÖSCH U; PANIZZON R, BLOCH PH, BURG G (2001); Guideline zur Therapie und Nachsorge des kutanen Melanoms. Nationales Krebsbekämpfungsprogramm der Schweizerischen Krebsliga (SKL) und des Bundesamtes für Gesundheit (BAG); Schweizerische Aerztezeitung 82 (21): 1080 – 1086

 

70.   HOFBAUER GFL, GEERTSEN R, LAINE E, BURG G, DUMMER R (2001)Impact of interferons on the expression of melanoma-associated antigens in melanoma short-term cell cultures; Melanoma Research 11: 213 – 218

 

71.   DUMMER R, BÖSCH U, PANIZZON R, BLOCH PH, BURG G (2001); Swiss Guidelines for the Treatment and Follow-Up of Cutaneous Melanoma; Dermatology 203: 75 - 80 (Special Report)

 

72.   WILLER J, UROSEVIC M, LAINE E, GEERTSCHEN R, KÜNDIG TH, BURG G, DUMMER R (2001); Discreased intraindividual HLA Class I Expression is due to Reduced Transcription in Advance Melanoma and does not correlate with HLA-G Erpession.; J Invest Dermatol 117:1498-1504, 2001

 

73.   SCHNORF M, HELFENSTEN U, BLUM A, ELLWANGER U, GARBE C, BURG G, DUMMER R (2001); Erhebungen zur ‚prätherapeutischen Phase‘ des malignen Melanoms der Haut in der Schweiz in den Jahren 1996 – 1998; Praxis 2001; 90: 2193-2198

 

74.   HOFBAUER GFL, BOENI R, SIMMEN D, MIHIC D, NESTLE FO, BURG G, DUMMER R (2002); Histological, immunological and molecular features of a nasal mucosa primary melanoma associated with nasal melanosis; Melanoma Research 2002, 12, pp. 77-82

 

75.   HEINZERLING L, DUMMER R, PAVLOVIC J, SCHULTZ J, BURG G, MOELLING K (2002); Tumor regression of human and murine melanoma after intratumoral injection of IL-12-encoding plasmid DNA in mice; Experimental Dermatology 2002: 11: 232-240 (Blackwell Munksgaard)

 

76.   KAZAKOV DV, BELOUSOVA I, MUELLER B, PALMEDO G, SAMTSOV A, BURG G, KEMPF W (2002); Primary cutaneous plasmacytoma: a clinicpathological study of two cases with a long-term follow-up and review of the literature; J Cutan Pathol 2002: 29: 244-248 (Blackwell Munkgsgaard)

 

77.   HEINZERLING L M, DUMMER R, PANIZZON R G, BLOCH P H, BARBEZAT R, BURG G (2002); Prevention Campaign against Skin Cancer; Dermatology 2002; 205:229-233

 

78.   BOGDAN I, SMOLLE J, KERL H, BURG G, BOENI R (2003); Melanoma ex naevo: a study of the associated neavus; Melanoma Research 2003, 13; 213-217

 

79.   HAUSCHILD A, WEICHENTHAL M, BALDA BR, BECKER JC, WOLFF HH, TILGEN W, SCHULTE KW, RING J, SCHADENDORF D, LISCHNER S, BURG G, DUMMER R (2003); Prospective Randomized Trial of Interferon Alfa-2b and Interleukin-2 as Adjuvant Treatment for Resected Intermediate- and High-Risk Primary Melanoma Without Clinically Detectable Node Metastasis; Journal of Clinical Oncology 2003: 15; 2883-2888

 

80.   HOFBAUER GF, BURKHART A, SCHULER G, DUMMER R, BURG G, NESTLE FO (2004); High frequency of melanoma-associated antigen or HLA class I loss does not correlate with survival in primary melanoma; J Immunother. 2004: 27; 73-8

 

81.   MEIER S, BAUMERT BG, MAIER T, WELLIS G, BURG G, SEIFERT B, DUMMER R (2004); Survival and Prognostic Factors in Patients with Brain Metastases from Malignant Melanoma; Onkologie 2004; 27:145-149

 

82.   HAFNER J, HESS SCHMID M, KEMPF W, BURG G, KUENZI W, MEULI-SIMMEN C, NEFF P, MEYER V, MIHIC D, GARZOLI E, JUNGIUS K-P., SEIFERT B, DUMMER R, STEINERT H.; Clinical an Laboratory Investigations; Baseline staging in cutaneous malignant melanoma; British Journal of Dermatology 2004; 150: 677-686

 

83.   MURER K, UROSEVIC M, WILLERS J, SELVAM PH, LAINE E, BURG G, DUMMER R (2004); Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients; Melanoma Research 2004; 14: 257 – 262

 

84.   DUMMER R, PANIZZON R., BLOCH P.H., BURG G., on behalf of the task force „Skin Cancer“ (2005); Updated Swiss Guidelines for the Treatment and Follow-Up of Cutaneous Melanoma; Dermatology 2005:210:39-44

 

85.   GERLINI G., TUN-KYI A., DUDLI CH., BURG G., PIMPINELLI N., NESTLE F.O. (2004); Metastatic Melanoma Secreted IL-10; Down-Regulates CD1 Molecules on Dendritic Cells in Metastatic Tumor Lesions; American Journal of Pathology 2004:165:1853-1863

 

86.   HEINZERLING L, BURG G, DUMMER R, MAIER T, OBERHOLZER PA, SCHULTZ J, ELZAOUK L, PAVLOVIC J, MOELLING K (2005); Intratumoral injection of DNA  encoding human interleukin 12 into patients with metastatic melnaoma: clinical efficacy; Human Gene Therapy 2005;16:35-48

 

87.   BURG G, JAFFE E.S, KEMPF W, BERTI E, CERRONI L, CHIMENTI S, DUMMER R, TORO J.R, DIAZ-PEREZ J.L, DUNCAN L, HARRIS N.L, KERL H, KNOBLER R, KURRER M, MEIJER C, PIMPINELLI N, RALFKIAER E, SANDER C, SANTUCCI M, STERRY W, SWERDLOW S.H, WECHSLER J, WHITTAKER S, WILLEMZE R (2006); WHO / EORTC Classification of cutaneous lymphomas;World Health Organization Classification of Tumours; Pathology & Genetics Skin Tumours 2006; 4:168, ISBN 92 832 2414 0

 

88.   PIMPINELLI N, OLSEN E, SANTUCCI M, VONDERHEID E, HAEFFNER A, STEVENS S, BURG G, CERRONI L, DRENO B, GLUSAC E, GUITART J, HEALD P, KEMPF W, KNOBLER R, LESSIN S, SANDER CH, SMOLLER B, TELANG G, WHITTAKER S, IWATSUKI K, OBITZ E, TAKIGAWA M, TURNER M, WOOD G (2005); Defining early mycosis fungoides; Journal of the American Academy of Dermatology 2005;53;1053-1063

 

89.   DUMMER R, MEIER S, BEYELER M, HAFNER J, BURG G (2006); Die aktualisierten schweizerischen Richtlinien zur Behandlung des kutanen Melanoms – wo stehen wir heute?; Schweizerisches Medizin-Forum 2006;6;196-201

 

90.   BEYELER M, WALDISPÜHL S, STROBEL K, JOLLER-JEMELKA H, BURG G,DUMMER R (2006); Detection of melanoma relapse:First comparative analysis on imaging techniques versus S-100 protein; Dermatology 213; 187-191

 

91.   CAVEGN B, PUPPIN D JR, BURG G (1992) ; Kontroversen zum primären Melanom der Haut im Stadium I; Schweiz Med Wschr 122:1883-1888

 

92.   BURG G, ALVERO-JACKSON H, BRAATHEN LR et al (1993); Das primäre maligne Melanom der Haut. Empfehlungen der Schweizer Gesellschaft für Dermatologie und Venerologie zur Diagnostik, Therapie und Nachsorge; Dermatologica Helvetica 187; 2: 22-30

 

93.   BURG G, ALVERO-JACKSON H, BRAATHEN LR ET AL (1993); Das primäre maligne Melanom der Haut; Schweizerische Ärztezeitung 74:1021-1024

 

94.   BURG G (1993); Das maligne Melanom. Perspektiven eines bösartigen Hauttumors; Swiss Med, 15(7);7-14

 

95.   CAVEGN BM, BURG G (1993); Diskussion um den Sicherheitsabstand in der Melanomchirurgie; Therapiewoche Schweiz 9:554-557

 

96.   BURG G, DUMMER R, CAVEGN B, PANIZZON R (1993); Malignes Melanom der Haut; Therapeutische Umschau 50, 12: 822 – 827

 

97.   DUMMER R, DAVIS-DANESHFAR A, DÖHRING CH, DÖBBELING U, BURG G (1995); Strategien zur Gentherapie des Melanoms; Hautarzt 46: 305 – 308

 

98.   DUMMER R, NESTLE FO, HOFBAUER G, BÖNI R, BURG G (1998); Therapie des kutanen Melanoms (Therapy of melanoma); Therapeutische Umschau 55 (8): 509 – 514

 

99.   BURG G (1998); Neue Therapiechancen bei malignem Melanom; Forschung und Praxis 262:10 – 12

 

100.NESTLE FO, BURG G, DUMMER R (1999); New perspectives on immunobiology and immunotherapy of melanoma; Immunology Today 20 (1): 5 – 7

 

101.NESTLE FO, TUN KYI A, GILLIET M, DUMMER R, BURG G (1999); Vakzinationstherapie des malignen Melanoms.; Therap Umschau 56 (6): 334 – 337

 

102.DUMMER R, NESTLE FO, BURG G (2000); Immuntherapie des Melanoms; Dtsch Med Wschr 125: 1240 – 1242

 

103.DUMMER R, BURG G (2000); What's new in the treatment of melanoma?; JEADV 14: 337 – 339

 

104.DUMMER R, HESS SCHMID M, BURG G, HAFNER J (2002); Melanozytäre Nävi und kutanes Melanom; Schweiz. Med Forum Nr. 10 6. März 2002 (224-231)

 

105.GARBE C, BÜTTNER P, BERTZ J, BURG G, D'HOEDT B, DREPPER H, GUGGENMOOS-HOLZMANN I, LECHNER W, LIPPOLD A, ORFANOS CE,: PETRES A, RASSNER G, SCHWERMANN M, STADLER R, STROEBEL W (1990).Die Prognose des primären malignen Melanoms. Eine multizentrische Studie an 5093 Patienten.. In: Orfanos CE, Garbe C (Hrsg): Das maligne Melanom der Haut. S. 41-59. . W. Zuckschwerdt Verlag, München - Bern - Wien - San Francisco

 

106.WOELFER LU, DUMMER R, BECKER JC, TALEGHANI BM, BURG G (1992): Herstellung Tumor-infiltrierender Lymphozyten aus Metastasen von Patienten mit malignen Melanomen. In: G Burg, AA Hartmann, B Konz (Hrsg.): Onkologisches Dermatologie. S 56-62. Springer Verlag, Berlin-Heidelberg-New York

 

107.HÄFFNER AC, GARBE C, BURG G, ORFANOS CE, RASSNER G (1992): Zur Klassifizierung maligner Melanome nach prognostischen Kriterien. In: G Burg, AA Hartmann, B Konz (Hrsg.): Onkologische Dermatologie. S 129-136. Springer Verlag, Berlin-Heidelberg-New York

 

108.KALHAMMER U, MICHAELIS A, DUMMER R, HARTMANN AA, BURG G (1992): DTIC und Interleukin-2 in der Melanomtherapie: Immunparameter im Therapieverlauf. In: G Burg, AA Hartmann, Konz B (Hrsg.): Onkologische Dermatologie, S 153-156. Springer Verlag, Berlin-Heidelberg-New York

 

109.SCHULTZ ES, DUMMER R, MUELLER W, HARTMANN AA, BURG G (1992) Immunmodulation mit Interferon-alpha und Interleukin-2 beim malignen Melanom. In: G Burg, AA Hartmann, B Konz (Hrsg.): Onkologische Dermatologie. S 157-161. Springer Verlag, Berlin-Heidelberg-New York

 

110.DUMMER R, BECKER JC, SCHULZ A, TSCHAMMLER A, HARTMANN AA, BURG G (1992): Interleukin-2 in Combination with Dacarbazine in the treat for Malignant Melanoma. In: M Freund, H Link, RE Schmidt, K Welte (eds.): Cytokines in Hemopoesis, Oncology, and AIDS II, S 729-735. Springer-Verlag, Berlin-Heidelberg-New York-London-Paris-Tokyo-HongKong-Barcelona-Budapest

 

111.BECKER JC, DUMMER R, SCHMIDT RE, BURG G, HARTMANN AA (1992): Characterization of CD3+ and CD56+ Lymphocyte Subsets in Melanoma Patients After In Vivo Recombinant Inteleukin-2 Administration. In: M Freund, H Link, RE Schmidt, K Welte (eds.): Cytokines in Hemopoesis, Oncology, and AIDS II, S 735-746. Springer-Verlag, Berlin-Heidelberg-New York-London

 

112.BURG G, DUMMER R (1994): Maligne Melanome. In: W. Wilmanns, D. Huhn, K. Wilms (eds.): Internistische Onkologie, S. 564-572. Georg Thieme Verlag Stuttgart, New York 1994

 

113.DUMMER R, BÖNI R, YUE F-Y, LAINE E, BURG G (1996): Cytokines in the immune biology of melanoma. In: J.A. Werner, B.M. Lippert, H.H. Rudert (eds): Head and Neck Cancer, Advances in Basic Research. S. 679 - 688 (Sonderdruck). Elsevier Sciences B.V., Amsterdam-Lausanne-New York-Oxford-Shannon-Tokyo

 

114.BÖNI R, STEINERTR, HUCH BÖNI RA, DUMMER R, BURG G, BERTHOLD T, von SCHULTHESS GK (1996): Staging des metastasierenden Melanoms: Vergleich von Ganzkörper-Positronenemissionstomo­graphie (FDG-PET), Ganzkörper-Dopamin-D2-Rezeptor-Szintigraphie und Ganzkörper-Szinti­graphie mit monoklonalen Anti-Melanom-F(ab)2-Antikörperfragmenten.. In: R. Dummer, R. Panizzon, G. Burg (Hrsg.): Fortschritte der operativen und onkologischen Dermatologie, Band 11, S. 143-149. Operative und konservative Dermatoonkologie im interdisziplinären Grenzbereich. Blackwell Wissenschaftsverlag Berlin-Wien

 

115.BÖNI R, STEINERT H, HUCH BÖNI RA, MEYER J, DUMMER R,FRÜH H,  BURG G, WESTERA G (1996): Radiojod-markiertes Alpha-Methyltyroxin beim Staging des malignen Melanoms: In vitro-Studien und erste Anwendung bei Patienten. . In: R. Dummer, R. Panizzon, G. Burg (Hrsg.): Fortschritte der operativen und onkologischen Dermatologie, Band 11, S. 150-151. Operative und konservative Dermatoonkologie im interdisziplinären Grenzbereich. Blackwell Wissenschaftsverlag Berlin-Wien

 

116.DUMMER R, BÖNI R, DÖBBELING U, NESTLE F, BURG G (1996): Melanomtherapie-nach der Exzision beginnt die immunologische Evaluation.. In: R. Dummer, R. Panizzon, G. Burg (Hrsg.): Fortschritte der operativen und onkologischen Dermatologie, Band 11, S.189-193. Operative und konservative Dermatoonkologie im interdisziplinären Grenzbereich. Blackwell Wissenschaftsverlag Berlin-Wien 1996

 

117.BECKER JC, DUMMER R, HARTMANN AA, BURG G (1992): Charakterisierung Tumor-infiltrierender Lymphozyten in primären Melanomen. In: G Burg, AA Hartmann, B Konz (Hrsg.): Onkologische Dermatologie. S 49-55. Springer Verlag Berlin Heidelberg New York 1992

 

118.BURG G (1998): Nationales Krebs-Bekämpfungsprogramm (NKBP). Hautkrebs: das maligne Melanom Fakten und Handlungsbedarf. S. 28 – 31. G. Burg (Hrsg.); BAG und SKL (franz. Uebersetzung: Dr. Jann Lübbe)

 

119.DUMMER R, HÄFFNER AC, BURG G (1999): Therapeutischer Einsatz von Interleukin-2 beim Melanom, S. 504 – 506. In: A. Plettenberg, W.N. Meigel, I. Moll (Hrsg.): Dermatologie an der Schwelle zum neuen Jahrtausend . Aktueller Stand von Klinik und Forschung. Springer Verlag Berlin, Heidelberg, New York

 

120.HEINZERLING L, PAVLOVIC J, SCHULTZ J, DUMMER R, BURG G, MOELLING K (1999): Wachstumsverzögerung und Rückbildung von Melanomen in vivo durch Therapie mit IL-12, S. 510 – 514. In: A. Plettenberg, W.N. Meigel, I. Moll (Hrsg.): Dermatologie an der Schwelle zum neuen Jahrtausend . Aktueller Stand von Klinik und Forschung. Springer Verlag Berlin, Heidelberg, New York

 

121.DUMMER R, KAMARASHEV J, BURG G (1999): Melanoma. In:  G. Burg (Hrsg): Atlas of Cancer of the Skin, S. 38 - 67 . Churchill Livingstone, New York

 

122.RUEBBEN A, BOGDAN I, GRUSSENDORF-CONEN E-I, BURG G, BOENI R (2002) : Loss of Heterozygosity and Microsatellite Instability in Acquired Melanocytic Nevi: Towards a Molecular Definition of the Dysplastic Nevus. (Buch) Cancers of the Skin / Proceedings of the 8th World Congress (S 100 - 110)

 

Malum perforans, neuropathische Erkrankungen

 

1.     BURG G, BURG D (1993): Neurotrophe Ulzera; In: Venenleiden und Haut; E. Schöpf, J. Staubesand (Hrsg), Kagerer Kommunikation; Vasomed, S. 61-76

 

2.     BURG G, BURG D (1990): Das Bureau-Barrière-Syndrom ; Phlebol Proktol 19:147-152

 

3.     BURG G, BURG D (1993); Neurotrophe Ulzera; In: Venenleiden und Haut; E. Schöpf, J. Staubesand (Hrsg), Kagerer Kommunikation; Vasomed, S. 61-76

 

4.     ALLMANN K.-H, LEU H, BURG G, HODLER J (1996); Hereditary sensory and autonomic neuropathy type I (Thévenard’s disease); Skeletal Radiol 25: 501 – 504

 

5.     FRITZ T, BURG G, BÖNI R (2000); Carpal Tunnel Syndrome with Ulcerous Skin Lesions; Dermatology 201: 165 – 167

 

6.     KREYDEN O.PH, HAFNER J, BURG G, NESTLE FO (2001); Fallbericht zur Therapie mit Granulozyten stimulierendem Faktor beim diabetischem Fuss; Hautarzt 52: 327 – 330

 

7.     BURG G, BURG D (1995); Hautsymptome bei neurologischen Erkrankungen (Skin symptoms in neurologic diseases); Ther Umschau 52; 4: 243-250

 

8.     HAFNER J, BURG G (1999); Dermatologische Aspekte zur Prävention und Therapie des diabetischen Fuss-Syndroms; Praxis 88: 1170 – 1177

 

9.     BURG G, BURG D (1983): Dermatosen durch Neuropathien. In: O. Braun-Falco und G. Burg (Hrsg.): Fortschritte der praktischen Dermatologie und Venero­logie Bd. 10, S 28-35. Springer Verlag, Berlin-Heidelberg-New York

 

10.   BURG G, BURG D (1986): Neurotrophic ulcers of palms and soles. In: A. Kansky (Hrg.): Dermatologic Lesions of Palms and Soles, S. 251-258. School of Medicine University Zagreb

 

11.   BURG G, BURG D (1992): Haut und Nervensystem. In: W Gerok, E Hartmann, H-P Schuster (Hrsg.): Innere Medizin der Gegenwart. Bd 12: DE Pongratz (Hrsg) Klinische Neurologie, S 678-686. Urban & Schwarzenberg, München, Wien, Baltimore

 

12.   BURG G, DUMMER R, SCHMID MH, FELLER A (1993): B-cell lymphomas and B-cell pseudolymphomas. In: W.H.C. Burgdorf, S.I. Katz (eds.): Dermatology, Progress & Perspectives. The Proceedings of the 18th World Congress of Dermatology. The Parthenon Publisher Group, New York, Casterton, London 1993, p 618-621

 

13.   BURG G (1994): Ulcere neuropatiche / Dermatologia e i suoi Limitrofi. 31° Congresso Nazionale Associazione Dermatologi Ospedalieri Italiani. Merano, 28.-31. Ottobre 1992 (Kongressbuch: Erschienen VII n. 2 Maggio 1994, S. 89-90)

 

14.   BURG G (1994): Ulcere neuropatiche / Dermatologia e i suoi Limitrofi. 31° Congresso Nazionale Associazione Dermatologi Ospedalieri Italiani. Merano, 28.-31. Ottobre 1992. (Kongressbuch: Erschienen VII n. 2 Maggio 1994, S. 89-90)

 

15.   BURG D, PONGRATZ D, BURG G (1995): Hereditary sensory and autonomic neuropathies - classification and clinical characteristics. In: A.K. Asbury, H. Budka, E. Sluga (eds.): Sensory Neuropathies, S. 57 – 73. Springer-Verlag Berlin-Heidelberg

 

 

 

Mohs Chemosurgery

 

1.     BURG G (1972): Chemochirurgische Behandlung; Ärztl Praxis XXIV, Nr. 45: S. 2453

 

2.     BURG G, HIRSCH RD, KONZ B, BRAUN-FALCO O (1975) : Histographic surgery: accuracy of the visual assessment of the margins of basal-cell epithelioma; J Derm Surg 1: 21-24

 

3.     BURG G, HIRSCH RD (1977) : Verbesserte Prognose maligner Hauttumoren durch mikroskopisch kontrollierte Chirurgie; Therapiewoche 27: 7364-7376

 

4.     HAFNER J, SCHÜTZ K, MORGENTHALER W, STEIGER E, MEYER V, BURG G (1999); Micrographic Surgery ('Slow Mohs') in Cutaneous Sarcomas; Dermatology 1999; 198: 37 – 43

 

5.     BURG G, ROBINS P (1972) ; Chemochirurgie. Chirurgische Entfernung chemisch fixierten Tumorgewebes mit mikroskopi­scher Kontrolle; Hautarzt 23: 16-20

 

6.     BURG G, BRAUN-FALCO O (1973) ; Chemochirurgie des Basalioms; Dtsch Ärztebl 70: 2303-2312

 

7.     BURG G, KONZ B, BRAUN-FALCO O (1975) ; Mikroskopisch kontrollierte Chirurgie (MKC) des Basalioms ; Therapiewoche 25: 2865-2874

 

8.     BURG G, DORN M (1976); Chemochirurgie des Basalioms; Hautarzt, Suppl I: 31-33

 

9.     HAFNER J, HESS SCHMID M, KEMPF W, BURG G (2002); Mikrografische Chirurgie von Hauttumoren (Symposium ‚Dermatochirurgie für die Praxis’ vom 17. Januar 2002, Universität Zürich-Irchel); medicos 2/2002

 

10.   BREUNINGER H, KONZ B, BURG G (2007); Mikroskopisch kontrollierte Chirurgie bei malignen Hauttumoren; Dtsch Ärztebl 104 (7), 427-432

 

11.   BURG G, KONZ B (1975): Mikroskopisch kontrollierte Basaliombehandlung im Gesichtsbereich. Kongreßband der 5. Tagung d. Vereinigung d. Deutschen Plastischen Chirurgen, S. 147-156. Hrsg.: H. Bohmert . Thieme Verlag, Stuttgart

 

12.   BURG G (1975): Mikroskopisch kontrollierte (histographische) Chirurgie des Basalioms. In: O. Braun-Falco, S. Marghescu (Hrsg.): Fortschritte d. prakt. Dermatologie und Venerologie, S.69-78. Springer, Berlin-Heidelberg-New York

 

13.   BURG G (1977) Mikroskopisch kontrollierte (histographische) Chirurgie. In: B. Konz, G. Burg (Hrsg.): Dermatochirurgie in Klinik und Praxis. S. 72-82. Springer, Berlin-Heidelberg-New York

 

14.   ROBINS P, BURG G (1977): Klinische Bedeutung der mikroskopisch kontrollierten Chirurgie. In: B. Konz, G. Burg (Hrsg.): Dermatochirurgie in Klinik und Praxis. S. 83-88. Springer, Berlin-Heidelberg-New York

 

15.   BURG G, KONZ B, WEISSMANN I, BÖNNINGER-BECKERS F (1981): Mikroskopisch kontrollierte (histographische) Chirurgie der Basaliome nach Mohs: Methode und Indikationen. In: F. Eichmann, U.W. Schnyder (Hrsg.): Das Basaliom, S. 113-120. Springer Verlag, Berlin-Heidelberg-New YorkWEISSMANN

 

16.   I, KONZ B, BURG G, BÖNNINGER-BECKERS F (1981): Mikroskopisch kontrollierte (histographische) Chirurgie der Basaliome: Operatives Vorgehen und Behandlungsergebnisse. In: F. Eichmann, U.W. Schnyder (Hrsg.): Das Basaliom, S. 121-128. Springer Verlag, Berlin-Heidelberg-New York

 

17.   HAFNER J, SCHÜTZ K, MORGENTHALER W, STEIGER E, MÜLLER B, BURG G (1999): Mikrographische Chirurgie bei kutanen Sarkomen. S. 267 – 273. In: R. Rompel, J. Petres (Hrsg.) Operative onkologische Dermatologie. Springer Verlag Berlin Heidelberg New York 1999 (ISBN 3.540-65216-7)

 

Transplantations-Dermatosen

 

1.     HOFBAUER GFL, DUMMER R, HAFNER J, BURG G, BINSWANGER U, KEMPF W (2001); Skin Cancers in Organ Transplant Recipients: Two Cases of Virus-Induced Neoplasms; Dermatology 202: 359 – 361

 

2.     DRAGIEVA G, KEMPF W, BURG G, HESS M, SCHÄRER L, KETTELHACK N, PRINZ BM, DUMMER R, HAFNER J (2003); Hautveränderungen bei organtransplantierten, immunsupprimierten Patienten; HAUT 5/2003; Band XIV:172-180

 

3.     DRAGIEVA G, KEMPF W, BURG G, HESS M, SCHÄRER L, KETTELHACK N, PRINZ BM, DUMMER R, HAFNER J (2003); Hautveränderungen bei organtransplantierten, immunsupprimierten Patienten; Haut 2003; XIV: 172

 

4.     KEMPF W, DUMMER R, HOFBAUER G,BINSWANGER U, BURG G (2006); Hautveränderungen bei Transplantatempfängern; Dtsch Artebl 2006; 103(34-35):A 2245-9

 

5.     BREUNINGER H, KONZ B, BURG G (2007): Mikroskopisch kontrollierte Chirurgie bei malignen Hauttumoren. Dtsch Ärztebl 104 (7), 427-432

 

 

 

Porphyrien

 

1.     BURG G (1969); Protoporphyrinämische Lichtdermatose unter dem Bild der Hidroa aestivalia;Dtsch Med Wschr 94: 1319-1325

 

2.     BURG G (1970): Erythropoetische protoporphyrinämische Lichtdermatose; Dtsch med Wschr 95: 1120-1123

 

3.     BRAUN-FALCO O, BURG G, SCHMIDT D (1970):Protoporphyrinämische Lichtdermatose vom Typ des Quinckeschen Ödems ; Münch Med Wschr 112: 1443-1447

 

4.     BURG G, PLEWIG G (1972): Saisonaler Pruritus als Symptom der erythropoetischen protoporphyrinämischen Lichtdermatose (EPL); Hautarzt 23: 553-555

 

5.     BURG G, ZOLLER W, STRASSNER C, DOSS M (1988): Erythrozytopherese zur Behandlung der Porphyria cutanea tarda; Hautarzt 39, S VIII: 300-302

 

6.     ZOLLER WG, BURG G (1989) : Therapie der Porphyria cutanea tarda: Erste Ergebnisse der Erythrozytoapherese; Der Kassenarzt 9: 42-47

 

7.     SCHNEIDER-YIN X, SCHÄFER BW, MÖHR P, BURG G, MINDER EI (1994); Molecular defects in erythropoietic protoporphyria with terminal liver failure; Hum Genet 93: 711-713

 

8.     BURG G (1971); Die Therapie der Porphyrien; Dtsch med Wschr 96: 914-915

 

9.     HAFNER J, MÜLLER B, BURG G (1997); Mikrographische Chirurgie mit der Randstreifenmethode am Paraffinschnitt (Tübinger Torte, 3D-Histologie); 78. Jahresversammlung der SGDV, Genf, 19.-21.09.1996; Dermatologica Helvetica 16-18 (Nouvelles de cliniques)

 

STI/Anogenital

 

1.     HACKEL H, HARTMANN AA, ELSNER P, BURG G (1990): Prevalence of Ureaplasma urealyticum in the Urethra of Men without Urethritis in Relation to Clinical Diagnosis; Dermatologica 180: 76-78

 

2.     ELSNER P, HARTMANN AA, BURG G (1990): Erfahrungen mit der Oxytetracyclin-Therapie der nicht-gonorrhoischen Urethritis durch Ureaplasma urealyticum; Hautarzt 41: 94-97

 

3.     HARTMANN AA, ELSNER P, BURG G (1991): Intravenous Single-Dose Ceftriaxone Treatment of Chancroid1; Dermatologica 183:132-135

 

4.     HACKEL H, HARTMANN AA, BURG G (1991): Vulvitis granulomatosa and Anoperineitis granulomatosa; Dermatologica 182:128-131

 

5.     GOLDSTEIN RK, BASTIAN BA, ELSNER P, BURG G (1991): Giant lichenification of the vulva with marked ulcerations. A case report; J Reprod Med 36:309-311

 

6.     NESTLE FO, TRÜEB RM, BURG G (1997); Korymbiformes Syphilid bei einem HIV-positiven Patienten; H+G 9 (72): 681- 684

 

7.     HACKEL H, HARTMANN AA, ELSNER P, MARTIUS J, ENGEL C, BURG G (1991); Stellenwert der Gardnerella-vaginalis-Kultur bei  BV-Score-gesicherter bakterieller Vaginose; Hautarzt 42:173-175

 

8.     Burg G (2011): History of sexually transmitted Infections. G ITAL DERMATOL VENEREOL 2012;147-

 

9.     BURG G (1975) : Die Therapie der Porphyrien. In: Hrsg.: H. Hornborstel, W. Kaufmann, W. Siegenthaler (Hrsg.): 1971 Aktuelle Diagnostik, Aktuelle Therapie. Thieme Verlag, Stuttgart

 

Viren, Herpes, HIV

 

1.     KÄMPGEN E, BURG G, WANK R (1988) : Association of Herpes simplex Virus-Induced Erythema multiforme with the Human Leukocyte Antigen DQw3; Arch Dermatol 124: 1372-1375KEMPF W, ADAMS V, KLEINHANS M, BURG G, PANIZZON RG, CAMPADELLI-FIUME G, NESTLE FO (1999): Pityriasis Rosea Is Not Associated With Human Herpesvirus 7; Arch Dermatol 135: 1070-1072

 

2.     KEMPF W, BURG G (2000); Pityriasis rosea – a virus-induced skin disease? An update; Arch Virol 145: 1509 – 1520

 

3.     BURG G, VON DER HELM D, KAUDEWITZ P, KLEPZIG K, BRAUN-FALCO O (1988) : Antihuman T-cell leukemia/lymphoma virus antibodies in three patients with primary cutaneous B-cell lymphoma; J Dermatol Surg Oncol 14: 653-656

 

4.     BURG G, VON DER HELM D, KAUDEWITZ P, KLEPZIG K, BRAUN-FALCO O (1988) : Antihuman T-cell leukemia/lymphoma virus antibodies in three patients with primary cutaneous B-cell lymphoma; J Dermatol Surg Oncol 14: 653-656

 

5.     KEMPF W, KADIN ME, KUTZNER H, LORD CL, BURG G, LETVIN NL, KORALNIK IL (2001); Lymphomatoid papulosis and human herpesviruses - A PCR-based evaluation for the presence of human herpesvirus 6, 7 and 8 and related herpesviruses; J Cutan Pathol 28: 29 – 33

 

6.     MICHAELIS S, KAZAKOV D, SCHMID M, DUMMER R, BURG G, KEMPF W (2003); Hepatitis C and G viruses in B-cell lymphomas of the skin ; J Cutan Pathol 2003: 30; 369-372

 

7.     KEMPF W, PERNICIARO C, ADAMS V, MUELLER B, BURG G (1999); Human herpesvirus 8 (HHV-8) in familial Kaposi's sarcoma; Exp Dermatol 8: 68 – 70

 

8.     KEMPF W, KADIN ME, DVORAK AM, LORD CC, BURG G, LETVIN NL. KORALNIK IJ (2003); Endogenous retroviral elements, but not exogenous retroviruses, are detected in CD30-positive lymphoproliferative disorders of the skin; Carcinogenesis 2003: 24; 301-6

 

9.     DUMMER R., HASSEL J.C., FELLENBERG F., EICHMÜLLER ST., MAIER T., SLOS PH., ACRES B., BLEUZEN P., BATAILLE V., SQUIBAN P., BURG G.,; UROSEVIC M (2004); Adenovirus-mediated intralesional interferon-g gene transfer induces tumor regressions in cutaneous lymphomas; Blood 2004; 104: 1631 – 1638

 

10.   KEMPF W, KAZAKOV DV, BURG G (2001); Applications of Molecular Virology to Modern;    Dermatopathology; Current Topics in Pathology 94: 40 – 47

 

11.   CARROZZA PM, MERLANI GM, BURG G, HAFNER J (2002); CO(2) laser surgery for extensive, cualiflower-like anogenital condylomata acuminata: restrospective long-term study on 19 HIV-positive and 45 HIV-negaitve men; Dermatology 2002: 205; 255-9

 

12.   SCHRANER CH., HASSE B., HASSE U., BAUMANN D., FAEH A., BURG G., GRIMM F., MATHIS A., WEBER R., GÜNTHARD H.F. (2005); Successful Treatment with Miltefosine of Disseminated Cutaneous Leishmaniasis in a Severely Immunocopromised Patient Infected with HIV-1; Clinical Infectious Diseases 2005:40:e120-4

13.   KEMPF W, KAZAKOV DV, BURG G (2001); Applications of Molecular Virology to Modern Dermatopathology; Current Topics in Pathology 94: 40 – 47

14.   KmokokkpkpkpkkKEMPF W, KAZAKOV D, BURG G (2001): Applications of Molecular Virology to Modern Dermatopathology; P 39 – 48.In: R. Cerio (Hrsg): Dermatopathology . Springer Verlag Heidelberg

 

15.   KEMPF W, BURG G (2003): Die Rolle onkogener Herpesviren in der Dermatologie. In: G. Plewig, J. Prinz (Hrsg.): Fortschritte der praktischen Dermatologie und Venerologie 2002. Springer Verlag Heidelberg

 

 

 

 

 

B Monographien/Themenhefte/Broschüren/Medienpublikationen (Autor/Herausgeber)

 

 

 

1.     BURG G, GEISEL G: Examensfragen Dermatologie. 1. Und 2. Aufl.; 3. Aufl. 1975 zus.m. G. Geissl, W. Müller, Th. Nasemann, W. Schmidt, W. Adam; 4. Aufl. 1979 zus.m. R. Kolz, G. Lonsdorf. Portugiesische Ausgabe: Dermatologia: Questoes de atualizacao e revisao (L.H. Camargo Paschoal), Sao Paulo, 1981

 

2.     BURG G: Examina medica-visuell. Dermatologie I. Farbdia-Sammlung, München: J.F. Lehmanns Verlag 1970

 

3.     BURG G, ROBINS P: Chemochirurgie. Technik und Anwendung (Chemosurgery. Technique and Application). Wissenschaftlicher Film (2O'). Englische und deutsche Fassungen. München/Regensburg (Studio Sorgend) 1972

 

4.     BURG G, BRAUN-FALCO O: Cytochemical differentiation of inflammatory cells. Exposé zur wissenschaftlichen Ausstellung,. XIV. Congressus Internationalis Dermatologiae. Venedig 22.-27. Mai 1972

 

5.     BURG G, BRAUN-FALCO O: Erkrankungen des retikulohistiozytären Systems (RHS) der Haut. Exposé zur wissenschaftlichen Ausstellung. 30. Tagung der Deutschen Dermatologischen Gesellschaft. Graz, 10.-14. Sept. 1974

 

6.     BURG G (Guest Editor): The Journal of Dermatologic Surgery 1/3, 1975. Surgical edition S. 1-84

 

7.     BURG G, BRAUN-FALCO O, SCHMOECKEL C, WOLFF HH: Fortschritte in der Diagnostik kutaner Lymphome. Exposé zur Wiss. Ausstellung.. VIII. Fortbildungswoche für praktische Dermatologie und Venerologie, München 26.-30. Juli 1976

 

8.     BRAUN-FALCO O, WOLFF HH, BURG G (Hrsg): Dia-Klinik. VIII. Fortbildungswoche für praktische Dermatologie und Venerologie, München 26.-30. Juli 1976

 

9.     KONZ B, BURG G: Dermatochirurgie in Klinik und Praxis. Springer Verlag, Berlin-Heidelberg-New York 1977. 238 Seiten, 144 Abbildungen

 

10.   BURG G, KERL H, BRAUN-FALCO O, SCHMOECKEL C, WOLFF HH, KRESBACH H: Morphological and functional typing of lymphoma cutis. International Dermatopathology Symposium, München,. 16.-18. Juni 1978; 78 Seiten, 38 Abbildungen

 

11.   KRESBACH H, Kerl H, BRAUN-FALCO O (Hrsg.) BURG G (Mitarb.): Retikulosen und Lymphome der Haut aus heutiger Sicht. Hautarzt 29, Suppl. III. Springer Verlag, Berlin-. Heidelberg-New York 1978; 108 Seiten, 88 Abbildungen

 

12.   RING J, BURG G (eds): New Trends in Allergy I. 333 Seiten, 106 Abbildungen. Springer Verlag, Berlin-Heidelberg, New York 1981

 

13.   BURG G, BRAUN-FALCO O: In cooperation with: Kerl H, Leder LD, Schmoeckel C, Wolf HH, Leider M. Cutaneous lymphomas, Pseudolymphomas and Related Disorders. A textatlas covering clinical, histological, cytochemical, immunological and finestructural features. 543 Seiten, 615 Abbldg. Springer Verlag, Berlin-Heidelberg-New York, Tokyo 1983

 

14.   BRAUN-FALCO O, BURG G (Hrsg.): Fortschritte der praktischen Dermatologie und Venerologie. 10. Band. 534 Seiten, 176 Abbildungen. Springer Verlag, Berlin-Heidelberg-New York 1983

15.   HUHN D, BURG G, EMMERICH B, FINK U, HILLER E, ROLOFF R, SIEGERT W, THEML H, THIEL E: Maligne Lymphome. Empfehlungen zur Diagnostik, Therapie und Nachsorge. Schriftenreihe des Tumorzentrums München, 1983

16.   BURG G (Guest Editor): Special Issue: Cutaneous B-Cell Lymphomas. J Dermatol Surg Oncol 10:245-318, 1984

17.   RING J, BURG G (eds): New Trends in Allergy II. 361 Seiten, 105 Abbildungen, 71 Tabellen. Springer Berlin, Heidelberg, New York, London, Paris, Tokyo 1986

18.   BURG G: Kutane Lymphome. 48 Seiten, 18 Abbildungen. EORTC-Projektgruppe / BMFT-Feldstudie Juli 1986

19.   BURG G, GEORGII A, GOLLHAUSEN R, PRZYBILLA B (1987) : Publikationen der Dermatologischen Klinik der LMU . München 1967-1986. Selbstverlag München 1987

20.   BURG G und Mitarbeiter der Klinik (Eds): Chronik der Dermatologischen Klinik und Poliklinik der Ludwig-Maximilians-Universität München 1967-1987. Festschrift anläßlich des 65. Geburtstages von Prof. Dr.med.Dr.h.c.Otto Braun-Falco. Selbstverlag München 1987

21.   BURG G, EMMERICH B, ENNE W, GERHARTZ H, HILLER E, PERMANETTER W, ROHLOFF R, THIEL E (Eds): Maligne Lymphome: Empfehlungen zur Diagnostik, Therapie und Nachsorge. Schriftenreihe des Tumorzentrums München, 3. völlig neu bearbeitete Auflage 1987

22.   BORELLI S, BRAUN-FALCO O, BREIT R, BREIT K, BURG G, EHRENBERG I, LOCHER W, MAIER R, RING J, VIELUF D (Hrsg): Geschichte der Dermatologie und Venerologie in München. Grosse Verlag, Berlin 1988

 

23.   BRAUN-FALCO O, BURG G, LANDTHALER M, BORELLI S, REMY W, BREIT R, MACIEJEWSKI W (Hrsg): Dia-Klinik 35. Tagung der DDG; 27. April - 1. Mai 1988. München, Derma-Service, Essex

 

24.   BURG G (Hrsg): Dermatologie. Entwicklungen und Beziehung zu anderen Fachgebieten. 441 Seiten, 72 Abbldg.. Urban & Schwarzenberg-Verlag, München, Wien, Baltimore 1988

 

25.   BURG G, ELSNER P, HARTMANN AA: Der Ekzempatient in der Praxis. Walter de Gruyter, Berlin, New York 1990

 

26.   BURG G, KUNZE J, PONGRATZ D, SCHEURLEN PG, SCHINZEL A, SPRANGER J (Hrsg): Leiber: Die klinischen Syndrome.Syndrome, Sequenzen und Symptomenkomplexe. 7. Aufl; Urban & Schwarzenberg, München, Wien, Baltimore 1990

 

27.   KERL H, BURG G (eds): Cutaneous Lymphomas and Pseudolymphomas. Seminars in Diagnostic Pathology. 8:53-124 (1991)

 

28.   BURG G, HARTMANN AA, KONZ B: Onkologische Dermatologie. Neue Aspekte/Altersbedingte Besonderheiten. Springer Verlag Berlin, Heidelberg, New York, London, Paris, Tokyo, Hong Kong, Barcelona, Budapest 1992

 

29.   BURG G: Das Melanom. Wissenswertes über Muttermal, Sonne und andere Risikofaktoren. Informationen und Ratschläge. R. Piper GmbH & Co. KG, München. VCH Verlagsgesellschaft mbH, Weinheim 1993

 

30.   BURG G, KERL H, THIERS B (eds): Cutaneous Lymphomas.. Dermatologic Clinics.. W.B. Saunders Company, Philadelphia, London, Toronto, Montreal, Sidney, Tokyo (1993).

 

31.   BURG G, KERL H (Hrsg.): Praktisch wichtige Dermatosen. Therapeutische Umschau, Sonderheft 52:221-287. Verlag Hans Huber, Bern, Göttingen, Toronto, Seattle, 1995

 

32.   BURG G, DUMMER RG (eds.): Strategies for Immunointerventions in Dermatology. Springer-Verlag Berlin, Heidelberg, New York, 1997

 

33.   BECKER DH, BURG G, LANZIUS D, MEAUME S, STARK GB, STERRY W, TEOT L, WERNER KG, WOLFF K (eds.): Handlungsleitlinien für die ambulante Behandlung chronischer Wunden und Verbrennungen (163 Seiten). Compliance Netzwerk Aerzte / HFI e.V.. Blackwell Wissenschafts-Verlag GmbH, Berlin, 1998

 

34.   DUMMER R, PANIZZON R, BURG G (Hrsg.)(1998): Physikalische Therapie in der Dermatologie. Blackwell Wissenschafts-Verlag Berlin-Wien

 

35.   BURG G, DUMMER R (Hrsg.) (1999): Malignes Melanom. Verlag Hans Huber, Bern, Göttingen, Toronto, Seattle. Therapeutische Umschau, 56 (6): 283 – 348

 

36.   BENBOW M, BURG G, CAMACHO MARTINEZ F, ERIKSSON E, FLOUR M, MEAUME S, MOFFATT CJ, NEUMANN HAM, RODEHEAVER GT, ROMANELLI M, STARK GB, TEOT L, WERNER KG, WOLFF K (eds.) (1999): Guidelines for the Outpatient Treatment of Chronic Wounds and Burns (p 1 - 168). In: Compliance Network Physicians/Health Force Initiative. Blackwell Science Berlin - Vienna - Oxford etc.

 

37.   BURG G, LEBOIT PH (eds), KEMPF W, MÜLLER B (co-eds)(2001): Cutaneous Lymphomas. Unusual Cases. Steinkopff-Verlag Darmstadt (ISBN 3-7985-1250-7

 

38.   NESTLE FO, DUMMER R (Hrsg.) (2001): 85 Jahre Universitätsklinik für die Dermatologie und Venerologie. Zürich (1916-2001).. Eine Bilanz der letzten 10 Jahre anlässlich des 60. Geburtstages von Herrn Prof. Dr. G. Burg.. Steinkopff Verlag Darmstadt

 

39.   BURG G, GEIGES M (2001): Die Haut, in der wir leben. Zu Markt getragen und zur Schau gestellt. . Rüffer & Rub Sachbuchverlag, Zürich

 

40.   DUMMER R, NESTLE F O, BURG G (2002): Cancers of the Skin – Proceedings of the th World Congress. Springer Verlag, Berlin / Heidelberg / New York

 

41.   BURG G, KREYDEN O P, BOENI R (2002): Hyperhidrosis and Botulinum Toxin in Dermatology. Karger Verlag

 

42.   BURG G (2003): Telemedicine and Teledermatology. Karger Verlag

 

43.   BURG G (2000): Atlas of Cancer of the Skin. Churchill Livingstone – New York, Edinburgh, London, Madrid, Melbourne, San Francisco, Tokyo

 

44.   DUMMER R, PANIZZON R, BURG G (Hrsg.) (1996): Operative und konservative Dermatoonkologie im interdisziplinären Grenzbereich. Fortschritte der operativen und onkologischen Dermatologie, Band 11. Blackwell Wissenschafts-Verlag Berlin, Wien, etc.

 

45.   ADLER G, BURG G, KUNZE J, PONGRATZ D, SCHINZEL A, SPRANGER J (Hrsg.) (1996): Leiber, Die klinischen Syndrome. Krankheitsbilder. Syndrome, Sequenzen und Symptomkomplexe. Band 1. 8. Aufl. Urban & Schwarzenberg München – Wien – Baltimore

 

46.   ADLER G, BURG G, KUNZE J, PONGRATZ D, SCHINZEL A, SPRANGER J (Hrsg.) (1997): CD-ROM: Syndrome, Sequenzen und Symptomkomplexe. Leiber, Die klinischen Syndrome, Band 1. Urban & Schwarzenberg München – Wien – Baltimore

 

47.   BURG G, MUELLER, DUMMER R, KEMPF W, KAMARASHEV J, ROHR, NEOCORTEX FOUNDATION: CD-ROM: Virtual Microscope. Cutaneous Lymphoma. Hans Huber Publishers Bern Göttingen Toronto Seattle

 

48   BURG G, MUELLER, GRAF M, KEMPF W (2001): CD-ROM: Club Unna Darier. Collegium Dermatopathologicum, September 1-3, Zürich 2000

 

49.   BURG G, KEMPF W (2005): Cutaneous Lymphomas. Taylor & Francis Group – Boca Raton,  FL

 

50.   LEBOIT PH.E, BURG G, WEEDON D, SARASIN A (2006): Pathology & Genetics Skin Tumours. World Health Organization Classification of Tumours – Lyon 2006. ISBN 92 832 2414 0

 

51.   BURG G, GEIGES M (Eds.) (2006): Rundum Haut. Verlag Rüffer & Rub, Zürich. ISBN (10) 3-907625-24-2. ISBN (13) 978-3-907625-24-8

 

52.   BURG G, KEMPF W, MICHAELIS, FEITH J (Eds.) (2006): Cutaneous Lymphomas. Unusual Cases 2.. Steinkopff Verlag, Darmstadt. ISBN 3-7985-1609-X

 

53.   BURG  G: Von Hippokrates zum E-Learning. Zum Lehren und Lernen in der Medizin. Film anlässlich der 175 Jahrfeier der Universität Zürich, Zürich März 2008. Produktion MELS UniTV, Zürich

 

54.   GÜNTER BURG, PETER SCHMID-GRENDELMEIER, VAHID DJAMEI, LARS FRENCH: DOIT. Dermatology Online with Interactive Technology. Das Webbook zum interaktiven e-Learning Programm. Dermatologie für Studierende der Medizin. www.swisdom.org. Herausgegeben von Günter Burg, Zürich in Zusammenarbeit mit Peter Schmid-Grendelmeier, Vahid Djamei und Lars French, Zürich. Eigenverlag 2012. Amazon

 

 

 

55.   BURG G, KEMPF W, KUTZNER H, FEIT J, KARAI L (2015): Atlas of Dermatopathology. Practical Differential Diagnosis by Clinicopathologic Pattern. Wiley Blackwell, Chichester West Sussex UK. 392 pages

 

56.   BURG G (Founding Ed.) et al. : DOIT. Dermatology Online with Interactive Technology. Undergraduate E-Learning Plattform. www.cyberderm.net.

 

57.   BURG G, GOLLNICK H: Dermokrates. Postgraduate E-Learning Plattform für Weiter- und Fortbildung. www.dermokrates.org

 

58.   BURG G, ITIN P, MCGRATH J: DOIT. Dermatology Online with Interactive Technology. Das englischsprachige Webbook zum interaktiven e-Learning Programm. ABW Eissenschaftsverlag, Berlin  2017

 

 

 

59.   BURG G, KUTZNER H, KEMPF W, FEIT J, Smoller B (2018): Textatlas of Dermatopathology. Tumors, Nevi and Cyxsts. Wiley Blackwell, Chichester West Sussex UK. (To be published in 2018)

 

 

 

C Auftragspublikation

 

1.     JÄGGI M (2004):  In primo loco. Geschichte der Medizinischen Fakultät Zürich 1833-2003.  Rüffer+Rub 2004